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XCL1  XC-chemokine ligand 1 
 
Y   Tyrosine amino acid 
 
ZAP70  ζ(zeta)-chain associated protein kinase of 70 kDa 
 
7-AAD  7-aminoactinomycin D 
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Abstract 
 
While many factors can influence the fate of developing T cells in the thymus, among 
the most influential are the strength and timing of signals transmitted by the T cell 
antigen receptor (TCR). Weak TCR binding to peptide/major histocompatibility complex 
(MHC) ligands induces thymocytes to develop into naïve T cells, a process called 
positive selection. Mechanisms that prevent naïve T cell development are termed 
“negative selection” and include apoptotic deletion and agonist selection into non-naïve 
T cell lineages. Strong TCR binding to pMHC ligands induces negative selection of 
thymocytes. 
 
Thymocytes interact with two broad types of antigen-presenting cells (APCs): bone 
marrow (BM)-derived APCs and thymic epithelial cells (TECs). The traditional view of 
thymic selection is that positive selection occurs in the thymic cortex via interaction with 
TECs, followed by negative selection in the thymic medulla via interaction with BM-
APCs. However, recent studies reveal that thymocytes can undergo either cortical or 
medullary negative selection, which differ in terms of the phenotypes of the thymocytes 
involved and their timing during T cell development. It remains unclear which APC 
types are required to mediate these two negative selection processes, which are called 
“Wave 1” and “Wave 2” of negative selection. In addition, the contributions of MHC 
class I (MHCI) and MHC class II (MHCII) to the two waves are unclear. 
 
To dissect thymic selection, two assays were used in this study. First, the transcription 
factor, Helios, was used in a flow cytometry assay as a marker of negatively selected 
cells, in conjunction with chemokine receptor-7 (CCR7) to distinguish thymocyte 
maturation stages. Apoptosis-defective mice were used to inhibit death of negatively 
selected cells, allowing direct quantification of negative selection. Genetic ablation of 
MHCII expression within BM-APCs or autoimmune regulator (Aire–/–) within TECs was 
used to examine the roles of APC types in thymic selection. Mice lacking expression of 
MHCI and/or MHCII were also examined. Second, a TCR sequencing assay was used 
to examine the characteristics of positively and negatively selected TCR repertoires in 
mice lacking expression of MHCI and/or MHCII.  
 
In TCR transgenic and polyclonal models, MHCII+ BM-APCs were required to induce 
wave 1 negative selection. Ablation of MHCII+ BM-APCs either abrogated negative 
selection completely or delayed negative selection from wave 1 to wave 2. Although 
MHCI and MHCII were found to induce similar frequencies of TCR-signalled 
thymocytes, MHCII was found to make a greater contribution to negative selection than 
MHCI. Sequencing data revealed that TCRs that provoke negative selection at wave 1 
are enriched with hydrophobic amino acids in the region expected to interact with the 
peptide component of pMHC ligands. Interestingly, hydrophobic amino acids are also 
enriched in the same region of TCRs that transmit a signal in mice lacking MHC 
expression. These results provide new insight into the determinants of thymic negative 
selection.  
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General introduction  
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1.1 Function of the thymus 
 
T lymphocytes (or T cells) play an essential role in defending organisms from threats 
such as infectious pathogens or cancerous cells. T cells develop in the thymus. The 
function of the thymus was revealed only about 56 years ago as an organ required for 
the development of immunological competence (Miller, 1961). It is important to produce 
self-tolerant T cells that are not strongly reactive towards self-antigens to prevent 
autoimmune diseases. However, these T cells should be responsive towards foreign 
pathogens to fight against diseases. 
 
During T cell development, developing thymocytes undergo a series of differentiation, 
T cell receptor (TCR) gene arrangement and selection mechanisms. All these 
mechanisms are supported by the thymic microenvironment containing different thymic 
antigen presenting cell (APC) types. Major histocompatibility complex (MHC) restriction 
is part of a crucial process during T cell selection. MHC restriction is defined as the 
obligatory recognition of MHC molecules on the surface of the APC by the TCR on T 
cells. MHC restriction was discovered 43 years ago in an experiment that revealed the 
requirement of virus-specific cytotoxic T cells to recognise antigen together with MHC 
class I in an antiviral response (Zinkernagel and Doherty, 1974).  
 
During the selection process, the TCRs on thymocytes recognise linear self-peptides 
that are bound and presented by MHC molecules on thymic APCs (Davis and 
Bjorkman, 1988). Thymocytes with low TCR affinity for self-peptide-MHC are able to 
differentiate and mature into naïve T cells, a process known as positive selection 
(Germain, 2002; Klein et al., 2014) (Fig. 1.1). The mature T cells are eventually 
exported out of the thymus into the periphery to perform their immune function. 
Thymocytes with high TCR affinity for self-peptide-MHC, also described as self-reactive 
or autoreactive, are eliminated or inhibited in the thymus (Burnet, 1959, 1962) (Fig. 
1.1), in order to acquire central tolerance in the thymus. This process is known as 
negative selection (Klein et al., 2014; Nossal, 1994). Thymocytes bearing non-
functional TCRs or TCRs that are not able to recognise self-peptide-MHC, die by 
neglect (Fig. 1.1) (Hernandez et al., 2010; Surh and Sprent, 1994).  
 
 
1.2 T cell differentiation and proliferation in the thymus 
 
In mice and humans, the thymus can be broadly divided into two anatomical locations: 
the outer cortex and the inner medulla. The area that connects these two locations is   
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Figure 1.1. TCR affinity for self-peptide-MHC dictates thymocyte fate. Low TCR 
affinity or weak TCR interaction with self-peptide-MHC complexes mediates positive 
selection. Positive selection allows the maturation of thymocytes into single positive 
naïve T cells and prevents the thymocytes from dying by neglect. High TCR affinity or 
strong TCR interaction with self-peptide-MHC complexes mediates negative selection. 
Negative selection includes clonal deletion by apoptosis or clonal diversion (also 
known as agonist selection) into Forkhead box P3 transcription factor (FoxP3)+ 
regulatory T (T-reg) cells, precursor of unconventional CD8αα+ intestinal intraepithelial 
T cells (iIEL) or natural killer T (NKT) cells.   
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known as the cortico-medullary junction (CMJ). The thymic cortex contains a network 
of cortical thymic epithelial cells (cTECs) and some bone marrow (BM)-derived antigen 
presenting cells (APCs), including dendritic cells (DCs). The thymic medulla contains a 
network of medullary thymic epithelial cells (mTECs) and the majority of BM-derived 
APCs in the thymus (Barclay and Mayrhofer, 1981; Le Borgne et al., 2009; Raviola and 
Karnovsky, 1972; Takahama, 2006) (Fig. 1.2). CTECs and mTECs are also found in 
human thymus (Gotter et al., 2004; Takahama et al., 2017; Tomaru et al., 2009). 
 
The circulating BM-derived lymphoid progenitors migrate to the thymus via blood 
vessels in the CMJ. Stages of thymocye differentiation can be categorised based on 
the surface expression of CD4 or CD8 molecules in thymocytes in mice and humans 
(Salomon et al., 1994). CD4 or CD8αβ molecules are also known as the coreceptors of 
T cells as they cooperatively bind to MHC molecules when the TCR engages peptide-
MHC complexes. Thymocytes migrate from the thymic cortex to the medulla as they 
mature. Thymocyte differentiation begins with the absence of CD4 and CD8 
coreceptors, known as the immature CD4–CD8– double negative (DN) stage. Within the 
DN thymocytes, four sequential developmental stages were described based on the 
expression of CD44 and CD25: CD44+CD25– (DN1), CD44+CD25+ (DN2), CD44–
CD25+ (DN3) and CD44–CD25– (DN4) (Godfrey et al., 1993). DN thymocytes can give 
rise to T cells that express either αβTCR or γδTCR heterodimers (Germain, 2002). 
 
In both mice and humans, after the DN stage, thymocytes may upregulate both 
coreceptors to become CD4+CD8+ double positive (DP) cells (Fig. 1.2). Some DP 
thymocytes eventually differentiate into mature CD4+CD8– CD4 single positive 
(CD4SP) or CD8+CD4– CD8SP thymocytes (Fig. 1.2) (Salomon et al., 1994). The 
thymic cortex primarily contains DN and DP thymocytes, whereas the thymic medulla 
contains most of the SP thymocytes (Ehrlich et al., 2009; Kurd and Robey, 2016; 
Takahama, 2006; Xing and Hogquist, 2012).  
 
During T cell development, thymocytes undergo up to three phases of proliferation. 
Two phases occur during the pre-selection stage and one during the post-selection 
stage. Also, thymocytes undergo up to two TCR gene rearrangement phases, giving 
rise to the expression of a mature TCR on the thymocyte surface. Two recombination-
activating genes, named RAG1 and RAG2, encoding the RAG1 and RAG2 proteins, 
are essential to cleave double-stranded DNA during the TCR gene rearrangement 
process (McBlane et al., 1995; Mombaerts et al., 1992; Shinkai et al., 1993) (Fig. 1.2). 
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Figure 1.2. αβT cell development in thymus. Thymic progenitor cells derived from 
bone marrow (BM) enter the thymus via blood vessels around the cortico-medullary 
junction (CMJ). Thymocytes undergo several stages of maturation starting as double 
negative (DN), lacking CD4 and CD8 coreceptor expression. DN cells are divided into 
four sequential stages: DN1 (CD44+CD25–), DN2 (CD44+CD25+), DN3 (CD44–CD25+) 
and DN4 (CD44–CD25–). Thymocytes undergo the first proliferation phase during DN1-
DN3 stages. TCRβ gene arrangement commences at the DN2 and completes at the 
DN3 stage. Productive TCRβ chain expression in DN3 cells induces β-selection with 
progression through the DN4 stage and subsequently to the DP stage. During this DN 
to DP transition, thymocytes undergo a second (and largest) proliferative phase and 
also undergo TCRα gene rearrangement. DP cells which express the α and β TCR 
chains are subjected to selection processes. Positively selected DP cells differentiate 
into SP thymocytes and upregulate C-C chemokine receptor type 7 (CCR7). Some SP 
cells undergo a third proliferation phase in the medulla before they egress to the 
periphery.  
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Each pre-selection proliferation phase precedes a distinct phase of TCR gene 
rearrangement. During the DN1 to DN3 stages, thymocytes proliferate through ~2-3 
cell divisions, as revealed by using bromodeoxyuridine (5-bromo-2'-deoxyuridine,  
BrdU), a thymidine analogue, to track cell proliferation in vivo (Pénit et al., 1995). 
Rearrangement of the TCRβ, g and d genes commences at the DN2 stage and 
completes at the DN3 stage (Hayday and Pennington, 2007; Livák et al., 1999; von 
Boehmer, 2004; Yui and Rothenberg, 2014) (Fig. 1.2). Thymocytes with unproductive 
TCR gene rearrangements undergo apoptosis at the DN3 stage (Mandal et al., 2005).  
Thymocytes that express a functional gdTCR at the DN3 stage diverge into the gd T cell 
lineage (Prinz et al., 2006) and migrate out of the thymus to the periphery (Hayday and 
Pennington, 2007). Only 1-5% of T cells expresses γδ TCR (Vantourout and Hayday, 
2013). Thymocytes with a productive TCRβ gene rearrangement, results in the pairing 
of TCRβ chain with an invariant pre-Tα (pTα) chain to form a pre-TCR (von Boehmer, 
2005). The pre-TCR signaling allows the maturation of thymocytes from the DN3 stage 
into the DN4 and DP stages (Hayday and Pennington, 2007), and this process is 
known as β-selection (von Boehmer, 2005). Proliferation during b-selection occurs in 
between two phases of RAG1 and RAG2 expression (Hoffman et al., 1996; Wilson et 
al., 1994). TCRα mRNA molecules were detected in DP “blasts”, i.e. cells with large 
cell diameter, presumably still proliferating during b-selection (Guidos et al., 1990). 
Proliferation during b-selection occurs in the outer cortex (Penit, 1988) and contains the 
largest number of proliferating thymocytes, accounting for 98% of the thymocyte 
proliferation during T cell development (Pénit et al., 1995).  
 
As thymocytes mature from the DN stage to the DP stage, thymocytes upregulate both 
CD4 and CD8 coreceptors to become DP cells, and the RAG1 and RAG2 proteins are 
re-expressed (Hoffman et al., 1996; Wilson et al., 1994). TCRα gene rearrangement 
commences during the DN-DP transition and completes at the DP stage, in which 
heterodimeric αβTCR are expressed on DP cells (Hogquist et al., 2005; Petrie et al., 
1995). DP thymocytes have a life span of approximately 3.5 days to undergo selection 
(Egerton et al., 1990). Within this time frame, DP thymocytes bearing TCRs that are 
unable to recognise self-peptide-MHC complexes presented by cTECs die by neglect 
as they do not receive survival signals to undergo further maturation. It is estimated 
that up to 90% of DP thymocytes undergo death by neglect in the thymic cortex 
(Hernandez et al., 2010; Palmer, 2003). Apoptotic thymocytes in the cortex were found 
to be approximately as abundant in wild-type mice and mice lacking MHC Class I- and 
MHC Class II (Surh and Sprent, 1994). This is consistent with the hypothesis that most 
thymocytes undergo death by neglect.  
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DP thymocytes bearing TCRs that bind weakly to self-peptide-MHC complexes on 
cTECs mature to become CD4SP or CD8SP cells, a process known as positive 
selection (Germain, 2002; Klein et al., 2009). Weak binding between TCRs and 
peptide-MHC Class I (MHCI) complexes positively selects DP thymocytes into MHCI-
restricted CD8+ cytotoxic T cells. CD8+ T cells are responsible for destroying infected 
cells (Germain, 2002). The weak binding between TCRs and peptide-MHC Class II 
(MHCII) complexes positively selects DP thymocytes into MHCII-restricted CD4+ helper 
T cells (Fig. 1.5). CD4+ T cells cooperate with other haematopoetic cells in the immune 
response to infection (Germain, 2002). Not all thymocytes abide by this rule of single 
MHC class restriction. Recent studies reported that some thymocytes are responsive to 
MHCI and also MHCII, termed as MHC class cross-reactive thymocytes (Huseby et al., 
2005; McDonald et al., 2015). In addition, in the absence of both MHC classes and 
both CD4 and CD8 coreceptors, some thymocytes are able to differentiate into CD4SP 
or CD8SP cells (Van Laethem et al., 2007). 
 
Cortical TECs are the only thymic APC type known to mediate positive selection of 
CD4+ and CD8+ T cells (Bill and Palmer, 1989; Cosgrove et al., 1992). MHC expression 
on BM-APCs is not sufficient for the development of SP thymocytes (Brocker et al., 
1997; van Meerwijk et al., 1997). During the commitment of DP thymocytes to the CD4 
or CD8 T cell lineage, DP thymocytes first downregulate both CD4 and CD8 
coreceptors (CD4loCD8lo). Then, the CD4loCD8lo thymocytes upregulate CD4 
coreceptor while still remaining low for CD8 coreceptor, to attain an intermediate 
CD4+CD8lo phenotype. Class II-restricted CD4+CD8lo thymocytes continue to 
downregulate CD8 and become CD4SP (CD4+CD8–) cells, whereas Class I-restricted 
CD4+CD8lo thymocytes reverse expression of their coreceptors to go through further 
intermediary stages (CD4loCD8lo, then CD4loCD8+), before becoming CD8SP (CD4–
CD8+) thymocytes (Fig. 1.3) (Lucas and Germain, 1996). Just before CD4SP or 
CD8SP thymocytes emigrate from the thymus, 2-5% of the SP cells with a mature 
phenotype (TCRβhi CD24– Qa-2hi) undergo the third proliferative burst (Pénit and 
Vasseur, 1997). 
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Figure 1.3. Maturation stages that characterise commitment of DP thymocytes to 
the CD4 or CD8 T cell lineage. DP thymocytes committed to CD4 or CD8 T cell 
lineage first downregulate both the CD4 and CD8 coreceptors (CD4loCD8lo) and then 
upregulate the CD4 coreceptor while still remaining low for the CD8 coreceptor 
(CD4+CD8lo).  DP thymocytes committed to CD4 T cell lineage mature into CD4SP 
(CD4+CD8–) thymocytes. On the other hand, thymocytes committed to CD8 T cell 
lineage downregulate both coreceptors again (CD4loCD8lo), then upregulate the CD8 
coreceptor while still maintaining low CD4 expression (CD8+CD4lo), and finally mature 
into CD8SP (CD8+CD4–) thymocytes. 
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1.3 Generation of TCRs via TCR gene recombination  
 
The TCR is a disulfide-linked heterodimer comprised of either ab or gd chains (Raulet, 
1989). TCR α and γ chains are composed of Variable (V), Joining (J) and Constant (C) 
regions, whereas TCRβ and δ chains are composed of V, Diversity (D), J and C 
regions (Livák et al., 1999; Petrie et al., 1995). Genes that encode αβTCRs are 
generated via somatic recombination at the TRA and TRB loci, encoding α chains and 
β chains, respectively. Similar rearrangements at TRG and TRD loci produce genes 
that encode the γ and δ chains of γδTCRs (Livák et al., 1999; Petrie et al., 1995). This 
thesis focuses on thymocytes bearing αβTCRs.   
 
The human TRA locus contains 43-49 TRAV genes (also called V segments) and ~50 
TRAJ genes (also called J segments) (Attaf et al., 2015; Rossjohn et al., 2015). The 
mouse TRA locus contains 72-82 TRAV genes (Bosc and Lefranc, 2003) and 60 TRAJ 
genes (Genolet et al., 2012). Productive TCRa chain genes contain one V segment 
joined to one J segment (Fig. 1.4A). The human TRB locus contains 40-48 TRBV 
segments, 2 TRBD segments and 12-13 TRBJ segments (Attaf et al., 2015; Rossjohn 
et al., 2015). Productive TCRb chain genes contain one segment from each of the V, D 
and J segment clusters (Fig. 1.4B). In both TCRα and TCRβ chains, the intervening 
sequence between the J segment and a single C segment (i.e. TRAC or TRBC) is 
removed during mRNA splicing (Fig. 1.4) (Attaf et al., 2015). V(D)J somatic 
recombination generates about 10% of total TCR diversity (Cabaniols et al., 2001; 
Miles and Burrows, 2013). During V(D)J recombination, nucleotides are removed or 
non-templated nucleotides (N-nucleotides) are inserted at the junction between V and J 
gene segments (i.e. VJ junction) for TCRα chains or at the VD and/or DJ junctions for 
TCRβ chains (Fig. 1.4), in a process that requires the enzyme terminal 
deoxynucleotidyl transferase (TdT) (Cabaniols et al., 2001; Davis and Bjorkman, 1988) 
(Fig. 1.4). It is estimated that these deletions and insertions account for 90% of the 
diversity in TCR sequences (Cabaniols et al., 2001; Miles and Burrows, 2013). 
 
Each TCR chain has three complementarity-determining regions (CDRs), namely 
CDR1, CDR2 and CDR3. CDR1 and CDR2 loops, encoded by the germline V gene 
segments, give rise to a limited TCR diversity and commonly contact the MHC 
molecule (Davis and Bjorkman, 1988) (Fig. 1.4). On the other hand, CDR3 loops are 
encoded by the more variable V(D)J junction(s) (Pannetier et al., 1993). The CDR3 
loops are the portion of the TCR that commonly interacts with the peptide (Rudolph et 
al., 2006) (Fig. 1.4).   
	 12 
 
Figure 1.4.  Generation of αβTCRs via TCRα and TCRβ gene recombination. (A) 
To produce TCRα chains, one segment of the Variable (V) gene is recombined with 
one segment of the Joining (J) gene, followed by a mRNA splicing process to join the 
Constant (C) gene. This forms TCRα chains containing a V, J and C region. (B) To 
produce TCRβ chains, one segment of the Diversity (D) gene is recombined with one 
segment of the J gene, which is known as DJ recombination. One segment of the V 
gene is recombined with the recombined DJ genes, which is known as V to DJ 
recombination. Messenger RNA splicing occurs to join the C gene with VDJ to form 
TCRβ chains containing a V, D, J and C region. (A, B) The rearranged TCR are further 
diversified by removal or insertion of non-templated nucleotides (N) at the V(D)J 
junctions. The germline V gene encodes the complementarity-determining region 
(CDR)1 and CDR2 loops. CDR1 and CDR2 loops recognise MHC molecules. The most 
variable CDR3 loops are mainly encoded by the J region (and D region) and partially 
encoded by the V region. CDR3 consists of the V region, N-nucleotides, and/or (D) 
region and J region that straddles the V(D)J junction. CDR3 loops recognise bound 
peptide.  
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1.4 MHC structure and antigen presentation to T cells 
 
1.4.1 MHC Class I 
 
MHC class I molecules (MHCI) are expressed on almost all nucleated cells (Ploegh et 
al., 1981) and on some non-nucleated cells such as platelets (Rowley et al., 2011). The 
MHC class I molecule is a heterodimer consisting of a polymorphic membrane-
spanning α chain (also known as the heavy chain) and a non-membrane spanning β2-
microglobulin (β2m, also known as the light chain) non-covalently bound to the α chain 
(Fig. 1.5A) (Klar and Hämmerling, 1989). The α chain folds into three domains. Two 
domains α1 and α2 (that form α1 and α2 helices) create a peptide-binding cleft 
(Bjorkman et al., 1987) that binds a short peptide of 8-10 amino acids. The peptide’s N 
(amine)- and C (carboxyl)-terminal ends are anchored into the pockets at the ends of 
the peptide binding cleft (Rossjohn et al., 2015). The binding of peptide onto the MHCI 
is essential for the formation of stable MHCI protein (Bijlmakers et al., 1993). The third 
domain, the conserved α3 domain, spans the membrane (Fig. 1.5A). There are three 
classical polymorphic MHCI genes in humans (HLA-A, HLA-B and HLA-C) and mice 
(H2-K, H2-D and H2-L) (Rossjohn et al., 2015). The non-classical monomorphic MHCI-
like molecules, CD1d and MR1, also require B2m for stable expression on the cell 
surface (Rossjohn et al., 2015).  
 
The non-classical MHCI molecules, CD1d and MR1, are recognised by natural killer T 
(NKT) cells and mucosa-associated invariant T (MAIT) cells, respectively (Borrego et 
al., 2002; Kochan et al., 2013). CD1d presents lipid-based antigens that can be 
recognised by αβ (Matsuda et al., 2000) or γδ TCRs (Rossjohn et al., 2015). The NKT 
cells express an invariant TCRα chain and a restricted but not invariant TCRβ chain 
(Godfrey et al., 2004). MR1 presents vitamin B precursors or metabolites than can be 
recognised by MAIT cells, an innate-like T cell population (Kjer-Nielsen et al., 2012). 
MAIT cells were thought to express an invariant TCRα chain that pairs with a limited 
array of β chains (Kjer-Nielsen et al., 2012). Recently, MAIT cells are reported to have 
a semi-variable TCRα chain and fairly variable β chains (Gherardin et al., 2016; 
Kurioka et al., 2016; Napier et al., 2015). 
 
1.4.2 MHC Class II 
 
MHCII is a transmembrane heterodimer consisting of an α chain and a β chain. The α 
chain consists of α1 and α2 domains. Similarly, the β chain consists of β1 and β2 
domains. α1 and β1 form the peptide-binding cleft, whereas α2 and β2 domains span   
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Figure 1.5. TCR recognition of self-peptide-MHC complexes. (A) Structure of MHC 
Class I (MHCI) and its recognition by CD8+ T cells. MHCI consists of an α chain and a 
beta-2 microglobulin (β2m) chain. The α1 and α2 domains of α chain present the 
peptide, whereas the conserved α3 domain associates primarily with β2m necessary 
for MHC stability. The heterodimeric αβTCR of MHCI-restricted CD8SP thymocytes 
binds to the peptide presented on MHCI molecules by antigen presenting cells (APCs), 
with the simultaneous binding of CD8 coreceptor to the conserved region (α3 domain) 
of MHCI. (B) Structure of MHC Class II (MHCII) and its recognition by CD4+ T cells. 
MHCII consists of an α chain and a β chain. Each chain of MHCII consists of two 
domains (i.e. α1 and α2, and β1 and β2). α1 and β1 domains of MHCII present the 
peptide to the TCR of MHCII-restricted CD4SP cells, with the simultaneous binding of 
the CD4 coreceptor to the conserved region of MHCII (α2 and β2 domains) during the 
TCR-recognition for self-peptide. Ribbon diagrams on the right of (A, B) are reproduced 
from Rossjohn et al. (2015).  
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the membrane (Fig. 1.5B). The peptide binding cleft of MHCII molecule is open at both 
ends, allowing the binding of a longer peptide (>11 amino acids) compared to MHCI 
(Rammensee et al., 1995). There are three MHC-II gene loci in humans (HLA-DR, 
HLA-DQ, and HLA-DP) and two in mice (H2-A and H2-E) (Rossjohn et al., 2015). H2-A 
is the only functional MHCII molecule in the C57BL/6 laboratory mouse strain, owing to 
an inactivating mutation in the promoter of H2-Ea gene, which encodes the a chain of 
the H2-E MHCII molecule (Mathis et al., 1983). The master regulator of MHCII 
expression is MHC class II transactivator (CIITA) (Reith et al., 2005). MHCII molecules 
are expressed on specialised APCs encompassing the haemapoeitic DCs, 
macrophages and B cells, and the non-haemapoetic cTECs and mTECs in the thymus 
(Holling et al., 2004). 
 
1.4.3 Overview of antigen presentation by MHC Class I and MHC Class II 
 
MHCI presents peptides derived from an endogenous (intracellular) source, with the 
exception of cross presentation, in which exogenously derived peptides are loaded on 
MHCI (Neefjes et al., 2011). By contrast, MHCII presents exogenous peptides, with the 
exception of macroautophagy. Macroautophagy is a process of bulk degradation of 
endogenous proteins encapsulated in autophagosomes (cytoplasmic vacuoles) 
following fusion with a lysosomal compartment. In the lysosomal compartment, the 
degraded endogenous peptides are loaded onto MHCII for antigen presentation (Klein 
et al., 2009). Bulk cytoplasmic autophagy usually occurs during starvation in other cell 
types, but the thymic tissue has an unusually high constitutive macroautophagy even 
without starvation (Mizushima et al., 2004). 
 
Briefly, MHCI antigen presentation involves the degradation of cytosolic or nuclear 
proteins by the proteasome. Then the degraded proteins are translocated into the 
endoplasmic reticulum (ER) by transporter associated with antigen presentation (TAP) 
(Neefjes et al., 2011). The α chain and β2m of MHCI are assembled in the ER and are 
stabilised by chaperone proteins when no peptide is bound (Neefjes et al., 2011). The 
peptide-MHCI complexes are released from the chaperone proteins only after the 
loading of a peptide onto MHCI. They then leave the ER and are transported across 
the Golgi and to the plasma membrane for antigen presentation to CD8+ T cells (Fig. 
1.6). Peptides and MHCI that fail to form a complex are transported to the cytosol via 
the ER-associated protein degradation (ERAD) for degradation (Hughes et al., 1997; 
Neefjes et al., 2011) .  
 
In MHCII antigen presentation, exogenous proteins can enter the endocytic pathway   
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Figure 1.6. MHC Class I antigen presentation. Intracellular proteins are degraded by 
proteasomes. The degraded proteins are translocated into the endoplasmic reticulum 
(ER) via transporter associated with antigen presentation (TAP). The peptides are 
loaded onto MHCI molecules that are assembled in the ER. The peptide-MHC 
complexes are transported to the cell surface of APC, presenting to conventional CD8+ 
T cells. Peptides and MHCI that are not bound to each other are transported to the 
cytosol for degradation via the ER-associated protein degradation (ERAD). 
Reproduced from Neefjes et al. (2011).  
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Figure 1.7. MHCII antigen presentation. Extracellular proteins are internalised and 
cleaved by proteases in an early endosome. Early endosomes fuse with the late 
endosomal-lysosomal antigen-processing compartment, also known as the MHC class 
II compartment (MIIC) for further antigen proteolysis and for the formation of peptide-
MHCII complex. The α chain and β chain of MHCII are assembled in the ER and are 
associated with CD74 (MHC Class II invariant chain li). The MHCII-li complexes are 
transported to MIIC via Golgi or via Golgi and plasma membrane. In MIIC, the li is 
digested, producing the class II-associated li peptide (CLIP) in the peptide-binding 
groove of MHCII. A newly-formed peptide is exchanged with CLIP, with the help of 
HLA-DM. Finally, the peptide-MHCII complexes are transported to the plasma 
membrane for antigen presentation to the MHCII-restricted CD4+ T cells. Reproduced 
from Neefjes et al. (2011).  
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via internalisation of proteins into an early endosome, in which the protein can be 
cleaved by protease. The early endosome fuses with a late endosomal-lysosomal 
antigen-processing compartment known as the MHC class II compartment (MIIC), for 
further antigen proteolysis (Neefjes et al., 2011; Roche and Furuta, 2015). The α chain 
and β chain of MHCII are assembled in the ER and are associated with CD74 (MHC 
Class II invariant chain li) (Fig. 1.7) (Stumptner-Cuvelette and Benaroch, 2002). The 
MHCII-li complex is transported to the MIIC via Golgi or via Golgi and plasma 
membrane. MIIC is also where the peptide-MHCII complex formation takes place. In 
MIIC, the li is digested, generating a residual fragment of li known as class II-
associated li peptide (CLIP) in the peptide-binding groove of MHCII (Fig. 1.7) (Neefjes 
et al., 2011; Roche and Furuta, 2015). CLIP is removed from the CLIP-MHCII complex 
and replaced with peptide, facilitated by HLA-DM enzyme (Sloan et al., 1995). The 
peptide-MHCII complex is then transported to the plasma membrane for antigen 
presentation to CD4+ T cells (Neefjes et al., 2011; Roche and Furuta, 2015). 
 
 
1.5 Induction of TCR signalling 
 
The extracellular domains of the CD4 or CD8 coreceptor bind to the non-polymorphic 
region of MHCII (Doyle and Strominger, 1987) and MHCI (Norment et al., 1988), 
respectively (Fig. 1.5, 1.8).  CD8 binds to the MHCI α3 domain loop while CD4 binds to 
a hydrophobic region between MHCII α2 and β2 domains (Reinherz and Wang, 2015). 
The intracellular domains of the CD4 or CD8 coreceptor bind to Lck (also known as 
p56-Lck), a tyrosine kinase belonging to the SRC family kinase (SFK) (Brownlie and 
Zamoyska, 2013; Turner et al., 1990) (Fig. 1.8). Binding of the CD4 or CD8 coreceptor 
to Lck has been suggested to have role in initiating TCR signalling (Veillette et al., 
1988; Veillette et al., 1989). A later study concluded that the principal function of CD4 
and CD8 coreceptors is to enhance Lck recruitment, but not to stabilise TCR-peptide-
MHC interactions (Artyomov et al., 2010).  
 
An overview of TCR signaling is described as follows (Brownlie and Zamoyska, 2013; 
Li and Rudensky, 2016) and is depicted in Fig. 1.8. TCR signaling is initiated after the 
interaction of TCR with a peptide-MHC complex, with the simultaneous binding of the 
CD4 or CD8 coreceptor to the extracellular portion of MHCII and MHCI, respectively. 
Lck is the first molecule to be recruited to the TCR-CD3 complex after TCR 
engagement. Lck phosphorylates the immunoreceptor tyrosine-based activation motifs 
(ITAMs) of CD3δ-, γ-, ε-and ζ-chains, thereby initiating TCR signalling.  
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Phosphorylation of ITAMs allows the recruitment of the SYK family kinase Zap70 (ζ-
chain associated protein kinase of 70 kDa) to the TCR-CD3 complex, and allows the 
phosphorylation of Zap70 by Lck. The phosphorylated Zap70 propagates TCR 
signalling by phosphorylating tyrosine residues on linker for activation T cells (LAT). 
The phosphorylated LAT recruits adaptor proteins including growth factor receptor-
bound protein 2 (GRB2)-related adaptor protein (GADS), SH2 domain-containing 
leukocyte protein of 76 kDa (SLP76), phospholipase Cγ1 (PLCγ1) adhesion and 
interleukin-2-inducible T cell kinase (ITK), forming a multiprotein complex (Brownlie and 
Zamoyska, 2013; Li and Rudensky, 2016).  
 
This multiprotein complex nucleated by LAT propagates TCR signalling to four major 
signalling pathways: (1) protein kinase AKT pathway, (2) calcium (Ca2+) signalling, (3) 
transcription factor nuclear factor-κB (NF-κB) signalling pathway and (4) mitogen-
activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway 
(MAPK/ERK pathway) (Brownlie and Zamoyska, 2013; Li and Rudensky, 2016). These 
signalling pathways result in the translocation of transcription factors to the nucleus 
and their activation, including Forkhead Box O1 (FOXO1), nuclear factor of activated T 
cells (NFAT), NF-κB and activator protein 1 (AP-1), respectively. These transcription 
factors are important for gene expression and T cell growth and differentiation 
(Brownlie and Zamoyska, 2013; Li and Rudensky, 2016).  
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Figure 1.8. Overview of TCR signalling. Upon TCR engagement, Lck (a tyrosine 
kinase) associates with the intracellular domain of the CD4 coreceptor (or CD8 
coreceptor). Lck phosphorylates the CD3δ-, γ-, ε-and ζ-chains at the immunoreceptor 
tyrosine-based activation motifs (ITAMs) thereby initiating TCR signalling. 
Phosphorylation of ITAMs enables the recruitment of ζ-chain associated protein kinase 
of 70 kDa (Zap70) to the TCR-CD3 complex, and allows the phosphorylation of Zap70 
by Lck. Zap70 phosphorylates multiple targets, including linker for activation T cells 
(LAT). The phosphorylated LAT recruits a few adaptor proteins including growth factor 
receptor-bound protein 2 (GRB2)-related adaptor protein (GADS), SH2 domain-
containing leukocyte protein of 76 kDa (SLP76), phospholipase Cγ1 (PLCγ1) adhesion 
and interleukin-2-inducible T cell kinase (ITK), forming a multiprotein complex. This 
LAT multiprotein complex propagates TCR signalling to four major signalling pathways. 
These signalling pathways are the (1) protein kinase AKT pathway, (2) Ca2+ signalling, 
(3) transcription factor nuclear factor-κB (NF-κB) signalling pathway and (4) mitogen-
activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway 
(MAPK/ERK pathway), which in turn translocate or activate the transcription factors 
Forkhead Box O1 (FOXO1), nuclear factor of activated T cells (NFAT), NF-κB and 
activator protein 1 (AP-1), respectively, in the nucleus. These transcription factors are 
essential for gene expression and T cell growth and differentiation. P, phosphorylated. 
Modified from Li and Rudensky (2016).  
 
  
	 22 
1.6 Characteristics of TCR-signalling during positive and negative selection  
 
Previous studies revealed that the patterns of TCR signalling of negatively selected 
thymocytes are different from positively selected thymocytes. In a foetal thymic organ 
culture (FTOC) system, one study stimulated ovalbumin (OVA) peptide-specific OT-I 
(TAP–/–) transgenic T cells arrested at DP stage with different OVA-derived peptides. 
This study reported that the negative selecting ligands induce a rapid and robust ERK 
activation, whereas the positive selecting ligands stimulate a lower intensity but 
sustained ERK activation (McNeil et al., 2005). These observations indicate that the 
kinetics of ERK activation in negative selection are different from positive selection 
(McNeil et al., 2005). Another study used a similar system by incubating OT-I Tg Rag–/–
B2m–/– cells arrested at the DP stage with tetramers of H2-Kb loaded with a positive 
selecting or negative selecting peptide (Daniels et al., 2006). This study demonstrated 
that phosphorylated ERK, and several molecules “upstream” of ERK in the TCR 
signaling pathway, accumulated at the plasma membrane during negative selection, 
whereas these molecules were either undetectable or distributed throughout the 
cytoplasm during positive selection (Daniels et al., 2006). By contrast, phosphorylated 
Jun amino-terminal kinase (JNK) accumulated throughout the cytoplasm in both 
positive and negative selecting conditions. This study concluded that the subcellular 
localisation of ERK and JNK is different in negative selection and positive selection.  
 
Another study reported distinct temporal patterns of TCR signalling and motility in 
positively selected versus negatively selected thymocytes (Melichar et al., 2013). This 
study used multi-photon imaging to observe thymocytes undergoing positive or 
negative selection in thymic slices. Two TCR transgenic MHCI-restricted models were 
used: OVA peptide specific-OT-I thymocytes and male peptide specific-HYCD4 
thymocytes. Positive selection was characterised by low cytosolic Ca2+ concentration 
with brief and infrequent signalling events separated by periods of migration of 
thymocytes. Negative selection was characterised by persistent increase in intracellular 
Ca2+ concentration with prolonged signalling events and migratory arrest of thymocytes 
(Melichar et al., 2013).  
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1.7 Positive selection 
Before 2008, the traditional view of thymic selection is that positive selection occurs in 
the cortex, followed by negative selection (in particular clonal deletion) in the medulla 
of the thymus (Fig. 1.9A). The classical definition of positive selection is the induction 
of immature DP thymocytes with low/intermediate TCR affinity to self-peptide-MHC 
complexes to differentiate into mature SP thymocytes (Klein et al., 2014). This process 
commences in the cortex and the positively selected cells may be subsequently 
negatively selected in the medulla (Moran and Hogquist, 2012) (Fig. 1.9A). In this 
thesis, the intent is to formulate a binary scheme to distinguish positive selection from 
negative selection. Towards this end, positive selection refers to the complete 
maturation of CCR7– (similar to DP) thymocytes into CCR7+ (similar to naïve SP) 
thymocytes in the medulla (Fig. 1.9B). Negative selection is any process that prevents 
a self-reactive thymocyte from undergoing positive selection. In this scheme, negative 
selection comprises two separate mechanisms: apoptotic deletion and agonist 
selection (Fig. 1.9B) (section 1.8). 
 
1.8 Negative selection 
 
1.8.1 Negative selection occurs in the thymic medulla 
 
Negative selection is commonly used synonymously with clonal deletion, which is 
defined as the apoptosis of self-reactive TCRs with high affinity for self-antigens 
(Germain, 2002; Klein et al., 2009; Klein et al., 2014; Xing and Hogquist, 2012). In this 
thesis, negative selection is defined as mechanisms that prevent strongly TCR-
signalled self-reactive thymocytes from maturing into naïve T cells. Negative selection 
in this context encompasses clonal deletion and agonist selection (Fig. 1.9B). Agonist 
selection is the clonal diversion of strongly TCR-signalled cells by agonist ligands into 
non-naïve T cell lineages such as TCRαβ+ DN intestinal intraepithelial lymphocyte 
(iIEL) precursors (Pobezinsky et al., 2012), Forkhead box P3 transcription factor 
(FoxP3)+ T-regulatory (T-reg) cells (Kawahata et al., 2002; Moran et al., 2011), NKT 
cells or MAIT cells (Moran et al., 2011; Stritesky et al., 2012) (Fig. 1.1, 1.9B). This 
concept of negative selection is consistent with previous views that include anergy 
(Nossal, 1994)  and  survivors of self-reactive thymocytes that differentiate into iIEL 
precursors (Pobezinsky et al., 2012), as negative selection.  
Clonal deletion was thought to occur primarily in the medulla of the thymus (Fig. 1.9A). 
This view was based on the first direct evidence of clonal deletion, demonstrating that   
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Figure 1.9. Terminology used to describe thymic selection events. (A) The 
traditional view of thymic selection before 2008. DP thymocytes with low TCR affinity 
for self-peptide-MHC complexes undergo positive selection in the thymic cortex, and 
continue to mature into naïve SP cells in the thymic medulla. In the medulla, positively 
selected SP thymocytes with high TCR affinity for self-peptide-MHC complexes 
undergo negative selection in the thymic medulla. (B) The terminology used in this 
thesis. Positive selection is the process by which CCR7– (~DP) thymocytes with low 
TCR affinity for self-peptide-MHC complexes in cortex completely mature into naïve 
CCR7+  (~SP) cells in the medulla. Thymocytes with high TCR affinity for a self-
peptide-MHC complex may undergo negative selection either at the CCR7– (~DP) 
stage, termed as wave 1 negative selection or at the CCR7+ stage, termed as wave 2 
negative selection. Waves 1 and 2 negative selection comprise two separate 
mechanisms: apoptotic deletion and agonist selection into precursors of intestinal 
intraepithelial lymphocytes (iIELs) in wave 1 or FoxP3+ T-regulatory cells in wave 2.   
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T cells bearing Vβ17a+ TCR that are specific to superantigen in the presence of MHC 
class II protein (IE) were selectively eliminated from mature SP thymocytes in mice 
expressing IE, but did not affect the immature DP thymocytes (Kappler et al., 1987). 
This indicates that clonal deletion of superantigen-reactive thymocytes occurs at the 
SP stage and therefore is thought to occur in the thymic medulla (Kappler et al., 1987). 
Superantigen is a protein that binds to and activates all T cells that express a particular 
set of Vβ TCR genes (Klein et al., 2009). Terminal deoxynucleotidyl transferase (TdT)-
mediated 2'-deoxyuridine 5'-triphosphate (dUTP) nick end-labelling (TUNEL) assay has 
been used to label apoptotic nuclei in the thymus, which allows visualisation of 
apoptotic thymocytes in situ (Surh and Sprent, 1994). In another study, the deletion of 
superantigen specific-TCR Vβ5 transgenic thymocytes in H-2E+ mice showed that a 
large number of apoptotic TUNEL+ cells was observed in the thymic medulla based on 
the immunohistochemistry (Surh and Sprent, 1994), suggesting that thymic deletion 
occurs in the medulla. Furthermore, early study showed that BM-APCs were sufficient 
to delete superantigen-reactive Vβ17α+ T cells (Marrack et al., 1988) and most BM-
APCs are located in the thymic medulla (Barclay and Mayrhofer, 1981). These findings 
support the view that clonal deletion occurs in the thymic medulla.   
 
Later, a study suggested that ectopic expression of a specific isoform of a tissue-
specific antigen (TSA), known as proteolipid protein (PLP), in the thymic epithelium is 
important in mediating central tolerance and preventing autoimmune encephalomyelitis 
in mice (Klein et al., 2000). TSAs are normally found in the periphery but are also 
expressed ectopically in the thymic medulla, particularly in the mTECs (Derbinski et al., 
2001). This ectopic expression of TSAs is partly regulated by autoimmune regulator 
(Aire), a crucial transcription factor in the thymus (Anderson et al., 2002). Studies also 
demonstrated that the hen egg lysozyme (HEL)-specific 3A9 transgenic (Tg) TCR 
(Liston et al., 2003) and the ovalbumin (OVA)-specific OT-II Tg TCR (Anderson et al., 
2005) undergo negative selection at the SP stage in which the TSAs are Aire-
dependent. These findings suggest that the expression of Aire and TSAs in the thymic 
medulla facilitates negative selection in the medulla. 
 
A few studies used two-photon microscopy to observe thymocyte migration and cellular 
interactions in a 3-dimensional thymic tissue slices, in the presence of positive or 
negative selecting ligands. In the thymic medulla, the negatively selected F5 TCR 
transgenic thymocytes that are specific to NP366–374 peptide (derived from influenza 
nucleoprotein) underwent rapid calcium flux and migratory arrest when the thymic 
slices were perfused with medium containing NP366–374 peptide (Dzhagalov et al., 2013). 
This observation is consistent with the hallmark of negatively selected thymocytes 
	 26 
(Melichar et al., 2013). Although negatively selected MHCI-restricted OT-I Tg 
thymocytes specific for an Aire-dependent membrane-OVA (mOVA) self-antigen 
(Anderson et al., 2005; Gallegos and Bevan, 2004; Kurts et al., 1997) did not show 
migratory arrest, the migration of these thymocytes was slower than positively selected 
thymocytes and occurred in a confined environment (Le Borgne et al., 2009).  
 
1.8.2 Negative selection occurs in the thymic cortex 
 
Early studies showed that clonal deletion could occur at the immature DN to DP 
transition in 2C transgenic TCR (Sha et al., 1988) and in transgenic TCR specific to 
ubiquitous HY self-antigen expressed in male mice  (i.e. HY model) (Kisielow et al., 
1988). This early clonal deletion was possibly due to premature expression of the 
transgenic TCR at the DN stage. In 2008, a detailed analysis revealed that thymic 
negative selection can occur in the thymic cortex in a HYcd4 transgenic model 
(McCaughtry et al., 2008). In the HY and HYcd4 transgenic models, the CD8 Tg TCR 
binds strongly to a self-antigen expressed ubiquitously in male but not female mice 
(McCaughtry et al., 2008). In the HYcd4 transgenic model, the onset of TCRα 
expression occurs at the physiological stage in DP cells, resulting in deletion at the DP 
to SP transition (Baldwin et al., 2005), unlike the early clonal deletion at the DN to DP 
transition in HY model (Kisielow et al., 1988).  
 
An antibody that binds to active caspase 3 has been used to identify thymocytes 
undergoing apoptosis (McCaughtry et al., 2008; Stritesky et al., 2013). Caspase 3 is an 
effector caspase that is responsible for proteolytic cleavage of cellular targets leading 
to apoptosis (Shi, 2002). During apoptosis, inactive caspase 3 is required to be 
proteolytically cleaved at aspartic acid (position 175) to produce the active form of 
caspase 3 (Nicholson et al., 1995). Active caspase 3 mediates apoptosis in 
mammalian lymphocytes and promyelocytes (Fernandes-Alnemri et al., 1994). Active 
caspase 3 has been used as a marker of apoptotic thymocytes. Active caspase 3+ cells 
were reported to be 4.8-fold higher in HYcd4 male mice (that facilitate clonal deletion) 
compared to HYcd4 female mice (that facilitate positive selection) (McCaughtry et al., 
2008). In addition, immunofluorescent staining on a thymic tissue section of a male 
mouse demonstrated that the self-reactive HYcd4 Thy 1.2+ thymocytes were found to be 
co-localised with active caspase 3+ staining throughout the thymic cortex, but not in the 
medulla (McCaughtry et al., 2008). This provides evidence that clonal deletion could 
occur in the thymic cortex. This observation raises the possibility that apoptosis 
detected in the thymic cortex by Surh and Sprent (1994) may include cells dying by 
deletion.   
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The two-photon microscopy on thymic slices reported that negatively selected NP366–
374-specific F5 TCR Tg DP thymocytes exhibited rapid calcium flux and migratory arrest 
in the thymic cortex (Dzhagalov et al., 2013). Similarly, OVA specific OT-I Tg DP 
thymocytes undergoing negative selection in the thymic cortex increased intracellular 
Ca2+ concentrations, resulting in migratory arrest and translocation of the transcription 
factor NFAT to the nucleus (Melichar et al., 2013). These patterns of TCR signaling 
and migration of the negatively selected thymocytes observed in the thymic cortex 
provide real time evidence supporting negative selection can occur in the thymic 
cortex. 
 
The discovery of cortical negative selection has led scientists to revisit negative 
selection at the immature developmental stage. Characterisation of thymocyte deletion 
at the immature DP or CCR7– stage has advanced with the advent of molecular 
markers, Nur77 and Helios, which identify strongly TCR-signalled thymocytes (Daley et 
al., 2013; Stritesky et al., 2013). These two studies used mice lacking pro-apoptotic 
protein BCL-2-interacting mediator of cell death (BIM; also known as BCL2L11) (Bim–/–) 
(Bouillet et al., 2002). In Bim–/– mice, instead of undergoing rapid deletion, strongly 
TCR-signalled thymocytes persist and can be quantified. The first study used 
transgenically expressed GFP under the control of the promoter of the Nr4a1 gene, 
which encodes Nur77 (Stritesky et al., 2013). In these Nur77GFP reporter mice, the GFP 
expression correlates to the TCR signal strength (Moran et al., 2011). Compared to 
pre-selection DP thymocytes, Nur77 transcription factor is expressed 10-fold higher in 
negatively selected thymocytes but it is also expressed 2-fold higher in positively 
selected thymocytes (Baldwin and Hogquist, 2007). Bim-deficient Nur77GFP mice had 
an increased number of thymocytes expressing high levels of Nur77GFP at the immature 
DP stage, and at the more mature SP stage (Stritesky et al., 2013). 
 
The second study used an endogenously expressed Helios transcription factor as a 
marker to quantify negative selection (Daley et al., 2013). Helios is upregulated in 
strongly TCR-signalled thymocytes as evident in the Bim-deficient HEL-specific 3A9 
TCR × insHEL double Tg mouse model in which CD4SP thymocytes undergo negative 
selection. In contrast, Helios is downregulated in weakly TCR-signalled thymocytes as 
shown in Bim-deficient 3A9 TCR single Tg mice modeling positive selection (Daley et 
al., 2013). Using Helios in conjunction with CCR7 to mark maturation stages of 
developing thymocytes, our group revealed that negative selection occurs in the 
superantigen specific CCR7– immature thymocytes and in the self-antigen specific 
CCR7+ mature thymocytes (Fig. 1.9B), similar to DP and SP stages, respectively 
(Daley et al., 2013).   
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CCR7 is important for localisation of SP thymocytes within the medulla and for 
migration of developing thymocytes from the cortex to the medulla. Mice deficient in 
CCR7 or double deficient in the medullary CCR7 ligands CCL19/CCL21, resulted in the 
accumulation of SP cells in the cortex (Kwan and Killeen, 2004; Ueno et al., 2004). In 
another study using two-photon microscopy to visualise migration of DN, DP and 
CD4SP thymocytes on thymic slices also revealed that CCR7 is important in mediating 
the chemotaxis of CD4SP thymocytes towards the medulla (Ehrlich et al., 2009). 
Thymocytes that exhibit the phenotype of Helios+ CCR7– are characterised as wave 1 
negative selection, whereas thymocytes exhibiting Helios+ CCR7+ phenotype are 
characterised as wave 2 negative selection by our group (Fig. 1.9B) (Daley et al., 
2013). Wave 1 and wave 2 thymocytes were also detected in the polyclonal thymocyte 
repertoire (Hu et al., 2016). 
 
Based on the use of Nur77GFP as a negative selection marker, it was reported that 57% 
of thymocytes undergo DP cortical negative selection (Stritesky et al., 2013). Similarly, 
~55% of CD69+ TCR-signalled nascent thymocytes labelled with BrdU were deleted 
(with Helios upregulation) at the CCR7– (similar to the DP) stage (Daley et al., 2013). 
20% (Daley et al., 2013) to 60% (Stritesky et al., 2013) of thymocytes were estimated 
to undergo negative selection at the CCR7+ or SP stage in the CD4 lineage. The 
proportion of cells undergoing negative selection at the immature stage is higher than 
positive selection, and higher than the proportion of cells undergoing negative selection 
at the more mature stage of thymocyte development (Daley et al., 2013; Stritesky et 
al., 2013). Within the active caspase 3+ CD69+ CD5+ thymocyte population undergoing 
TCR-signalled apoptosis (i.e. deletion), the proportion of DP thymocytes exceeds SP 
thymocytes by 2-3 fold (Stritesky et al., 2013). These studies indicate that developing 
thymocytes are constantly exposed to negatively selected self-antigens and are 
eliminated by apoptotic deletion at multiple stages of thymocyte development in the 
normal thymus (Fig. 1.9B).  
 
Although the proportions of selectable thymocytes undergoing apoptotic deletion have 
been studied, the proportions of selectable (i.e. TCR-signalled) thymocytes responsive 
to MHCI or MHCII, and the proportions of strongly TCR-signalled thymocytes induced 
by MHCI or MHCII, remain unclear. Sinclair et al. (2013) tracked the Zap70-dependent 
thymocyte differentiation or cell death contributed by MHCI or MHCII throughout T cell 
development using mice bearing a tetracycline-inducible Zap70 (TetZap70) transgene. 
In TetZap70 mice, Zap70–/– thymocytes were arrested at the DP stage but the Zap70 
expression within the Zap70–/– thymocytes could be turned on by administration of 
tetracycline (Saini et al., 2010). BM chimeras were generated by reconstituting the 
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irradiated B2m–/– Rag1–/– and H2-Ab1–/– (referred to as MHCII–/– by the authors) Rag1–/– 
hosts with wild-type TetZap70 BM cells. This study concluded that the proportion of 
selectable thymocytes induced by MHCII or MHCI was similar at the initiation stage 
(Sinclair et al., 2013). However, as the BM cells transferred into the single MHC-
deficient hosts expressed both MHC Class I and II, it is possible that some TCR 
signalling events were mediated by the MHC class that was supposed to be “absent” 
on BM-APCs. Furthermore, the transgenic Zap70 expression does not replicate 
physiological Zap70 expression. Therefore, whether MHCI and MHCII have equivalent 
or different capacities to induce TCR signalling in thymocytes remains unclear. 
 
1.8.3 Characteristics and timing of the two waves of negative selection 
 
The two waves of negative selection are phenotypically distinctive. Like negatively 
selected DP thymocytes in the HYcd4 Tg model, the wave 1 (Helios+ CCR7–) negatively 
selected thymocytes in a superantigen-mediated model (Daley et al., 2013) and in the 
polyclonal repertoire (Hu et al., 2016), upregulate program death inhibitory receptor 
(PD-1) expression, and downregulate both CD4 and CD8 coreceptors, also termed as 
coreceptor dulling (Daley et al., 2013; Hu et al., 2016; McCaughtry et al., 2008). The 
coreceptor dulling phenotype is also consistent with in vitro TCR-activated DP 
thymocytes undergoing apoptosis (Page et al., 1993; Swat et al., 1991). By contrast, 
wave 2 (Helios+ CCR7+) negatively selected thymocytes, like SP thymocytes in the 3A9 
TCR × insHEL double Tg mouse model, activate a TCR-Card11-NF-κB response which 
opposes Bim-mediated apoptosis (Daley et al., 2013). The TCR-Card11-NF-κB 
responses include the upregulation of CD25 (also known as Interleukin-2 receptor 
alpha chain, IL-2RA), OX40 (CD134, tumour necrosis factor (TNF) receptor), 
glucocorticoid-induced TNF receptor (GITR) and c-Rel (Daley et al., 2013). Wave 2 
negative selection is reported to be the stage in which FoxP3+ T-reg differentiation 
occurs (Hu et al., 2016), consistent with the upregulation of CD25, OX40 and GITR in 
FoxP3+ T-reg cells (McHugh et al., 2002). 
 
Wave 1 negatively selected thymocytes are also temporally and spatially separable 
from wave 2 negatively selected thymocytes based on studies using BrdU or 5-ethynyl-
2'-deoxyuridine (EdU) to label proliferating cells in vivo and in vitro (Salic and 
Mitchison, 2008; Yu et al., 2009). EdU is a compound chemically similar to BrdU, a 
novel alternative to BrdU (Buck et al., 2008). BrdU and EdU are thymidine analogues 
that are incorporated into newly synthesised DNA in cells during S (synthesis) phase of 
the cell cycle (Gratzner, 1982). EdU uses a click-it reaction in which copper (I) 
catalyses the reaction between the alkane group in EdU and the azide which contains 
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the fluorochrome (Buck et al., 2008). BrdU/EdU has a half-life of 15-30 min in mice 
injected with a single bolus (Cheraghali et al., 1994; Matiašová et al., 2014; Packard Jr 
et al., 1973). 
 
EdU time course experiments conducted by our group recently showed that wave 1 
induction peaked at day 2, whereas wave 2 induction peaked at day 5 (but detected at 
days 4-7), after the major proliferation phase at the DN to DP transition (i.e. after EdU 
injection) (Hu et al., 2016). Given that BrdU+ thymocytes were detected exclusively in 
the thymic cortex after 2 days of BrdU injection (Penit, 1986), and apoptotic (active 
caspase 3+) negatively selected CCR7– DP MHCI-restricted TCR Tg thymocytes were 
detected in the thymic cortex (McCaughtry et al., 2008), all these findings indicate that 
wave 1 negative selection occurs in the thymic cortex. A few BrdU+ thymocytes were 
detected in thymic medulla at 3 days after BrdU injection, whereas all BrdU+ 
thymocytes were detected in the thymic medulla 5-7 days after BrdU injection (Penit, 
1986). Given the requirement for CCR7 in facilitating the migration of thymocytes from 
the cortex to medulla (Kwan and Killeen, 2004; Ueno et al., 2004), these findings 
suggest that wave 2 thymocytes occur in the thymic medulla.  
 
Although these studies demonstrated that wave 1 and wave 2 negatively selected 
thymocytes are phenotypically distinctive in wild-type mice based on cellular studies, it 
has not been shown whether there are qualitative differences between the wave 1 TCR 
repertoire and the positively selected CD4SP and CD8SP TCR repertoires using a 
TCR sequencing approach.  
 
1.8.4 Early agonist selection: iIEL precursors develop at wave 1 
 
Precursors of the unconventional CD8αα+ CD4– iIELs found in the small intestinal 
epithelium have been identified in the thymus where they undergo agonist selection 
(Gangadharan et al., 2006; Klose et al., 2014; Leishman et al., 2002). Thymocytes 
forced to express a TCR derived from CD8αα+ CD4– iIEL attained a TCRαβ+ 
CD4loCD8lo PD-1hi phenotype (Mayans et al., 2014; McDonald et al., 2014), 
characteristic of strongly TCR-signalled wave 1 CCR7– thymocytes (Fig. 1.9B) (Daley 
et al., 2013; McDonald et al., 2015). CD4loCD8lo PD-1hi thymocytes are referred to as 
iIEL precursors hereafter. The self-reactive thymocytes that survive clonal deletion 
either in the absence of CD28 co-stimulation or in transgenic overexpression of anti-
apoptotic proteins Bcl-2 or Mcl-1 are clonally diverted into TCRαβ+ CD4loCD8lo PD-1hi 
iIEL precursors (Pobezinsky et al., 2012).   
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1.8.5 Late agonist selection: T-reg differentiation occurs at wave 2 
 
FoxP3+ CD25+ CD4+ T-reg cells have roles in suppressing autoimmune inflammation 
(Sakaguchi et al., 1995; Takahashi et al., 2000). Our group demonstrated that FoxP3+ 
induction predominantly occurs in strongly TCR-signalled wave 2 (Helios+ CCR7+) 
thymocytes (Fig. 1.9B), at 4-8 days after proliferation at the DN-DP transition, based on 
EdU time course analyses (Hu et al., 2016). Previous studies also reported that Helios 
is expressed in thymic FoxP3+ T-reg cells (Thornton et al., 2010) and in the peripherally 
induced T-reg cells (Gottschalk et al., 2012). Consistently, FoxP3 induction was also 
reported to occur at the CCR7+ CCR9– CD4SP mature stage by quantitative PCR and 
flow cytometry (Cowan et al., 2013). Altogether, these findings suggest that the thymic 
medulla is the site where thymocytes upregulate FoxP3. Surprisingly, the absence of 
CCR7 increased FoxP3+ T-reg numbers in the thymus (Cowan et al., 2014). This was 
explained recently by the role of CCR7 in limiting peripheral T-reg recirculation back to 
the thymus (Cowan et al., 2016). 
 
 
1.9 Types of thymic APCs involved in T cell selection 
 
The interaction between thymocytes and different types of thymic APCs in the thymus 
is important in facilitating positive or negative selection. Thymic APCs can be broadly 
divided into BM-derived APCs (DCs, macrophages and B cells) and non-BM-derived 
APCs (cTECs and mTECs). Cortical TECs in the thymic cortex are important for 
positive selection, whereas mTECs and DCs in the medulla are important for negative 
selection (Klein et al., 2014; Xing and Hogquist, 2012). 
 
1.9.1 Cortical thymic epithelial cells (cTECs) are important for positive 
selection  
 
Cortical TECs are the major thymic APCs that mediate positive selection as evident by 
the following observation: In MHCII-deficient (H2-Ab–/–) mice reconstituted with one of a 
panel of transgenes restoring MHCII expression to different cell types, only transgenes 
that drove MHC Class II expression on cTECs enhanced CD4SP thymocyte formation 
(Bill and Palmer, 1989; Cosgrove et al., 1992).  
 
Precisely why cTECs are required for positive selection is unclear. However, cTECs do 
have unique properties in terms of antigen presentation via MHCI and MHCII 
molecules. For instance, the β5t (PSMB11) protein is exclusively expressed in cTECs 
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and forms one subunit of a “thymoproteasome” (Florea et al., 2010). The 
thymoproteasome is thought to play a role in positive selection of CD8+ T cells, as mice 
lacking β5t have impaired CD8+ T cell development (Murata et al., 2007).  
 
Cortical TECs also express a unique thymus-specific serine protease (TSSP) (Bowlus 
et al., 1999) that is thought to be involved in generating MHCII positively selecting 
ligands, as TSSP-deficiency decreased the positive selection of MHCII transgenic 
TCRs (Gommeaux et al., 2009). Cathepsin L, a unique lysosomal protease in MHCII 
antigen processing, preferentially expressed in the cTECs (Nakagawa et al., 1998), 
plays a role in producing positively selecting peptide ligands (Honey et al., 2002) and in 
positive selection of polyclonal CD4+ T cells (Nakagawa et al., 1998).  
 
Although cTECs express MHCII, cTECs are not efficient in presenting the exogenous 
proteins on MHCII molecules via the classical MHCII endocytic pathway (Klein et al., 
2009; Klein et al., 2001). Instead, cTECs use an unconventional processing of 
endogenous peptides in the context of MHCII, known as macroautophagy. 
Macroautophagy is an antigen processing mechanism that involves the sequestration 
of cytoplasm into autophagosomes of non-lysosomal origin followed by the loading of 
intracellular peptides onto MHCII (Nedjic et al., 2009). It has been shown that 
macroautophagy occurs constitutively in 70% of cTECs (Nedjic et al., 2008). 
Thymocytes expressing certain TCRs fail to develop into CD4SP cells in mice lacking 
macroautophagy in TECs due to inactivation of the autophagy-related gene 5 (Atg5–/–), 
suggesting that macroautophagy is important for positive selection (Nedjic et al., 2008). 
 
1.9.2 Medullary thymic epithelial cells (mTECs) are important for 
negative selection  
 
Medullary TECs express a large number of TSAs which are dependent on Aire 
(Anderson et al., 2002; Derbinski et al., 2001) or transcriptional regulator FEZ Family 
Zinc Finger 2 (Fezf2) (Takaba et al., 2015). Each TSA is expressed only by 1-3% of 
mTECs at any give time as revealed by RNA in situ hybridisation on thymic sections 
(Klein et al., 2014). Aire is expressed in the medullary region (Klein et al., 2014), 
exclusively by a subset of mTECs (Hubert et al., 2008) with a mature (MHCIIhi CD80hi) 
phenotype (Derbinski et al., 2005). Fezf2 is also expressed in mTECs (Takaba et al., 
2015). In addition to their role as an antigen reservoir, mTECs can serve as APCs in 
inducing negative selection (Hinterberger et al., 2010). 
 
In C2TAkd mice, partial (~90%) reduction of MHCII expression on mTECs by 
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microRNA-mediated CIITA degradation suggested an autonomous role of mTECs in 
inducing negative selection of CD4+ T cells (Hinterberger et al., 2010). This study 
measured the frequency of CD4SP thymocytes in 4 groups of chimeric mice. Two 
groups, namely, wild-type hosts bearing MHCII-deficient BM, and C2TAkd hosts 
bearing wild-type BM, had significantly higher CD4SP frequencies (at different levels) 
than control wild-type hosts with wild-type BM-APCs. This suggests that the impairment 
of clonal deletion mediated by BM-APCs or by mTECs occurs at a different extent, thus 
revealing the non-redundant roles of mTECs and BM-APCs in mediating clonal 
deletion (Hinterberger et al., 2010).  The same study also studied DO11.10 × Aire-OVA 
double Tg mice in which the DO11.10 Tg T cells are specific to the OVA peptide 
specifically expressed in mTECs. The authors showed that DCs are not required to 
mediate clonal deletion in this model. However, combined deficiency of DCs and 
MHCII-deficiency in mTECs (Aire-OVA × C2TAkd recipients with DO11.10 × ΔDC bone 
marrow) caused an increase in DO11.10+ FoxP3– Tg T cells. This indicates the role of 
mTECs in clonal deletion (Hinterberger et al., 2010). In another study, sequencing of 
TCRα chains with a fixed transgenic TCRβ chain concluded that 5% Foxp3– CD4SP 
TCRs failed to undergo negative selection in C2TAkd mice (Perry et al., 2014).  
 
Like cTECs, mTECs are extremely inefficient in delivering epitopes derived from 
exogenous antigens onto MHC class II (conventional pathway), a characteristic that is 
different from thymic DCs (Klein et al., 2001). 5-10% of mTECs (particularly the mature 
CD80hi MHCIIhi Aire+ subset) showed evidence of macroautophagy with high numbers 
of autophagosomes (Nedjic et al., 2008). Macroautophagy in mTECs has been shown 
to play a role in inducing CD4+ T cell negative selection (Aichinger et al., 2013). 
 
1.9.3 Dendritic cells (DCs) are important in mediating negative selection 
 
There are three distinct subsets of thymic DCs. Two DC subsets belong to the 
conventional DCs (cDCs), i.e. CD8+ cDCs (also known as resident DCs) and signal 
regulatory protein α (SIRPα)+ cDCs (also known as migratory DCs). The third subset is 
plasmacytoid DCs (pDCs) (Klein et al., 2014; Perry and Hsieh, 2016; Wu and 
Shortman, 2005). The intrathymically developed CD8+ cDCs comprise ~50% of all 
thymic DCs, whereas the extra-thymically developed SIRPα+ cDCs and plasmacytoid 
DCs that migrate to the thymus account for 20% and 30%, respectively, of all thymic 
DCs (Oh and Shin, 2015; Wu and Shortman, 2005).  
 
Thymic DCs can acquire antigens from mTECs, from the blood, or from peripheral 
tissues and home to the thymus (Oh and Shin, 2015). SIRPα+ migratory DCs found in 
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CMJ perivascular space and around small vessels, have been shown to be able to 
present blood-borne antigens (Baba et al., 2009). CD8+ resident cDCs are found 
predominantly in the thymic medulla (Klein et al., 2014; Lei et al., 2011). Plasmacytoid 
DCs (and potentially SIRPα+ DCs) can transport peripheral (extrathymic) antigens and 
migrate to the thymus to promote tolerance (Bonasio et al., 2006; Hadeiba et al., 
2012). 
 
Self-antigens can be presented directly by BM-APCs or mTECs (direct presentation), 
or indirectly presented via antigen transfer from mTECs to BM-APCs (indirect 
presentation), to induce tolerance. An early BM chimera experiment showed that 
superantigen-reactive Vβ17α+ T cells were reduced when MHCII I-E expression was 
confined to BM-APCs but not when I-E expression was confined to radioresistant 
thymic epithelium, suggesting that BM-APCs are important in clonal deletion (Marrack 
et al., 1988). Later studies showed that MHCII-deficiency on BM-APCs (Hinterberger et 
al., 2010; van Meerwijk et al., 1997) or in vivo ablation of CD11c-expressing DCs using 
a diphtheria toxin a chain transgene (Ohnmacht et al., 2009) resulted in increased 
CD4SP thymocytes. These findings indicate the role of BM-APCs, in particular DCs, in 
mediating clonal deletion.  
 
Based on TCRα sequencing in mice with a fixed transgenic TCRβ, 20% of CD4SP 
TCRs were found to depend on MHCII+ BM-APCs for deletion (Perry et al., 2014). The 
TCRs dependent on MHCII+ BM-APCs for deletion were partly distinct from the TCRs 
that were dependent on high MHCII expression in mature mTECs, revealing the non-
redundant roles of BM-APCs and mTECs in inducing negative selection (Perry et al., 
2014).  
 
Antigen transfer (also called indirect presentation or antigen handover) from mTECs to 
BM-APCs is an important antigen-presenting mechanism underlying negative selection 
in the thymus. APCs purified from the thymus can induce T cells to proliferate in vitro, if 
they present a peptide that is recognised by the T cells. In such an assay, purified 
thymic DCs were found to stimulate more T-cell proliferation than purified mTECs, even 
when the peptide was expressed within mTECs and not DCs (Koble and Kyewski, 
2009). This suggests that antigen handover can "amplify" the T-cell stimulatory 
capacity of mTEC-derived self-antigens. In vivo studies have shown that some mTEC-
derived self-antigens require antigen handover in order to induce thymocyte deletion 
(Aichinger et al., 2013; Hubert et al., 2011; Taniguchi et al., 2012). Antigen handover is 
also important for T-reg selection in the thymus, as a TCR sequencing approach 
revealed that almost half of the TCRs that required Aire to undergo T-reg 
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differentiation, also required MHCII+ BM-APCs in order to meet this fate (Perry et al., 
2014). It is thought that CD8+ cDCs can contribute to indirect presentation in the 
thymus. This is because mTECs are the only thymic stromal cells that express the Aire-
dependent XC-chemokine ligand 1 (XCL1) and XCL1 is important in localising DCs in 
the medulla, and CD8+ cDCs express the XCL1 receptor (Lei et al., 2011). 
Furthermore, Perry et al. (2014) also showed a role for Batf3 (Basic Leucine Zipper 
ATF-Like Transcription Factor 3)-dependent CD8+ cDCs in inducing negative selection 
by indirectly presenting Aire-induced self-antigens to thymocytes. 
 
The above studies (sections 1.9.2 and 1.9.3) revealed the roles of mTECs and/or BM-
APCs in mediating thymic medullary negative selection, either via direct presentation or 
indirect presentation (antigen handover mechanism). As increases in CD4SP 
thymocytes were observed when mTECs and/or BM-APCs were defective, it was 
inferred that these APC types mediate negative selection at or around the DP-SP 
transition. However, these studies did not directly measure negative selection by using 
markers of negatively selected thymocytes, such as Helios or Nur77. It remains unclear 
which thymic APC is important in mediating the large amount of negative selection that 
occurs at wave 1 and whether different APC types are required to mediate waves 1 
and 2 negative selection during thymocyte development.   
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1.10 Aims 
 
The contributions of thymic APC types to negative selection have largely been focused 
at the mature CD4SP developmental stage. It remains elusive whether different APC 
types mediate negative selection at different stages of thymocyte development. 
Although the proportion of thymocytes undergoing apoptotic deletion has been studied, 
the proportions of positively selected and negatively selected thymocytes responsive to 
MHCI or MHCII, remain unclear. Finally, the TCR repertoires that provoke positive or 
negative selection in response to one MHC class, or in the absence of both MHC 
classes, have not been defined. 
 
This thesis aimed to dissect thymic negative selection mechanisms by examining: 
i) the role of thymic APC types (MHCII+ BM-APCs versus Aire) in thymic 
negative selection (Chapter 3); 
ii) the role of MHC Class I and MHC Class II in inducing TCR signalling and 
thymic negative selection (Chapter 4); and 
iii) the comparison between TCR repertoires in wild-type mice and in mice 
lacking one or both MHC classes using a TCR sequencing approach 
(Chapter 5).  
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CHAPTER 2 
 
Materials and methods 
 
 
  
	 38 
  
	 39 
2.1 Mice 
 
All mice used in this study were bred and housed in the Australian Phenomics Facility 
(APF), The Australian National University (ANU), Canberra. The strains used were 
B10.BR (H-2k); C57BL/6 (H-2b); 3A9 TCR (Ho et al., 1994), insHEL and thyroHEL 
(initially called ILK-3 and TLK-2, respectively) (Akkaraju et al., 1997) ; Bim–/– 
(Bcl2l1tm1Ast); Tg(Vav-BCL2)1Jad (called Bcl-2 Tg here) (Ogilvy et al., 1999); Aire–/– 
(Airetm1Pltn); B2m–/– (B2mtm1Jae); H2-Aa–/– (H2-Aatm1Blt); Tcra–/– (Tcratm1Mom) and Yae62b 
transgenic mice (62b-Tg, with a transgenic TCRβ chain) (Stadinski et al., 2011). Mice 
were genotyped for transgenes and mutations by the APF Genotyping Laboratory 
using PCR assays. Mice were used between 7 and 28 weeks (predominantly between 
10 and 16 weeks) after birth. All mice were hemizygous for the 3A9, insHEL, thyroHEL, 
Bcl-2 Tg and 62b-Tg transgenes. The Animal Experimentation Ethics Committee of the 
ANU approved all procedures. 
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2.2 Materials 
 
2.2.1 Antibodies  
 
Table 2.1. List of extracellular antibodies for flow cytometry 
Extracellular 
Antibody 
Clone Conjugate Vendor 
Anti-mouse CD4 RM4-5  F700 Biolegend,  
BD Pharmingen* 
Anti-mouse CD4 GK1.5 FITC BD Biosciences 
Anti-mouse B220 RA3-6B2 APC BD Biosciences 
Anti-mouse CD8 53-6.7 APC-Cy7 
 
Biologend 
Anti-mouse CD197 
(CCR7) 
 
4B12 
 
APC eBioscience 
Biotin, PE Biolegend 
Anti-mouse CD5  
 
53-7.3 APC eBioscience 
Biotin, PerCP BD Biosciences 
Anti-mouse CD24 M1/69 PerCPCy5.5 eBioscience 
Anti-mouse CD45.1 A20 FITC, PE BD Pharmingen 
Anti-mouse CD45.2 104 
 
APC eBioscience 
Pacific Blue Biolegend 
PerCP BD Pharmingen 
Anti-mouse CD69 
 
H1.2F3 
 
Biotin BD Pharmingen 
FITC BD Biosciences 
Anti-mouse CD11b M1/70 FITC BD Biosciences 
Anti-mouse CD11c N418 APC Cy7 Biolegend 
Anti-mouse OX40 OX-86 PE Biolegend 
Anti-mouse PD-1 
(CD279) 
29F.1A12 BV421 Biolegend 
J43 PE eBioscience 
Anti-mouse TCRβ H57-597 
 
Biotin BD Pharmingen 
FITC, 
PerCPCy5.5 
eBioscience 
Anti-mouse I-A/I-E 
(MHC Class II) 
M5/114.15
.2 
 
APC  Biolegend 
eFlour 450 eBioscience 
**Streptavidin- - BV605 Biolegend 
7-AAD viability staining 
solution 
- - BD Biosciences 
Anti-mouse IgG1  A85-1 Biotin BD Pharmingen 
Anti-mouse B220 APC RA3-6B2 BD Biosciences 
1G12  1G12 hybridoma cells obtained from American Type 
Culture Collection (ATCC) were cultured in 5% FCS-RPMI 
until the medium was exhausted. Tissue culture 
supernatant was then harvested, azide was added at 0.1% 
(m/v) and stored at -20°C until use.  
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Table 2.2. List of intracellular antibodies for flow cytometry 
Intracellular antibody Clone Conjugate Vendor 
Anti-mouse FoxP3 FJK-16s FITC 
eFlour 450 
PerCP-Cy5.5 
eBioscience 
Anti mouse/human 
Helios 
22F6 FITC 
Pacific blue 
PE 
Biolegend 
Anti-Cleaved Caspase-
3 (Asp 175) rabbit 
monoclonal antibody 
D3E9 AF488 
AF647 
Cell Signalling 
Technology 
Abbreviations for Table 2.1 and 2.2: AF, alexa fluor; APC, Allophycocyanin; APC-Cy7, 
Allophycocyanin and cyanine 7 tandem conjugate; BV, Brilliant Violet; FITC, 
Fluorescein isothiocyanate; IgG1, Immunoglobulin isotype G1; PE, Phycoerythrin; 
PerCP, Peridinin chloroplast protein; PerCP-Cy5.5, peridinin-chlorophyll-protein and 
cyanine 5.5 tandem conjugate; 7-AAD, 7-aminoactinomycin D.  
 
*compulsory to use when staining TCR3A9 Tg cells. This is because the comparable 
reagent purchased from BioLegend contains mouse IgG1, being harvested from 
ascites fluid in mice. Since the 1G12 antibody is also a mouse IgG1, the non-specific 
mouse IgG1 in the BioLegend reagent absorbed anti-mouse IgG1 during the final layer 
of extracellular staining, preventing detection of 1G12-labelled cells.  
 
**to detect biotinylated antibodies. 
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2.2.2 Solutions, chemicals or buffers (unless specified in section 2.3) 
 
1× Phosphate buffered saline (PBS) (The John Curtin School of Medical Research 
(JCSMR) Media Facility) 
 
Dulbecco’s PBS (also known as commercial PBS) (Sigma) 
 
Roswell Park Memorial Institute RPMI-1640 medium (Gibco or Sigma) 
 
Heat-inactivated fetal calf serum (FCS) (Sigma)  
 
Heat-inactivated bovine serum (BS) (Thermo Fisher Scientific) 
 
Bovine serum albumin (BSA) (Bovogen Biologicals) 
 
16% Paraformaldehyde (formaldehyde) aqueous solution (Electron Microscopy 
Sciences) 
 
RNAse Zap (Ambion or Invitrogen) 
 
Agarose, Molecular Grade (Bioline) 
 
EDTA (Sigma or VMR) 
 
Sodium azide solution 10% (Australian Chemical Reagents, ARC) 
 
Trypan blue solution 0.4% (Sigma)  
 
Culture supernatant from the 1G12 hybridoma (specific for TCR3A9; American Type 
Culture Collection), diluted 1 in 4 with FACS buffer during flow cytometry staining. 
 
Turks solution 
2% (v/v) acetic acid and 0.01% crystal violet in deionised water. 
 
FACS buffer PBS containing 2% (v/v) heat-inactivated bovine serum and 0.01% (v/v) 
sodium azide solution. 
 
FACS sort buffer 
Commercial Dulbecco’s PBS containing 0.5% (v/v) 0.5M EDTA and 1% (v/v) FCS. 
 
Red blood cell (RBC) lysis buffer (10×) 
8.3 g ammonium chloride (Ajax Finechem, Thermo Fisher Scientific), 1 g potassium 
bicarbonate (Ajax Finechem, Thermo Fisher Scientific), 37 mg EDTA disodium salt 
(VWR) in 100 mL deionised water. Buffer was diluted with deionised water to 1× 
concentration prior to use and adjusted to pH 7.3 with hydrochloric acid solution.   
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Tris-borate-EDTA (TBE) buffer (10×) 
108 g Tris base (Trizma® base, Sigma), 55 g boric acid (Amresco, reorder from 
ASTRAC) and 40 mL 0.5M EDTA (pH8.0) were added in 2 L with MilliQ water. Buffer 
was diluted to 1× concentration with MilliQ water prior to use. 
  
2.2.3 Common consumables (unless specified in section 2.3) 
 
70 μm nylon cell strainer (Falcon) 
 
96-well round bottom plate (Corning) 
 
Flat 8 cap strips for 96-well PCR plate (Thermo scientific) 
 
96-well PCR Plates, skirted (green colour) (Eppendorf) 
 
Sterile filter pipette tips: 
10 μL; 1-20 μL; 1-200 μL; 1000 μL Maxymum Recovery (Axygen) 
 
Non-sterile non-filter pipette tips: 
White TXL-10 (0.1-10 μL); Yellow T-200-Y; Bluo\e T-1000-B (Axygen) 
 
15mL and 50mL tubes (Falcon) 
 
5 mL Polypropylene tubes (Falcon) 
 
0.5 mL and 1.5 mL microtubes (Axygen) 
 
Disposable sterile 5 mL, 10 mL and 25 mL pipettes (Corning and Coaster) 
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2.3 Methods 
 
2.3.1  Flow cytometry 
 
2.3.1.1 Isolation of thymocytes or splenocytes for flow cytometry 
 
Dissected thymus or spleen was collected in FACS buffer stored on ice, broken into 
single cell suspensions by mechanical agitation against a 70 uM cell strainer. Single 
cell thymocyte suspensions were mixed 1:20 with Turks solution for cell counting using 
haemocytometer. 3-4 × 106 thymocytes per well were added into a round-bottom 96 
well plate. Thymocytes were centrifuged at 1300 rpm, 8°C for 4 min. This is the 
standard centrifugal condition unless specified elsewhere.  
 
The standard sequence of antibody staining is as follow: Chemokine receptor CCR7 
labelling (section 2.3.1.2), 1G12 supernatant labelling (only for 3A9 transgenic TCRs) 
(section 2.3.1.3), extracellular antibody staining (section 2.3.1.4), intracellular antibody 
staining (section 2.3.1.5 or 2.3.1.6) and EdU staining (if required) (section 2.3.3).  
 
2.3.1.2 Chemokine receptor CCR7 labelling 
 
The cell pellet on 96-well plate was stained with 50 μL of CCR7-fluorochrome 
conjugated antibody for 60 mins, at 37°C in the dark. Cells were pelleted by 
centrifugation and were washed once with 150 μL of FACS buffer. If polyclonal cells 
were used, proceed to section 2.3.1.4. If 3A9 TCR transgenic cells were used, proceed 
to section 2.3.1.3. 
 
2.3.1.3 1G12 labelling  
 
After CCR7 labelling, if 3A9 TCR transgenic thymocytes were analysed, cells were 
incubated in 50 μL of culture supernatant from the 1G12 hybridoma (diluted with FACS 
buffer, 1 in 4) for 30 min at 4°C. Cells were pelleted by centrifugation. 
 
2.3.1.4 Extracellular antibody staining 
 
Cells were stained with 50 μL of extracellular antibody cocktail and/or or mouse IgG1 
(to detect 1G12) for 30 mins, at 4°C in the dark. Cells were pelleted by centrifugation 
and were washed once with FACS buffer.  
 
	 45 
2.3.1.5 Intracellular antibody staining 
 
Prior to intracellular antibody staining, cells were first fixed by adding 50 μL fixation 
buffer (containing 4× fixation concentrate diluted with fixation diluent, 1 in 4; 
eBioscience FoxP3 staining kit) into each well and incubated for 30 mins, at 4°C in the 
dark. Cells were pelleted by centrifugation and washed once with FACS buffer, 
followed by permeabilization in 50 μL of permeabilisation buffer (containing 10× 
permeabilisation buffer diluted with Milli-Q water, 1 in 10; eBioscience FoxP3 staining 
kit) for 10 mins at 4°C in the dark. Cells were pelleted by centrifugation and incubated 
with 50 μL of intracellular antibody cocktail, including streptavidin-BV 605 conjugate to 
detect biotinylated antibodies, for 30 mins, at 4°C in the dark. Cells were pelleted by 
centrifugation and washed once with 150 μL permeabilization buffer, and washed once 
with FACS buffer.  
 
2.3.1.6 Active caspase 3 intracellular staining 
 
If active caspase 3 staining was required, after extracellular staining in section 2.3.1.4, 
thymocytes were fixed and permeabilized using 100 μL BD Cytofix/Cytoperm fixation 
and permeabilization solution (BD Bioscience) for 10 min, at 4°C in the dark, followed 
by two washes with 150 μL BD Perm/Wash buffer (containing 10× Perm/Wash buffer 
concentrate diluted with Milli-Q water, 1 in 10). Cells were stained intracellularly with 
Cleaved Caspase-3 (Asp 175) rabbit monoclonal antibody (Cell Signalling Technology) 
for 30 min, at room temperature in dark, and washed once with 150 μL BD Perm/Wash 
buffer.  
 
2.3.1.7 Flow cytometry data acquisition  
 
Stained cells were resuspended in 40 μL FACS buffer per sample in each cluster tube. 
Single colour stained and unstained compensation controls were resuspended in 150 
μL FACS buffer. FACS samples were acquired by BD LSRFortessaTM or BD LSRII 
cytometer.  
 
 
2.3.2 Cell sorting 
 
Thymus or spleen was collected in 5 mL of FACS sort buffer. Single cell suspensions 
of thymocytes or splenocytes were obtained through 70 uM cell strainer in FACS sort 
buffer. Single cell suspensions were pelleted by centrifugation at 1300 rpm, 8°C for 4 
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min (standard centrifugal condition unless specified elsewhere). Splenocytes were 
lysed by adding 1 mL of 1× RBC lysis buffer for ~2-4 mins. Lysis reaction was stopped 
by topping up to 10 mL with FACS sort buffer. Cells were pelleted by centrifugation. 
The lysed splenocytes were washed again with FACS sort buffer and pelleted by 
centrifugation.   
 
Approximately 100 × 106 of thymocytes or splenocytes from each mouse were stained 
with 1.5 mL of extracellular antibody cocktail under similar condition and washed as 
described (section 2.3.1.4), except by using 4 mL FACS sort buffer in each wash.  The 
pelleted stained cells were resuspended in 1.5 mL of FACS sort buffer and filtered via 
70 nμ nylon cell strainer into a 5 mL polyprolylene tube prior to cell sort. Cells were 
sorted using BD FACSAria I and FACSAria II cell sorters (BD biosciences). Sorted cells 
were collected in polyprolylene tube containing 500 μL FCS. 
 
 
2.3.3 In vivo EdU pulse labelling  
 
5-ethynyl-2’-deoxyuridine (EdU) is a thymidine analogue that is incorporated into DNA 
during DNA synthesis (Fig. 2.1) (Salic and Mitchison, 2008). EdU labelling was 
performed using Click-iT® EdU AF488, AF647 or Pacific Blue Flow Cytometry Assay 
Kits (Molecular Probe Life Technology) according to the manufacturer’s instructions 
with slight modification. All reagents are provided in the kits unless specified.  
 
Briefly, 0.25 mg EdU was injected intraperitonally (0.1 mL of a 2.5 mg/mL m/v in DMSO 
solution (Sigma)) into each mouse. 1h to 7 days post-EdU injection, thymus was 
collected. After intracellular staining as described above (section 2.3.1.5 or 2.3.1.6), 
cells were washed in 150 μL 1% (w/v) bovine serum albumin (BSA) in PBS (1% BSA-
PBS, not from kit). Thymocytes were refixed with 50 μL of 4% (v/v) paraformaldehyde 
(PFA) in PBS for 5 min at room temperature, and were centrifuged and washed with 
150 μL 1% BSA-PBS. Cells were then re-permeabilised with 150 μL permeabilisation 
buffer (containing 10× saponin-based permeabilisation buffer diluted with 1% BSA-
PBS, 1 in 10). Cells in each well were resuspended in 100 μL of fresh Click-iT® 
reaction buffer containing 95.5% of 1× PBS, 2% 100 mM copper sulphate, 2% 1× 
Click-iT® EdU buffer additive (Component G, which was used at one-fifth of the 
concentration recommended), 0.5% of azide conjugated with fluorescent dye. Cells 
were incubated for 30 min at room temperature, in the dark. The buffer addictive 
reduces Cu2+ ions into Cu+ ions. Cu+ ions catalyse the covalent reaction between azide 
(that is coupled to a fluorescent dye) and alkyne (that is found in the ethynyl moiety of  
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Figure 2.1. Click-iT® reaction between EdU and azide-conjugated with 
flurorescent dye. The detection of EdU is based on a click reaction. The EdU 
incorporated into the DNA contains an alkyne. Azide is conjugated to a fluorescent dye 
for detection. Upon the addition of buffer addictive and copper sulphate, copper (I) 
causes the alkyne in EdU to react with the azide conjugated with fluorochrome, to form 
a stable triazole ring, enabling EdU detection using flow cytometry. The small size of 
the detection azide allows the use of mild conditions to access the EdU incorporated 
into the DNA. Adapted from EdU manual (Molecular Probes) (revised July 2010, 
MP10044). 
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EdU) (Salic and Mitchison, 2008) (Fig. 2.1). 100 μL of Click-iT® reaction buffer without 
azide component was added to the single stained and the unstained compensation 
controls for flow cytometry. After incubation, cells were washed once with 
permeabilisation buffer, and washed once with 1% BSA-PBS, and resuspended in 
FACS buffer for flow cytometry. 
 
 
2.3.4 Thymic stromal cell Isolation for individual thymus 
 
This procedure was performed as previously described with adaption (Gray et al., 
2002). Fat and connective tissue of each thymus were trimmed off thoroughly. Each 
thymic lobe was dissected. The capsule of each lobe was nicked 6-10 times on both 
sides (top and bottom) with fine scissors (Kaisers). Each thymus was agitated in 3 mL 
of RPMI using a wide-bore transfer pipette to gently flush out thymocytes until the 
media was visibly cloudy. The supernatant (containing thymocytes) was collected and 
kept on ice. The thymic fragment (pellet) was incubated at 37°C for 15 min in 2 mL 
digestion buffer containing 0.125% (w/v) Collagenase D (from Clostridium histolyticum, 
Roche Diagnostics) and 0.5 mL of 0.1% (w/v) DNAse I (from Bovine pancreas (grade 
II), Roche Diagnostics) in RPMI. The thymic fragments were with agitated gently using 
wide-bore transfer pipette for 12 times at every 5 min during the 15 min incubation 
interval. After 15 min, fragments were allowed to settle. The supernatant was collected 
(and labelled as “Digest 1”) and kept on ice. The same digestion buffer was added into 
the remaining settled thymic fragments and incubated for 15 min with gentle agitation 
every 5 min, and the supernatant collected was and labelled as “Digest 2”). This 
digestion procedure was repeated for a third time, supernatant collected was labeled 
as “Digest 3”. Digest 1, 2 and 3 were kept on ice. 
 
After 3 digestions, the remaining aggregates were incubated in 3 mL of digestion buffer 
containing 0.125% (w/v) Collagenase/Dispase (from Vibrio alginolyticus/ Bacillus 
polymyxa, Roche Diagnostics) and 0.3 mL of 0.1% (w/v) DNAse I in RPMI for 20-25 
min, with gentle agitation every 5 min during the incubation interval. The supernatant 
was collected and pooled with “Digest 3”, and were centrifuged at 1200 rpm, 8°C for 5 
min. The pellet was resuspended in 1 mL cold EDTA/FACS buffer (containing 5mM 
EDTA in PBS, 5% FCS and and 0.1% NaN3). Cells were filtered through 100 μm cell 
strainer and counted by mixing with Turks solution (1 in 20). Approximately 3-4 × 106 
cells per well were stained for flow cytometry. 
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2.3.5 Generation of bone marrow chimeras 
 
2.3.5.1 Isolation and freezing of bone marrow cells  
 
Bones from the tibia, femur and pelvis of mice were collected, while muscles attached 
to the bones were removed using scissors and forceps in a laminar flow cabinet. Bones 
were then immersed in RPMI medium containing 5% FCS (FCS-RPMI) and stored at 
4°C. Bone marrow (BM) was harvested by flushing out cells using 1 mL syringe and 26 
Gauge needle under sterile condition. Single cell suspensions were prepared by 
teasing the tissues apart through a 70 μm nylon cell strainer with a 1 mL syringe 
plunger. BM cells were topped up to 20 mL with FCS-RPMI. BM cells were counted on 
haemocytometer using Turks solution. Cells were pelleted by centrifugation for 10 min, 
1200 rpm, at 8°C. Cells were resuspended in 3 mL of BM freezing media comprising 
FCS and 10% (v/v) of DMSO, and were added into two Nunc vials, 1.5 mL per vial. The 
vials were placed in dry ice for ~10 mins, followed by storage at -80°C. 
 
2.3.5.2 Thawing of frozen BM 
 
Frozen BM were quick thawed by immersion in a 37°C waterbath.  BM cells for each 
vial were resuspended in 13.5 mL of RPMI with 5% FCS for counting. BM cell 
suspensions was mixed with Trypan blue (1:1 dilution). The non-blue (i.e. colourless) 
cells, identified as the viable marrow cells, were counted using haemocytometer under 
the microscope. Absolute cell number was determined. Cells were pelleted by 
centrifugation for 10 mins, 1200 rpm, at 8°C and resuspended with 1x commercial PBS 
and filtered using 70μm nylon cell strainer. 
 
2.3.5.3 Mouse irradiation 
 
Mice (minimum 8 weeks of age) to be irradiated were fed with blue antibiotic water 
containing polymyxin, neomycin and blue dye, at least 48h before irradiation. Mice 
were sub-lethally irradiated for 2 doses at 450 cGy, with the second dose 4h apart from 
the first irradiation dose. This is to deplete the recipients’ haematopoietic cells. Mice 
were heated under a lamp for ~2 mins. A minimum of 2 × 106 BM cells, resuspended in 
commercial 1x PBS, were injected intravenously (iv) into each recipient mouse. Mice 
were allowed to recover for a four to six-week period before analysis.  
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2.3.6 High-throughput sequencing of TCRα chains 
 
2.3.6.1 RNA extraction  
 
50,000 cells of each FACS sorted population (CD4lo CD8lo PD1hi CCR7–, non- DN 
CD4SP CCR7+ and non- DN CD8SP CCR7+ thymocytes, or splenocytes TCRβ+ B220– 
Fig. 5.2) were extracted for RNA using RNAeasy Kit (Qiagen) according to the 
manufacturer’s instructions with slight modifications. Briefly, sorted cells were pelleted 
by centrifugation in 1.5 mL microcentrifuge tubes. 350 μL of Buffer RLT was added 
followed by a quick 10 sec votex to disrupt the membrane of the cells. 350 μL of 70% 
ethanol was added to the lysate, and mixed well by pipetting.  700 μL of the sample 
were transferred to a RNeasy Mini spin column containing silica-based membrane 
placed in a 2 mL collection tube. The column was centrifuged for 1 min at ≥8000 x g 
(standard centrifugation condition in section 2.3.6.1 unless specified). The flow-through 
was discarded. 700 μL Buffer RW1 was added to the column followed by centrifugation 
and removal of the flow-through.  500 μL Buffer RPE was added to the column and 
centrifuged. The flow-through was discarded. 500 μL Buffer RPE was added again to 
the column, but was centrifuged for 2 min at ≥8000 x g. Column was centrifuged at full 
speed for 2 min to dry the membrane. The column was placed in a new 1.5 mL 
collection tube. Finally, 23 μL RNase-free water was added directly to the centre of 
column membrane and centrifuged to elute the RNA. The purity and concentration of 
RNA were determined using Nanodrop 2000c Spectrophotometer (Thermo Scientific) 
by using 1 μL of extracted RNA. 
 
2.3.6.2 cDNA synthesis  
 
cDNA from the extracted RNA was generated using iScriptTM cDNA Synthesis Kit (Bio-
Rad), stored at -20°C. In each reaction, 15 μL RNA template (max 1 μg total RNA) was 
added to 5 μL of master mix containing 1 μL iScript reverse transcriptase and 4 μL of 
5x iScript reaction mix, summing up to a total volume of 20 μL per reaction. A negative 
control containing 5 μL of master mix and 15 μL of ultrapure nuclease-free distilled 
water (Invitrogen) was included. cDNA was synthesised using polymerase chain 
reaction (PCR) Mastercycler ep Gradient S (Eppendorf) with the following conditions: 1 
cycle at 25°C for 5 min, 1 cycle at 42°C for 30 min, 1 cycle at 85°C for 5 min and on 
hold at 4°C.   
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2.3.6.3 PCR amplification of TCRα chain (first PCR) 
 
The TCRα chain sequence of the synthesised cDNA was amplified using Q5® High 
Fidelity PCR Kit (New England BioLabs Inc), 14 forward internal primers and one 
reverse internal primer (GeneWorks) (Table 2.3) specific for TCRα chain (Fig. 2.2A). 
Each individual forward primer stock was reconstituted to 70 μM. Each of the 14 
forward primers was combined (14 forward primers × 5 μL of each) in a 0.5 mL 
microtube, collectively known as TRAV (TCRα chain variable region) forward primers, 
to a working stock concentration of 5 μM. The reverse primer is also known as TRAC 
(TCRα chain constant region) primer. The working stocks of forwards and reverse 
primers were stored at -20°C. Some of the TRAV primers are degenerate primers, 
which are defined as a mix of oligonucleotide sequences in which some positions 
contain a number of possible bases, giving a population of primers with similar 
sequences that cover all possible nucleotide combinations for a given protein 
sequence (Iserte et al., 2013). 
 
The forward primers and reverse primers contain a 5’ adapter sequence which was 
used as a target, in a second PCR amplification (also known as indexing PCR, section 
2.3.6.6), for the addition of sample-specific “barcodes” plus P5/P7 sequences to 
facilitate binding of amplicons to the Illumina flowcell (Fig. 2.2A, B).  
 
In each reaction, 5 μL cDNA template was added to 20 μL of master mix containing 
12.5 μL of Q5® High-fidelity 2× master mix, 0.25 μL of 5 μM forward primers, 0.25 μL of 
5 μM reverse primer and 7 μL of nuclease-free water, constituting a total of 25 μL per 
reaction (or per sample). The TCRα chain was PCR amplified using Mastercycler ep 
Gradient S (Eppendorf) with the following conditions: 1 cycle at 98°C for 5 min; 
followed by 35 cycles of 95°C for 30 sec, 55°C for 30 sec, 72°C for 1 min; 1 cycle at 
72°C for 5 min, and on hold at 4°C. Amplified cDNA samples were stored at -80°C if 
not used immediately for indexing PCR (section 2.3.6.6). 
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Table 2.3 Sequences of 14 Vα forward internal primers and one Cα reverse 
primer  
Primer name Sequence (5’ to 3’) 
Forward primers 
TRAV1 INT ADP TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG CTC CAC ATT CCT GAG CC 
TRAV2 INT ADP TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG ACT CTG AGC CTG CCC T 
TRAV5(D)-4 INT ADP TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG AGA ATC CTA AGC TCA TCA TTG AC 
TRAV6.5_6.6(D) INT 
ADP 
TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG GTK CRR TAT CCY GGA GAA GGT C 
TRAV8 INT ADP TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG AGA GCC ACC CTT GAC AC 
TRAV11 INT ADP TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG AAC AGG ACA CAG GCA AAG 
TRAV12 INT ADP TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG GGT TCC ACG CCA CTC 
TRAV13 INT ADP TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG CCT TGG TTC TGC AGG AG 
TRAV14 INT ADP TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG CTC TGA CAG TCT GGG AAG G 
TRAV15 INT ADP TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG AYT CTG TAG TCT TCC AGA AAT CAC 
TRAV16 INT ADP TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG ATT ATT CTC TGA ACT TTC AGA AGC 
TRAV18 INT ADP TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG CAA GAT TTC ACC GCA CG 
TRAV19 INT ADP TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG GCT GAC TGT TCA AGA GGG A 
TRAV21 INT ADP TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG AAT AGT ATG GCT TTC CTG GC 
Reverse primer 
TRAC INT ADP GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG 
ACA GGC ACA TTG ATT TGG GAG TC 
All primers were ordered from GeneWorks, with the 3’ portion of the sequences based 
on Dash et al. (2011) with modifications by those authors, communicated with 
permission to the host laboratory by Nicole La Gruta, Monash University, Melbourne, 
Australia. Nucleotide symbols in bold represent 5’ overhang adapter sequence, which 
allows the binding of index adapter primers, adopted by Mandeep Singh and Yogesh 
Jeelall in the host laboratory. 5’ TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA 
CAG, Read 1 adapter; 5’ GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA 
G, Read 2 adapter. 
 
Mixed (or degenerate) base codes according to The International Union of Pure and 
Applied Chemistry (IUPAC): R(A or G), Y(C or T), K(G or T). 
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Figure 2.2. Primers and region of interest for PCR amplifications and 
sequencing of TCRα chain. (A) CDR3 region of TCRα chain, consists of TRAV, 
TRAV-TRAJ junction and TRAJ, was amplified via first round of PCR using 14 TRAV 
forward primers and one TRAJ reverse primer. Each of the forward and reverse 
primers contains a 5’ overhang adapter sequence (red). First round PCR also adds 5’ 
overhang adapter sequences to the PCR amplified region. (B) Second round of PCR 
known as indexing PCR add sequencing adapters to the CDR3 region of TCRα chain 
to barcode each sample prior to sequencing. Each sequencing adapter contains (i) a 
P5 (green) or P7 adapter sequence (purple) to make template compatible to flow cell, 
(ii) unique 8-bp index 1 or index 2 sequence (blue), and (iii) sequence that binds to 5’ 
overhang adaptor sequence, also known as read 1 or read 2 sequencing primer (R1SP 
and R2SP, respectively) (red). (C) After the second PCR, the sample is ready for a 2 x 
250 bp paired-end sequencing using Illumina MiSeq. The read sequence in forward 
direction up to 250 bp (known as Read 1, R1), the read sequence in reverse direction 
up to 250 bp (known as Read 2, R2). Information obtained from Illumina Adapter 
Sequences (February 2016, Document # 1000000002694 v01), and Illumina Data 
sheet: DNA Sequencing Nextera® DNA Library Preparation Kits (January 2016). 
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2.3.6.4 Gel electrophoresis of amplified TCRα chain  
 
To confirm the successful amplification of TCRα chain (after first PCR, section 2.3.6.3), 
or successful indexed cDNA samples (second PCR, section 2.3.6.6), 2% (w/v) agarose 
gel was prepared by mixing 2g of agarose powder with 100 mL of 1× TBE buffer and 
microwaved for 2 min until the gel was completely dissolved. Gel was slightly cooled 
down before adding 1 μL of 10x GelRedTM nucleic acid gel stain (Biotium) into the gel to 
enable DNA viewing. Gel was poured into a gel cast with combs and left for at least 30 
mins to solidify. 5 μL of amplified DNA or 5 μL of Quick-Load® Purple 2-Log DNA 
ladder (0.1-10kb bp, Fig. 2.3) (NEB) was mixed with 1 μL of 6× gel purple loading dye 
(NEB), and loaded into each gel well. Gel was run at 120 volts for ~1h in 1x TBE 
running buffer. Gel was viewed under UV transilluminator (GeneGenius Bioimaging 
System) and image was taken to determine the size of each band based on the DNA 
ladder loaded. PCR product between 300-400bp was expected after the first PCR, 
whereas product size between 500-600bp was expected after the second PCR. 
 
 
 
Figure 2.3. The mass and size of individual fragment of 19 fragments of Quick-
Load® Purple 2-Log DNA ladder (NEB).   
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2.3.6.5 Post-PCR clean up  
 
To remove oligonucleotides <100bp in length, amplified cDNA (section 2.3.6.3) or 
amplified indexing cDNA samples (section 2.3.6.6) were “cleaned up” using AMpure 
XP beads (Beckman Coulter) (Fig. 2.4). The Agencourt AMPure XP Reagent (brown 
colour) containing magnetic beads stored 4°C was left at room temperature for ~30 
min. The 96-well PCR plate containing the amplified products was centrifuged for 1 
min, at 1500 rpm. Beads were resuspended thoroughly before added into the amplified 
products at a ratio of 0.8, namely 20 μL of reagent containing beads into 25 μL of PCR 
product per well. The 96-well plate was placed onto a magnetic stand (Ambion) for 2.5-
3 min until the reagent turned clear. Supernatant was removed carefully without 
disturbing the bead pellet held on to the magnetic stand. While still on the magnetic 
stand, samples were washed twice with 200 μL of 80% ethanol ensuring the beads 
were fully covered. Beads were incubated for 30 sec in each ethanol wash before 
removing the ethanol with a pipette. The samples were left to dry for 15 minutes on 
magnetic stand. The plate was removed from the magnetic stand. Sample in each well 
was resuspended with 23 μL of ultrapure distilled water (Invitrogen), mixed thoroughly 
and incubated at room temperature for 5 min. The plate was placed onto the magnetic 
stand again and left for 5 min. While still on the magnetic stand, 20 μL of the 
supernatant was collected into a new 96-well PCR plate, preventing from capturing the 
beads. The cleaned up samples were stored at stored at -80°C if not used immediately. 
 
                
Figure 2.4. PCR product purification via Agencourt AMPure XP purification 
system. (1) Agencourt AMPure XP Reagent containing magnetic beads was left at 
room temperature for 30 min and (2) added to PCR amplicons to allow binding of PCR 
amplicons to magnetic beads. (3) PCR amplicons bound to magnetic beads held by a 
magnetic bar were separated from contaminants. (4) PCR amplicons were washed 
with ethanol. Steps 2-4 were repeated once. (5) Nuclease-free water was used to elute 
of PCR amplicons from the magnetic particles. (6) The purified PCR amplicons were 
transferred away from the beads into a new plate. Modified from Beckman Coulter 
website:  Agencourt AMPure XP - PCR Purification.   
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2.3.6.6 Indexing PCR (second PCR) 
 
Indexing PCR (limited-cycle amplification) was performed using the 96-sample 
Nextera™ Index Kit (Ilumina) that contains the following index primers: 
Index 1 Read 
5’ CAAGCAGAAGACGGCATACGAGAT[i7]GTCTCGTGGGCTCGG, which 
corresponds to 5’ P7 sequencing adapter [index 1] Read 2  
 
Index 2 Read 
5’ AATGATACGGCGACCACCGAGATCTACAC[i5]TCGTCGGCAGCGTC, which 
corresponds to 5’ P5 sequencing adapter [index 2] Read 1  
 
These index primers append the three following components: (1) Read 1 or Read 2 
sequencing primers (which were added into the beginning of each sequencing read; (2) 
two 8-bp index sequences (or dual index barcodes), which are index 1 (i7) and index 2 
(i5)) (Table 2.4), and (3) two Illumina sequencing adapters (P7 and P5 adapter), to 
each sample. Index 1 (i7) primers (orange caps) were used to add Read 2 sequencing 
primer, i7 index and P7 adapter (all adjacent to each other, Fig. 2.2B) to each sample. 
Index 2 (i5) primers (white caps) were used to add Read 1 sequencing primer, i5 index 
and P5 adapter (Fig. 2.2B) to each sample. This kit contains 12 different Index 1 (i7) 
adapters (N701–N712), corresponding to columns (1-12) in a 96-well plate, as well as 
8 different Index 2 (i5) (N502-N508 and N517) adapters, corresponding to rows (A-H). 
This dual indexing therefore allows a sample to have a unique combination of indexes. 
In the Index adapter name, N or refers to Nextera XT sample preparation, 7 or 5 refers 
to Index 1 (i7) or Index 2 (i5), respectively. The 01-12 refers to the Index number 
(Table 2.4). 
 
Prior to the addition of indexing PCR master mix, 2.5 μL of one of the twelve i7 index 
primers was pipetted into each well of corresponding column, and 2.5 μL of one of the 
eight i5 index primers was pipetted into each well of the corresponding row. In short, 
each reaction for indexing PCR contained 2.5μL of i7 index primer, 2.5 μL of i5 index 
primer, 20 μL of the purified cDNA after first PCR (section 2.3.6.3), 25 μL of Q5 High-
fidelity 2× master mix, summed to a final volume 50 μL per reaction. 
 
The indexing PCR was performed using PCR Mastercycler ep Gradient S (Eppendorf) 
under the following conditions: 1 cycle at 72°C for 3 min, 1 cycle at 98°C for 30 sec; 
followed by 5 cycles of 98°C for 10 sec, 63°C for 30 sec, 72°C for 3 min; on hold at 
4°C. Indexed samples following PCR were cleaned up for the second time as 
described in section 2.3.6.5, except that 40 μL of beads were added to 50 μL of 
indexed PCR product. The purified indexed PCR products were subjected to gel 
electrophoresis (section 2.3.6.4). The remaining products were stored at -80°C. 
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Table 2.4 List of Index 1 (i7) and Index 2 (i5) sequences. Adapted from Illumina 
Adapter Sequences (October 2015, Document # 1000000002694 v00, page 10-11). 
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2.3.6.7 Pooling of TCRα chain cDNA library and sequencing 
 
2 μL of each purified indexed sample from section 2.3.6.6 was analysed on the 
LabChip® GXII (Perkin Elmer) by JCSMR Biomolecular Resource Facility (BRF) to 
determine the concentration and the size of individual cDNA segments (bands) per 
sample.  LabChip® GX is a high throughput microfluidics platform that performs high-
resolution, reproducible electrophoretic separation. The individual bands of cDNA of 
TCRα chain were estimated to be between 380 and 610 bp in each sample. The 
concentrations of cDNA with the size ranging from 380-610 bp in each sample were 
summed up to determine the total concentration of TCRα chain cDNA in each sample. 
 
5 μL of each purified indexed sample was diluted in the appropriate amount of water to 
give a final concentration of cDNA to 2 nM in each sample. 5 μL of 2 nM cDNA from 
each sample was pooled into a single library in a 1.5 mL microtube. This TCRα library 
was sent to BRF for TCRα deep sequencing using the Illumina MiSeq sequencer 
performing 250 paired-end read (Fig. 2.2C). 
 
 
2.3.7 Data analyses 
 
2.3.7.1 Flow cytometry data analysis 
 
Flowjo Tree Star 9.6.4 and 9.9 were used to analyse the flow cytometry data in fcs 
format. 
 
2.3.7.2 Statistical analyses 
 
PRISM 6 was used to perform the following statistical analyses: 
i) Unpaired Student’s t-tests;  
ii) Multiple t-tests without assuming a consistent standard deviation, but with 
correction for multiple testing using the Holm-Sidak method; 
iii) 1-way ANOVA with Tukey’s or Dunn’s post-tests; 
iv) 2-way-ANOVA with Tukey’s post-tests; 
v) r2 and two-tailed P values from the Pearson correlation coefficient 
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2.3.7.3 TCRα chain sequencing analyses  
 
i) PANDAseq  
PANDAseq (PAired-eND Assembler for Illumina sequences) software was used to 
assemble the raw TCRα chain Illumina paired-end sequence reads (forward read (read 
1) and reverse read (read 2)) in FASTQ file into a single sequence (Masella et al., 
2012). 
 
ii) MiTCR  
MiTCR (V-(D)-J mapping software) was used to convert the assembled sequencing 
reads into TCR “nucleotypes” by aligning to V and J segments of the Tcra locus 
(Bolotin et al., 2013).  
 
iii) VDJtools  
 
VDJtools software package (Version 1.0.9) was used to analysis TCR sequencing data 
after converting data in MiTCR format into VDJtools format. TCR sequencing data 
were analysed and reported using different routines in VDJtools (Shugay et al., 2015). 
The following VDJtools routines were used in Chapter 5: CalcBasicStats, Correct, 
FilterNonFunctional, CalcPairwiseDistances, ClusterSamples, SelectTop, 
TrackClonotypes, PoolSamples, OverlapPair, CalcSegmentUsage and 
CalcCdrAAProfile. Further detail on these routines is provided in Chapter 5.  
 
CalcPairwiseDistances and ClusterSamples routines used F pairwise similarities metric 
(formula below), which is the geometric mean of relative clonotype overlapping 
frequencies in first and second sample in pair, to measure how similar the TCR 
repertoire is between the two samples. 
 
The formula of F metric: Geometric mean of relative overlap frequencies 
 
 
Adapted from Shugay, M. (December 2015), vdjtools Documentation, Release 
SNAPSHOT. 
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2.3.7.4 CDR3α amino acid sequence analysis 
 
IceLogo software (http://iomics.ugent.be/icelogoserver/create) was used to provide 
visualisation of CDR3 amino acid sequences and intuitive comparison between two 
datasets (the experimental set and the reference set) (Colaert et al., 2009; Maddelein 
et al., 2015).  
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CHAPTER 3 
 
Contributions of MHCII+ BM-
APCs and Aire to the two 
waves of thymic negative 
selection 
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3.1 Introduction 
 
T cell clonal deletion occurs when strong binding to a thymic APC results in thymocyte 
death (Kappler et al., 1987). Strong TCR-signalling can trigger thymocyte deletion to 
prevent thymocytes with cross-reactive TCRs from becoming mature naive T cells 
(Huseby et al., 2003; Huseby et al., 2005; McDonald et al., 2015). Although thymocytes 
may be deleted at any stage after they first express an ab TCR (Baldwin et al., 1999), it 
is unclear whether deletion at different stages of T cell development requires distinct 
thymic APC subsets. 
 
The two major thymic APC types are TECs and BM-APCs. Medullary TECs (mTECs) 
express a broad array of tissue-specific self-antigens (TSAs), some of which are 
regulated by the transcription factor, Aire (Anderson et al., 2002; Derbinski et al., 2005; 
Sansom et al., 2014). MTEC-derived self-antigens can be presented to thymocytes by 
the mTECs directly (Hinterberger et al., 2010; Klein et al., 2001) or mTEC-derived self-
antigens can be presented indirectly via antigen handover to BM-APCs 
(Aschenbrenner et al., 2007; Gallegos and Bevan, 2004; Hubert et al., 2011; Koble and 
Kyewski, 2009; Taniguchi et al., 2012). In the thymus, BM-APCs, particularly DCs, can 
also present self-antigens that they express themselves (Apostolou et al., 2002), blood-
borne self-antigens (Atibalentja et al., 2009; Baba et al., 2009) or peripheral tissue 
antigens captured by migratory or plasmacytoid DCs in the periphery (Bonasio et al., 
2006; Hadeiba et al., 2012).  
 
The crucial role of BM-APCs in deletion has been revealed by studies demonstrating 
that depletion of BM-APCs, or defective MHCII expression on BM-APCs, markedly 
increases the number of CD4SP thymocytes (Ohnmacht et al., 2009; Shimoda et al., 
2006; van Meerwijk et al., 1997) or self-antigen-binding CD4+ T cells (Chu et al., 2010). 
While diminished MHCII expression within mature mTECs in C2TAkd mice 
(Hinterberger et al., 2010) and ablation of Aire-expressing mTECs also increases 
CD4SP thymocyte number (Metzger et al., 2013), no such effect is observed in Aire-
deficient mice (Anderson et al., 2002). In a TCRb transgenic mouse strain, TCRa chain 
sequencing of CD4+ Va2+ T cells revealed that 25% of TCRs are deleted by MHCII+ 
BM-APCs, whereas 7% of TCRs are deleted in an Aire-dependent manner (Perry et 
al., 2014). Almost half of the TCRs that required Aire also required MHCII+ BM-APCs to 
undergo deletion (Perry et al., 2014). While these findings show that MHCII+ BM-APCs 
and Aire have autonomous and cooperative roles in thymocyte deletion, it is unclear 
whether these APC types delete self-reactive T cells at distinct stages of thymocyte 
development.  
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The experiments described in this chapter aimed to quantify the contributions of 
MHCII+ BM-APCs and Aire to thymocyte deletion at the CCR7– and CCR7+ 
developmental stages, characterised respectively as “wave 1” and “wave 2” of 
thymocyte deletion. Two different types of experimental models were used. Some 
experiments used TCR transgenic models, which provide a setting in which the self-
reactive TCR and the self-antigen responsible for mediating thymocyte deletion are 
known. One advantage of TCR transgenic models is that the self-reactive thymocytes 
are identifiable, in this case using a monoclonal antibody, called 1G12, which binds to 
the 3A9 TCR (Van Parijs et al., 1998). The 3A9 TCR is stimulated by the MHCII 
molecule, I-Ak, complexed with the HEL46-61 peptide (Brooks et al., 1991). 3A9 TCR 
(TCR3A9) transgenic thymocytes are deleted earlier in development, and fewer T cells 
escape deletion, when membrane bound-HEL is expressed under the thyroglobulin 
(thyroHEL) promoter compared to the insulin (insHEL) promoter (Akkaraju et al., 1997; 
Liston et al., 2004a; Liston et al., 2004b). TCR3A9 thymocyte deletion by insHEL and 
thyroHEL is absolutely dependent on Aire (Liston et al., 2004a), but whether BM-APCs 
have roles in these deletion mechanisms had not been examined. The second type of 
experimental model examines mice with natural TCR repertoires. As these latter 
experiments rely on the use of Helios and CCR7, one goal of the TCR transgenic 
experiments was to compare findings based on the conventional approach of staging 
thymocyte deletion using CD4 and CD8 with an alternative approach that uses Helios 
and CCR7.  
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3.2 Results 
  
3.2.1 Crucial roles for MHCII+ BM-APCs in TCR3A9 transgenic thymocyte 
deletion mediated by insHEL and thyroHEL  
 
3.2.1.1 Differential escape from wave 1 deletion in insHEL versus 
thyroHEL mice with intact APCs  
 
To define the stages of T cell development at which insHEL and thyroHEL mediate 
deletion, thymocytes from 3A9 x insHEL or 3A9 x thyroHEL double-transgenic (Tg) 
mice were compared to 3A9 single-Tg and non-Tg controls (i.e. carrying neither 3A9 
nor HEL transgenes) using flow cytometry. In mice bearing the 3A9 TCR transgene, 
10-20% of thymocytes were stained by the 1G12 antibody, versus <0.05% of 
thymocytes in non-Tg mice (Fig. 3.1A), which indicates that the 1G12 antibody binds 
specifically to the 3A9 TCR (TCR3A9). TCR3A9+ FoxP3– thymocytes were analysed for 
CD4/CD8 expression to define different thymocyte maturation stages (Fig. 3.1B). All 
3A9 TCR Tg groups had similar numbers of TCR3A9+ FoxP3– thymocytes at the least 
mature CD4– CD8– double-negative (DN) stage (Fig. 3.1B). Compared to 3A9 mice, 
3A9 x insHEL mice had a 68% reduction in the number of DP cells and a 93% 
reduction in CD4SP cells (Fig. 3.1B, middle and right). The corresponding reductions in 
3A9 x thyroHEL mice were 88% at the DP stage and 99% at the CD4SP stage (Fig. 
3.1B). The use of CCR7 alone as a maturation marker yielded similar results, as 3A9 x 
insHEL mice had 61% fewer CCR7– cells and 92% fewer CCR7+ cells than 3A9 
controls (Fig. 3.1C). Compared to 3A9 mice, 3A9 x thyroHEL mice had 81% fewer 
CCR7– cells and 99% fewer CCR7+ cells than 3A9 mice (Fig. 3.1C). The difference in 
CCR7+ thymocyte number indicates that escape from wave 1 deletion is less common 
in 3A9 x thyroHEL mice than in 3A9 x insHEL mice (Fig. 3.1C). 
 
In 3A9 single-Tg mice without HEL antigen, Helios expression was significantly lower in 
the CCR7+ subset than in the CCR7– subset (Fig. 3.1D), consistent with Helios 
downregulation as thymocytes mature into naïve T cells (Daley et al., 2013). Compared 
to 3A9 single-Tg controls, Helios expression was significantly higher in 3A9 x insHEL 
thymocytes only at the CCR7+ stage (Fig. 3.1D). Helios expression was significantly 
higher in 3A9 x thyroHEL mice at both CCR7– and CCR7+ stages (Fig. 3.1D). 
Decreased escape from wave 1 deletion in 3A9 x thyroHEL mice was thus associated 
with high Helios expression in CCR7– thymocytes. 
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Figure 3.1. Differential escape from wave 1 deletion mediated by insHEL and 
thyroHEL self-antigens. (A) Representative flow cytometry plots show expression of 
the 3A9 TCR (TCR3A9) versus FoxP3 on thymocytes from non-Tg, 3A9, 3A9 × insHEL 
and 3A9 × thyroHEL mice, with gates enclosing the TCR3A9+ FoxP3– population. (B, C) 
TCR3A9+ FoxP3– population was analysed for CD4 and CD8 (B left) and Helios and 
CCR7 (C left). Column graphs show the number of TCR3A9+ FoxP3– cells per thymus at 
the indicated stages of development (middle). To visualise the extent of self-reactive 
thymocyte deletion within the different stages, line graphs (right) show the same data 
with the 3A9 group normalised to 100. (D) Helios relative fluorescence intensity (RFI) 
on CCR7– and CCR7+ subsets of TCR3A9+ FoxP3– thymocytes normalised to non-Tg 
FoxP3– DP thymocytes, as gated in (A, B).  (B-D) Columns or symbols show the group 
mean and error bars the SEM compiled from 3 independent experiments with a total of 
6-7 mice per group. Statistical analyses used one-way ANOVA (B, C) or (D) 2-way 
ANOVA and Tukey’s post-tests; only statistical significant P values are shown with 
symbols: * <0.05; ** <0.01; *** <0.001; **** <0.0001. 
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Bim–/– mice were used to investigate the consequences of an apoptosis defect on 
thymocyte deletion in the two models. Mixed chimeras were generated by 
reconstituting non-Tg, insHEL and thyroHEL hosts with 5% Bim–/– TCR3A9 (CD452/2) 
and 95% Bim+/+ (CD451/1 or CD451/2) BM. Among CD452/2 (Bim–/–) TCR3A9+ FoxP3– 
thymocytes, compared to non-Tg and insHEL hosts, thyroHEL hosts had a significantly 
lower frequency of CCR7+ cells (Fig. 3.2A). This indicates that thyroHEL recognition 
prevented the self-reactive thymocytes from fully upregulating CCR7, whereas insHEL 
recognition did not (Fig. 3.2A). ThyroHEL hosts had the highest frequency of 
CD4loCD8lo cells among Bim–/– TCR3A9+ FoxP3– thymocytes and also induced the 
highest level of PD-1 expression (Fig. 3.2B, C). Since thyroHEL induced coreceptor 
dulling and high PD-1 expression, which are the hallmarks of strong TCR-signalling at 
wave 1 (Daley et al., 2013; McCaughtry et al., 2008), and thyroHEL recognition 
prevented self-reactive thymocytes from upregulating CCR7, it is concluded that 
thyroHEL predominantly mediates deletion at wave 1. 
 
3.2.1.2 The insHEL and thyroHEL transgene products responsible for 
deletion are not BM-APC-derived 
  
3A9 thymocytes are not deleted when only the BM-APCs carry the insHEL transgene 
(Liston et al., 2005). To test whether BM-APCs carrying the thyroHEL transgene can 
mediate deletion directly, mixed chimeras were made by reconstituting non-Tg hosts 
with BM from non-Tg, insHEL or thyroHEL mice that was mixed 9:1 with 3A9 BM. Six 
weeks later, the CD4SP cell frequency among TCR3A9+ FoxP3– thymocytes was similar 
in all groups (~75%) (Fig. 3.3). This finding demonstrates that neither insHEL nor 
thyroHEL deletes 3A9 thymocytes via direct presentation by BM-APCs when the 
transgenes are confined to only the BM-APCs.  
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Figure 3.2. ThyroHEL but not insHEL triggers coreceptor dulling and PD-1 
upregulation when apoptosis is defective. Mixed BM chimeras were generated by 
reconstituting irradiated non-Tg (n=12), insHEL (n=13) or thyroHEL (n=9) hosts with a 
mixture consisting of 5% Bim–/– TCR3A9 BM (CD452/2) and 95% Bim+/+ BM (CD451/1 or 
CD451/2). Six week post-reconstitution, Bim–/– TCR3A9+ FoxP3– thymocytes were 
analysed for Helios and CCR7 (A left). (A) Summaries show frequency of CCR7– and 
CCR7+ cells among Bim–/– TCR3A9+ FoxP3– population (middle) and Helios RFI on 
CCR7– and CCR7+ subsets normalised to non-Tg FoxP3– DP thymocytes (right). (B) 
CD4/CD8 phenotype (left) and summary shows frequency of gated CD4loCD8lo, DP 
and CD4SP subsets among Bim–/– TCR3A9+ FoxP3– thymocytes (right). (C) 
Representative histogram of PD-1 expression on Bim–/– TCR3A9+ FoxP3– thymocytes. 
(A, B) Graphs show mean and error bars the SEM. Statistical analyses used one-way 
ANOVA and Tukey’s post-tests; only statistical significant P values are shown with 
symbols: ** <0.01; *** <0.001. 
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Figure 3.3: Neither insHEL nor thyroHEL mediates deletion when confined to 
only the BM-APCs. Irradiated non-Tg hosts (CD452/2) were reconstituted with non-
transgenic, insHEL or thyroHEL (CD451/1) BM mixed with 3A9 (CD451/2) BM at a ratio of 
9:1. Six weeks later, CD451/2 TCR3A9+ FoxP3– thymocytes were analysed for CD8/CD4 
phenotype (left) and the CD4SP cell frequency (group mean and error bars the SEM) 
was determined (right). 
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3.2.1.3 MHCII-deficiency within BM-APCs abrogates insHEL-mediated 
deletion and shifts thyroHEL-mediated deletion towards wave 2 
 
To test whether indirect presentation by BM-APCs (antigen handover mechanism from 
mTECs to BM-APCs, which present the antigen to thymocytes) influences thymocyte 
deletion by insHEL or thyroHEL, chimeras were generated using wild-type or MHCII-
deficient (H2-Aa–/–) 3A9 BM. InsHEL and thyroHEL hosts with wild-type BM-APCs had 
thymocyte CD4/CD8 and CCR7/Helios profiles (Fig. 3.4A, B) similar to non-chimeric 
3A9 x insHEL and 3A9 x thyroHEL mice (Fig. 3.1B, C), indicative of thymocyte deletion 
as expected.  
 
i) MHCII+ BM-APCs are essential for Helios induction and deletion in 
insHEL mice 
 
Strikingly, insHEL hosts with MHCII-deficient BM-APCs were indistinguishable from 
non-Tg hosts in terms of the number of DP and CD4SP (Fig. 3.4A) or CCR7– and 
CCR7+ thymocytes (Fig. 3.4B). Helios expression at CCR7– and CCR7+ stages was 
also indistinguishable between these two groups (Fig. 3.4C).  MHCII-deficiency within 
BM-APCs thus completely abrogates insHEL-mediated deletion. Taken together with 
the inability of BM-APCs to produce the self-antigen that mediates thymocyte deletion 
(Fig. 3.3), the data indicate that indirect presentation by MHCII+ BM-APCs is absolutely 
required for insHEL to induce Helios in, and delete, 3A9 thymocytes.   
 
ii) MHCII+ BM-APCs enhance Helios induction and are required for 
wave 1 deletion mediated by thyroHEL 
 
The number of CD4SP and CCR7+ thymocytes in thyroHEL hosts with MHCII-deficient 
BM-APCs was lower than in non-Tg hosts with MHCII-deficient BM-APCs, but higher 
than in thyroHEL hosts with wild-type BM-APCs (Fig. 3.4A, B). This finding suggests 
that MHCII+ BM-APCs enhance thyroHEL-mediated deletion at wave 1. MHCII-
deficiency within BM-APCs significantly decreased, but did not abolish, Helios 
induction in thyroHEL hosts (Fig. 3.4C).  
 
Considering all chimeras, the number of CCR7+ thymocytes was inversely correlated 
with Helios expression in CCR7– thymocytes (Fig. 3.4D). At one extreme, non-Tg 
hosts, as well as insHEL hosts of MHCII-deficient BM-APCs, had high numbers of 
CCR7+ thymocytes and low Helios expression in CCR7– thymocytes, a pattern 
consistent with the absence of thymocyte deletion (Fig. 3.4D). At the other extreme, 
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thyroHEL hosts with wild-type BM-APCs had low numbers of CCR7+ thymocytes and 
high Helios expression in CCR7– thymocytes, indicative of effective deletion at wave 1 
(Fig. 3.4D). In the intermediate zone, thyroHEL hosts with defective BM-APCs were 
clustered with insHEL hosts bearing wild-type BM-APCs (Fig. 3.4D).  
 
iii) Increased OX40 expression in self-reactive CCR7+ thymocytes 
compared to CCR7– thymocytes 
 
OX40 is a protein highly expressed in FoxP3+ T-reg cells (Takeda et al., 2004). OX40 
expression was low to undetectable in TCR3A9+ FoxP3– CCR7– thymocytes regardless 
of host genotype (Fig. 3.5A). When compared to the analysis of Helios expression 
above (Fig. 3.4B, C), it is evident that TCR3A9+ FoxP3– CCR7– thymocytes can 
upregulate Helios without upregulating OX40. In non-Tg hosts, most TCR3A9+ FoxP3– 
CCR7+ thymocytes were also negative for OX40, although a subset did express OX40 
at intermediate levels (Fig. 3.5A). Consistent with the Helios and CCR7 analyses (Fig. 
3.4B, C), OX40 expression in insHEL hosts with MHCII-deficient BM-APCs was 
indistinguishable from non-Tg hosts. In the other 3 groups of chimeras (i.e. insHEL 
hosts with wild-type BM-APCs, thyroHEL hosts with wild-type or MHCII-deficient BM-
APCs), a subset of TCR3A9+ FoxP3– thymocytes expressed OX40 at high levels (Fig. 
3.5A). In these 3 groups, cells that expressed OX40 at high levels tended to also 
express high levels of CCR7 (Fig. 3.5A). In self-reactive thymocytes, the capacity to 
express high levels of OX40 is associated with reaching the CCR7+ stage of 
development. 
 
ThyroHEL hosts with MHCII-deficient BM-APCs had a significant increase in FoxP3+ T-
reg cells compared to thyroHEL hosts with wild-type BM-APCs (Fig. 3.5B). Nascent 
FoxP3+ thymocytes are a mixture of CCR7– CD24+ and CCR7+ cells whereas non-
nascent thymic FoxP3+ cells are predominantly CCR7– CD24– cells (Hu et al., 2016). 
Among the TCR3A9+ FoxP3+ thymic T-reg cells, only the CCR7+ subset was significantly 
increased in thyroHEL mice with MHCII-deficient BM-APCs compared to thyroHEL 
mice wild-type BM-APCs (Fig. 3.5C). This suggests that MHCII-deficiency in BM-APCs 
increases nascent FoxP3+ thymocyte induction in thyroHEL hosts.  
  
	 72 
 
 
  
	 73 
Figure 3.4. MHCII-deficiency within BM-APCs abrogates insHEL-mediated 
deletion and shifts thyroHEL-mediated deletion towards wave 2. Irradiated Non-
Tg, insHEL or thyroHEL hosts were reconstituted with 3A9 BM that was either MHCII-
sufficient (H2-Aa+/+) or MHCII-deficient (H2-Aa–/–) and analysed 4-6 weeks later. (A, B) 
Gated TCR3A9+ FoxP3– thymocytes were analysed for (A) CD4/CD8 expression to 
distinguish DN, DP and CD4SP subsets and (B) Helios/CCR7 expression to distinguish 
CCR7– and CCR7+ subsets. (A, B) Column graphs (middle) show number + SEM of 
TCR3A9+ FoxP3– cells within each stage per thymus and line graphs (right) show the 
same data normalised by stage with Non-Tg mean = 100. (C) Helios RFI on CCR7– 
and CCR7+ subsets of TCR3A9+ FoxP3– thymocytes relative to Non-Tg (i.e. non-HEL 
and non-3A9 Tg) DP thymocytes. (D) For each group of chimeras (represented by a 
square symbol), the Helios RFI on CCR7– cells was plotted against the number of 
TCR3A9+ FoxP3– CCR7+ cells per thymus. (A-D) Graphs show mean and SEM. In (A-C), 
H2-Aa+/+ and H2-Aa–/– groups were compared using t tests for each T cell stage (DP, 
CD4SP, CCR7– or CCR7+) and host genotype (Non-Tg, insHEL or thyroHEL) 
combination, without assuming a consistent standard deviation, but with correction for 
multiple testing using the Holm-Sidak method. In (D), group mean and error bars the 
SEM obtained in (B) and (C) were plotted as XY pairs. The r2 and two-tailed P values 
were calculated from the Pearson correlation coefficient by GraphPad Prism. Data 
were compiled from 2 independent cohorts of chimeras with a total of 6-8 mice per 
group. P value symbols: * <0.05; ** <0.01; *** <0.001; **** <0.0001.  
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Figure 3.5. In self-reactive thymocytes, the capacity to express high levels of 
OX40 is associated with reaching the CCR7+ stage of development. From the 
chimeras described in Fig. 3.4, (A) TCR3A9+ FoxP3– thymocytes were analysed for 
OX40/CCR7 (left) and summary (right) shows OX40 RFI for the CCR7– and CCR7+ 
subsets, relative to Non-Tg (i.e. non-HEL and non-3A9 Tg) FoxP3– DP thymocytes; (B) 
total thymic TCR3A9+ FoxP3+ cells were gated (left) and enumerated (right), and (C) 
thymic TCR3A9+ Foxp3+ cells were divided into 3 subsets based on CD24/CCR7 
expression (left) and the absolute number of cells within each subset per thymus were 
enumerated (right). (A-C) Statistical analysis used two-way ANOVA and Tukey’s post-
tests. Columns show the group mean and error bars the SEM compiled from 2 
independent cohorts of chimeras with 6-8 mice per group in total. P value symbols: * 
<0.05; ** <0.01. 
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3.2.2 Contributions of MHCII+ BM-APCs and Aire to the induction of the two 
waves of polyclonal thymocyte negative selection  
 
3.2.2.1 MHC expression is important to induce Helios and CCR7 
expression in polyclonal thymocytes 
 
In mice with natural TCR and self-antigen repertoires, a Helios+ CCR7– phenotype 
marks wave 1 thymocytes, Helios+ CCR7+ marks wave 2 thymocytes, Helios– CCR7+ 
identifies thymocytes that have received a weak TCR signal conducive to naïve T cell 
formation, and a Helios– CCR7– phenotype identifies thymocytes with no evidence of a 
TCR signal (Daley et al., 2013; Hu et al., 2016). To analyse thymocytes that would 
normally be deleted by apoptosis, mice expressing human Bcl-2 under the mouse 
Vav1 promoter (Bcl-2 Tg) (Ogilvy et al., 1999) were used. To focus the analysis on 
newly formed thymocytes, mice were injected with with 5-ethynyl-2'-deoxyuridine 
(EdU). This procedure labels DNA-synthesising thymocytes, which are predominantly 
at the stage immediately before they express an ab TCR (Lucas et al., 1993).  
 
3 days after the EdU injection, EdU+ thymocytes were analysed for Helios and CCR7 
expression. Among the EdU+ cohorts, the frequencies of Helios+ CCR7–, Helios+ 
CCR7+ and Helios– CCR7+ thymocytes were markedly decreased in H2-Aa–/–B2m–/– 
Bcl-2 Tg mice compared to Bcl-2 Tg control mice with normal MHC expression (Fig. 
3.6). This indicates that induction of Helios and CCR7 expression in nascent 
thymocytes largely depends on MHC expression. 
 
3.2.2.2 A role for MHCII+ BM-APCs in wave 1 negative selection 
 
To quantify effects of MHCII-deficiency within BM-APCs on thymocyte negative 
selection (deletion), chimeras were generated using either H2-Aa+/+ or H2-Aa–/– BM 
donors. To verify that Helios+ thymocytes are susceptible to deletion by apoptosis, the 
BM donors were either Bim+/+ or Bim–/–. To confine the analysis to MHCII-responsive 
thymocytes, the irradiated hosts (on C57BL/6 background) were b2-microglobulin 
(B2m)-deficient so that the thymic epithelial cells would lack MHCI expression (Zijlstra 
et al., 1990).  
 
This and subsequent experiments excluded mature T cells by considering only EdU+ 
cells with high CD24 expression. CD24 is downregulated starting ~3 days after the 
main phase of thymocyte proliferation (Lucas et al., 1993). Five weeks after BM 
reconstitution, and 3 days after EdU injection, the EdU+ CD24+ thymocyte frequency in   
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Figure 3.6. MHC-dependence of Helios and CCR7 induction in nascent 
thymocytes. Bcl-2 Tg MHC wild-type (n=9) and Bcl-2 Tg H2-Aa–/–B2m (n=5) mice 
were injected with EdU 3 days before EdU+ thymocytes were analysed for 
Helios/CCR7 expression (top) with summaries (bottom) showing the frequency among 
EdU+ thymocytes of Helios+ CCR7–, Helios+ CCR7+ and Helios– CCR7+ subsets. Each 
symbol represents one mouse and each line represents mean. Data were compiled 
from two independent experiments. Statistical analyses used unpaired Student’s t-
tests. P value symbols: ** <0.01; **** <0.0001. 
  
	 77 
the Bim–/– H2-Aa–/– group was significantly higher than in the Bim+/+ H2-Aa–/– group 
(Fig. 3.7A). Otherwise, the nascent thymocyte cohorts under analysis were similar in 
size. 
 
The EdU+ CD24+ thymocyte cohorts were analysed for Helios and CCR7 expression. 
Comparing the two Bim+/+ groups with normal apoptosis, the frequency of Helios– 
CCR7+ cells in hosts with H2-Aa–/– BM was significantly higher than hosts with H2-Aa+/+ 
BM (6.7% vs 4.0%, respectively) (Fig. 3.7B). This increase in naïve T cell induction 
provides indirect evidence that thymocyte deletion was impaired when the BM-APCs 
lacked MHCII. However, the Helios+ CCR7– and Helios+ CCR7+ cell frequencies were 
similar in Bim+/+ groups with H2-Aa+/+ versus H2-Aa–/– BM (Fig. 3.7B).  
 
Comparing the two groups with H2-Aa+/+ BM (filled circles), Bim-deficiency significantly 
increased the frequencies of Helios+ CCR7– and Helios+ CCR7+ thymocytes (Fig. 
3.7B), showing that the apoptosis defect caused by Bim-deficiency prolongs the 
survival of strongly TCR-signalled Helios+ cells. This allows direct quantification of 
strongly TCR-signalled Helios+ cells in the nascent thymocyte cohort. 
 
In the two Bim–/– groups with defective apoptosis (open circles), the Helios+ CCR7– cell 
frequency was 8.6% in hosts with H2-Aa+/+ BM versus 4.6% in hosts with H2-Aa–/– BM 
(Fig. 3.7B). This finding provides direct evidence that MHCII-deficiency within BM-
APCs decreased wave 1 negative selection. In subsequent experiments, induction of 
waves 1 and 2 was considered to be 100% efficient in chimeras with normal APCs but 
apoptosis-defective thymocytes. By these criteria, MHCII-deficiency within BM-APCs 
caused a 46.5% decrease in wave 1 negative selection [calculated as (8.6 – 4.6 / 8.6) 
× 100]. 
 
Helios+ CCR7+ cell frequencies in Bim–/– groups with H2-Aa+/+ or H2-Aa–/– BM (both 
~0.7%) were significantly higher than in the Bim+/+ groups with H2-Aa+/+ and H2-Aa–/– 
(both ~0.2%) (Fig. 3.7B), indicating that nascent thymocytes with the potential to 
become wave 2 cells are normally deleted in a Bim-dependent manner. However, 
MHCII-deficiency within BM-APCs did not change wave 2 quantitatively. 
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Figure 3.7. Apoptosis defect reveals the role for MHCII+ BM-APCs in wave 1 
negative selection. (A) Irradiated B2m–/– (C57BL/6, H-2b) hosts were reconstituted 
with Bim+/+ or Bim–/– BM, which was additionally either H2-Aa+/+ (filled circles) or H2-Aa–
/– (open circles), resulting in 4 groups of chimeras analysed 5 weeks later and 3 days 
after a single EdU injection. Thymocytes were analysed for CD24 and EdU expression 
(left) and the summary (right) shows the frequency of EdU+ CD24+ cells among all 
thymocytes. (B) Plots (left) show EdU+ CD24+ thymocytes subdivided using 
Helios/CCR7 expression with summaries (right) showing frequencies of each 
Helios/CCR7 subset. (A, B) Data were compiled from 2 independent experiments. 
Each symbol represents one mouse; each line represents group mean. Statistical 
analyses used two-way ANOVA with Tukey’s post tests; P value symbols: * <0.05; ** 
<0.01; **** <0.0001. 
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3.2.2.3 Reduction of MHCII expression within BM-APCs in chimeras 
reconstituted with MHCII-deficient BM 
 
The frequency of BM-derived APCs (DC and macrophages) in the four groups of BM 
chimeras described above (Fig. 3.7) was determined. After thymic stroma digestion, 
viable 7AAD– cells that were TCRβlo and of haemapoeitic origin as indicated by CD45+, 
were analysed to identify CD11c+ cells (DCs) and CD11b+ CD11c– cells (predominantly 
macrophages) (Fig. 3.8A) (Gray et al., 2002). The frequency of CD11c+ among CD45+ 
cells was similar in all four groups (Fig. 3.8B). Among CD45+ cells, the frequency of 
CD11b+ CD11c– cells was also similar in all groups (Fig. 3.8C). These data suggest 
that the frequencies of BM-APCs are similar in the presence of absence of Bim or 
MHCII within the haemapoetic compartment. 
 
The MHCII expression on BM-APCs in the four groups of chimeras was analysed. The 
frequencies of MHCIIhi cells within CD45+ CD11c+ cells (Fig. 3.9A) were significantly 
reduced in chimeras reconstituted with H2-Aa–/– BM compared to H2-Aa+/+ BM, 
regardless of Bim genotype. Similarly, the frequencies of MHCIIhi cells within CD45+ 
CD11b+ CD11c– cells were reduced in chimeras reconstituted with H2-Aa–/– BM 
compared to H2-Aa+/+ BM (Fig. 3.9B). These findings confirm that the transplantation 
procedure depleted MHCII+ BM APCs from the host mice. Comparing the two groups 
receiving H2-Aa+/+ BM, Bim-deficiency seems to increase the frequency of MHCIIhi cells 
in CD11c+ cells and CD11b+ CD11c– cells (Fig. 3.9). 
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Figure 3.8. MHCII-deficiency within BM-APCs did not affect the frequency of DCs 
and macrophages regardless of the Bim genotype. Five weeks after BM 
reconstitution, thymic stromal cells of the irradiated B2m–/– (C57BL/6, H-2b) hosts 
bearing BM of the indicated Bim and H2-Aa genotypes were collagenase digested. (A) 
The digested thymic samples were gated for singlets, followed by 7AAD– TCRβlo cells 
to exclude the non-viable cells. 7AAD– TCRβlo cells were gated for CD45+ 
haematopoietic cells were gated for CD11c+ to identify DCs and gated for CD11b+ 
CD11c– to identify macrophages. Finally, CD11c+ and CD11b+ CD11c– cells were 
analysed for MHCIIhi cells. (B, C) Summaries show frequency of (B) CD11c+ and (C) 
CD11b+ CD11c– among CD45+ 7AAD– TCRβlo cells. A total of n = 3-7 mice per group 
compiled from a cohort of chimeras. Lines represent mean; non-significant statistical 
values were obtained between all comparison groups using two-way ANOVA with 
Tukey’s post-tests.  
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Figure 3.9. Reduced MHCII expression on DCs and macrophages in thymus of 
chimeras bearing H2-Aa–/– BM. Five weeks after BM reconstitution, thymic stromal 
cells of the irradiated B2m–/– (C57BL/6, H-2b) hosts bearing BM of the indicated Bim 
and H2-Aa genotypes were collagenase digested. 7AAD– TCRβlo cells were gated for 
CD45+ haematopoietic cells. CD45+ cells were gated for CD11c+ (A), and gated for 
CD11b+ CD11c– (B), and analysed for MHCIIhi cells. (Right of A and B) Summaries 
show frequency of MHCIIhi cells among CD11c+ CD45+ 7AAD– TCRβlo cells and 
CD11b+ CD11c– CD45+ 7AAD– TCRβlo cells. A total of n = 3-7 mice per group compiled 
from a cohort of chimeras. Lines represent mean; statistical analyses used two-way 
ANOVA with Tukey’s post tests; P value symbols: * <0.05; **** <0.0001.  
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3.2.2.4 A possible role for Aire in Helios+ thymocyte induction in mice on 
the B10.BR genetic background 
 
To test the effect of Aire-deficiency within non-BM-APCs on the two waves of 
thymocyte negative selection, Bim–/– BM was used to reconstitute irradiated Aire+/+, 
Aire+/– and Aire–/– hosts on the B10.BR genetic background, and the resulting chimeras 
were analysed as above (section 3.2.2.2). The Aire+/– hosts were not significantly 
different from Aire+/+ controls in all three Helios/CCR7 subsets analysed (Fig. 3.10).  
 
Among EdU+ CD24+ thymocytes, the mean frequency of Helios+ CCR7– cells was 
significantly reduced in Aire–/– hosts (9.2%) compared to Aire+/+ hosts (11.6%) (Fig. 
3.10), representing a 21% decrease in wave 1 negative selection. The mean frequency 
of Helios+ CCR7+ cells was 1.1% in Aire–/– hosts versus 2.1% in Aire+/+ hosts (Fig. 
3.10), revealing a 48% decrease in wave 2 cells due to Aire-deficiency. The mean 
frequency of Helios– CCR7+ cells was similar at ~10% regardless of host Aire genotype 
(Fig. 3.10). These results suggest that Aire is required for normal Helios+ thymocyte 
induction in mice on the B10.BR background. 
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Figure 3.10. A role for Aire in Helios+ thymocyte induction in B10.BR mice. 
Irradiated Aire+/+, Aire+/– or Aire–/– hosts were reconstituted with Bim–/– BM [all on the 
B10.BR (H-2k) background] and chimeras were analysed 5 weeks later, 3 days after a 
single EdU injection. Flow cytometry phenotype (top) and summaries (bottom) show 
frequencies of three subsets defined using Helios and CCR7 expression among EdU+ 
CD24+ thymocytes. Data were compiled from 2 independent cohorts of chimeras. Each 
symbol represents one mouse in summaries; each line represents group mean. 
Statistical analyses used one-way ANOVA with Tukey’s post tests; P value symbols: ** 
<0.01, *** <0.001. 
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3.2.2.5 The contribution of Aire to Helios+ thymocyte induction requires 
the BM-APCs to express MHCII 
 
To test requirements for MHCII+ BM-APCs and Aire in parallel, chimeras were 
generated by transferring Bcl-2 Tg donor BM that was additionally either H2-Aa+/+ (filled 
circles) or H2-Aa–/– (open circles), into irradiated Aire+/+ or Aire–/– hosts (Fig. 3.11). This 
resulted in four groups of chimeras with C57BL/6 genetic background: (1) thymic APCs 
were normal, (2) MHCII-deficiency within BM-APCs, (3) Aire-deficiency within non-BM-
APCs and (4) both thymic APC types were defective (MHCII-deficiency within BM-
APCs and Aire-deficiency within non-BM-APCs). 
 
Comparing the two Aire+/+ groups, the mean frequency of Helios+ CCR7– cells in the 
EdU+ CD24+ cohort was significantly reduced by 37.4% in hosts bearing H2-Aa–/– BM-
APCs (5.7%) compared to H2-Aa+/+ BM-APCs (9.1%) (Fig. 3.11). This recapitulates the 
findings above using B2m-deficient hosts (Fig. 3.7B) and confirms that MHCII+ BM-
APCs are necessary for normal negative selection at wave 1.  
 
The Helios+ CCR7– cell frequency in Aire–/– hosts with H2-Aa+/+ BM-APCs (8%) was 
significantly higher than in Aire+/+ hosts with H2-Aa–/– BM-APCs (5.7%) (Fig. 3.11), 
demonstrating that wave 1 relies more on MHCII+ BM-APCs than on Aire, at least in 
quantitative terms. 
 
When the BM-APCs were wild-type, Aire-deficiency did not significantly affect the 
Helios+ CCR7– frequency in these chimeras on the B6 background (Fig. 3.11). One 
mouse in the Aire–/– group had a very high Helios+ CCR7– cell frequency, while the 
remaining mice in the Aire–/– group did appear to have slightly lower Helios+ CCR7– 
frequencies than the Aire+/+ group (Fig. 3.11).  
 
In chimeras with wild-type BM-APCs, the Helios+ CCR7+ frequency was significantly 
decreased in Aire–/– hosts compared to Aire+/+ hosts (1.0% vs 1.5%) (Fig. 3.11), 
indicating a 33% decrease in wave 2 cells due to Aire-deficiency. This is consistent 
with the result in the B10.BR background and strengthens the evidence that Aire is 
required for normal Helios+ CCR7+ thymocyte induction (Fig. 3.10). Comparing groups 
with defective BM-APCs (open circles), Aire-deficiency did not have any significant 
effect on the parameters examined (Fig. 3.11). This suggests the contribution of Aire to 
Helios+ thymocyte induction requires the BM-APCs to express MHCII.  
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Figure 3.11. MHCII+ BM-APCs are required to detect Aire’s contribution to Helios+ 
thymocyte induction. Irradiated Aire+/+ or Aire–/– [C57BL/6 (B6), H-2b] hosts were 
reconstituted with Bcl-2 Tg BM that was either H2-Aa+/+ or H2-Aa–/–. Chimeras were 
analysed 5 weeks later, 3 days after a single EdU injection. Flow cytometry phenotype 
(top) and summaries (bottom) show frequencies of subsets defined using Helios and 
CCR7 expression among EdU+ CD24+ thymocytes. Each symbol represents one 
mouse in summaries; lines represent group means. Statistical analyses used two-way 
ANOVA with Tukey’s post tests; P value symbols: * <0.05, ** <0.01, *** <0.001, **** 
<0.0001. 
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3.2.3 Contributions of BM-APCs and/or Aire to the induction of CD4loCD8lo PD-
1hi polyclonal thymocytes 
 
While strong TCR signalling in DP or CCR7– thymocytes induces deletion, some 
thymocytes survive this type of stimulus and subsequently differentiate into small 
intestinal intraepithelial lymphocytes (iIEL) (Gangadharan et al., 2006; Mayans et al., 
2014; McDonald et al., 2015; McDonald et al., 2014; Pobezinsky et al., 2012). The DN 
TCRβ+ thymocyte population, which is thought to contain iIEL precursors, is expanded 
in apoptosis-defective mice and in mice lacking CD28 or CD80 and CD86 (Pobezinsky 
et al., 2012). As wave 1 was reduced by 46.5% in mice with MHCII-deficient BM-APCs 
based on Helios/CCR7 approach (Fig. 3.7B), the same samples were interrogated for 
possible effects on the thymic IEL precursor population using CD4loCD8lo PD-1hi 
approach. 
 
3.2.3.1 High PD-1 expression in CD4loCD8lo TCRβ+ thymocytes 
 
DN TCRb+ thymocytes in CD80/CD86-deficient mice on the B6 background express 
the PD-1 protein at extremely high levels (Pobezinsky et al., 2012). In B6 mice, using a 
CD24+ Foxp3– gate to exclude mature (CD24–) and T-reg (Foxp3+) cells from the 
analysis, the CD4loCD8lo population was found to contain a discrete TCRb+ population 
(Fig. 3.12A). The CD4loCD8lo TCRb+ population contained 79.3% of PD-1hi cells [(6.7 / 
6.7+1.74) ×100] in wild-type mice with normal apoptosis and 81.9% of PD-1hi cells in 
Bcl-2 Tg mice (Fig. 3.12A). The CD4loCD8lo PD-1+ population contained 48.3% of 
TCRb+ cells [(6.7/ 7.17+6.7) ×100] in wild-type mice and 92.7% of TCRb+ cells in Bcl-2 
Tg mice (Fig. 3.12A). This suggests that that among CD4loCD8lo thymocytes in 
apoptosis-defective mice, PD-1 and TCRb expression correlate closely. In wild-type 
mice however, there is a PD-1+ TCRb– subset that makes up a large proportion of the 
PD-1+ population.  
 
3.2.3.2 Role for MHCII+ BM-APCs in CD4loCD8lo PD-1hi thymocyte induction 
in B2m-deficient hosts 
 
This analysis was performed on samples from the chimeric B2m-deficient hosts 
bearing Bim+/+ or Bim–/– BM that was additionally either H2-Aa+/+ or H2-Aa–/– (as 
described in section 3.2.2.2). The PD-1hi subset of CD24+ Foxp3– CD4loCD8lo 
thymocytes was enumerated as a percentage of all thymocytes and in absolute 
numbers. Comparing the two groups with MHCII+ BM-APCs (filled black circles), Bim-
deficiency significantly increased the frequency and number of CD4loCD8lo PD-1hi 
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thymocytes (Fig. 3.12B). This indicates that CD4loCD8lo PD-1hi thymocytes are normally 
susceptible to Bim-mediated apoptosis, including when the thymic epithelial cells lack 
B2m expression.   
 
Comparing CD24+ FoxP3– CD4loCD8lo PD-1hi thymocytes in the two Bim-deficient 
groups, MHCII-deficiency within BM-APCs reduced their frequency by 66.5% (1.8 
versus 5.5%) and their absolute number by 68% (2.13×106 versus 6.65×106) (Fig. 
3.12B). No significant differences were detected when comparing the two Bim-
sufficient groups (Fig. 3.12B). The PD-1 versus Helios plots show that the CD24+ 
FoxP3– CD4loCD8lo PD-1hi population in Bim-sufficient mice contains a mixture of 
Heliosintermediate and Helios+ cells, whereas this population is predominantly Helios+ in 
Bim-deficient mice (Fig. 3.12B). These findings, which do not rely on the use of Helios 
as a molecular marker, indicate that MHCII+ BM-APCs are required to induce the 
formation of strongly TCR-signalled CD4loCD8lo PD-1hi thymocytes, consistent with the 
conclusion of the analysis using Helios and CCR7. 
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Figure 3.12. Quantification of requirement for MHCII+ BM-APCs in inducing 
strongly TCR-signalled CD4loCD8lo PD-1hi thymocytes. The same cohort of BM 
chimeras described in Fig. 3.7 was analysed. (A) Gating strategy for analysis CD24+ 
FoxP3– CD4loCD8lo PD-1hi population. After doublets exclusion using FSC-W (forward 
scattered light-width) versus FSC-H (FSC-height) and SSC (side scattered light)-W 
versus SSC-H gates, thymocytes were analysed for CD24 and FoxP3 expression. 
CD24+ FoxP3– thymocytes were gated for CD4loCD8lo population. CD4loCD8lo 
population was analysed for PD-1 and TCRβ in wild-type and Bcl-2 Tg mice. 
Alternatively, the gated immature CD24+ FoxP3– CD4loCD8lo thymocytes were analysed 
for (B, left) PD-1 expression (PD-1 versus Helios). Helios expression is irrelevant to the 
enumeration of PD-1+ cells.  (B, right) Summaries show the frequency and number of 
CD24+ FoxP3– CD4loCD8lo PD-1hi events among all thymocytes. Data were compiled 
from two independent experiments with a total of n = 8-13 mice per group. Lines 
represent mean. Statistical analyses used 2-way ANOVA and Tukey’s post-tests; P 
value symbol: **** <0.0001; ** <0.01.  
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3.2.3.3 No evidence of a role for Aire in CD4loCD8lo PD-1hi induction in 
B10.BR mice 
 
The Aire+/+, Aire+/– and Aire–/– BM chimeras on the B10.BR background described in 
section 3.2.2.4 were analysed as above (Fig. 3.12). The CD24+ FoxP3– CD4loCD8lo PD-
1hi thymocyte populations made up a similar frequency of all thymocytes across the 
three groups ~3.5%. However, the absolute number of cells was significant reduced in 
the Aire–/– group (1.66×106) compared to Aire+/+ controls (3.70×106) (Fig. 3.13). The 
effect on CD4loCD8lo PD-1hi thymocyte number may reflect a requirement for Aire in the 
overall thymus size or architecture (Yano et al., 2008) rather than a specific role in 
inducing thymic iIEL precursors. 
 
3.2.3.4 A role for MHCII+ BM-APCs in CD4loCD8lo PD-1hi induction in B6 
mice with normal B2m expression 
 
The same four groups of BM chimeras (Bcl-2 Tg BM donor H2-Aa+/+ or H2-Aa–/– à 
Aire+/+ or Aire–/– hosts) generated in section 3.2.2.5 were analysed. Comparing the 
Aire+/+ groups, the mean frequency of CD24+ FoxP3– CD4loCD8lo PD-1hi among all 
thymocytes was significantly reduced in hosts bearing H2-Aa–/– BM-APCs (1.9%) 
compared to H2-Aa+/+ BM-APCs (5.8%) by 67% (Fig. 3.14). Likewise, the number of 
CD24+ FoxP3– CD4loCD8lo PD-1hi thymocytes was significantly decreased in hosts 
bearing H2-Aa–/– BM-APCs (15.5×106) compared to H2-Aa+/+ (15.5×106) by 76% (Fig. 
3.14). These results recapitulated the findings in section 3.2.3.2, indicating the 
requirement of MHCII+ BM-APCs in inducing strongly TCR-signalled CD4loCD8lo PD-1hi 
thymocytes. 
 
Comparing the two groups with MHCII-deficient BM-APCs, Aire-deficiency had no 
detectable effect on the frequency or number of CD24+ FoxP3– CD4loCD8lo PD-1hi 
thymocytes (Fig. 3.14). Comparing the two groups with wild-type BM-APCs, Aire-
deficiency did not significantly affect the frequency of CD24+ FoxP3– CD4loCD8lo PD-1hi 
cells among all thymocytes, but did significantly reduce the absolute number of these 
cells by ~50% (7.8×106 versus 15.5×106) (Fig. 3.14). This is consistent with the result 
observed in B10.BR mice (section 3.2.3.3). 
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Figure 3.13. Quantification of requirement for Aire in inducing strongly TCR-
signalled CD4loCD8lo PD-1hi thymocytes. The gated immature CD24+ FoxP3– 
CD4loCD8lo thymocytes in the same cohort of BM chimeras described in Fig. 3.10 were 
analysed for PD-1 expression (left). Summaries show the frequency and number of 
CD24+ FoxP3– CD4loCD8lo PD-1hi events among all thymocytes (right). Data were 
compiled from two independent experiments with a total of n = 7-9 mice per group. 
Lines represent mean. Statistical analyses used 1-way ANOVA and Tukey’s post-tests; 
P value symbol: * <0.05. 
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Figure 3.14. A role for MHCII+ BM-APCs in CD4loCD8lo PD-1hi thymocyte 
induction. The gated CD24+ FoxP3– CD4loCD8lo thymocytes in the same cohort of BM 
chimeras described in Fig. 3.11 were analysed for PD-1 expression (left). Summaries 
(right) show the frequency and number of CD24+ FoxP3– CD4loCD8lo PD-1hi events 
among all thymocytes. Data were compiled from one experiment with a total of n = 7 
mice per group. Lines represent mean. Statistical analyses used 2-way ANOVA and 
Tukey’s post-tests; P value symbols: **** <0.0001; *** <0.001; ** <0.01; ns, non-
significant. 
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3.3 Discussion  
 
This study examined how defects in MHCII+ BM-APCs and Aire affect the induction of 
Helios+ thymocytes at CCR7– and CCR7+ stages of T cell development, which are 
characterised as waves 1 and 2 negative selection, respectively. The 3A9 TCR Tg 
results show that MHCII-deficiency within BM-APCs impaired deletion at wave 1 by 
causing a shift towards deletion at wave 2, or a complete abrogation of deletion. In 
polyclonal thymocytes, wave 1 was markedly impaired by MHCII-deficiency in BM-
APCs. These findings indicate the requirement for MHCII+ BM-APCs in inducing wave 
1 negative selection. Preliminary evidence suggests that Aire has a role in mediating 
wave 2 negative selection in the polyclonal thymocyte repertoire. However, further 
experiments are required to confirm this preliminary evidence. 
 
The similar phenotypes of non-transgenic thymic grafts in non-transgenic and insHEL 
transgenic hosts exclude circulating HEL as a potential source of the insHEL self-
antigen that deletes 3A9 thymocytes (Liston et al., 2005). In addition, the similar thymic 
phenotypes of non-transgenic hosts implanted with 3A9 versus 3A9 x insHEL BM 
excludes BM-APCs as a potential source of the insHEL that deletes 3A9 thymocytes 
(Liston et al., 2005 and Fig. 3.3 above). However, the level of insHEL mRNA 
expression within CD45– thymic stromal cells and the extent of mature CD4SP 
thymocyte deletion are proportional to the Aire gene dose (Liston et al., 2004a) and 
Aire-deficiency abrogates insHEL-mediated deletion (Liston et al., 2003). The latter 
observations suggest that TECs contribute to Aire-dependent insHEL-mediated 
deletion. MHCII-deficiency within BM-APCs completely abolished insHEL-mediated 
deletion, suggesting that insHEL+ TECs do not directly delete 3A9 thymocytes, but 
instead they rely entirely on self-antigen transfer from TECs to BM-APCs to induce 
deletion. The Aire-dependent self antigens such as RIP-OVAhi (Hubert et al., 2011), 
Aire-GCLG120A (Aichinger et al., 2013) and the natural self-antigen, interphotoreceptor 
retinoid-binding protein (IRBP) (Taniguchi et al., 2012) are also co-dependent on TECs 
and MHCII+ BM-APCs to delete CD4+ thymocytes. As about half of all TCRs that 
require Aire also require MHCII+ BM-APCs to undergo deletion (Perry et al., 2014), 
insHEL, RIP-OVAhi, Aire-GCLG120A and IRBP may represent an extensive class of self-
antigens for which thymocyte deletion requires both TECs and BM-APCs, but only BM-
APCs actually present the self-antigen to thymocytes to induce deletion. 
 
The serum HEL protein concentration is lower in thyroHEL mice than in insHEL mice 
(0.5 ng/mL and 1.2 ng/mL, respectively) (Akkaraju et al., 1997), suggesting that 
circulating HEL is an unlikely source of the thyroHEL self-antigen that triggers 3A9 
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thymocyte deletion. The similar thymic phenotypes of non-transgenic hosts implanted 
with 3A9 versus 3A9 x thyroHEL BM excludes BM-APCs as a source of thyroHEL that 
deletes 3A9 thymocytes. Unlike insHEL-mediated deletion, thyroHEL-mediated 
deletion still occurred when BM-APCs lacked MHCII expression, indicating that 
thyroHEL+ TECs directly present HEL self-antigen to 3A9 thymocytes. However, 
thyroHEL-mediated deletion was detectably shifted towards wave 2 (later T cell 
developmental stage) instead of wave 1 in the absence of MHCII+ BM-APCs. In 
thyroHEL hosts, Helios induction was greater, and fewer thymocytes escaped from 
wave 1 deletion, when the BM-APCs expressed MHCII, suggesting that BM-APCs also 
present HEL self-antigen in thyroHEL hosts. The effect on Helios expression indicates 
that BM-APCs amplify thyroHEL-induced TCR-signalling. This finding has a precedent, 
as mTEC-derived self-antigens elicited more T cell proliferation when presented by 
thymic DCs than by the mTECs themselves (Koble and Kyewski, 2009). The finding 
that BM-APCs enable thymocyte deletion to occur earlier in T cell development could 
explain why the ePCC transgenic self-antigen, which is predominantly expressed within 
mTECs (Aichinger et al., 2013), causes an 83% reduction in CD4SP thymocytes in 
mice expressing the AD10 TCR, whereas it causes a 51% reduction when the BM-
APCs lack MHCII (Oehen et al., 1996). ThyroHEL thus represents a class of self-
antigens for which TECs alone can delete thymocytes, but for which stringent deletion 
at wave 1 requires cooperation between TECs and BM-APCs (i.e. indirect presentation 
by BM-APCs). 
 
Dampening of thymocyte deletion can be accompanied by increased FoxP3+ 
thymocyte induction (Cozzo Picca et al., 2009; Hinterberger et al., 2010), as observed 
in thyroHEL hosts with defective BM-APCs compared to functional BM-APCs. The 
blunting of thyroHEL-mediated Helios induction by MHCII-deficiency within BM-APCs is 
fully consistent with the “avidity model”, which postulates that strong TCR signalling 
triggers deletion whereas intermediate TCR signalling induces FoxP3 upregulation 
(Hinterberger et al., 2010). However, it is also relevant that MHCII-deficiency within 
BM-APCs shifted thyroHEL-mediated deletion towards wave 2, at which a marked 
increase in induction of the T-reg-associated protein, OX40 (Takeda et al., 2004), was 
observed, compared to wave 1. FoxP3 upregulation has also been reported to occur in 
wave 2 (Helios+ CCR7+ CD4SP) thymocytes (Hu et al., 2016). The stage of T cell 
development is another key variable in the deletion versus Treg selection “decision”. It 
is possible that MHCII+ BM-APCs limit thyroHEL-mediated T-reg differentiation by 
inducing deletion at wave 1, before the thymocytes are mature enough to respond to 
strong TCR signalling in a manner that enables T-reg differentiation to occur. 
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In BM chimeras bearing 3A9 thymocytes, Helios expression in CCR7– thymocytes 
correlated negatively with the absolute number of CCR7+ thymocytes. Based entirely 
on thymocytes with normal apoptosis, this correlation extends the evidence that a 
Helios+ phenotype marks thymocytes susceptible to deletion. However, when apoptosis 
is normal, enumerating Helios+ thymocytes is not a sensitive method to quantify the 
overall amount of deletion occurring in the thymus. This is highlighted in the 
investigation of polyclonal thymocytes with normal apoptosis, in which MHCII-
deficiency within BM-APCs had no effect on wave 1 or wave 2 cell frequencies. 
However, when the lifespan of Helios+ thymocytes was extended by defective 
apoptosis, MHCII-deficiency within BM-APCs decreased wave 1 by 46.5%, indicating 
the crucial role of MHCII+ BM-APCs in mediating wave 1. Enumerating Helios+ cells 
within apoptosis-defective thymocyte cohorts thus provides a sensitive method to 
measure thymocyte deletion in the polyclonal repertoire. 
 
It is possible that B2m-deficiency in TECs may not capture all of the normal wave 1 
negative selection and could have altered the amount of wave 1 negative selection. 
However, MHCII-deficiency within BM-APCs consistently reduced wave 1 cells by a 
comparable frequency, 46.1% and 37.4% in the irradiated bone marrow recipients with 
B2m–/– and B2m+/+ within the TECs, respectively. Therefore, B2m-deficiency in TECs 
made no obvious difference to the amount of negative selection, at least within the 
limits of the assay employed. These consistent results confirm that MHCII+ BM-APCs 
are necessary for normal negative selection at wave 1. 
 
Wave 1 cells are characterised by coreceptor dulling and PD-1 induction (Daley et al., 
2013; McCaughtry et al., 2008). Using the published method independent of 
Helios/CCR7 to identify strongly TCR-signalled CD4loCD8lo PD-1hi thymocytes (Mayans 
et al., 2014; McDonald et al., 2015; McDonald et al., 2014; Pobezinsky et al., 2012) 
that are mostly CCR7– (McDonald et al., 2015),  MHCII-deficiency within BM-APCs 
reduced the number of these cells by 68% (in Bim–/–) and ~76% (in Bcl-2 Tg). 
Consistent with the Helios/CCR7 analysis, this indicates that MHCII+ BM-APCs are 
required to induce negative selection in immature thymocytes yet to upregulate CCR7. 
 
Thymocytes reside in the thymic cortex for at least 2 days after they proliferate as 
precursors with no or low ab TCR expression (Penit, 1986). Progression from the 
proliferating precursor stage to the Helios+ CCR7– stage peaks at 2 days (Hu et al., 
2016), suggesting that wave 1 thymocytes are located in the thymic cortex. The 
reduction in wave 1 caused by MHCII-deficiency within BM-APCs suggests that cortical 
BM-APCs are crucial for inducing wave 1. Consistent with this, imaging analysis of 
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cortical deletion in situ demonstrated that thymocytes were arrested and signalled 
adjacent to DCs, implicating DCs in mediating cortical deletion (Melichar et al., 2013). It 
remains unclear which types of DCs are found in the thymic cortex. Migratory DCs 
have been reported to accumulate around blood vessels in the cortex (Baba et al., 
2009), from which they take up proteins circulating in the blood (Baba et al., 2009; 
Raviola and Karnovsky, 1972). A small subset (~2%) of cortical DCs was observed to 
migrate actively within the thymic cortex (Ladi et al., 2008). Alternatively, migratory DCs 
could potentially transport self-antigens derived from outside the thymus (Baba et al., 
2009; Bonasio et al., 2006) or from mTECs (Koble and Kyewski, 2009) into the cortex.  
 
Unexpectedly, ~40-50% of wave 1 (Helios+ CCR7–) or CD24+ FoxP3– CD4loCD8lo PD-
1hi induction still occurred when the BM-APCs lacked MHCII and the non-BM-APCs 
lacked Aire or B2m. This observation could be explained by four non-mutually 
exclusive possibilities. First, the remaining wave 1 thymocytes may be induced by 
MHCII+ non-BM-APCs based on the evidence that they delete Va11+ T cells in 
C57BL/6 mice (Stadinski et al., 2011). Consistent with this line of evidence, cortical 
epithelial cells have been demonstrated to deliver a strong TCR signal and induce 
phenotypic changes associated with thymocyte deletion including PD-1 upregulation 
(McCaughtry et al., 2008). TSCOT (thymic stromal cotransporter)+ CDR1+ cTECs have 
been reported to delete neo-antigen-specific T cells in the cortex without depending on 
Aire, mTECs or DCs (Ahn et al., 2008). Second, host-derived MHCII+ BM-APCs that 
survived irradiation may be responsible for inducing the remaining wave 1 thymocytes. 
This seems unlikely because MHCIIhi expression was severely reduced in DCs and 
macrophages in BM chimeras bearing MHCII-deficient BM. Third, donor-derived B2m+ 
BM-APCs may be responsible. In support of this, DP thymocytes are sufficient to 
induce negative selection of co-resident Ag-specific DP thymocytes (Melichar et al., 
2015). Fourth, BM-APCs may acquire MHCII molecules from epithelial cells by 
intercellular transfer (Koble and Kyewski, 2009; Millet et al., 2008).  
 
Although MHCII-deficiency within BM-APCs did not diminish wave 2 (Helios+ CCR7+) 
quantitatively, this does not exclude TCR repertoire (qualitative) changes within the 
wave 2 thymocyte cohort. The results in 3A9 TCR Tg chimeras with MHCII-deficient 
BM-APCs suggest that wave 2 would lose self-antigens that behave like insHEL, and 
gain self-antigens that behave like thyroHEL, when the BM-APCs lack MHCII. 
 
Aire-deficiency had variable effects on wave 1, reducing it by 21% in mice on the 
B10.BR background, yet failing to significantly reduce wave 1 induction in mice on the 
C57BL/6 background. Aire-deficiency did not decrease the frequency of CD4loCD8lo 
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PD-1hi polyclonal thymocytes. It is currently not clear that Aire plays an essential role in 
wave 1 negative selection, but any potential contribution of Aire to wave 1 appears to 
be dependent on BM-APCs. If migratory DCs that acquire self-antigens derived from 
mTECs (Koble and Kyewski, 2009) transport them into the cortex, this may provide an 
explanation for how Aire, which is expressed within mTECs (Heino et al., 1999), 
contributes to wave 1 in the cortex. It is hypothesised that wave 1 deletion occurs in the 
cortex. Aire may have indirect effects on thymocytes in the thymic cortex. For example, 
Aire may impact chemokine expression and/or haemopoietic APC migration patterns 
(Lei et al., 2011), which could affect wave 1 deletion.  
 
The only setting in which a decrease in wave 2 was detected was when the BM-APCs 
were normal and the non-BM-APCs lacked Aire. Aire-deficiency diminished the 
frequency of wave 2 cells by 48% in mice on the B10.BR background, and by 33% in 
mice on the C57BL/6 background. This suggests that wave 2 depends crucially on 
Aire, presumably due to its role in diversifying self-antigen expression within mTECs 
(Anderson et al., 2002; Derbinski et al., 2005; Sansom et al., 2014) and perhaps by 
promoting the normal localisation or migration of BM-APCs in the thymic medulla (Lei 
et al., 2011). Time course experiments revealed that it takes ~5 days for thymocytes to 
progress from the proliferating precursor stage into wave 2 (Hu et al., 2016). As the 
frequency of wave 2 cells detected at 3 days after EdU injection was rather low, future 
experiments should be performed at 5 days after EdU injection to determine whether 
Aire-deficiency impacts wave 2 in a quantitative manner.  
 
A self-reactive thymocyte may first receive a strong TCR signal at the CCR7– or CCR7+ 
stage of development, due to differences in the self-antigen repertoires and APC 
networks encountered at these two stages. Thymocytes bound for deletion at the 
immature CCR7– stage express very high levels of PD-1 (Daley et al., 2013; McDonald 
et al., 2015), whereas more mature CCR7+ thymocytes bound for deletion commonly 
upregulate CD25 and OX40 (Cozzo Picca et al., 2009; Daley et al., 2013; Wirnsberger 
et al., 2009). This phenotypic divergence of the two waves seems central to self-
reactive thymocyte fate, as CCR7– CD4loCD8lo PD-1hi iIEL thymic survivors colonise 
the small intestinal epithelium (Mayans et al., 2014; McDonald et al., 2015; McDonald 
et al., 2014), whereas wave 2 survivors upregulate FoxP3 and differentiate into the T-
reg lineage (Cowan et al., 2013; Hu et al., 2016).  
 
On quantitative terms, this study concludes that MHCII+ BM-APCs are crucial in 
mediating wave 1 negative selection in monoclonal or polyclonal thymocyte repertoires. 
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Preliminary evidence suggests that Aire has a role in mediating wave 2 negative 
selection in the polyclonal thymocyte repertoire. 
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CHAPTER 4 
 
Quantification of the thymocyte 
repertoire that depends on 
MHC Class I and/or MHC Class 
II for TCR-signalling 
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4.1 Introduction 
   
In mice, naïve CD8+, but not CD4+, T cell development is markedly reduced in the 
absence of B2m (Koller et al., 1990; Zijlstra et al., 1990). Naïve CD4+, but not CD8+, T 
cell development is markedly reduced in the absence of MHCII expression (Cosgrove 
et al., 1991; Grusby et al., 1991). These findings demonstrate the requirement for B2m, 
which is required for stable expression of MHCI on the cell surface (Zijlstra et al., 
1990), in CD8+ T cell development and the requirement for MHCII in CD4+ T cell 
development. 
 
There are more CD4+ T cells than CD8+ T cells in the thymus and peripheral lymphoid 
organs of healthy and young mice and humans. The mechanism that gives rise to this 
imbalance is unclear. In theory, two factors could be at play. First, more MHCII-binding 
T cells may initiate development. In other words, of all the thymocytes that receive a 
TCR signal in the thymus, the MHCII-responsive fraction exceeds the MHCI-responsive 
fraction. A second possibility is that, once initiated, completion of T cell development 
may be more common in CD4+ T cells than in CD8+ T cells.  
  
Sinclair et al. (2013) concluded that there is no imbalance at the initiation step. These 
authors used mice lacking endogenous Zap70, but bearing a tetracycline-inducible 
Zap70 (TetZap70) transgene, to track Zap70-dependent developmental events in 
thymocytes. Zap70 is essential for mature T cell development and T cell signaling 
(Negishi et al., 1995). In TetZap70 mice, Zap70 expression is able to be switched on 
(or off) in Zap70–/– thymocytes by administration (or withholding) of tetracycline (Saini et 
al., 2010). This model revealed that DP thymocytes could be delineated into three 
substages, namely the DP1 (CD5loTCRβlo) pre-selection stage, the DP2 (CD5hiTCRβint) 
stage, which contains CD4SP precursors and CD8SP precursors, and the DP3 
(CD5intTCRβhi) stage, which contains the direct precursors of CD8SP cells only (Saini 
et al., 2010). The authors used TetZap70 BM cells to reconstitute irradiated B2m–/– 
Rag1–/– and H2-Ab1–/– (referred to as MHCII–/– by the authors) Rag1–/– hosts to track the 
maturation of MHCII-responsive cells and MHCI-responsive cells, respectively. Upon 
tetracycline feeding, the maturation rates from DP1 to DP2 cells were similar in the two 
groups of hosts, suggesting MHCII can induce a TCR signal in a similar proportion of 
thymocytes as can MHCI (Sinclair et al., 2013). 
 
Sinclair et al. (2013) concluded that cell death during the maturation of TCR-signalled 
thymocytes is higher in MHCI-responsive cells than in MHCII-responsive cells. 
Specifically, the rate of cell death at the DP2 stage was higher in MHCII–/– Rag1–/– 
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hosts than in B2m–/– Rag1–/– hosts. The authors concluded the imbalance between 
CD4+ and CD8+ T cells arises from a higher cell death rate in TCR-signalled MHCI-
responsive thymocytes compared to TCR-signalled MHCII-responsive thymocytes.  
 
Transgenic overexpression of the pro-apoptotic protein, Bax, in T cells increases 
apoptosis in thymocytes (Brady et al., 1996; Williams et al., 1998). Endogenous Bax 
mRNA expression levels are similar throughout thymocyte development (Sinclair et al., 
2013). The authors studied mice expressing a transgene encoding Bax controlled by 
human CD2 promoter, which drives transgene expression throughout thymocyte 
development (de Boer et al., 2003). Transgenic Bax expression in T cells exaggerated 
the numeric imbalance in favour of CD4+ T cells over CD8+ T cells among CD24hi T 
cells in the thymus and spleen (Sinclair et al., 2013). This led the authors to conclude 
that increasing apoptotic stress preferentially impairs development of MHCI-responsive 
T cells. However, the opposite effect is not observed when apoptosis is impaired, as 
CD4+ T cells still outnumber CD8+ T cells in Bim–/– and Bcl-2 Tg mice (Daley et al., 
2013). Thus, it is not entirely clear that the CD4:CD8 imbalance is explained by 
differential sensitivity to apoptosis after thymocytes have received TCR signalling. 
 
Several points should be considered when interpreting the results using the TetZap70 
experimental system. First, the Zap70 expression in DP1 TetZap70 thymocytes is 
broader than in wild-type thymocytes, ranging from the low level observed in wild-type 
DP1 thymocytes to the higher levels observed in wild-type DP2 thymocytes (Saini et 
al., 2010). This could potentially change the sensitivity of pre-selection DP1 thymocytes 
to antigen, altering the frequency of thymocytes that initiate development. Second, the 
stage-dependent regulation of Zap70 expression observed in wild-type mice is absent 
in TetZap70 mice. Zap70 expression increases progressively as thymocytes develop 
from DP1 to DP3 in wild-type mice. By contrast, TetZap70 mice exhibit the lowest Zap 
70 expression at DP3 (Saini et al., 2010). This results in a partial developmental block 
of CD8SP thymocytes (Saini et al., 2010). Third, since BM-derived cells in the chimeric 
mice were capable of expressing both MHC classes, some thymocytes may have 
received pro-survival or pro-death TCR signals from the MHC class that was supposed 
to be absent on BM-derived cells. 
 
Results in chapter 3 revealed that nascent thymocyte cohorts contain a much higher 
proportion of Helios+ cells in apoptosis-defective mice compared to mice with normal 
apoptosis. It was inferred that defective apoptosis enabled the identification and 
enumeration of strongly TCR-signalled Helios+ thymocytes, which would have 
undergone apoptosis or been phagocytosed in mice with normal apoptosis (Dzhagalov 
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et al., 2013). Impairing apoptosis is thus a promising strategy to preserve and 
enumerate TCR-signalled thymocytes in a way that is difficult to achieve in mice with 
normal apoptosis.  
 
Recent research has provided evidence that the CD4loCD8lo TCRb+ PD-1hi thymocyte 
population contains cells that are susceptible to clonal deletion, yet this population also 
contains precursors of T cells that colonise the small intestinal epithelium. The absolute 
number of CD4loCD8lo TCRb+ PD-1hi thymocytes increases in the absence of 
costimulatory receptor CD28 or costimulatory ligands CD80 and CD86, and when 
apoptosis is inhibited by Bcl-2 transgene expression in haemopoietic cells (Pobezinsky 
et al., 2012). Compared to conventional CD4+ and CD8+ T cells in the thymus and 
lymph nodes, CD4loCD8lo TCRb+ PD-1hi thymocytes and CD8aa+ small intestinal 
intraepithelial lymphocytes (CD8aa+ iIEL) are enriched in cells expressing 
superantigen-reactive TCRs (Pobezinsky et al., 2012), which are known to be 
susceptible to clonal deletion (Kappler et al., 1987). Most thymocytes forced to express 
TCRs derived from CD8aa+ iIEL attain a CD4loCD8lo TCRb+ PD-1hi phenotype before 
undergoing apoptosis in the thymus (Mayans et al., 2014; McDonald et al., 2015; 
McDonald et al., 2014). However, some CD4loCD8lo TCRb+ PD-1hi thymocytes survive 
and colonise the small intestinal epithelium in a manner that requires the transcription 
factors, Runx3 and T-bet (Klose et al., 2014; Pobezinsky et al., 2012). These findings 
outline a putative differentiation pathway, which involves strong TCR signalling at the 
DP stage of thymocyte development inducing a CD4loCD8lo TCRb+ PD-1hi intermediate 
population that contains cells susceptible to clonal deletion by apoptosis, but from 
which a small subset of cells survives and ultimately colonises the small intestinal 
epithelium. Hereafter in this thesis, the term “iIEL precursors” refers to the CD4loCD8lo 
PD-1hi thymocyte population. 
 
Some information is available regarding the MHC molecules that induce the formation 
of iIEL precursors. One study identified 19 TCRs that induced thymocytes to attain a 
CD4loCD8lo phenotype. These 19 TCRs all consisted of one of 3 TCRb chains paired 
with various TCRa chains derived in various ways, including from pre-selection 
thymocytes. Out of these 19 TCRs, approximately 25% recognised B2m-dependent 
ligands, 40% recognised MHCII, and 35% recognised both B2m-dependent ligands 
and MHCII (McDonald et al., 2015). Another study found that 5 out of 5 iIEL-derived 
TCRs recognised B2m-dependent ligands (but not MHCII) in the thymus (Mayans et 
al., 2014). No information is available on the relative contributions of MHCI versus 
MHCII to induction of iIEL precursors across the natural TCR repertoire. 
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The experiments below investigated the contributions of MHCI and MHCII to the 
induction of TCR-signalling in thymocytes. As the focus of this study concerns 
mechanisms underlying nascent T cell development, mature T cells that have 
recirculated into the thymus from the periphery (such as memory T cells and T-reg 
cells) (McCaughtry et al., 2007; Thiault et al., 2015) or have resided in thymus long 
term (such as NKT cells) (Berzins et al., 2006; Godfrey et al., 2010) may confound the 
results. Thus, EdU was used to label a nascent cohort of thymocytes undergoing DNA 
synthesis in vivo. All experimental animals expressed wild-type Zap70. To capture 
thymocytes that would normally be lost through apoptosis, mice with defective 
apoptosis were analysed alongside mice with normal apoptosis. The data show that in 
mice with normal apoptosis, while the absence of both MHC classes markedly 
diminished the size of the TCR-signalled cohort, the absence of one MHC class had no 
significant effect. However, results from apoptosis-defective mice indicate that the 
absence on one MHC class does have an effect, and the fraction of the thymocyte 
repertoire that requires MHCII to receive a TCR-signal is similar in size to the fraction 
that requires B2m-dependent ligands to receive a TCR signal. The apoptosis-defective 
dataset revealed that induction of Helios+ thymocytes was diminished to a significantly 
greater extent by the absence of MHCII compared to the absence of MHCI. These 
results reveal novel contrasts between the contributions of MHCI and MHCII to the 
induction of strong TCR-signalling within thymocytes.  
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4.2 Results 
 
4.2.1 Characterisation of the phenotypic transitions in thymocyte cohorts 
labelled during DNA synthesis in vivo  
 
To examine the expansion and reduction of the progeny of a single cohort of DNA 
synthesizing thymocytes in vivo over time, each mouse was injected intraperitoneally 
with a single bolus of 250 μg EdU from 0.04 (1 hour) to 7 days before flow cytometric 
analysis. It is assumed that thymocytes labelled with EdU were synthesising DNA 
within a short interval at the time of injection or shortly afterwards. Wild-type and 
apoptosis-defective Bcl-2 Tg mice were injected with EdU at various time points and 
their thymocytes were all analysed by flow cytometry on the same day (Fig. 4.1A). 
Uninjected mice were included to ensure the detection of EdU+ cells was specific (Fig. 
4.1A). The frequency and number of EdU+ thymocytes per mouse were determined at 
different time points after EdU injection. Thymocytes synthesising DNA at the time of 
EdU injection, identified as EdU+ thymocytes, are also referred to as nascent 
thymocytes in this thesis. 
 
In non-Tg mice the EdU+ thymocyte frequency increased from 0.04 (1 hour) to 2 days 
after EdU injection, when it peaked at a mean frequency of 16.4% (Fig. 4.1B). The 
mean frequency of EdU+ thymocytes declined from 2 to 7 days after EdU injection, with 
a sharp decrease from 12.5% at 3 days to 0.6% at 5 days after EdU injection. The 
number of EdU+ thymocytes in non-Tg mice increased by 17-fold from 1 hour to 2 days 
after EdU injection, and declined by 59-fold from 2 to 7 days after EdU injection (Fig. 
4.1B). This shows that within a cohort of nascent thymocytes, addition of cells via 
proliferation outweighs subtraction of cells for about 2 days in non-Tg mice. After 2 
days, subtraction outweighs addition.  
 
In Bcl-2 Tg mice the frequency of EdU+ thymocytes increased from 1 hour to 3 days 
after EdU injection, when it peaked at 13.6% (Fig. 4.1B). A 16-fold increase in number 
of EdU+ thymocytes was observed between 1 hour and 3 days after EdU. This 
suggests that addition of nascent cells to the thymocyte pool outweighs subtraction for 
about 3 days in Bcl-2 Tg mice, 1 day longer than in non-Tg mice.   
 
At early time points (1 hour to 2 days) after EdU injection, non-Tg mice had up to ~2-
fold higher frequency of EdU+ thymocytes, and 1.3 to 2.7-fold higher number of EdU+ 
thymocytes than Bcl-2 Tg mice (Fig. 4.1B). Although not statistically significant, the 
data suggest that Bcl-2 Tg expression may blunt thymocyte proliferation during the DN- 
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Figure 4.1. Expansion and reduction of DNA synthesising thymocytes over 1 
week. Non-Tg and Bcl-2 Tg mice were injected with EdU from 1 hour (0.04d) to 7 days 
before flow cytometric analysis of thymocytes. Uninjected mice were analysed in 
parallel as a control. (A) All thymocytes were analysed for SSC/EdU (top). (B) 
Summaries show percentages of EdU+ events among all thymocytes (left) and absolute 
number of EdU+ thymocytes (right) over time after EdU injection. Only P values <0.05 
between non-Tg and Bcl-2 Tg groups were indicated with asterisk(s). (C) Graph shows 
total number of cells per thymus in wild-type (n = 51) and Bcl-2 Tg (n = 36) mice. Data 
were compiled from 1 to 4 independent experiments with a total of n = 2-11 mice per 
group. Symbols and error bars represent mean and SEM. Statistical analyses used 
unpaired Student’s t-tests comparing between non-Tg and Bcl-2 Tg groups; P value 
symbols: **** <0.0001; *** <0.001; ** <0.01; * <0.05; ns (non-significant) >0.05. EdU 
was used in three independent experiments and BrdU was used in one experiment. 
Mice in all four experiments were EdU or BrdU injected by Daniel Hu, and two 
experiments were performed by Daniel Hu. 
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DP transition. At 3 days after EdU injection, Bcl-2 Tg mice had a similar frequency and 
number of EdU+ thymocytes to non-Tg mice (Fig. 4.1B). 
 
In Bcl-2 Tg mice the frequency of EdU+ thymocytes decreased by only 2-fold from 3-7 
days after EdU injection. The number of EdU+ thymocytes did not change detectably 
during the same interval (Fig. 4.1B). While Bcl-2 Tg mice did not have significantly 
higher number of total thymocytes than non-Tg mice (Fig. 4.1C), the frequency and the 
number of EdU+ thymocytes were significantly higher in Bcl-2 Tg mice than in non-Tg 
mice between 4 and 7 days after EdU injection. These findings show that Bcl-2 
transgene prolongs the lifespan of nascent thymocytes. 
 
4.2.1.1 Characterisation of thymocytes expressing TCRβ and CD5  
 
i) Nearly all DNA synthesising (EdU+) thymocytes are TCRβ– CD5– 
 
TCRβ and CD5 are upregulated in DP thymocytes by Zap70-dependent signalling 
(Saini et al., 2010). TCRβ and CD5 are also expressed by CD4SP and CD8SP 
thymocytes (Azzam et al., 1998) and post-selection TCRαβ+ CD4loCD8lo thymocytes 
(Pobezinsky et al., 2012). This suggests that TCRβ and CD5 expression may be 
sensitive markers of TCR-signalled thymocytes generally, not just within the DP 
population. It follows that TCRb and CD5 may be useful markers to measure the 
percentage of TCR-signalled cells within nascent thymocyte cohorts.  
 
Thymocytes undergoing proliferation either before TCRb gene recombination (DN2-
DN3) or before TCRa gene recombination (DN-DP) would be expected to have a 
TCRb– CD5– phenotype (Pénit et al., 1995), whereas those proliferating in the last 24 
hours before emigration would be expected to have a TCRb+ CD5+ phenotype (Pénit 
and Vasseur, 1997). To define the phenotype of DNA synthesising thymocytes, the 
EdU+ population was examined 1 hour after EdU injection. In non-Tg mice, ~1% of the 
EdU+ thymocytes were TCRβ+ CD5+ at 1 hour after EdU injection, whereas ~10% of 
EdU– thymocytes were TCRβ+ CD5+ (Fig. 4.2A, B). Likewise in Bcl-2 Tg mice, ~3% of 
EdU+ thymocytes were TCRβ+ CD5+ at 1 hour after EdU injection (Fig. 4.2A, B). This 
demonstrates that most DNA synthesising thymocytes are TCRβ– CD5–.   
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Figure 4.2. DNA synthesising thymocytes have a TCRβ– CD5– phenotype. Non-Tg 
and Bcl-2 Tg mice were injected with EdU 1 hour before flow cytometric analysis of 
thymocytes. (A) All thymocytes were first gated for EdU+ and EdU– populations. These 
two populations were analysed for TCRβ and CD5 expression. (B) Summaries show 
the frequencies of TCRβ+ CD5+ (red) and TCRβ– CD5– (grey) cells among EdU+ 
thymocytes in the indicated genotypes. Data were compiled from 2 independent 
experiments in non-Tg mice (n = 4), and one experiment for Bcl-2 Tg mice (n = 2). 
Lines represent mean. 
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ii) A subset of EdU+ thymocytes attains a TCRβ+ CD5+ phenotype after DNA 
synthesis 
 
To track phenotypic changes during thymocyte development, EdU+ thymocytes were 
analysed throughout the time course (Fig. 4.3A). In non-Tg mice, the number of EdU+ 
TCRβ+ CD5+ thymocytes increased sharply from 1 hour (mean = 2.1 × 104) to 2 days 
(mean = 1.4 × 106) after EdU injection (Fig. 4.3B), representing a 67-fold expansion. In 
theory, this order of population expansion could be achieved if every EdU+ TCRβ+ 
CD5+ cell underwent 6 mitoses in the 47-hour interval and all its progeny survived 
(since 26 = 64). The number of EdU+ TCRβ– CD5– thymocytes increased from 2.5 × 106 
to 1.4 × 107 within the same time interval (Fig. 4.3C). This represents a ~6-fold 
expansion requiring 2-3 mitoses. The EdU+ TCRβ+ CD5+ cells and EdU+ TCRβ– CD5– 
cells had a similar mean fluorescence intensity (MFI) of EdU labeling (Fig. 4.4A, B). As 
the EdU MFI would be expected to halve with every round of mitosis, this finding 
excludes the possibility that EdU+ TCRβ+ CD5+ cells underwent 3 or 4 more mitoses 
than the EdU+ TCRβ– CD5– cells. These data favour an alternative interpretation, which 
is that a subset of EdU+ TCRβ– CD5– thymocytes became EdU+ TCRβ+ CD5+ cells 
between 1 hour and 2 days after EdU injection. Notably, the MFI of EdU labelling in 
EdU+ thymocytes was higher in Bcl-2 Tg mice than in non-Tg mice throughout the time 
course, regardless of TCRb/CD5 phenotype (Fig. 4.4A, B).  
 
In non-Tg mice, the number of EdU+ TCRβ– CD5– thymocytes decreased from 3 days 
(mean = 8.5 × 106) to 5 days (mean = 3.4 × 105) after EdU injection, representing a 25-
fold reduction (Fig. 4.3C). The number of EdU+ TCRβ+ CD5+ thymocytes decreased 
from 1.5 × 106 to 5.5 ×105, representing a 2.7-fold reduction within the same interval 
(Fig. 4.3B). The steep decline in the major population of EdU+ TCRβ– CD5– thymocytes, 
without a corresponding increase in EdU+ TCRβ+ CD5+ thymocytes, demonstrates that 
most EdU+ TCRβ– CD5– thymocytes die 3-5 days after incorporating EdU without ever 
attaining an EdU+ TCRβ+ CD5+ phenotype.   
From 3 to 7 days after EdU injection in non-Tg mice, the number of EdU+ TCRβ+ CD5+ 
thymocytes declined by 3.7-fold (Fig. 4.3B), compared to a 78-fold decline in the 
number of EdU+ TCRβ– CD5– thymocytes (Fig. 4.3C). The lower disappearance rate 
demonstrates that a greater fraction of the EdU+ TCRβ+ CD5+ thymocytes persist in the 
thymus >3 days after incorporating EdU. This is consistent with onward differentiation 
in EdU+ TCRβ+ CD5+ thymocytes. 
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Figure 4.3. Some nascent TCRb– CD5– thymocytes differentiate into TCRb+ CD5+ 
thymocytes. As part of the time course experiment described in Fig. 4.1, (A) EdU+ 
thymocytes were divided into TCRβ+ CD5+ (red) and TCRβ– CD5– (grey) subsets. (B) 
Summaries show the frequency of TCRβ– CD5– cells among EdU+ thymocytes (left) 
and the number of EdU+ TCRβ– CD5– thymocytes (right) enumerated over time after 
EdU injection. (C) Summaries show the frequency of TCRβ+ CD5+ cells among EdU+ 
thymocytes (left) and the number of EdU+ TCRβ+ CD5+ thymocytes (right) enumerated 
over time after EdU injection. Data were compiled from 2 independent experiments in 
non-Tg mice (n = 5-6 per group), and one experiment for Bcl-2 Tg mice (n = 2-3 per 
group). Symbols and error bars represent mean and SEM. Statistical analyses used 
unpaired Student’s t-tests comparing between non-Tg and Bcl-2 Tg groups at 
individual time point; P value symbols: **** <0.0001; *** <0.001; ** <0.01; * <0.05.   
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Figure 4.4. The EdU+ TCRβ+ CD5+ thymocytes and EdU+ TCRβ– CD5– thymocytes 
have a similar mean fluorescence intensity (MFI) of EdU labeling. As part of the 
time course experiment described in Fig. 4.1, the level of EdU labeling in (A) EdU+ 
TCRβ+ CD5+ cells (red) and EdU+ TCRβ– CD5– (grey) cells was analysed in non-Tg and 
Bcl-2 Tg mice over time after EdU injection. Numbers on histograms represent mean 
fluorescence intensity (MFI) of gated TCRβ/CD5+ or TCRβ/CD5– events. (B) Summary 
shows the EdU MFIs of EdU+ TCRβ+ CD5+ (red) and EdU+ TCRβ– CD5– (grey) of non-
Tg mice (solid line) and Bcl-2 Tg (dotted line). Data were compiled from an experiment 
with a total of n = 3 mice per group, except n = 2 mice per group for 0.04 day after EdU 
for non-Tg and Bcl-2 Tg, and for 7 days after EdU in non-Tg mice. Symbols and error 
bars represent mean and SEM.    
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In Bcl-2 Tg mice, the number of EdU+ TCRβ– CD5– thymocytes increased from 1 hour 
(mean = 8.5 × 105) to 3 days (mean = 1.3 × 107) after EdU injection (Fig. 4.3C), 
representing a 16-fold expansion. The number of EdU+ TCRβ+ CD5+ thymocytes 
increased from 2.9 × 104 to 3.5 × 106 within the same time interval (Fig. 4.3B), 
representing a 121-fold expansion. Based on the logic outlined above, this data 
suggests that a subset of EdU+ TCRβ– CD5– thymocytes became EdU+ TCRβ+ CD5+ 
cells between 1 hour and 3 days after EdU injection. 
 
There are large differences between non-Tg and Bcl-2 Tg genotypes in the latter 
section of the time course. During the interval 3-7 days after EdU injection, the number 
of EdU+ TCRβ– CD5– thymocytes declined by only 4-fold in Bcl-2 Tg mice, compared to 
79-fold in non-Tg mice (Fig. 4.3C). In the case of EdU+ TCRβ+ CD5+ thymocytes, the 
Bcl-2 Tg mice only had a 1.7-fold decline compared to 3.7-fold in non-Tg mice between 
3 and 7 days after EdU injection (Fig. 4.3B). The difference observed for EdU+ TCRβ+ 
CD5+ thymocytes between the two genotypes is much smaller than observed for EdU+ 
TCRβ– CD5– thymocytes. These findings demonstrate that the most pronounced 
extension in lifespan afforded by Bcl-2 Tg expression is within thymocytes that remain 
TCRβ– CD5– after incorporating EdU. 
 
iii) EdU+ TCRβ– CD5– thymocytes commonly retain a DP phenotype, whereas 
EdU+ TCRβ+ CD5+ thymocytes commonly attain non-DP phenotypes 
 
To further characterise the phenotypic divergence of TCRβ– CD5– and TCRβ+ CD5+ 
thymocytes, the CD4/CD8 profile of these two subsets among the nascent EdU+ 
cohorts was analysed. EdU+ TCRβ– CD5– (Fig. 4.5A) and EdU+ TCRβ+ CD5+ (Fig. 4.6A) 
subsets were subdivided into four populations, namely DP, CD4loCD8lo (coreceptor 
dull), CD4SP and CD8SP. DP cells dominated the TCRβ– CD5– subset in both non-Tg 
(Fig. 4.5B) and Bcl-2 Tg mice (Fig. 4.5C) throughout the time course, despite a gradual 
decrease in DP cells at day 4-7 in non-Tg mice (Fig. 4.5B). This demonstrates that 
nascent TCRb– CD5– thymocytes commonly retain a DP phenotype. 
 
EdU+ TCRβ+ CD5+ thymocytes had a wider spectrum of CD4/CD8 phenotypes. In non-
Tg mice, although EdU+ TCRβ+ CD5+ thymocytes were predominantly DP cells at 1-2 
days after EdU injection, a progressive increase in the frequency of CD4SP cells was 
observed from 1-4 days after EdU injection (Fig. 4.6B). The frequency of CD4loCD8lo 
and CD8SP thymocytes remained relatively low throughout the time course, although 
the CD8SP frequency increased between 4 and 7 days after EdU injection (Fig. 4.6B). 
These findings show that attainment of non-DP phenotypes is more common in TCRβ+   
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Figure 4.5. Retention of DP phenotype is common in TCRb– CD5– thymocytes. As 
part of the time course experiment described in Fig. 4.1, (A) EdU+ TCRβ– CD5– 
thymocytes were analysed for CD4/CD8 over time after EdU injection. (B) Summaries 
show the frequency of DP (green), CD4loCD8lo (black), CD4SP (orange) and CD8SP 
(blue) subsets among EdU+ TCRβ– CD5– thymocytes over time after EdU injection. 
Data were compiled from an experiment with a total of n = 3 mice per group, except n = 
2 mice for 0.04 day in both genotypes and for 7 days after EdU in non-Tg mice. 
Symbols and error bars represent mean and SEM. 
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Figure 4.6. Attainment of non-DP phenotypes is common in TCRb+ CD5+ 
thymocytes. As part of the time course experiment described in Fig. 4.1, (A) EdU+ 
TCRb+ CD5+ thymocytes were analysed for CD4/CD8 phenotype. (B) Summaries show 
the frequency of DP (green), CD4loCD8lo (black), CD4SP (orange) and CD8SP (blue) 
subsets among EdU+ TCRb+ CD5+ thymocytes over time after EdU injection. Data were 
compiled from an experiment with a total of n = 3 mice per group, except n = 2 mice for 
0.04 day in both genotypes and for 7 days after EdU in non-Tg mice. Symbols and 
error bars represent mean and SEM. 
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CD5+ thymocytes than in TCRβ– CD5– thymocytes. They are also consistent with 
reports that thymocytes progress to a CD4SP phenotype more rapidly than to a 
CD8SP phenotype (Lucas et al., 1993; Saini et al., 2010). 
 
EdU+ TCRβ+ CD5+ thymocytes in Bcl-2 Tg mice were also more heterogeneous than 
TCRβ– CD5– counterparts. The frequency of CD4SP thymocytes increased gradually 
between 1 and 5 days after EdU injection, with the concomitant reduction of DP cell 
frequency during this interval (Fig. 4.6C). Although the frequency of CD4loCD8lo and 
CD8SP thymocytes remained relatively low throughout the time course in Bcl-2 Tg 
mice, CD4loCD8lo cell frequency increased gradually over time, while the CD8SP cell 
frequency started to increase at day 5 after EdU injection (Fig. 4.6C). Considering 
EdU+ TCRβ+ CD5+ thymocytes, a contrast between genotypes was an increased 
CD4loCD8lo cell frequency in the Bcl-2 Tg mice. Coreceptor dulling is a hallmark of the 
response to strong TCR signaling at the DP stage of thymocyte development (Daley et 
al., 2013; McCaughtry et al., 2008; McGargill and Hogquist, 1999; Swat et al., 1991). 
This effect is therefore probably due to the persistence in Bcl-2 Tg mice of strongly 
TCR-signalled thymocytes that would normally undergo apoptosis in non-Tg mice. 
 
iv) EdU+ TCRβ+ CD5+ thymocytes express more CD69 and Helios than EdU+ 
TCRβ– CD5– thymocytes 
 
To extend the analysis above, the EdU+ TCRβ+ CD5+ and EdU+ TCRβ– CD5– thymocyte 
subsets were examined for expression of additional markers of TCR activation. CD69 
is upregulated in thymocytes and T cells in response to TCR signaling (Testi et al., 
1989) or type I interferon signaling (Shiow et al., 2006; Sun et al., 1998). Helios is a 
marker of strongly TCR-signalled thymocytes (Daley et al., 2013). In both non-Tg and 
Bcl-2 Tg mice, the TCRβ+ CD5+ subset had higher CD69 expression than the TCRβ– 
CD5– subset throughout the time course after EdU injection (Fig. 4.7A). This suggests 
that thymocytes that attain a TCRβ+ CD5+ phenotype are TCR-signalled whereas there 
is no evidence that the TCRβ– CD5– thymocytes are TCR-signalled. Within the TCRβ+ 
CD5+ subset of both non-Tg and Bcl-2 Tg mice, the CD69 MFI decreased on day 5-7 
after EdU injection, and a bimodal distribution of CD69 expression was observed at 
these later times after EdU (Fig. 4.7A). CD69 downregulation at later time points was 
expected based on the phenotype of mature SP cells: Qa-2hiCD62LhiHSAloCD69lo 
(Kishimoto and Sprent, 1997). CD69 downregulation may have a functional role in 
emigration of mature SP cells from the thymus (Shiow et al., 2006) 4-5 days after 
becoming single-positive thymocytes (McCaughtry et al., 2007). Bcl-2 Tg expression 
subtly increased CD69 MFI on the TCRβ+ CD5+ subset of EdU+ thymocytes from 1 hour 
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to 3 days after EdU injection, in comparison to non-Tg mice (Fig. 4.7A).    
 
In both non-Tg and Bcl-2 Tg mice, Helios expression was consistently higher in the 
TCRβ+ CD5+ subset than in the TCRβ– CD5– subset throughout the time course after 
EdU injection (Fig. 4.7B). This provides further evidence that TCRβ+ CD5+ thymocytes 
are TCR-signalled, whereas TCRβ– CD5– thymocytes are TCR-unsignalled. Helios MFI 
in the TCRβ+ CD5+ subset was higher in Bcl-2 Tg mice than in non-Tg mice, especially 
at 2 or more days after EdU injection, whereas Helios MFI in the TCRβ– CD5– subset 
was similar across the two genotypes (Fig. 4.7B). This suggests that Bcl-2 transgene 
enhances the survival of Helios+ thymocytes, as observed previously (Daley et al., 
2013).  
 
In summary, this section (4.2.1.1) provides evidence that TCRβ and CD5 co-
expression identifies the TCR-signalled subset of nascent thymocytes, including 
thymocytes with non-DP phenotypes, in both wild-type and apoptosis-defective mice.  
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Figure 4.7. The nascent TCRb+ CD5+ thymocyte population expresses more CD69 
and Helios than the nascent TCRb– CD5– population. As part of the time course 
experiment described in Fig. 4.1, histograms show EdU+ TCRβ+ CD5+ (red) and EdU+ 
TCRβ– CD5– (grey) thymocytes analysed for CD69 (A) and Helios (B) over time after 
EdU injection. Numbers on histograms represent MFI of gated TCRβ+ CD5+ or TCRβ– 
CD5– events. Summaries show the MFIs of CD69 (A bottom) and Helios (B bottom) of 
EdU+ TCRβ+ CD5+ (red) and EdU+ TCRβ– CD5– (grey) of non-Tg mice (solid line) and 
Bcl-2 Tg (dotted line). Data were compiled from an experiment with a total of n = 3 
mice per group, except n = 2 mice per group for 0.04 day after EdU for non-Tg and Bcl-
2 Tg, and for 7 days after EdU in non-Tg mice. Symbols and error bars represent mean 
and SEM.  
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4.2.1.2 Characterisation of thymocytes expressing active caspase 3 
 
To characterise thymocytes that are committed to apoptosis, this section analyses cells 
bound by an antibody specific for active caspase 3. Active caspase 3, one of the 
executioner caspases (Shi, 2002), has been reported to be the primary regulator of 
apoptosis via proteolytic inactivation of DFF45/ICAD (DNA fragmentation factor-
45/inhibitor of caspase-activated DNase), which releases endonuclease active 
DFF40/CAD (caspase-activated DNase) (Wolf et al., 1999). DNA fragmentation was 
observed via agarose gel electrophoresis and ethidium bromide when pro-DFF40/CAD 
was incubated with rat liver nuclei and caspase 3 (Wolf et al., 1999).   
 
i) Apoptosis-defective mice have fewer active caspase 3+ thymocytes 
 
To analyse thymocytes presumably committed to undergo apoptosis, active caspase 3+ 
events were interrogated (Fig. 4.8A). Among all thymocytes, the mean active caspase 
3+ frequency was 0.46% in non-Tg mice (Fig. 4.8B). A 7-fold lower frequency was 
observed in Bcl-2 Tg mice (Fig. 4.8B). This demonstrates that overexpression of anti-
apoptotic Bcl-2 protein impairs the formation of active caspase 3+ thymocytes. This is 
consistent with Bim-deficient HYCD4 male mice having greatly diminished active 
caspase 3+ thymocyte frequencies compared to Bim-sufficient HYCD4 male mice 
(McCaughtry et al., 2008). 
 
ii) Attainment of an active caspase 3+ phenotype in thymocytes peaks at 3 
days after DNA synthesis 
 
To track the time interval during which thymocytes acquire an active caspase 3+ 
phenotype after DNA synthesis, EdU+ thymocytes were analysed for active caspase 3 
expression in non-Tg and Bcl-2 Tg mice (Fig. 4.9A). In non-Tg mice, the number of 
EdU+ active caspase 3+ thymocytes increased by 81-fold from 1 hour to 3 days after 
EdU injection, when it peaked at 1.6×105 (Fig. 4.9B). The EdU+ active caspase 3+ 
thymocytes then decreased by 19-fold between 3 and 5 days, and continued to decline 
over time (Fig. 4.9B). Overall, these findings suggest that thymocytes undergo 
apoptosis from 1 to 5 days after DNA synthesis, but thymocyte apoptosis peaks around 
3 days after DNA synthesis. 
 
In Bcl-2 Tg mice, the number of EdU+ active caspase 3+ thymocytes also peaked at 3 
days after EdU injection at 1.6×104 (Fig. 4.9B), 10-fold lower than non-Tg mice. The 
number of EdU+ active caspase 3+ thymocytes was similar from 3 to 6 days, as  
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Figure 4.8. Decreased active caspase 3+ thymocytes in mice overexpressing Bcl-
2 transgene within haemopoietic cells. (A) All thymocytes of non-Tg (n=25) and Bcl-
2 Tg (n = 23) mice were analysed for active caspase 3 expression. (B) Summaries 
show the frequency of. active caspase 3+ events among all thymocytes (left) and 
number of active caspase 3+ thymocytes (right) in steady state. Data were compiled 
from one experiment, and were representative of four experiments. Symbols and error 
bars represent mean and SEM. Statistical analyses used unpaired Student’s t-tests; P 
value symbol: **** <0.0001.  
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Figure 4.9. Active caspase 3+ thymocyte formation peaks at day 3 after DNA 
synthesis. Non-Tg and Bcl-2 Tg mice were injected with EdU from 1 hour (0.04d) to 7 
days before flow cytometric analysis of thymocytes. (A) EdU+ thymocytes were 
analysed for SSC/active caspase 3 over time after EdU injection. (B) Summaries show 
the frequency of EdU+ active caspase 3+ among all thymocytes (left) and absolute 
number of EdU+ active caspase 3+ thymocytes (right) in non-Tg (black solid line) and 
Bcl-2 Tg (grey dotted line). Data were compiled from 2 independent experiments in 
non-Tg mice (n = 4-6 per group), and one experiment for Bcl-2 Tg mice (n = 2-3 per 
group). Symbols and error bars represent mean and SEM.  
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opposed to a sharp decline between 3 to 5 days after EdU injection in non-Tg mice. 
EdU+ active caspase 3+ thymocytes decreased by 2.9–fold between 6 and 7 days after 
EdU injection in Bcl-2 Tg mice (Fig. 4.9B). Bcl-2 Tg mice had consistently fewer EdU+ 
active caspase 3+ thymocytes than non-Tg mice throughout the time course, indicating 
that Bcl-2 transgene impairs the formation of nascent active caspase 3+ thymocytes.  
 
iii) Delineation of active caspase 3+ thymocytes into CD69+ CD5+ and CD69– 
CD5– subsets 
 
Active caspase 3+ thymocytes from Nur77-GFP reporter mice were subdivided into 
CD69+ CD5+ and CD69– CD5– subsets, with high and low expression of GFP, 
respectively (Stritesky et al., 2013). The CD69+ CD5+ subset was a mixture of DP and 
CD4SP cells, whereas the CD69– CD5– subset was mostly DP cells. As these 
observations strongly suggest that the CD69+ CD5+ subset has undergone TCR-
signalling but the CD69– CD5– subset has not, the authors concluded that the two 
active caspase 3+ subsets are undergoing apoptosis by deletion and apoptosis by 
neglect, respectively (Stritesky et al., 2013). Among the active caspase 3+ thymocytes 
in non-Tg mice, CD69– CD5– cells outnumbered CD69+ CD5+ cells by ~2-fold (Fig. 
4.10A, B). This was not observed in Bcl-2 Tg mice, in which the CD69+ CD5+ and 
CD69– CD5– subsets were approximately equal to each other in frequency (Fig. 4.10B). 
The absolute numbers of active caspase 3+ thymocytes in both subsets defined by 
CD69 and CD5 were significantly higher in non-Tg mice than in Bcl-2 Tg mice (Fig. 
4.10B).  
 
iv) Appearances of the CD69+ CD5+ and CD69– CD5– subsets of active caspase 
3+ thymocytes peak at a similar time after DNA synthesis 
 
To track the appearance of apoptosis-committed thymocytes with TCR-signalled and 
TCR-unsignalled populations over time after DNA synthesis, the nascent EdU+ active 
caspase 3+ population was analysed for CD69 and CD5 (Fig. 4.11A). In non-Tg mice, 
CD69+ CD5+ cells made up <3% of EdU+ active caspase 3+ thymocytes at 1 hour after 
EdU injection, but this frequency increased sharply to ~40% at 1-2 days after EdU 
injection (Fig. 4.11B, left). This parameter decreased to 18.6% at 3 days after EdU 
injection, followed by a progressive increase between 4 and 7 days after EdU injection, 
reaching a second peak of ~50% at the day 7 time point (Fig. 4.11B, left). In absolute 
cell number terms, the data suggest that only ~70 EdU+ active caspase 3+ CD69+ CD5+ 
thymocytes were present in the thymus 1 hour after EdU injection, whereas 3.0×104 
such cells were present at 2-3 days after EdU injection (Fig. 4.11B, right). The number   
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Figure 4.10. Delineation of active caspase 3+ thymocytes into CD5+ CD69+ and 
CD5– CD69– subsets in steady state. (A) Active caspase 3+ thymocytes were 
analysed for CD69/CD5 expression in non-Tg (n = 25) and Bcl-2 Tg (n = 23) mice. (B) 
Summaries show the frequency of CD69+CD5+ (red) and CD69-CD5– (grey) among 
active caspase 3+ thymocytes (left), and the number of active caspase 3+ thymocytes in 
each of the two subsets (right). Data were compiled from 1 experiment, and were 
representative of four experiments. Lines represent mean. Statistical analyses used 
unpaired Student’s t-test; P value symbol: **** <0.0001.  
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decreased to fewer than 5.0×103 cells at 4-5 days after EdU injection, and fewer than 
1.0×103 cells at 6-7 days after EdU injection (Fig. 4.11B, right). These data suggest 
that death by deletion peaks during the interval 2-3 days after DNA synthesis. 
 
In non-Tg mice the number of the active caspase 3+ CD69– CD5– thymocytes peaked at 
1.3×105 cells 3 days after EdU injection, more than 3-fold higher than the number of 
these cells detected at 2 days after EdU injection (Fig. 4.11C, right). This suggests that 
death by neglect peaks at day 3 after DNA synthesis. The data also suggest that death 
by neglect is more synchronous than death by deletion. 
 
In Bcl-2 Tg mice, the frequency of CD69+ CD5+ cells within the active caspase 3+ 
population was ~20% at 1 to 2 days after EdU injection, ~55% at 2 to 4 days, and 
declined progressively from 4 to 7 days after EdU injection to 25% (Fig. 4.11B, left). In 
Bcl-2 Tg mice, the number of active caspase 3+ CD69+ CD5+ thymocytes increased 
from ~200 at 1 hour after EdU injection to peak at 9×103 at 3 days after EdU injection 
(Fig. 4.11B, right). This number was maintained between 3 and 6 days after EdU, and 
declined only at 7 days after EdU injection (Fig. 4.11B, right). The number of active 
caspase 3+ CD69– CD5– thymocytes increased from ~500 at 1 hour after EdU injection 
to 4.5×103 at 1 day after EdU injection, maintained at a similar number up to 6 days, 
and declined at 7 days after EdU injection (Fig. 4.11C, right).  
 
Compared to non-Tg mice, Bcl-2 Tg mice had fewer EdU+ active caspase 3+ 
thymocytes in both subsets between 1 to 4 days after EdU injection, but the reverse 
was true at 6 days after EdU injection (Fig. 4.11B, C, right). This suggests that Bcl-2 
transgene prolongs the life span of thymocytes before they undergo apoptosis by 
deletion or by neglect.   
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Figure 4.11. Appearance of active caspase 3+ thymocyte subsets over time after 
DNA synthesis. In the EdU time course experiment described in Fig. 4.9, (A) EdU+ 
active caspase 3+ thymocytes were divided into CD69+ CD5+ (red) and CD69– CD5– 
(grey) subsets. (B) Summaries show the frequency of CD69+ CD5+ cells among active 
caspase 3+ population (left), and the number of active caspase 3+ CD69+ CD5+ 
thymocytes (right), in non-Tg (solid line) and Bcl-2 Tg mice (dotted line). (C) 
Summaries show the frequency of CD69– CD5– cells among active caspase 3+ 
population (left), and the number of active caspase 3+ CD69– CD5– thymocytes (right). 
Data were compiled from two independent experiments in non-Tg mice (n = 4-6 per 
group), and one experiment for Bcl-2 Tg mice (n = 2-3 per group). Symbols and error 
bars represent mean and SEM. 
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v) Within the EdU+ active caspase 3+ population, CD69– CD5– thymocytes 
commonly retain a DP phenotype, whereas CD69+ CD5+ thymocytes commonly 
attain non-DP phenotypes 
 
To characterise phenotypes of TCR-signalled and TCR-unsignalled thymocytes 
committing to apoptosis over time, CD69– CD5– (Fig. 4.12A) and CD69+ CD5+ (Fig. 
4.13A) subsets within the EdU+ active caspase 3+ population were analysed for CD4 
and CD8 expression from 1 to 7 days after EdU injection. Data for the 1-hour time point 
after EdU injection was excluded as there were too few events to draw robust 
conclusions (Fig. 4.11A). The CD69– CD5– subset maintained a large proportion of DP 
cells (>60%) in both non-Tg (Fig. 4.12B) and Bcl-2 Tg mice (Fig. 4.12C) throughout the 
time course. Each non-DP population constituted <20% of the CD69– CD5– subset 
throughout the time course in both non-Tg mice and Bcl-2 Tg mice (Fig. 4.12B and C, 
respectively). These findings suggest that apoptotic thymocytes without a TCR-signal 
typically have a DP phenotype, consistent with the phenotype of thymocytes 
undergoing death by neglect (Stritesky et al., 2013). 
 
The CD69+ CD5+ subset was more phenotypically heterogeneous than the CD69– CD5– 
subset. In non-Tg mice, among EdU+ active caspase 3+ CD69+ CD5+ thymocytes, the 
CD4SP frequency increased from 17% at 1 day to 62% at 5 days after EdU injection 
(Fig. 4.13B). In Bcl-2 Tg mice, the CD4SP frequency was consistently the highest from 
1 to 6 days after EdU injection, ranging from 36% to 48% (Fig. 4.13C). The rest of the 
non-CD4SP populations each constituted between 10% and 40% of the CD69+ CD5+ 
subset in both non-Tg mice and Bcl-2 Tg mice (Fig. 4.13B and C, respectively). These 
data demonstrate that TCR-signalled apoptotic thymocytes are phenotypically 
heterogeneous compared to TCR-unsignalled apoptotic thymocytes, providing 
evidence that TCR-signalled thymocytes can undergo apoptosis at multiple stages of T 
cell development. 
 
vi) CD69+ CD5+ thymocytes have higher TCRβ expression than CD69– CD5– 
thymocytes within the EdU+ active caspase 3+ population 
 
As another measure of the maturity of CD69– CD5– and CD69+ CD5+ subsets within the 
EdU+ active caspase 3+ population, TCRβ expression was examined. TCRβ expression 
within the CD69– CD5– subset was consistently low throughout the time course, and 
was lower than TCRβ expression within the CD69+ CD5+ subset throughout the time 
course in both non-Tg and Bcl-2 Tg mice (Fig. 4.14). In both non-Tg and Bcl-2 Tg mice, 
TCRβ expression within the CD69+ CD5+ subset increased steadily throughout the time 
	 128 
course up to 6 days after EdU injection (Fig. 4.14B). The finding that CD69+ CD5+ 
thymocytes had low TCRβ expression at 1 day after EdU injection (Fig. 4.14B) 
excludes the possibility that these thymocytes incorporated EdU during pre-emigration 
proliferation (Pénit and Vasseur, 1997). 
 
 
 
 
 
Figure 4.12. Retention of DP phenotype is common in active caspase 3+ CD69– 
CD5– thymocytes. In the EdU time course experiment described in Fig. 4.9, (A) EdU+ 
active caspase 3+ CD69– CD5– thymocytes were analysed for CD4/CD8 over time after 
EdU injection. (B) Summaries show the frequency of DP (green), CD4loCD8lo (black), 
CD4SP (orange) and CD8SP (blue) subsets over time after EdU injection. Data were 
compiled from one experiment with a total of n = 3 mice per group, except n = 2 mice 
for 7 day after EdU in non-Tg mice. Symbols and error bars represent mean and SEM. 
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Figure 4.13. Attainment of non-DP phenotypes is common in active caspase 3+ 
CD69+ CD5+ thymocytes. In the EdU time course experiment described in Fig. 4.9, (A) 
EdU+ active caspase 3+ CD69+ CD5+ thymocytes were analysed for CD4/CD8 over time 
after EdU injection. (B) Summaries show the frequency of DP (green), CD4loCD8lo 
(black), CD4SP (orange) and CD8SP (blue) subsets over time after EdU injection. Data 
were compiled from one experiment with a total of n = 3 mice per group, except n = 2 
mice for 1 day after EdU in Bcl-2 Tg mice and 7 days after EdU injection in non-Tg 
mice. Symbols and error bars represent mean and SEM.  
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Figure 4.14. TCRβ expression is higher in CD69+ CD5+ thymocytes than CD69– 
CD5– thymocytes within the EdU+ active caspase 3+ population. In the EdU time 
course experiment described in Fig. 4.9, (A) CD69– CD5– (grey) and CD69+ CD5+ (red) 
subsets of EdU+ active caspase 3+ thymocytes were analysed for TCRβ expression, 
with numbers indicating the MFIs of TCRβ expression. (B) Summaries show the MFIs 
of TCRβ expression in the two subsets of EdU+ active caspase 3+ thymocytes. Data 
were compiled from one experiment with a total of n = 3 mice per group, except n = 2 
mice for 1 day after EdU in Bcl-2 Tg mice and 7 days after EdU injection in non-Tg 
mice. Symbols and error bars represent mean and SEM. 
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4.4.2 Contributions of MHCI and/or MHCII to TCR-signalling and apoptosis in 
the natural thymocyte repertoire  
 
The aim of this chapter is to investigate the mechanism underlying the numerical 
imbalance between CD4+ and CD8+ T cells. This investigation requires a method to 
count thymocytes that initiate T cell development. The results above establish such a 
method by demonstrating that a TCRb+ CD5+ phenotype marks the TCR-signalled 
subset of nascent thymocytes labelled with EdU. The investigation also requires a 
method to count thymocytes that die between the initiation and completion of T cell 
development in the thymus. The results above suggest a method to estimate this 
variable, based on evidence that an active caspase 3+ CD69+ CD5+ phenotype marks 
apoptosis-committed thymocytes that have received a TCR signal.  
 
The results above also reveal similarities and differences between non-Tg and Bcl-2 Tg 
mice. First, as in non-Tg mice, a TCRb+ CD5+ phenotype marks TCR-signalled 
thymocytes in Bcl-2 Tg mice. Second, Helios+ cells within the TCR-signalled population 
are normally susceptible to apoptosis in non-Tg mice but these cells persist (at least 
transiently) in the thymus of Bcl-2 Tg mice, allowing them to be included in calculation 
of the TCR-signalled subset. Third, while consistent with perturbed apoptosis in Bcl-2 
Tg mice, the low number of active caspase 3+ thymocytes in Bcl-2 Tg mice limits the 
use of this marker in apoptosis-defective mice. Fourth, the time course suggested that 
Bcl-2 transgene expression blunts thymocyte proliferation and prolongs thymocyte 
lifespan, especially in the TCR-unsignalled subset; however, the percentages and 
numbers of EdU+ thymocytes in non-Tg and Bcl-2 Tg mice were similar at 3 days after 
EdU injection. At this time point, a substantial fraction of the EdU+ cohort had attained a 
TCRb+ CD5+ phenotype, establishing that 3 days is sufficient time to allow MHC-
dependent TCR-signalling to be induced in nascent thymocytes. Finally, in non-Tg 
mice the EdU+ thymocyte frequency dropped sharply between 3 and 4 days after EdU 
injection, indicating that the nascent thymocyte cohort shrinks markedly during this 
interval. For these reasons, in subsequent experiments thymocytes were analysed 3 
days after EdU injection, and the non-Tg mice and Bcl-2 Tg mice are analysed 
separately, providing related but distinct information on the requirements for each MHC 
class in inducing TCR signalling in thymocytes. 
 
The section below investigates the fractions of the nascent natural thymocyte 
repertoire that require MHCI and/or MHCII (i) to perceive TCR-signalling or (ii) commit 
to apoptosis after receiving a TCR-signal. It concludes by using Helios and CCR7 to 
subdivide the TCR-signalled thymocyte cohorts into fractions that have received a 
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strong or weak TCR signal. 
 
4.2.2.1 Role of MHC classes in inducing apoptosis-committed thymocytes 
 
i)  Similar frequencies of apoptosis-committed TCR-signalled thymocytes in the 
absence of MHCI or MHCII  
 
The experiments below examined eight groups of mice: (1) wild-type (MHC-sufficient), 
(2) B2m–/– (absence of beta-2 microglobulin, also referred to as MHCI-deficient), (3) 
H2-Aa–/– (absence of histocompatibility 2, class II antigen A, alpha; also referred to as 
MHCII-deficient) and (4) B2m–/–H2-Aa–/– (also referred to as MHC-deficient). Groups 5-
8 were identical to groups 1-4, except that they carried the Bcl-2 transgene. Some 
experiments included a ninth group consisting of Tcra–/– mice (lacking αβ TCR 
expression).  
 
In steady state, the mean frequency of active caspase 3+ thymocytes was similar in the 
panel of non-Tg mice, except for B2m–/–H2-Aa–/– mice, which had a small but 
statistically significant increase compared to wild-type mice (Fig. 4.15B). Within the 
panel of Bcl-2 Tg mice, the mean frequency of active casapse 3+ thymocytes was 
similar across all groups, but it was ~4-fold lower than non-Tg mice (Fig. 4.15C). These 
data indicate that MHC expression does not markedly alter the frequency of apoptosis-
committed thymocytes. 
 
To confine the analysis to nascent thymocytes, the nine groups of mice were injected 
with EdU 3 days before analysis. Uninjected mice were analysed in parallel to ensure 
that detection of EdU+ thymocytes was specific (Fig. 4.16A). The frequency of EdU+ 
events among all thymocytes was similar across groups in non-Tg and Bcl-2 Tg mice 
(Fig. 4.16B), suggesting that MHCI- and/or MHCII-deficiency does not markedly alter 
overall thymocyte turnover. 
 
Among the EdU+ population in non-Tg mice, B2m–/–H2-Aa–/– mice had a significantly 
higher mean frequency of active caspase 3+ thymocytes at 2.08% than wild-type mice 
at 1.06% (Fig. 4.17B, left). Although not statistically significant, B2m–/– and H2-Aa–/– 
mice had slightly higher active caspase 3+ frequencies compared to wild-type mice, 
both at 1.4% (Fig. 4.17B, left). These observations mirrored the results found in steady 
state within the panel of non-Tg mice (Fig. 4.15B, left). Among all thymocytes, the  
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Figure 4.15. Normal active caspase 3+ thymocyte frequency in the absence of 
MHCI or MHCII expression in steady state. (A) All thymocytes in non-Tg mice and 
Bcl-2 Tg mice of the following groups: MHC wild-type, B2m–/– (MHCI–/–), H2-Aa–/– 
(MHCII–/–), B2m–/–H2-Aa–/– and Tcra–/– were analysed for active caspase 3 expression. 
Summaries show the frequency of active caspase 3+ events among all thymocytes in 
non-Tg mice (B) and Bcl-2 Tg mice (C). Data were compiled from three independent 
experiments with a total of n = 5-13 mice per group; each symbol represents 1 mouse. 
Lines represent mean. Statistical analyses used 1-way ANOVA and Tukey’s post-tests; 
P value symbol: * <0.05.   
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Figure 4.16. Absence of MHCI or MHCII expression does not obviously alter the 
turnover of nascent thymocytes. Nine groups of mice described in Fig. 4.15 were 
injected with EdU three days prior to flow cytometric analyses of thymocytes. (A) 
Representative FCS/EdU plots show all thymocytes with a gate for EdU+ events, using 
the staining of samples from uninjected control mice to aid gate placement. (B) 
Summaries show the frequency of EdU+ thymocytes for the indicated mouse 
genotypes; each symbol represents 1 mouse. A total of n = 5-10 mice per group 
compiled from three independent experiments. Lines represent mean. 1-way ANOVA 
and Tukey’s post-tests revealed non-significant P values in all comparison groups.  
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Figure 4.17. Normal formation of nascent active caspase 3+ thymocytes in the 
absence of MHCI or MHCII expression. (A) EdU+ thymocytes from Fig. 4.16 were 
analysed for active caspase 3+ expression. Summaries show the frequency of (B) 
active caspase 3+ events among EdU+ thymocytes as gated in the representative plots, 
and (C) EdU+ active caspase 3+ among all thymocytes for the indicated mouse 
genotypes; each symbol represents 1 mouse, compiled from three independent 
experiments. Lines represent mean. (B, C) Statistical analyses used 1-way ANOVA 
and Tukey’s post-tests; P value symbol: *** <0.001. (C) Non-significant in all 
comparison groups.  
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frequency of EdU+ active caspase 3+ cells in B2m–/– and H2-Aa–/– mice were also 
slightly higher than wild-type mice (Fig. 4.17C, left). 
 
In Bcl-2 Tg mice, the frequency of active caspase 3+ cells among EdU+ cells was 
similar across all groups (Fig. 4.17B, right), but it was 5 to 16-fold lower than observed 
in the panel of non-Tg mice (Fig. 4.17B, left). Consistent with the finding observed in 
steady state, overexpression of Bcl-2 anti-apoptotic molecule in mice inhibits the 
formation of active caspase 3+ thymocytes at 3 days after EdU injection. Due to the low 
number of relevant events acquired, Bcl-2 Tg mice were excluded from the subsequent 
analysis as robust conclusions could not be drawn. Overall, the phenotype and 
frequency of apoptosis-committed thymocytes within the nascent cohort were similar to 
the observations in steady state.  
 
ii) MHC and ab TCR expression are required for thymocytes to attain an 
active caspase 3/CD69/CD5+ phenotype 
 
In steady state, the mean CD69+ CD5+ cell frequency among active caspase 3+ 
thymocytes was 16% in wild-type mice, whereas this parameter was <0.9% in B2m–/–
H2-Aa–/– mice and Tcra–/– mice (Fig. 4.18B, left). A similar result was observed when 
the analysis was confined to EdU+ thymocytes (Fig. 4.18C, left). The mean CD69– 
CD5– cell frequency among active caspase 3+ thymocytes in steady state and in EdU+ 
thymocytes was >98% in B2m–/–H2-Aa–/– mice and Tcra–/– mice, compared to 81-85% in 
wild-type mice (Fig. 4.18D, E left). These data indicate that nearly all active caspase 3+ 
CD69+ CD5+ thymocytes have received a signal that requires MHC and ab TCR 
expression.  
 
iii) Single deficiency of MHCI or MHCII reduces active caspase 3/CD69/CD5+ 
thymocytes by similar amounts 
 
B2m–/– mice and H2-Aa–/– mice were examined to test for a selective effect of MHCI or 
MHCII (Fig. 4.18A). In steady state, the CD69+ CD5+ cell frequency in the active 
caspase 3+ population was 16.0% in wild-type, 9.4% in B2m–/– and 7.8% in H2-Aa–/– 
mice (Fig. 4.18B, left). Taking the wild-type measurement as 100%, there was a 41% 
and 51% reduction in this parameter in MHCI-deficient mice and MHCII-deficient mice, 
respectively. A similar trend was observed when the analysis was confined to EdU+ 
thymocytes (Fig. 4.18C, left). There was no statistically significant difference in this 
parameter between H2-Aa–/– mice and B2m–/– mice in the steady state (Fig. 4.18B, left) 
or among EdU+ thymocytes (Fig. 4.18C, left).   
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In steady state however, when the denominator is all thymocytes, the frequencies of 
active caspase 3+ CD69+ CD5+ population in B2m–/– mice and H2-Aa–/– mice were not 
significantly different from wild-type mice (Fig. 4.18B, right). A similar result was found 
when the analysis was confined to EdU+ thymocytes (Fig. 4.18C, right). This is due to 
the slightly higher frequencies of active caspase 3+ thymocytes in B2m–/– mice and H2-
Aa–/– mice compared to wild-type mice (Figs. 4.15B, 4.17B). 
 
The frequency of CD69– CD5– cells among active caspase 3+ thymocytes in steady 
state, and when confined to the EdU+ population, was significantly increased in B2m–/– 
mice and H2-Aa–/– mice compared to wild-type mice (Fig. 4.18D, E, left). When the 
denominator is all thymocytes, the frequencies of active caspase 3+ CD69– CD5– 
thymocytes in B2m–/– mice and H2-Aa–/– mice were not significantly different from wild-
type mice (Fig. 4.18D, right), but appeared to be slightly higher than wild-type mice. A 
similar result was found when the analysis was confined to the EdU+ thymocytes (Fig. 
4.18E, right). 
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Figure 4.18. Roles for MHCI and/or MHCII in inducing CD69+ CD5+ and CD69– 
CD5– subsets of active caspase 3+ thymocytes. Using the gating strategies shown 
in Figs. 4.16 and 4.17, (A) all (top) or EdU+ (bottom) active caspase 3+ thymocytes 
were analysed for CD69/CD5 expression. (B, C) Summaries show frequency of CD69+ 
CD5+ thymocytes in the active caspase 3+ population in steady state (B, left) and in the 
EdU+ active caspase 3+ population (C, left); and frequency of CD69+ CD5+ active 
caspase 3+ events among all thymocytes (B, right) or among EdU+ thymocytes (C, 
right). (D, E) Summaries show frequency of CD69– CD5– thymocytes in the active 
caspase 3+ population in steady state (D, left) and in the EdU+ population (E, left); and 
frequency of CD69– CD5– active caspase 3+ events among all thymocytes (D, right) or 
among EdU+ thymocytes (E, right).  Data were compiled from three independent 
experiments with a total of n = 5-10 mice per group. Each symbol represents 1 mouse 
and lines represent the group mean. Statistical analyses used 1-way ANOVA and 
Tukey’s post-tests; P value symbols: **** <0.0001; *** <0.001; ** <0.01; * <0.05.    
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4.2.2.2 Effect of MHC expression on the induction of TCR-signalling in the 
natural thymocyte repertoire 
 
The active caspase 3/CD69/CD5+ approach (section 4.2.2.1) would be expected to 
capture only strongly TCR-signalled cells undergoing clonal deletion. This section 
examines the overall TCR signalling induction in nascent thymocytes, including weak 
TCR-signalling that facilitates naïve T cell development. It quantifies effects on this 
parameter caused by the absence of MHCI and/or MHCII expression. 
 
i) No effect of single MHCI- or MHCII-deficiency on induction of TCR-
signalled thymocytes in mice with normal apoptosis 
 
Three days after EdU injection, EdU+ thymocytes were interrogated for TCRβ+ CD5+ 
events as a means to enumerate TCR-signalled cells (Fig. 4.19A). In the panel of non-
Tg mice (Fig. 4.19B), wild-type mice had the highest mean frequency of TCRβ+ CD5+ 
thymocytes at 17.3%. This parameter was reduced to <1% in B2m–/–H2-Aa–/– double-
deficient mice and Tcra–/– mice, demonstrating that formation of TCR-signalled cells 
depends largely on MHC and ab TCR expression. This parameter in B2m–/– mice 
(16.2%) and H2-Aa–/– mice (14.5%) was not significantly different from wild-type mice 
(Fig. 4.19B). Thus, in mice with normal apoptosis, there was no evidence that the 
absence of one MHC class alters the formation of TCRb+ CD5+ thymocytes among the 
nascent cohorts 3 days after DNA synthesis. 
 
ii) Inhibition of apoptosis reveals roles for MHCI and MHCII in inducing TCR-
signalling in nascent thymocytes  
 
In the panel of Bcl-2 Tg mice (Fig. 4.19C), the mean frequency of TCRβ+ CD5+ 
thymocytes among the EdU+ population was highest in wild-type mice at 22.1%, but 
was severely reduced to <1.5% in B2m–/–H2-Aa–/– double-deficient mice. This indicates 
that most thymocytes within the natural TCR repertoire require b2-microglobulin or 
MHCII expression to receive a TCR signal, including when the thymocytes have 
impaired apoptosis. The same parameter was significantly reduced in B2m–/– mice 
(15.5%) and H2-Aa–/– (14.3%) mice, compared to wild-type mice (22.1%) (Fig. 4.19C). 
Taking the wild-type measurement as 100%, there was a 30% and 35% reduction in 
this parameter in MHCI-deficient mice and MHCII-deficient mice, respectively. As the 
frequency of TCR-signalled cells was decreased to a similar extent in the absence of 
MHCI and in the absence of MHCII compared to wild-type mice, similar fractions of the 
thymocyte repertoire require MHCI versus MHCII to receive a TCR signal. It is 
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noteworthy that the sum of TCR-signalled frequencies in the two groups expressing 
only one MHC class exceeds the measurement for wild-type mice.  
 
 
 
 
Figure 4.19. An apoptosis defect reveals that similar fractions of the natural 
thymocyte repertoire require MHCI versus MHCII to induce TCR-signalling. EdU+ 
thymocytes gated in Fig. 4.16 were analysed for TCRβ and CD5 expression. 
Summaries show the frequency of CD5+ TCRb+ cells in non-Tg mice (B) and Bcl-2 Tg 
mice  (C). Data were compiled from three independent experiments, n = 5-10 mice per 
group. Lines represent mean. Statistical analyses used 1-way ANOVA and Tukey’s 
post-tests; P value symbol: **** <0.0001.  
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4.2.2.3 Subdivision of nascent TCR-signalled thymocytes using 
Helios/CCR7 expression  
 
As a TCRβ+ CD5+ phenotype marks the subset of nascent thymocytes that has 
received a TCR-signal, for brevity, the TCRβ+ CD5+ population is referred to as “TCR-
signalled” in the results below. To subdivide the TCR-signalled population into strongly 
and weakly TCR-signalled subsets, Helios and CCR7 expression were examined. The 
subsets expressing Helios and/or CCR7 correspond to the populations analysed in 
Chapter 3. However, the Helios– CCR7– subset is different from the subset described in 
Chapter 3, because a TCR-signalled phenotype was a prerequisite for inclusion in the 
Helios– CCR7– population described below. 
 
i) No decrease in Helios induction in apoptosis-intact mice lacking one MHC 
class 
 
In the presence or absence of the Bcl-2 transgene, B2m–/–H2-Aa–/– double-deficient 
mice had a markedly diminished frequency of all four TCR-signalled Helios/CCR7 
subsets (Fig. 4.20B, C), demonstrating that the populations of interest largely require 
MHC expression for their induction. In mice with normal apoptosis, the frequencies of 
TCR-signalled Helios– CCR7–, Helios+ CCR7– and Helios+ CCR7+ subsets among EdU+ 
thymocytes in B2m–/– mice and H2-Aa–/– mice were not significantly different from wild-
type mice (Fig. 4.20B). However, H2-Aa–/– mice had a significant decrease in Helios– 
CCR7+ thymocytes compared to wild-type and B2m–/– mice (Fig. 4.20B). This was 
attributable to a marked reduction in CD4SP cells in H2-Aa–/– mice (Fig. 4.21B), 
consistent with the well-established requirement for MHCII in naïve CD4+ T cell 
development. Reciprocally, few CD8SP cells were detected among TCR-signalled 
Helios– CCR7+ cells in B2m–/– mice (Fig. 4.21B). Compared to B2m–/– mice, H2-Aa–/– 
mice had a small but statistically significant increase in the frequency of TCR-signalled 
Helios+ CCR7– cells within the nascent thymocyte cohort (Fig. 4.20B).  
 
ii)  Apoptosis-defective mice reveal a greater requirement for MHCII than 
MHCI in Helios induction 
 
Mice with defective apoptosis presented a different picture. The frequencies of TCR-
signalled Helios– CCR7–, Helios+ CCR7+ and Helios– CCR7+ thymocytes were 
significantly lower in B2m–/– mice and H2-Aa–/– mice compared to wild-type mice; 
however, B2m–/– mice and H2-Aa–/– mice were not significantly different from each other 
in these parameters (Fig. 4.20C). Analysis of the TCR-signalled Helios– CCR7+ cells for   
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Figure 4.20. Quantification of requirements for MHC classes in nascent TCR-
signalled thymocytes subdivided using Helios and CCR7 expression. (A) EdU+ 
TCRβ+ CD5+ thymocytes gated in Fig. 4.19 were divided into four subpopulations using 
Helios/CCR7, consisting of Helios– CCR7– (grey), Helios+ CCR7– (red), Helios+ CCR7+ 
(blue) and Helios– CCR7+ (black). Summaries show the frequency of each of the four 
TCRβ+ CD5+ subsets, distinguished by Helios/CCR7 phenotype, among EdU+ 
thymocytes in non-Tg mice (B) and Bcl-2 Tg mice (C). Each symbol represents data 
from 1 mouse compiled from three independent experiments. Lines represent mean; 
statistical analyses used 1-way ANOVA and Tukey’s post-tests. P value symbols: **** 
<0.0001; *** <0.001; ** <0.01; * <0.05.   
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Figure 4.21. Quantification of nascent CD4SP and CD8SP thymocyte induction 
dependent on MHCI versus MHCII. (A) EdU+ TCRβ+ CD5+ Helios– CCR7+ thymocytes 
gated in Fig. 4.20 were analysed for CD4/CD8 expression and CD4SP and CD8SP 
subsets were quantified.  Summaries show the frequency of the gated CD4SP or 
CD8SP thymocytes in non-Tg mice (B) and Bcl-2 Tg mice (C). A total of n = 5-10 mice 
per group compiled from three independent experiments. Lines represent mean; 
statistical analyses used 1-way ANOVA and Tukey’s post-tests. P value symbols: **** 
<0.0001; ** <0.01; * <0.05.   
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CD4 and CD8 expression revealed that H2-Aa–/– mice had marked reductions in 
CD4SP cells, whereas B2m–/– mice had reduced CD8SP cells, compared to wild-type 
mice (Fig. 4.21C), as expected. 
 
The TCR-signalled Helios+ CCR7– cell frequency in wild-type mice (7.7%) was 
significantly greater than B2m–/– mice (5.8%) and H2-Aa–/– mice (4.1%) (Fig. 4.20C). 
Interestingly, the difference between H2-Aa–/– mice and B2m–/– mice (4.1% versus 
5.8%) was statistically significant (Fig. 4.20C). This finding reveals a greater 
requirement for MHCII than MHCI in Helios+ CCR7– thymocyte induction. 
 
4.2.3 Greater dependence of CD4loCD8lo PD-1hi thymocytes on MHCII than MHCI 
 
The results above provide evidence that the induction of strongly TCR-signalled 
thymocytes depends to a greater extent on MHCII than on B2m-dependent ligands. To 
corroborate that conclusion, using an approach that does not rely on Helios labelling, 
the CD4loCD8lo PD-1hi thymocyte population was enumerated, since this population is 
thought to contain iIEL precursors (Mayans et al., 2014; McDonald et al., 2015; 
Pobezinsky et al., 2012). To exclude mature T cells, the analysis was confined to 
CD24+ FoxP3– thymocytes, from which the CD4loCD8lo population was gated as 
described in Chapter 3 (Fig. 3.12A). In non-Tg mice, analysis of the CD4loCD8lo 
population revealed that the PD-1+ population consisted of a mixture of Heliosintermediate 
and Helioshigh cells (Fig. 4.22A). However, in Bcl-2 Tg mice, nearly all CD4loCD8lo PD-
1+ thymocytes were Helioshigh (Fig. 4.22A).  
 
In the non-Tg dataset, the frequency and number of CD24+ FoxP3– CD4loCD8lo PD-1hi 
thymocytes in B2m–/–, H2-Aa–/– and B2m–/–H2-Aa–/– mice were similar to wild-type mice 
(Fig. 4.22B). However, when apoptosis was defective in Bcl-2 Tg mice, the frequency 
of CD24+ FoxP3– CD4loCD8lo PD-1hi thymocytes was significantly reduced in H2-Aa–/– 
and B2m–/–H2-Aa–/– mice compared to wild-type mice (Fig. 4.22C). B2m–/– mice were 
not significantly different from wild-type mice on the Bcl-2 Tg background (Fig. 4.22C). 
This finding provides additional evidence that the induction of strongly TCR-signalled 
thymocytes depends to a greater extent on MHCII than on MHCI, consistent with the 
findings using Helios-labelling. As above, this effect was detectable only when 
apoptosis was defective. 
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Figure 4.22. Greater dependence of CD4loCD8lo PD-1hi thymocytes on MHCII than 
MHCI. (A) Immature CD24+ FoxP3– CD4loCD8lo thymocytes in non-Tg mice and Bcl-2 
Tg mice of the following groups: MHC wild-type, B2m–/– (MHCI–/–), H2-Aa–/– (MHCII–/–) 
and B2m–/–H2-Aa–/– were analysed for PD-1 expression. For reference to data above, 
dot plots show PD-1 versus Helios expression, although Helios expression is irrelevant 
to the placement of the PD-1+ gate. (B, C) Summaries show the frequency (top) and 
number (bottom) of CD24+ FoxP3– CD4loCD8lo PD-1hi events among all thymocytes in 
non-Tg mice (B) and Bcl-2 Tg mice (C). Data were compiled from the same three 
independent experiments described in Fig. 4.15, with a total of n = 5-12 mice per 
group. Lines represent mean. Statistical analyses used 1-way ANOVA and Tukey’s 
post-tests; P value symbols: **** <0.0001; ** <0.01. Non-significant P values were 
obtained between all comparison groups in (B, bottom) and (C, bottom).  
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4.2.4 MHCI induces higher fraction of wave 2 cells than MHCI at steady state 
 
The data above suggest that neither positive nor negative selection can explain the 
excess of CD4+ over CD8+ T cells. However, negative selection was measured within 
EdU+ thymocytes at 3 days after EdU, a time when the cells analysed were probably 
mostly in the thymic cortex. It is therefore possible that negative selection of the CD8+ 
T cells continues under the very different environment of wave 2, mainly in the medulla. 
If so, then negative selection at wave 2 may be mainly mediated by MHC I. While an 
analysis at 5 days after EdU injection is necessary to address this question, a 
preliminary analysis may be performed by looking at steady-state thymocytes. As most 
Foxp3+ thymocytes are Helios+, the analysis was performed on electronically gated 
Foxp3– thymocytes. 
Mice with normal apoptosis are included for completeness, but those results are 
difficult to interpret because most thymocytes induced to express Helios are rapidly 
eliminated by apoptosis. The data of most interest come from the apoptosis-deficient 
Bcl-2 Tg mice. On a Bcl-2 Tg background, H2Aa–/– mice had a significantly lower 
frequency of Helios+ CCR7– thymocytes than wild-type or B2m–/– mice (Fig. 4.23B), 
which replicates the observations above at day 3 after EdU pulse (Fig. 4.20) and 
reinforces the conclusion that MHCII makes a greater contribution than MHCI to 
negative selection at wave 1. Analysis of wave 2 revealed a different picture. On a Bcl-
2 Tg background, B2m–/– mice had a significantly lower frequency and number of 
Helios+ CCR7+ thymocytes than wild-type or H2Aa–/– mice (Fig. 4.23C). This suggests 
that MHCI may mediate the majority of negative selection at wave 2.  
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Figure 4.23. Quantification of requirements for MHC classes in Helios+ CCR7– 
and Helios+ CCR7+ thymocytes at steady state. (A) FoxP3– thymocytes were divided 
into four subpopulations using Helios/CCR7, consisting of Helios– CCR7– (grey), 
Helios+ CCR7– (red), Helios+ CCR7+ (blue) and Helios– CCR7+ (black). Summaries 
show the frequency and number of (B) FoxP3– Helios+ CCR7– thymocytes and (C)  
FoxP3– Helios+ CCR7+ thymocytes in non-Tg mice and Bcl-2 Tg mice. Each symbol 
represents data from 1 mouse compiled from three independent experiments. Lines 
represent mean; statistical analyses used 1-way ANOVA and Tukey’s post-tests. P 
value symbols: **** <0.0001; *** <0.001; ** <0.01; * <0.05.  
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4.3 Discussion 
 
The mechanism underlying the numerical imbalance between CD4+ and CD8+ T cells is 
enigmatic. The findings above indicate that a similar number of MHCI-responsive and 
MHCII-responsive thymocytes initiate development. Analysis of active caspase 
3/CD69/CD5 expression failed to uncover a difference in cell death between MHCI-
responsive and MHCII-responsive cells after initiation of TCR-signalling. However, as 
CD8+ T cell development takes twice as long as CD4+ T cell development (Saini et al., 
2010), an equivalent death rate would be expected to result in fewer CD8+ T cells 
completing development. Two independent analytical methods provided evidence that 
MHCII makes a greater contribution to induction of strongly TCR-signalled thymocytes 
than MHCI.  
 
To maintain a relatively constant number of thymocytes, cell loss via egress and death 
must be balanced by cell gain via ingress and mitosis. Ingress by itself constitutes a 
minor input, as the young adult mouse thymus contains ~1.5 x 108 thymocytes, but can 
accommodate only ~160 T-cell progenitors, and only ~10 niches are open to 
colonisation by circulating progenitors at any moment in time (Ziętara et al., 2015). 
Egress is a relatively minor output, as experiments blocking thymocyte egress using 
the FTY720 drug suggest that ~15% of SP cells (~2% of thymocytes) egress from the 
thymus per day (Sinclair et al., 2013). After repetitive administration of tritiated 
thymidine, the frequency of labelled thymocytes increases to 80-90% within 3 days, 
indicating that almost one-third of thymocytes arise by mitosis per day (Matsuyama et 
al., 1966). When thymic mass was substantially increased by transplantation of 
multiple thymuses under the skin, mitosis remained vigorous in each thymus graft, yet 
there was minimal impact on lymphocytes in peripheral lymphoid organs, 
demonstrating that most thymocytes die within the thymus (Matsuyama et al., 1966). 
Thus, thymocyte “turnover” is mainly governed by intra-thymic mitosis and cell death, 
with minor contributions by ingress and egress.  
 
Thymocyte mitosis may be estimated by accumulation of EdU+ thymocytes in the first 2 
days after EdU injection, termed “A” in the schematic shown in Fig. 4.24. As the EdU+ 
cell frequency among all thymocytes tended to be lower in Bcl-2 Tg mice than in non-
Tg mice at 1-2 days after EdU injection, Bcl-2 transgene expression appears to 
decrease the magnitude of A (Fig. 4.24). Considering cell loss, Bcl-2 Tg mice had a 
significantly lower frequency and number of active caspase 3+ thymocytes than non-Tg 
mice. It is not clear that all apoptosis-committed thymocytes express active caspase 3, 
nor is it clear that non-Tg and Bcl-2 Tg thymocytes express active caspase 3 for similar  
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Figure 4.24. 2-compartment model of TCR-signalling and apoptosis within the 
nascent thymocytes during T cell development. (A) The schematic incorporates 
data from three analytical approaches: TCRβ/CD5, active caspase 3/CD69/CD5 and 
Helios/CCR7. The first compartment consists of TCR-unsignalled TCRβ–CD5– cells, 
denoted “U”. The TCR-signalled TCRβ+ CD5+ cells, denoted “S”, form the second 
compartment. The input received by U as EdU+ cells proliferate is denoted “A”. Cells 
committed to apoptosis within U, measured as active caspase 3+ CD69– CD5– 
thymocytes, are denoted “B”. Transition of cells from U to S is denoted “C”. Cells 
committed to apoptosis within S, measured as active caspase 3+ CD69+ CD5+ 
thymocytes, are denoted “D”. S is subdivided into Helios– CCR7– thymocytes that are 
uncommitted to selection (Su), Helios+ strongly TCR-signalled (Ss) and Helios– CCR7+ 
weakly TCR-signalled (Sw). (B) Flow cytometric phenotypes of thymocytes analysed 3 
days after a single EdU injection that were used to estimate variables within the 2-
compartment scheme.   
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periods of time before disappearing. However, the diminished active caspase 3+ 
thymocyte population in Bcl-2 Tg mice is consistent with the hypothesis that Bcl-2 
transgene expression decreases cell death within the thymus. Together, these findings 
suggest that thymocyte “turnover” at equilibrium, defined as the rate of replacement of 
thymocyte loss by thymocyte mitosis, is decreased in Bcl-2 Tg mice. This difference 
complicates the comparison of nascent thymocyte cohorts in non-Tg versus Bcl-2 Tg 
mice. This issue may be avoided by considering the non-Tg and Bcl-2 Tg datasets as 
separate bodies of information relevant to my research question. 
 
To synthesise the data in this chapter, a 2-compartment model was conceived (Fig. 
4.24). This model ignores thymocyte egress based on the following two sets of 
observations. After Zap70-dependent TCR-signalling is initiated, it takes DP 
thymocytes 2 and 4 days to progress to the CD4SP and CD8SP stages, respectively 
(Saini et al., 2010). From the beginning of the single-positive stage, it takes another 4-5 
days for the nascent T cells to appear in the spleen (McCaughtry et al., 2007). As the 
experiments on mice lacking one or both MHC classes analysed thymocytes 3 days 
after in vivo proliferation, which precedes Zap70-dependent TCR-signalling, the 
nascent thymocyte cohorts examined were too immature to be influenced by egress.  
 
Within the nascent cohort of EdU+ thymocytes, the first compartment contains nascent 
TCR-unsignalled cells, defined as TCRb– CD5–, denoted “U” (Fig. 4.24). It is clear that 
most DNA-synthesising thymocytes belong to this compartment (Fig. 4.2). The second 
compartment contains TCR-signalled cells, defined as TCRβ+ CD5+, denoted “S” (Fig. 
4.24). Cell death within U is defined as the active caspase 3+ CD69– CD5– population, 
denoted “B” in the model, and corresponds to death by neglect in the literature. Cell 
death within S is defined as the active caspase 3+ CD69+ CD5+ population, denoted “D” 
in the model, and corresponds to death by clonal deletion in the literature. Similar 
estimates were obtained for B and D by analyzing all thymocytes or EdU+ thymocytes. 
The parameter of interest, which describes progression from U to S, is denoted “C” 
(Fig. 4.24).  
 
Among EdU+ active caspase 3+ cells in non-Tg mice, as CD69– CD5– thymocytes 
(~“B”) outnumbered CD69+ CD5+ thymocytes (~“D”) at all points in the time course, it 
may be inferred that apoptosis within the TCR-unsignalled pool, “B”, exceeds apoptosis 
within the TCR-signalled pool, “D”, consistent with published data (Stritesky et al., 
2013; Surh and Sprent, 1994). The time course experiment also revealed that EdU+ 
active caspase 3+ CD69– CD5– thymocytes peak at 3 days after EdU injection, whereas 
EdU+ active caspase 3+ CD69+ CD5+ thymocytes are equally numerous at 2 and 3 days 
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after EdU injection (Fig. 4.11). With the caveat that some thymocytes undergoing 
clonal deletion may not attain an active caspase 3+ phenotype, the data suggest that 
clonal deletion precedes, and coincides with, death by neglect during thymocyte 
development. 
 
The 2-compartment model may help to distinguish requirements for the 2 major MHC 
classes in inducing T cell development in the thymus. At 3 days after EdU injection, the 
EdU+ cell frequency among all thymocytes was similar across the non-Tg panel of mice 
(Fig. 4.16). This suggests that the input rate of thymocyte precursors (A) is similar 
within the non-Tg panel and not influenced by MHC. Considering cell death, the 
absence of both MHC classes clearly increased B and decreased D, relative to wild-
type mice (Fig. 4.18). This is consistent with increased death by neglect and decreased 
death by clonal deletion in the absence of MHC molecules. The value of S was 
decreased by >90% in MHC-deficient mice compared to wild-type mice (Fig. 4.19). 
These findings show that thymocyte development in MHC-deficient mice is largely 
confined to the first compartment, whereby U receives input via A and gives output via 
B, with relatively little flow of thymocytes into S.  
 
The groups lacking one MHC class had values for S and D that clearly exceeded the 
MHC-deficient group (Figs. 4.18, 19), indicating that expression of one MHC class was 
sufficient to restore a substantial flow of thymocytes into the second compartment, S. 
Relative to wild-type mice, there was no statistically significant decrease in the value of 
S in non-Tg mice lacking either MHC class (Fig. 4.19). This observation is discussed 
below, after the Bcl-2 Tg dataset is considered. 
 
In Bcl-2 Tg mice, as in non-Tg mice, it is clear that the absence of both MHC classes 
markedly reduced S (Fig. 4.19), demonstrating that most thymocytes that attain a TCR-
signalled phenotype require MHC to do so, even when apoptosis is defective. Unlike in 
non-Tg mice, however, the Bcl-2 Tg dataset also revealed highly significant decreases 
in S in both groups lacking one MHC class (Fig. 4.19). As Bcl-2 transgene markedly 
reduces the values of B and D (Fig. 4.10B), it is likely that B and D have little influence 
on the value of S in the Bcl-2 Tg dataset. By diminishing B and D, Bcl-2 transgene 
expression enables C to become the main determinant of S. Thus, when one MHC 
class is absent, it is postulated that the observed reduction in S is due to a significant 
reduction in C. These data provide evidence that each MHC class is required to induce 
significant fractions of the TCR-signalled cohort, and that those fractions are similar in 
size, representing 30-35% of the entire TCR-signalled cohort.   
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Further research is required to determine why the absence of one MHC class 
diminishes S in Bcl-2 Tg mice but not in non-Tg mice. It is possible that the absence of 
one MHC class diminishes C to the same extent in non-Tg mice as in Bcl-2 Tg mice, 
that is, by 30-35%. This explanation would predict that the absence of one MHC class 
fails to alter S in non-Tg mice because changes in B and/or D mask the effect of the 
reduction in C. Indeed, there is preliminary evidence that the absence of one MHC 
class alters B and D, relative to wild-type. Although not statistically significant, the 
groups lacking one MHC class tended to have higher values for B and lower values for 
D than the wild-type group (Fig. 4.18). Notably, increases in B and decreases in D 
would both tend to inflate the value of S in the model. Such inflationary effects may 
mask the deflationary effect of a decrease in C. Additional experiments, ideally 
performed as a time course, will be required to test this hypothesis. 
 
It is inferred that MHCI- and MHCII-single deficiencies decrease S by decreasing C. 
Since MHCI- and MHCII-single deficiencies decreases S to a similar extent compared 
to wild-type mice (Fig. 4.19), this suggests that C is similar between MHCI- and MHCII-
deficient mice. This indicates that a similar fraction of MHCI-responsive cells and 
MHCII-responsive cells register an initial TCR signal, and implies that the imbalance 
between the number of CD4+ and CD8+ T cells is not due to the initiation step. This is 
consistent with Sinclair et al.’s (2013) conclusion, as the maturation rates from DP1 to 
DP2 in MHCII-responsive cells was similar to MHCI-responsive cells. 
 
The active caspase 3/CD69/CD5+ population would be expected to contain strongly 
TCR-signalled cells committed to clonal deletion, D. MHC single deficiencies did 
significantly decrease a parameter similar to D, namely, the frequency of CD69+ CD5+ 
cells among active caspase 3+ thymocytes (Fig. 4.18). This parameter was reduced in 
the absence of MHCI to a similar extent as in the absence of MHCII. There was no 
evidence that the frequency of apoptosis-committed cells was higher in the MHCI-
responsive cohort than in the MHCII-responsive cohort. Given the evidence that 
equivalent numbers of MHCI-responsive cells and MHCII-responsive cells receive a 
TCR signal, and equivalent fractions of these TCR-signalled cohorts are committed to 
apoptosis at any moment in time, why do more CD4+ T cells complete development? 
Consistent with previous studies, the data above demonstrate that it takes 
approximately twice as long for thymocytes to develop into CD8+ T cells than CD4+ T 
cells (Lucas et al., 1993; Saini et al., 2010). The longer interval required for completion 
of T cell development should ultimately result in higher death in the CD8 lineage and 
fewer CD8+ T cells completing development, explaining why there are more CD4+ T 
cells than CD8+ T cells in the thymus. Alternatively, it is possible that MHCII may 
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induce the majority of wave 1 negative selection, whereas MHCI may induce majority 
of wave 2 negative selection, resulting in lower number of CD8+ T cells than CD4+ T 
cells in the thymus and periphery. This hypothesis is based on the evidence of 
decreased frequency of wave 1 cells only in MHCII-deficient mice but not in MHCI-
deficient mice at steady state (Fig. 4.23B), and decreased steady-state frequency of 
wave 2 cells only in MHCI-deficient mice (Fig. 4.23C). Whether MHCI induces majority 
of wave 2 negative selection in nascent thymocyte cohort has yet to be confirmed by 
conducting experiments on day 5-post EdU injection, which is the optimal time point to 
assess wave 2 negative selection (Hu et al., 2016). 
 
Sinclair et al. (2013) concluded that increased intrinsic susceptibility to apoptosis in 
MHCI-responsive cells at the DP2 stage gives rise to a higher death rate in MHCI-
responsive cells than MHCII-responsive cells. The in vivo development of MHCI-
restricted thymocytes was studied in the absence of MHCII on TECs. However, in 
these chimeras, recognition of wild-type MHCII molecules expressed on the surface of 
BM-derived cells may have induced deletion of thymocytes capable of developing into 
CD8+ T cells. Indeed, in immunised chimeric mice lacking MHCII expression in 
epithelial cells, the presence of MHCII expression in BM-APCs reduced the number of 
MHCII-tetramer-binding CD8+ T cells by 10-fold (Stadinski et al., 2011), suggesting that 
MHCII+ BM-APCs are capable of deleting thymocytes with the potential to develop into 
CD8+ T cells.  
 
Sinclair et al. (2013) estimated cell death rate by subtracting the cells that progress to 
the subsequent stage (outflow) from the cells that enter a stage (inflow). This method 
of calculating cell death does not provide information on whether the thymocytes die 
due to too strong or too weak TCR-signalling. A Helios+ phenotype marks thymocytes 
that have received a strong TCR signal, whereas a Helios– CCR7+ phenotype marks 
thymocytes that have received a weak TCR signal (Daley et al., 2013). Helios and 
CCR7 thus allow S to be subdivided into a Helios– CCR7– uncommitted subset (Su), a 
Helios+ strongly TCR-signalled subset (Ss) and a weakly TCR-signalled subset (Sw) 
(Fig. 4.24). The prolonged lifespan of Helios+ thymocytes in Bcl-2 Tg mice allows the 
enumeration of strongly TCR-signalled cells that would normally disappear due to 
apoptosis. Relative to wild-type mice, MHCI- and MHCII-single deficiencies decreased 
Su and Sw to a similar extent. However, MHCII-deficiency diminished Ss by a greater 
magnitude than MHCI-deficiency (Fig. 4.20). This indicates that Helios+ thymocyte 
induction depends more on MHCII than MHCI. This conclusion was corroborated by 
enumerating immature CD24+ FoxP3– CD4loCD8lo PD-1hi “iIEL precursors” (Fig. 4.22) 
(Mayans et al., 2014; McDonald et al., 2015; Pobezinsky et al., 2012). These findings 
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suggest that the induction of strongly TCR-signalled thymocytes depends substantially 
more on MHCII than on MHCI. 
 
Different mechanisms of cell death may operate in MHCI-responsive versus MHCII-
responsive thymocytes. This hypothesis is based on the facts that although both 
cohorts have similar fractions of apoptosis-committed cells, the MHCII-responsive 
cohort has a greater fraction of Helios+ strongly TCR-signalled cells. To date, the only 
well-appreciated mechanism of cell death in TCR-signalled thymocytes is clonal 
deletion due to TCR signaling above a certain threshold. The data suggest the 
existence of an additional mechanism of cell death, potentially induced in thymocytes 
with TCR signaling that is too weak. This putative cell death process is distinct from 
death by neglect because it occurs in cells expressing CD5 and TCRβ, i.e. TCR-
signalled cells. This mechanism of cell death may be more common in MHCI-
responsive thymocytes than in MHCII-responsive thymocytes. TNF-mediated cell death 
could be the distinct mechanism of cell death as CD8SP thymocytes were particularly 
sensitive to TNF-mediated cell death in the absence of NF-κB activation (Webb et al., 
2016). NF-κB signaling, essential for late stages of thymocyte maturation in the 
thymus, protects against TNF-mediated cell death (Xing et al., 2016).  Alternatively, 
clonal deletion may be the only mechanism of cell death in TCR-signalled thymocytes, 
but MHCI-responsive thymocytes are able to undergo clonal deletion as a 
consequence of TCR-signalling under the threshold for Helios upregulation.  
 
The conclusion that strong TCR-signalling is more dependent on MHCII than MHCI fits 
well with the difference in coupling of Lck (signal-initiating kinase) to CD4 or CD8 
coreceptor (Stepanek et al., 2014). Lck is crucial for TCR-signalling because it 
phosphorylates the intracellular domains of TCRz and CD3 molecules early after TCR 
engagement by MHC, and also phosphorylates Zap70 later in T cell activation (Straus 
and Weiss, 1992; Straus and Weiss, 1993). The increased coupling of Lck to CD4 
coreceptors compared to CD8 coreceptors lowers the deletion threshold for MHCII-
responsive cells compared to MHCI-responsive cells (Stepanek et al., 2014). When 
MHCI-restricted OT-I thymocytes bind to OVA-derived altered peptide ligands (APL) 
Q4R7 or T4, OT-I cells expressing a variant CD8 molecule bearing CD4’s intracellular 
domain (CD8.4) are deleted whereas wild-type OT-I cells with CD8’s intracellular 
domain are positively selected. Furthermore, by visualising the detachment of 
monomeric pMHC complexes from TCR transgenic thymocytes, it was shown that a 
positive selecting pMHCI ligand (T4) and a deleting pMHCII ligand (3K) have similar 
on-cell dwell times (i.e. 1.3s). These observations suggest that MHCII-responsive 
thymocytes may be more likely to upregulate Helios than MHCI-responsive thymocytes 
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due to CD4’s capacity to interact with MHCII and to CD4’s greater capacity to recruit 
Lck to engaged TCRs, explaining why MHCII makes a greater contribution than MHCI 
to Helios induction, especially in CCR7– thymocytes. 
 
It is also possible that the difference in proportions of Helios+ thymocytes stems from 
differences in the self-antigen repertoires presented to thymocytes by MHCII versus 
MHCI. Macroautophagy is an endogenous antigen processing pathway that promotes 
MHCII presentation (Dengjel et al., 2005). Macroautophagy was detected in 70% of 
cTECs, 5-10% of mTECs and <1% of thymic DCs in mice (Nedjic et al., 2008). 
However, another group detected macroautophagy in human epithelial cells, DCs and 
B cells (Schmid et al., 2007). TECs with an inactivated autophagy-related gene (Atg) 5 
have defective macroautophagy and defective development of certain MHCII-restricted 
TCR transgenic T cells, showing that macroautophagy is essential for thymic CD4+ T 
cell positive selection (Nedjic et al., 2008). Macroautophagy was also shown to be 
important in inducing CD4+ T cell clonal deletion in some but not all TCR transgenic 
models (Aichinger et al., 2013). Recent data suggests that MHCI-restricted antigen 
presentation is less dependent on macroautophagy, as the absence of Atg5 and Atg7 
autophagy factors increased MHCI surface levels due to decreased endocytosis and 
degradation of MHCI (Loi et al., 2016). The absence of Atg-dependent MHCI 
internalisation enhanced virus-specific CD8+ T cell responses (Loi et al., 2016). 
Although further research is required, macroautophagy may diversify the self-antigen 
repertoire presented by MHCII but not MHCI, increasing the scope for the induction of 
strong TCR interactions required for Helios+ thymocyte induction.  
 
Since it has often been mentioned in this thesis that Helios expression reports the 
“strength” of TCR signaling in thymocytes, it is pertinent to ask “What is the difference 
between a “weak” TCR signal and a “strong” one?” Real-time observation of living 
thymocytes in thymic slices has revealed that the average duration of interaction 
between a thymocyte and an APC is 4 minutes in positive selecting conditions versus 1 
hour in negative selecting conditions (Melichar et al., 2013). However, real-time 
observation of peptide/MHC monomers in solution with live T cells has revealed that 
the duration of a monomeric TCR:peptide/MHC interaction that leads to negative 
selection can be much shorter in duration (>0.2 s for MHCII-responsive TCRs and >0.9 
s for MHCI-restricted TCRs) (Stepanek et al., 2014). At an intermediate level between 
these extremes of interaction times, intracellular signaling proteins are modified, for 
example phosphorylated or dephosphorylated, within seconds of TCR engagement. 
While there are still many unknowns about the mechanisms underlying TCR signaling, 
it is likely that TCR signaling outcomes depend on the longevity of the “TCR 
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signalosome”, which includes the TCR, CD3, coreceptors, kinases (Lck, Zap70) and 
adapter proteins (LAT, SLP76). The CD4 and CD8 coreceptors are thought to 
contribute to the longevity of the TCR signalosome in two ways: by binding to MHC 
with their extracellular domain and by bringing Lck close to the TCR/CD3 complex with 
their intracellular domain, allowing Lck to phosphorylate TCR/CD3 and Zap70 (Straus 
and Weiss, 1992; Straus and Weiss, 1993). Although the affinity of CD8 for MHCI (Kd= 
50-200µM) (Merwe and Davis, 2003) is much higher than the affinity of CD4 for MHCII 
(Kd= 2.5mM) (Jönsson et al., 2016), it is unclear whether or how this difference impacts 
the multifactorial process of T cell activation. Furthermore, more CD4 coreceptors are 
loaded with Lck compared to CD8 (Stepanek et al., 2014). Data presented in this thesis 
provides the new insight that MHCII makes a greater contribution than MHCI to Helios 
induction in CCR7– thymocytes, whereas MHCI may make a greater contribution than 
MHCII to Helios induction in CCR7+ thymocytes. This suggests that there is a 
differential and stage-dependent contribution of MHCI vs MHCII to the induction of 
Helios+ thymocytes. 
 
It could be argued that the EdU+ thymocytes analysed in this present study may 
contain a small fraction of dividing SP cells instead of dividing DN-DP cells. To exclude 
this possibility, EdU+ CD24+ gate was used to mark the immature thymocytes, thereby 
excluding the DNA-synthesising SP cells that are CD24– (Chapter 3). Furthermore, at 
1h post-EdU injection, almost all (97-99%) recently EdU+ cells were TCRβ– CD5–, 
suggesting they had not received a TCR signal (Figs. 4.2 and 4.3). This shows that 
almost all the DNA-synthesising cells are at the DN-DP transition (the largest 
proliferative phase), instead of dividing SP cells.  
 
A weakness arises if one tries to measure negative selection, i.e. apoptotic deletion 
and agonist selection, by comparing apoptosis-sufficient mice with apoptosis-deficient 
mice. This is because the denominators may not be constant. In other words, the EdU+ 
population may differ in composition. For this reason, this study did not compare 
directly the data from apoptosis-sufficient mice with apoptosis-deficient mice. Rather, it 
considered the results obtained from non-Tg and Bcl-2 Tg mice as two separate sets of 
data. What is clear is that apoptosis defects prolong the lifespan of strongly TCR-
signalled Helios+ thymocytes. This allows apoptosis-defective mice to be used to 
quantify the change in negative selection caused by defects in MHC molecules or APC 
types. 
 
A weakness arises if one tries to measure negative selection, i.e. apoptotic deletion 
and agonist selection, by comparing apoptosis-sufficient mice with apoptosis-deficient 
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mice. This is because the denominators may not be constant. In other words, the EdU+ 
population may differ in both size and composition. However, the EdU+ thymocyte 
frequency is similar across all MHC genotypes in both non-Tg mice and in apoptosis 
defective Bcl-2 Tg mice (Fig. 4.16), ruling out the possibility that the EdU+ size in non-
Tg and Bcl-2 Tg mice are different. Furthermore, this study did not compare directly the 
data from apoptosis-sufficient mice with apoptosis-deficient mice, but consider the 
results obtained from non-Tg and Bcl-2 Tg mice as two separate sets of data. What is 
clear is that apoptosis defects prolong the lifespan of strongly TCR-signalled Helios+ 
thymocytes compared to apoptosis-sufficient mice, allowing the quantification of 
negative selection mediated by defects in MHC molecules or APC types to be possible 
when mice are defective in apoptosis. 
 
In summary, similar frequencies of TCR-signalled apoptotic cells were detected in mice 
expressing only one MHC class. However, as CD8+ T cell development takes longer 
than CD4+ T cell development, similar rates of apoptosis at any moment in time would 
be expected to result in fewer CD8+ T cells completing development, explaining why 
CD4+ T cells outnumber CD8+ T cells. Analysis of apoptosis-defective mice revealed 
that MHCI induces TCR signalling in a similar fraction of thymocytes as MHCII, but 
MHCII makes a greater contribution to induction of strongly TCR-signalled thymocytes 
than MHCI, particularly at the CCR7– stage.  
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CHAPTER 5 
 
A comparison of TCR 
repertoires positively or 
negatively selected in the 
absence or presence of one or 
both MHC classes 
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5.1 Introduction 
 
In chapter 4, the frequency of TCR-signalled cells (“S”) in nascent thymocyte cohorts 
was measured. When apoptosis is defective, wild-type mice had a greater frequency of 
TCR-signalled thymocytes than MHCI-deficient mice or MHCII-deficient mice, 
indicating that portions of the thymocyte repertoire require either MHCI or MHCII to 
receive a TCR signal. Mice lacking both MHCI and MHCII had very few TCR-signalled 
cells. Notably, the individual frequency of TCR-signalled thymocytes in MHCI-deficient 
mice and MHCII-deficient mice summed to a value 35% greater than the frequency of 
thymocytes in mice bearing both MHCI and MHCII. The 35% difference may be 
explained by two hypotheses: (1) interclonal competition between MHCI-responsive 
and MHCII-responsive thymocytes for access to a limited number of APCs or (2) 
existence of MHC class cross-reactive thymocytes that can receive a TCR signal from 
both MHCI and MHCII.  
 
Regarding the former hypothesis, many thymic APC types such as cTECs, mTECs, 
DCs and B cells, express both MHCI and MHCII. When all these APC types express 
only one class of MHC, thymocytes that can only interact with the absent MHC class 
may fail to compete against thymocytes that can interact with the expressed MHC 
class. Relaxation of this interclonal competition for access to APCs, together with the 
constant number of APCs, may allow a greater proportion of thymocytes to interact 
with the expressed MHC class to derive a TCR signal. This interpretation was favoured 
by Sinclair et al. (2013).  
 
The MHC class cross-reactivity hypothesis posits that a substantial proportion of TCRs 
are capable of binding to both MHCI and MHCII. As MHCI-deficiency decreased the 
production of TCR signalled thymocytes by 30% in apoptosis-defective mice, the 
inference was that 30% of the TCR-signalled repertoire in wild-type mice requires 
MHCI to derive a TCR signal. Following this logic, 35% of the TCR-signalled repertoire 
in wild-type mice requires MHCII. The MHC class cross-reactivity hypothesis postulates 
that the remainder of the TCR signalled cohort in wild-type mice (100 – 30 – 35 = 35%) 
expresses TCRs that are capable of deriving a TCR signal from either MHCI or MHCII. 
The hypothesis further predicts that, in mice lacking one MHC class, at least half of the 
TCR-signalled repertoire is MHC class cross-reactive (i.e. 35 / 70 = 50% of the TCR-
signalled repertoire in MHCI-deficient mice and 35 / 65 = 54% in MHCII-deficient mice).  
 
Consistent with the latter hypothesis, some TCRs are capable of binding to both MHCI 
and MHCII. Thymocytes expressing the YAe62.8 TCR are deleted in wild-type mice, 
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positively selected into CD4+ T cells in mice that express only one self-peptide/MHCII 
complex (Ep/H2-Ab) and positively selected into CD8+ T cells in mice lacking MHCII 
expression (H2-Ab1–/–)(Huseby et al., 2005). YAe62.8 TCR-expressing thymocytes 
undergo death by neglect in mice lacking MHCII and MHCI expression (H2-Ab1–/–B2m–
/–) (Huseby et al., 2005). Evidence that this phenomenon occurs in polyclonal T cells 
was established by immunising mice with recombinant vaccinia virus engineered to 
express a peptide, 3K, that is “foreign” to B6 mice. At 7-10 days after the immunisation, 
the number of CD8+ T cells capable of binding to 3K/H2-Ab (peptide/MHCII) tetramers 
were enumerated. Wild-type mice, and mice lacking both B2m and MHCII, had very 
few CD8+ T cells capable of binding to the tetramers. In contrast, MHCII-deficient mice 
were found to have at least 10-fold more tetramer-binding CD8+ T cells (Stadinski et 
al., 2011). This suggests that MHCII normally deletes some T cells with the capacity to 
develop into CD8+ T cells. In a recent study, out of a panel of 19 TCRs ascertained to 
drive deletion in B6 mice, approximately one-third were responsive to both MHCI and 
MHCII (McDonald et al., 2015). Of 12 TCRs that were expressed in thymocytes in vivo, 
11 drove deletion at the CCR7– stage and one drove deletion at the CCR7+ stage 
(McDonald et al., 2015). These observations suggest that MHC class cross-reactive 
TCRs facilitate deletion in the wild-type thymus, predominantly at the CCR7– stage of 
development. MHC class cross-reactivity has also been observed in humans, whereby 
virus specific CD8+ T cells can cross-recognise HLA DR4 (class II molecules) (Rist et 
al., 2009).  
 
The vast TCR diversity in polyclonal T cells makes TCR repertoire analysis 
challenging. Fixing the TCR b chain reduces TCR diversity and enables TCR repertoire 
analysis via sequencing of TCRa chains (Sant’Angelo et al., 1998) This approach can 
be used to analyse T cell selection in response to the natural self-antigen repertoire 
and has advanced our understanding of T cell development. For instance, a specific 
TCRa chain sequence was identified as a molecular marker for positive selection 
(Sant’Angelo et al., 1998). The TCR repertoires of T-reg and conventional CD4+ T cells 
were found to be distinct yet with significant overlap (Hsieh et al., 2004; Pacholczyk et 
al., 2006; Wong et al., 2007). This strategy was used to profile CD4+ T conventional 
and T-reg TCR repertoires in mice lacking MHCII expression in BM-APCs, in mice with 
reduced MHCII expression in mature mTECs, and in mice lacking Aire. It was 
concluded MHCII+ BM-APCs and Aire have distinct and cooperative roles in 
establishing central T cell tolerance via clonal deletion and T-reg selection (Perry et al., 
2014). This strategy was also used to reveal that Aire directs T cells expressing 
prostate-reactive TCRs into the T-reg cell lineage (Malchow et al., 2016) and to reveal 
that T-reg TCRs that recognise a peptide from the self-antigen, myelin oligodendrocyte 
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glycoprotein, have much higher TCR affinity than non-T-reg cells that recognise the 
same self-antigen (Kieback et al., 2016).  
 
To test the two hypotheses to explain why the individual values of TCR-signalled cells 
(S) in MHCI-deficient mice and MHCII-deficient mice summed to a value 35% greater 
than the frequency of TCR-signaled cells in mice with both MHC classes, deep 
sequencing of the TCRα chain repertoire was performed on samples from mice 
expressing a transgenic TCRβ chain (62b-Tg) (Stadinski et al., 2011) derived from the 
YAe62.8 TCR (Huseby et al., 2005). Data analysis was performed using the VDJtools 
software package, which was designed to standardise the analysis and reporting of 
TCR sequencing data (Shugay et al., 2015). 
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5.2 Results 
 
5.2.1 Genotype, age and gender of mice and the T cell subsets used for TCR 
sequencing 
 
To define TCR clonotypes that derive a TCR signal in the presence or absence of 
either MHC class, 62b-Tg thymocytes and/or splenocytes were sorted from wild-type, 
B2m–/–, H2-Aa–/– and B2m–/–H2-Aa–/– mice which all carried the 62b transgene 
(Stadinski et al., 2011). Each of these 4 groups comprised male and female mice (Fig. 
5.1). The average age of mice ranged from 7 to 11 weeks, with a slightly higher 
average age in B2m–/– mice and H2-Aa–/– mice compared to the rest of the groups (Fig. 
5.1). 
 
For wild-type mice, three thymocyte subsets were sorted, namely, wave 1 (W1), 
CD4SP and CD8SP (Fig. 5.2). The W1 thymocyte subset had the phenotype of DN 
(CD4loCD8lo) PD-1hi CCR7– (Fig. 5.2A), based on evidence that coreceptor dulling and 
PD-1 induction identify thymocytes that receive a strong TCR signal at the CCR7– 
stage (Daley et al., 2013). A CCR7– gate was set because CCR7 is a thymocyte 
maturation marker and the least mature thymocytes that have received a strong TCR 
signal were the population of interest for sorting. Thymocytes also attain a CD4loCD8lo 
PD-1hi CCR7– phenotype during agonist selection into small intestinal IEL (McDonald et 
al., 2015). Although the term “W1” is used in this chapter, the sorted CD4loCD8lo PD-1hi 
CCR7– cells might represent only a portion of the Wave 1 population. Thus, an 
alternative description for W1 is “cells that have survived deletion at Wave 1 and 
progressed to the next stage of agonist selection into IEL”.  
 
The mature thymic CD4SP and CD8SP subsets were sorted by gating the non-DN 
population into CD4SP and CD8SP subsets, from which CCR7+ cells were sorted (Fig. 
5.2B). The CCR7+ gate was used because the most mature of the newly formed 
thymocytes were the population of interest for sorting (Cowan et al., 2016). W1 and 
CD4SP were sorted from B2m–/– mice, while W1 and CD8SP were sorted from H2-Aa–/– 
mice. From B2m–/–H2-Aa–/– mice, W1, CD4SP and CD8SP thymocyte subsets were 
sorted, as well as TCRβ+ B220– splenocytes (Fig. 5.2C). TCRβ+ B220– splenocytes 
were sorted to i) identify TCRs in the periphery to examine whether peripheral MHC-
independent TCRs were similar to thymic MHC-independent TCRs and ii) to serve as a 
back up TCR data in the case of very few thymic TCRs obtained in the absence of 
MHC molecules. 
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In all cases, the number of cells sorted per cell type from each mouse was capped at 
50,000. However, there were four samples with fewer than 50,000 sorted cells: one 
CD4SP sample from the wild-type group, one W1 sample from the B2m–/– group and 
two samples (CD4SP and CD8SP subsets) from B2m–/–H2-Aa–/– mice (Fig. 5.3). Due to 
the failure to reliably obtain 50,000 cells in each thymocyte subset from B2m–/–H2-Aa–/– 
mice, two Bcl-2 Tg B2m–/–H2-Aa–/– mice were used (Fig. 5.3) based on the assumption 
that expression of the Bcl-2 transgene would increase the number of T cells available. 
Indeed, this assumption was correct as 50,000 cells were obtained in Bcl-2 Tg B2m–/–
H2-Aa–/– mice. 
 
 
 
 
 
Figure 5.1. Genotype, age and gender of mice used for TCR sequencing. Graph 
shows the age and gender of mice examined in the following groups: wild-type (n=5), 
B2m–/– (n=5), H2-Aa–/– (n=5), B2m–/–H2-Aa–/– (n=1), Bcl-2 Tg B2m–/–H2-Aa–/– (n=2), 
comprising a total of 18 mice used in TCR sequencing analysis. Each symbol 
represents an individual mouse. 
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Figure 5.2. Cell sorting strategy to define thymocyte and splenocyte subsets for 
TCR sequencing. Thymus was harvested from WT, B2m–/–, H2-Aa–/– and B2m–/–H2-
Aa–/– mice and spleen harvested from B2m–/–H2-Aa–/– mice. After doublet exclusion, (A) 
W1 thymocytes were identified as CD4–CD8– PD-1hi CCR7– and (B) CD4SP and 
CD8SP subsets were non-DN, CD4+ CCR7+ or CD8+ CCR7+ cells. (C) After excluding 
doublets, splenocytes were gated for TCRβ+ B220– population. A total of 50,000 cells 
were sorted for each subset or until the sample was exhausted.   
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Figure 5.3. Number of T cells sorted per sample. Graph shows the number of cells 
sorted for each of the 45 samples described in Figs. 5.1-5.2. Each symbol represents 
an individual sample. 
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5.2.2 Preparation and sequencing of TCRα chain libraries  
 
After cell sorting, RNA was extracted and reverse transcription performed to obtain 
cDNA (Fig. 5.4A). PCR was performed using a pool of 14 forward primers 
complementary to TCRα chain V (TRAV) segments and one reverse primer 
complementary to the TCRα chain constant (TRAC) region (Dash et al., 2011) (Fig. 
5.4A) (Table 2.3, Chapter 2). Each forward and reverse primer contains a 5’ adapter 
sequence, which was used as a target in a second PCR amplification (also known as 
indexing PCR), for the addition of sample-specific “barcodes” plus P5/P7 sequences to 
facilitate binding of amplicons to the Illumina flowcell (Bourlat et al., 2016). Gel 
electrophoresis of a representative sample following the first PCR demonstrated a 
prominent band at ~300bp, similar to a positive control thymocyte subset (Fig. 5.4B). 
This suggested that the first PCR amplifying TCRα chain transcripts was successful. 
 
Before and after the second PCR, the PCR products were processed using the 
Agencourt AMPure XP purification system. In this step, the DNA amplicons were 
immobilised with magnetic beads (Beckman Coulter) while the unincorporated dNTPs, 
primers, primer dimers and salts were removed (Fig. 2.4, Chapter 2). Gel 
electrophoresis after the indexing PCR demonstrated two distinct bands at 380 and 
400 bp, with the latter band being more prominent. This is consistent with successful 
incorporation of sequencing adaptors and sample-specific barcodes during the second 
PCR (Fig. 5.4C).  
 
The size and the concentration of the purified and indexed PCR amplicons in each 
sample were determined by PerkinElmer LabChip® GX high-resolution electrophoretic 
separation. Four bands between 300 and 700bp were detected in each of the sorted 
W1, CD4SP and CD8SP samples (Fig. 5.4D). In each sample, the concentration of 
PCR amplicons ranging from 380 to 610 bp were summed to facilitate their dilution to a 
final concentration of 2 nM per sample (section 2.3.6.7).  Finally, equivalent volumes of 
all 45 samples were pooled in a single tube for paired-end sequencing-by-synthesis 
using reversible terminator dye nucleotides on an Illumina MiSeq machine (2 x 250 
cycles) (Bentley et al., 2008; Kozich et al., 2013) (Fig. 5.4A).  
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5.2.3 Processing raw sequencing reads for TCRα chains into TCR nucleotypes 
 
PANDAseq (PAired-eND Assembler for Illumina sequences) software was used to 
assemble TCRα chain Illumina paired-end sequence reads (forward read (read 1) and 
reverse read (read 2)) into a single sequence (Masella et al., 2012). PANDAseq 
determines the amount of overlap between read 1 and read 2, and constructs a 
consensus sequence by correcting uncalled bases and mismatches in the overlapping 
region based on the read quality (quality score assigned to the assembled sequence) 
(Masella et al., 2012). 
 
MiTCR (V-(D)-J mapping software) was used to convert the assembled sequencing 
reads into TCR “nucleotypes”. A TCR nucleotype is a unique nucleotide sequence that 
MiTCR aligns to V and J segments of the Tcra locus. MiTCR also reports the read 
count of each TCR nucleotype within each sample (Bolotin et al., 2013) (Fig. 5.5). 
MiTCR uses the conserved cysteine (C) residue to mark the N-terminal residue of the 
CDR3, and Phenylalanine (F) or Tryptophan (W) to mark the C-terminal residue of the 
CDR3. Since multiple TCR nucleotypes could encode the same amino acid sequence 
(Miles et al., 2011), the term TCR “clonotype” denotes a unique combination of CDR3 
amino acid sequence (CDR3α) and V segment of TCRα chain (TRAV). 
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Figure 5.4. Strategy for TCRα chain amplification and sequencing. (A) Overview of 
the TCRα chain amplification and sequencing.  After cell sorting as described in Fig. 
5.2, RNA of the sorted cells was extracted for cDNA synthesis. TCRα chain was first 
PCR amplified using 14 Vα forward internal primers and one Cα reverse primer. Each 
primer contains a 5’ overhang adapter sequence, which allows the binding of index 
adapter primers (containing P5/P7 sequencing adaptors, unique 8bp-index sequence 
and sequence complementary to the 5’ overhang adaptor sequence) (Fig. 2.2, Chapter 
2) during the indexing (second) PCR. The indexing PCR was performed to add 
sequencing adapters and sample-specific indices to the amplicons. Agarose gel 
electrophoresis and purification of PCR products were performed after the first and 
second PCRs.  After purification of the indexed PCR products, samples were analysed 
by PerkinElmer LabChip® GX to perform high-resolution electrophoretic separations, to 
determine the concentration and size of the final PCR amplicons. After diluting all 
samples to a concentration of 2 nM, equal volumes of each sample were pooled into a 
single library for TCR deep sequencing. (B) Gel electrophoresis of the first PCR 
amplicons. (Left to right) DNA ladder, negative control (without cDNA template but with 
nuclease free water), positive control containing cDNA of unsorted mouse thymocytes 
and CD8SP thymocyte subset of a wild-type mouse. (C) Gel electrophoresis of indexed 
PCR amplicons. (Left to right) DNA ladder, negative control (without cDNA template 
but with nuclease free water), CD8SP sample from a wild-type mouse. (D) Gel 
appearance of the indexed TCRα amplicon from sorted W1, CD4SP and CD8SP 
sorted thymocyte subsets from a wild-type mouse as performed by LabChip® GX.   
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Figure 5.5. Ascertainment and counting of TCRα chain sequence reads by MiTCR 
software. Diagram of MiTCR interface shows (left to right column) the number of 
sequencing reads of each TCR nucleotype and the percentage of this nucleotype in a 
sample (equal to the number of sequencing reads for each TCR nucleotype divided by 
the total number of sequencing reads per sample), CDR3α amino acid sequence, 
CDR3α nucleotide sequence, the number of nucleotides encoding the CDR3α, the list 
of possible V segments and J segment for each TCR nucleotype. 
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5.2.4 Count and diversity of TCR nucleotypes 
 
TCR sequencing data were analysed using VDJtools software (Shugay et al., 2015). 
This required data to be converted from MiTCR format into VDJtools format. As 
VDJtools accepts only one TRAV segment per TCR nucleotype, for each TCR 
nucleotype only the TRAV segment listed first by MiTCR was retained in the datasets 
used for VDJtools analysis. The basic information on the TCR nucleotypes in each 
sample was obtained using CalcBasicStats routine. Across the groups defined by MHC 
genotype and T cell subset, the mean number of sequencing reads (i.e. “count” in 
VDJtools) ranged from 1.4 × 105 to 3.5 × 105 (Fig. 5.6A). The mean of number of TCR 
nucleotypes (i.e. “diversity” in VDJtools) ranged from 101 to 994 (Fig. 5.6B). CD4SP 
and CD8SP samples tended to have more TCR nucleotypes than the W1 samples, 
except for Non-Tg and Bcl2-Tg B2m–/–H2-Aa–/– mice (Fig. 5.6B). A W1 sample in the 
H2-Aa–/– group had the lowest number of sequencing reads (Fig. 5.6A) and also the 
lowest number of nucleotypes (Fig. 5.6B). The number of nucleotypes per sample 
correlated with the number of sequencing reads per sample (Fig. 5.6C). This suggests 
that the estimation of TCR nucleotype diversity in each sample was limited by the 
number of sequencing reads obtained. 
 
 
5.2.5 Pre-processing of the TCR nucleotypes  
 
Prior to assignment of TCR clonotype for subsequent analysis, the VDJtools Correct 
routine was used to merge low-abundance nucleotypes into higher-abundance 
nucleotypes with a similar nucleotide sequence. The maximum number of nucleotide 
mismatches allowed between merged sequences was 2. The maximum fold-difference 
in read frequency allowed between the low-abundance sequence and high-abundance 
sequence was 0.05. After the VDJtools Correct routine was performed, the mean 
frequency of nucleotypes retained, relative to pre-processing, was >97%. Some 
samples in B2m–/–H2-Aa–/– and Bcl-2 Tg B2m–/–H2-Aa–/– groups had as low as 91% of 
clonotypes retained (Fig. 5.7A). 
 
The VDJtools FilterNonFunctional routine was then used to remove sequences 
containing a stop codon or a frameshift in the putative TCRa sequence. Across all cell 
subsets and mouse groups, a mean of ~75% of nucleotypes were functional (Fig. 
5.7B). In mature T cells, non-functional TCRa chain sequences are transcribed from 
the Tcra locus situated on the homologous chromosome, which was rearranged during 
thymocyte development but failed to encode a functional protein.  
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Figure 5.6. Count and diversity of TCR nucleotypes. For the 45 samples 
described in Figs. 5.1-5.3, graphs show (A) number of sequencing reads (i.e. count), 
(B) number of TCR nucleotypes (i.e. diversity) and (c) XY plot for the count and 
diversity of each sample. The r2 and two-tailed P values were calculated from the 
Pearson correlation coefficient by GraphPad Prism. Each symbol represents a sample. 
Data were analysed using VDJtools CalcBasicStats routines.  
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Figure 5.7. Erroneous nucleotype correction and non-functional nucleotype 
filtering. For the 45 samples described in Figs. 5.1-5.3, graphs show the frequency of 
(A) TCR nucleotypes retained after correction and (B) functional nucleotypes after 
filtering the non-functional clonotypes. Each symbol represents a sample. Data were 
analysed using VDJtools Correct and FilterNonFunctional routines. 
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5.2.6 Unsupervised hierarchical clustering of TCR clonotypes 
 
Unless stated otherwise, analyses were performed based on data collapsed by “TCR 
clonotype”, which was defined as a unique combination of CDR3α amino acid 
sequence and TRAV segment. To gain an overview of the TCR sequencing data, 
VDJtools CalcPairwiseDistances and ClusterSamples routines were used to generate 
a multidimensional scaling (MDS) plot on which all samples were represented (Fig. 
5.8). The MDS plot was generated based on the default setting in VDJtools (the “F” 
metric). In this metric, the distance between a pair of samples is calculated as -log10 of 
the geometric mean of the frequencies of TCR clonotypes that were present in both 
samples in the pair (Shugay et al., 2015) (section 2.3.7.3 for formula). For example, 
two samples in which 10% of sequences encode shared TCR clonotypes would be 
placed 1 unit apart. Two samples in which 1% of sequences encode shared TCR 
clonotypes would be placed 2 units apart.   
 
In the wild-type dataset, W1, CD4SP and CD8SP repertoires formed three distinct 
clusters (Fig. 5.8, green symbols). This suggests the W1 repertoire and both positively 
selected CD4SP and CD8SP repertoires are all distinct from each other in wild-type 
mice. W1 and CD4SP repertoires in B2m–/– (orange) mice formed two distinct clusters, 
while W1 and CD8SP repertoires in H2-Aa–/– (blue) mice were also separated from 
each other (Fig. 5.8).  
 
In B2m–/–H2-Aa–/– (pink) and Bcl-2 Tg B2m–/–H2-Aa–/– (turquoise) mice, W1 repertoires 
were clustered together (Fig. 5.8). CD4SP and CD8SP repertoires from B2m–/–H2-Aa–/– 
and Bcl-2 Tg B2m–/–H2-Aa–/– mice formed a single cluster that was separate from W1 
repertoires (Fig. 5.8). The two TCRβ+ B220– splenocyte samples from B2m–/–H2-Aa–/– 
and Bcl-2 Tg B2m–/–H2-Aa–/– mice fell between the W1 cluster and the CD4SP/CD8SP 
cluster from the same mice (Fig. 5.8). Since the TCR repertoires between B2m–/–H2-
Aa–/– and Bcl-2 Tg B2m–/–H2-Aa–/– mice were similar in all cell subsets analysed, B2m–/–
H2-Aa–/– and Bcl-2 Tg B2m–/–H2-Aa–/– mice are collectively called “B2m–/–H2-Aa–/–” mice 
below.  
 
W1 repertoires in wild-type, B2m–/– and H2-Aa–/– mice were broadly clustered together, 
but were distinct from the W1 repertoires in B2m–/–H2-Aa–/– mice  (Fig. 5.8). However, 
there was a H2-Aa–/– W1 sample identified with an asterisk that was far from the rest of 
W1 samples and located at the centre of the plot. This particular sample also had the 
lowest number of sequencing reads and nucleotypes (Fig. 5.6).  
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Figure 5.8. Unsupervised clustering of TCR repertoires of different cell subsets 
across different mouse genotypes. For the 45 samples described in Figs. 5.1-5.3, 
the multidimensional scaling (MDS) plot shows the distance between TCR repertoires 
(i.e. samples) on a two-dimensional plane computed by CalcPairwiseDistances and 
ClusterSamples routines in VDJtools. The distances between samples were calculated 
based on F pairwise similarity metric. In this and subsequent analyses, a TCR 
clonotype was defined as a TCRa sequence, or family of TCRa nucleotypes, that 
encodes a unique combination of CDR3 amino acid sequence and V segment 
(specified by the code “-i aaV” in VDJtools). *Sample with lowest number of 
sequencing reads and nucleotypes.   
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The CD4SP repertoires in B2m–/– mice and wild-type mice were co-clustered (Fig. 5.8). 
By contrast, the wild-type CD8SP cluster was adjacent to, but detectably removed from 
the H2-Aa–/– CD8SP cluster. CD4SP/CD8SP repertoires in B2m–/–H2-Aa–/– mice did not 
cluster with either CD4SP or CD8SP repertoires in mice expressing one or other MHC 
class (Fig. 5.8). 
 
5.2.7 MHC class cross-reactive TCRs are not common in the Wave 1 TCR 
repertoire 
 
5.2.7.1 Sharing of TCR clonotypes within and across boundaries of cell 
type and MHC genotype 
 
As the number of TCR clonotypes per sample varied from 44 to 1654 across the 45 
samples (Fig. 5.9), this variation could affect estimates of the extent of TCR sharing 
between any pair of samples. To hold constant the number of clonotypes per sample, 
VDJtools SelectTop routine was used to select the 200* TCR clonotypes with the most 
sequencing reads in each sample. VDJtools TrackClonotypes routine was then used to 
investigate TCR sharing between pairs of samples**. The data are presented as 
heatmaps with individual samples arranged in the same order on the x- and y-axes, 
forming a grid. Darker squares on the grid indicate higher numbers of shared TCR 
clonotypes in the 2 samples whose column or row intersect at that square.  
 
5.2.7.1.1 TCR clonotype sharing within MHC genotype 
boundaries 
 
i) Distinct W1, CD4SP and CD8SP TCR repertoires in wild-type mice 
 
In the wild-type dataset derived from 5 mice, each pair of W1 samples shared between 
8 and 26 TCR clonotypes (Fig. 5.10A). CD4SP sample pairs showed slightly more 
overlap, between 9 and 41 shared TCR clonotypes, while CD8SP sample pairs shared 
21-49 TCR clonotypes (Fig. 5.10A). TCR clonotype sharing between CD4SP and 
CD8SP was detectable, albeit at a lower level, with up to 10 shared TCR clonotypes 
per pair (Fig. 5.10A). The lowest level of TCR clonotype sharing was detected between 
W1 and the CD4SP or CD8SP subsets. Here, the only overlaps detected were <8 TCR  
clonotypes in a particular W1 sample (#5) and one CD4SP sample (#23) plus one 
*Some samples contained <200 TCR clonotypes. These are indicated by asterisks. 
**This analysis (Fig. 5.13) was also performed on the samples containing all TCR 
clonotypes (not just the top 200 clonotypes). The results were consistent with the 
analysis reported and no additional conclusions were drawn.  
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Figure 5.9. The number of TCR clonotypes varies across all sequencing samples. 
Graph shows the number of TCR clonotypes detected in each of the 45 samples 
described in Figs. 5.1-5.3. Short lines represent group means. Samples below the long 
line have <200 TCR clonotypes. 
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Figure 5.10. The delineation between CD4SP and CD8SP TCR repertoires 
observed in wild-type mice requires MHC expression. VDJtools SelectTop routine 
was used to identify the 200 most abundant TCR clonotypes in each W1, CD4SP, 
CD8SP and/or TCRβ+ B220– splenocyte sample of (A) wild-type mice (n = 5) and (B) 
B2m–/–H2-Aa–/– mice (n = 2-3). VDJtools TrackClonotypes routine was used to generate 
heatmaps that indicate the number of shared TCR clonotypes (ranging from 0 to 50, 
see key at bottom) in pairs of samples denoted on the axes: W1, CD4SP, CD8SP 
thymocytes or TCRβ+ B220– splenocytes. Numbers in green and pink indicate an 
arbitrary sample identifier (1-45 for the entire dataset). * indicates sample with <200 
total TCR clonotypes. *Sample #5, 179 TCR clonotypes; *#22, 120 TCR clonotypes; 
*#36, 135 TCR clonotypes; *#41, 73 TCR clonotypes. 
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clonotypes in a particular W1 sample (#5) and one CD4SP sample (#23) plus one 
CD8SP sample (#36) (Fig. 5.10A). This suggests that in wild-type mice there is a sharp 
delineation between the W1 TCR repertoire and the other 2 TCR repertoires examined. 
The CD4SP and CD8SP TCR repertoires are also distinguishable from each other. 
 
ii) Mice lacking MHC expression have a “fused” CD4SP/CD8SP TCR 
repertoire that remains distinct from the W1 repertoire 
 
In the B2m–/–H2-Aa–/– dataset derived from 3 mice, the highest level of TCR clonotype 
sharing was observed in W1 samples (35-50 shared TCR clonotypes per pair), while 
CD4SP, CD8SP and TCRβ+ B220– splenocytes each had 15 to 31, 11 to 24, and 24 
shared TCR clonotypes per pair, respectively (Fig. 5.10B). TCR clonotypes in W1 
samples were less commonly shared with CD4SP and CD8SP samples (<10 per pair) 
(Fig. 5.10B).  This indicates that the W1 TCR repertoire is distinguishable from CD4SP 
and CD8SP repertoires in mice lacking MHC expression (Fig. 5.10B).   
 
In contrast to the wild-type dataset, there was a significant level of TCR clonotype 
sharing between CD4SP and CD8SP samples in the B2m–/–H2-Aa–/– dataset (4 to 25 
TCR clonotypes per pair) (Fig. 5.10B). This level of TCR clonotype sharing, across the 
so-called CD4SP/CD8SP cell type “boundary”, was similar to the level observed when 
comparing pairs of samples within each cell type. These data show that the delineation 
between CD4SP and CD8SP TCR repertoires observed in wild-type mice requires 
MHC expression. 
 
The TCRβ+ B220– splenocyte TCR repertoire overlapped with that of CD4SP and 
CD8SP thymocytes (2 to 20 shared TCR clonotypes per pair) in the B2m–/–H2-Aa–/– 
dataset (Fig. 5.10B). The W1 TCR repertoire overlapped more with the TCRβ+ B220– 
splenocyte TCR repertoire (13 to 23 per pair) than with CD4SP or CD8SP thymocyte 
repertoires (<10 per pair) (Fig. 5.10B).  
 
iii)  Distinct W1 and CD4SP TCR repertoires in B2m–/– mice 
 
In the B2m–/– dataset derived from 5 mice, 5 to 11 TCR clonotypes were shared per 
pair of W1 samples (Fig. 5.11A). CD4SP sample pairs showed more overlap, with 16 to 
35 shared TCR clonotypes (Fig. 5.11A). W1 samples generally did not share TCR 
clonotypes with CD4SP samples, except for one W1 sample (#7) and one CD4SP 
sample (#25)  (Fig. 5.11A). This suggests that W1 and CD4SP TCR repertoires remain 
distinct in mice lacking MHCI expression.  
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iv) Distinct W1 and CD8SP TCR repertoires in H2-Aa–/– mice 
 
In the H2-Aa–/– dataset derived from 4 to 5 mice, 23 to 33 TCR clonotypes were shared 
per pair of W1 samples, except for two samples #11 and #15 with lower TCR clonotype 
sharing (<16 per pair) (Fig. 5.11B). Within the CD8SP samples, 13 to 30 shared TCR 
clonotypes per pair were observed (Fig. 5.11B). W1 samples did not share TCR 
clonotypes with CD8SP samples (Fig. 5.11B). This suggests that W1 and CD8SP TCR 
repertoires remain distinct in the absence of MHCII expression. 
 
5.2.7.1.2 TCR clonotype sharing within cell type boundaries 
 
i) Elevated TCR clonotype sharing in W1 sample pairs involving wild-
type and H2-Aa–/– mice 
 
Within the W1 dataset, the extent of TCR clonotype sharing across MHC genotype 
“boundaries” was greatest when comparing WT with H2-Aa–/– mice (up to 25 TCR 
clonotypes per pair), exceeding the levels observed when comparing WT with B2m–/– 
mice (up to 12 shared TCRs per pair) (Fig. 5.12A). This observation suggests the W1 
repertoire in wild-type mice is enriched in TCRs responsive to MHC class I.  
 
TCR clonotype sharing was very low when comparing W1 samples from wild-type mice 
with B2m–/–H2-Aa–/– mice (<5 per pair) (Fig. 5.12A). More TCR sharing was detected 
when comparing W1 samples from mice lacking a single MHC class with B2m–/–H2-Aa–
/– mice (up to 9 per pair for both comparisons) (Fig. 5.12A). This observation suggests 
that deficiency of one MHC class may increase the appearance of MHC-independent 
TCRs in the W1 TCR repertoire. 
 
ii) The wild-type CD4SP TCR repertoire remains intact in B2m–/– mice, 
but is profoundly altered in B2m–/–H2-Aa–/– mice  
 
Within the CD4SP dataset, all wild-type mice shared TCR clonotypes with all B2m–/– 
mice. Wild-type samples #19-21 shared a higher number of TCR clonotypes with all 
B2m–/– mice (up to 37 per pair) (Fig. 5.12B). This suggests that the wild-type CD4SP 
TCR repertoire remains intact in the absence of MHCI. However, CD4SP samples from 
B2m–/–H2-Aa–/– mice exhibited little TCR clonotype sharing with CD4SP samples from 
wild-type or B2m–/– mice (Fig. 5.12B). This data provides no evidence that the absence  
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Figure 5.11. The delineation between W1 and CD4SP or CD8SP TCR repertoires 
remains intact in mice expressing only 1 MHC class. VDJtools SelectTop routine 
was used to identify the 200 most abundant TCR clonotypes in each W1, CD4SP or 
CD8SP thymocyte sample of (A) B2m–/– mice (n = 5) and (B) H2-Aa–/– mice (n = 4-5). 
VDJtools TrackClonotypes routine was used to generate heatmaps that indicate the 
number of shared TCR clonotypes (ranging from 0 to 35, see key at bottom) in pairs of 
samples denoted on the axes: W1, CD4SP or CD8SP thymocytes. Numbers in orange 
and blue indicate an arbitrary sample identifier (1-45 for the entire dataset). * indicates 
sample with <200 total TCR clonotypes. *Sample #10, 74 TCR clonotypes; *#11, 44 
TCR clonotypes; *#15, 68 TCR clonotypes.  
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Figure 5.12. Wild-type W1, CD4SP and CD8SP TCR repertoire remains largely 
intact in and/or H2-Aa–/– mice, but is altered in B2m–/–H2-Aa–/– mice.  VDJtools 
SelectTop routine was used to identify the 200 most abundant TCR clonotypes in the 
samples described in Figs. 5.1-5.3. VDJtools TrackClonotypes routine was used to 
generate heatmaps that indicate the number of shared TCR clonotypes (ranging from 0 
to 50, see key at top right) in pairs of samples denoted on the axes: thymocyte 
samples of each MHC genotype. Numbers indicate an arbitrary sample identifier (1-45 
for the entire dataset). * indicates sample with <200 total TCR clonotypes. *Sample #5, 
179 TCR clonotypes; #10, 74 TCR clonotypes; *#11, 44 TCR clonotypes; *#15, 68 
TCR clonotypes; *#22, 120 TCR clonotypes; *#36, 135 TCR clonotypes; *#41, 73 TCR 
clonotypes.   
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of MHCI expression alters the CD4SP TCR repertoire, whereas the additional absence 
of MHCII is sufficient to markedly alter the CD4SP TCR repertoire.  
 
iii) The wild-type CD8SP TCR repertoire remains largely intact in H2-
Aa–/– mice, but appears to be altered in B2m–/–H2-Aa–/– mice 
 
Within the CD8SP dataset, TCR clonotype sharing was detected between all wild-type 
mice and all H2-Aa–/– mice (8 to 17 TCR clonotypes per pair) (Fig. 5.12C). This 
suggests that the wild-type CD8SP TCR repertoire remains largely intact in H2-Aa–/– 
mice. Two out of three B2m–/–H2-Aa–/– CD8SP samples did not share TCR clonotypes 
with CD8 samples in wild-type or H2-Aa–/– mice (Fig. 5.12C). However, one B2m–/–H2-
Aa–/– CD8SP sample (#41) shared TCR clonotypes with nearly all wild-type samples 
(up to 12 per pair) (Fig. 5.12C). This data provides no obvious evidence that the 
absence of MHCII expression alters the CD8SP TCR repertoire. With the caveat that 1 
out of 3 B2m–/–H2-Aa–/– CD8SP samples generated different results, it appears that the 
additional absence of both MHCI and MHCII is sufficient to markedly alter the CD8SP 
TCR repertoire. 
 
5.2.7.1.3 TCR clonotype sharing across MHC genotype and 
cell type boundaries  
 
To look for unexpected examples of TCR clonotype sharing, a comparison was 
performed that included all possible pairs derived from the 45 samples, filtered to 
contain only the top 200 TCR clonotypes in each sample. This procedure has the 
potential to reveal TCR clonotype sharing across both types of boundary: MHC 
genotype and cell type. Such putative TCR clonotype sharing would have been missed 
by the analysis described above. 
 
In Fig. 5.13, the 45 samples are arranged in the same order on the x- and y-axes. 
There is a trend for TCR sharing, indicated by darker shading, to occur in square 
blocks along the diagonal (Fig. 5.13). There are 2 large square blocks of darker 
shading: the first is delimited by CD4SP samples from WT and B2m–/– mice and the 
second by CD8SP samples from WT and H2-Aa–/– mice (Fig. 5.13). While the CD4SP 
block is relatively homogenous, the CD8SP block may be divided into quadrants, in a 
pattern consistent with greater TCR sharing within MHC genotypes than across MHC 
genotypes (Fig. 5.13). Other blocks of darker shading fall along the diagonal, due to 
the grouping of samples according to cell type and MHC genotype. W1 samples from 
B2m–/– mice provide an exception to this trend, because these samples exhibit a   
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Figure 5.13. TCR clonotype sharing across both types of boundary: MHC 
genotype and cell type. Considering only the 200 most abundant TCR clonotypes in 
the 45 samples described in Figs. 5.1-5.3, VDJtools TrackClonotypes routine was used 
to generate heatmaps that indicate the number of shared TCR clonotypes (ranging 
from 0 to 50, see key at top right) in pairs of samples denoted on the axes: thymocyte 
samples of each cell type and MHC genotype. Numbers indicate an arbitrary sample 
identifier (1-45 for the entire dataset). * indicates sample with <200 total TCR 
clonotypes. *Sample #5, 179 TCR clonotypes; #10, 74 TCR clonotypes; *#11, 44 TCR 
clonotypes; *#15, 68 TCR clonotypes; *#22, 120 TCR clonotypes; *#36, 135 TCR 
clonotypes; *#41, 73 TCR clonotypes.   
	 189 
somewhat lower level of TCR sharing (Fig. 5.11A and 5.13). In areas outside the 
diagonal, several blocks of darker shading correspond to examples of TCR sharing 
described above. First, W1 samples from WT mice overlap with W1 samples from H2-
Aa–/– mice. Second, in the B2m–/–H2-Aa–/– dataset, there is TCR sharing between each 
thymocyte subset and TCRb+ B220– splenocytes and also between the CD4SP and 
CD8SP samples (Fig. 5.13).  Third, a low level of TCR sharing is detectable between 
CD8SP samples from WT mice and CD4SP samples from WT or B2m–/– mice. This 
contrasts with W1 samples from WT mice, which did not overlap with either CD4SP or 
CD8SP samples, as described above (Fig. 5.10A). 
 
There is one other noteworthy area of darker shading.  A significant amount of TCR 
sharing was detected between a particular CD8SP sample (#41) from a B2m–/–H2-Aa–/– 
mouse and many other samples, including the W1, CD4SP and CD8SP cell types and 
all MHC genotypes (Fig. 5.13). As it shares TCR clonotypes with a wide range of 
samples across both cell type and MHC genotype boundaries, sample 41 is an outlier 
in this dataset. It is possible that sample #41 was contaminated with material from 
another sample at some stage preceding the indexing (second) PCR. 
 
5.2.7.2 TCR clonotype sharing in W1 samples across MHC genotype 
boundaries fails to identify MHC class cross-reactive TCRs 
 
One limitation of the analysis above is that it was confined to the top 200 TCR 
clonotypes from each sample. To search for MHC class cross-reactive TCRs across 
the entire dataset, the data were reanalysed.  The input files for this analysis had been 
pre-processed with the VDJtools Correct routine to merge low-abundance nucleotypes 
with high-abundance nucleotypes that differed in a maximum of 2 nucleotides, as 
described (section 5.2.5). They had also been processed with the VDJtools 
FilterNonFunctional routine to remove sequences that could not encode a functional 
TCRa chain, as described (section 5.2.5). Based on evidence that MHC class cross-
reactive TCRs are commonly deleted at the CCR7– stage of thymocyte development 
(McDonald et al., 2015), the analysis focussed on the W1 samples, which were sorted 
based on their CCR7– CD4loCD8lo PD-1+ phenotype. 
 
W1 samples within each MHC genotype were pooled to form a single virtual sample 
using the VDJtools PoolSamples routine. The frequency of each TCR in the virtual 
sample was calculated as the number of reads encoding that TCR divided by the 
cumulative number of reads in all samples within that group. The VDJtools OverlapPair 
routine was then used to determine the number and percentage of shared TCRs and 
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reads between each pair of virtual samples. A summary of the results is presented in 
Table 5.1.   
 
The wild-type W1 repertoire shared more TCR clonotypes with the B2m–/– and H2-Aa–/– 
W1 repertoires (12.0% and 11.1% of wild-type W1 TCRs, respectively) than with the 
B2m–/–H2-Aa–/– W1 repertoire (2.5% of wild-type W1 TCRs) (Table 5.1). The B2m–/–H2-
Aa–/– W1 repertoire shared a low percentage of TCR clonotypes with the wild-type, 
B2m–/– and H2-Aa–/– W1 repertoires (4.1%, 6.2 and 7.3% of B2m–/–H2-Aa–/– W1 TCRs, 
respectively). However, this low frequency of clonotypes contributed a large 
percentage of reads (29.0% to 48.5%) in the B2m–/–H2-Aa–/– W1 samples (Table 5.1).  
 
The level of TCR sharing between W1 samples from B2m–/– and H2-Aa–/– mice was 
3.3% of TCR clonotypes and 6.7% of reads in the B2m–/– W1 dataset (Table 5.1). This 
level of TCR sharing was not greater than that observed between B2m–/– and the B2m–
/–H2-Aa–/– W1 repertoires (4.7% of TCR clonotypes and 9.8% reads, calculated as a 
percentage of the B2m–/– W1 dataset) (Table 5.1). Similarly, the level of TCR sharing 
between W1 samples from B2m–/– and H2-Aa–/– mice contributes to only 5.0% of TCR 
clonotypes and 8.9% of reads in H2-Aa–/– mice, which was smaller than the TCR 
sharing observed between H2-Aa–/– and the B2m–/–H2-Aa–/– repertoire (8.3% of TCR 
clonotypes and 10.0% reads, calculated as a percentage of the H2-Aa–/– W1 dataset) 
(Table 5.1). The lower amount of TCR sharing between B2m–/– and H2-Aa–/– mice 
compared to the TCR sharing between each of these single MHC class-deficient 
repertoires and B2m–/–H2-Aa–/– repertoire provides no support for the MHC class cross-
reactivity hypothesis.  
 
To visualise TCR sharing in the virtual W1 samples described in Table 5.1, scatterplots 
generated by the VDJtools OverlapPair routine are shown (Fig. 5.14). The clonotype 
scatterplot shows the abundance of only the overlapping clonotypes, with each 
clonotype represented by a circle. The size of the circle is scaled to the geometric 
mean of clonotype frequency in a pair of virtual samples. The axes represent log10 
clonotype frequencies in each W1 virtual sample (i.e. MHC genotype). The horizontal 
red histogram represents the frequency distribution of the overlapping TCR clonotypes 
in the virtual sample represented on the x-axis, whereas the horizontal grey histogram 
shows the frequency distribution of all TCRs (both non-overlapping and overlapping) in 
the virtual sample represented on the x-axis (Shugay et al., 2015). A single TCR 
clonotype (red arrows, Fig. 5.14) contributed ~18% of the reads in the B2m–/–H2-Aa–/– 
dataset, exceeding the peak TCR clonotype in the other datasets by ~10-fold. This 
partially explains why a low number of shared TCR clonotypes contributed a large 
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percentage of reads in the B2m–/–H2-Aa–/– W1 sample. 
 
 
 
Table 5.1. W1 TCR clonotype sharing. After pre-processing of the TCR 
sequencing data as described in section 5.2.5, W1 samples within each of the four 
MHC genotypes were pooled to form a “virtual” sample for each MHC genotype using 
the VDJtools PoolSamples routine. The percentage of overlapping wave 1 TCR 
clonotypes between any two MHC genotypes was determined by taking the number of 
overlapping wave 1 TCRs (the numerator) divided by the number of total TCRs (i.e. 
overlapping and non-overlapping) in one MHC genotype (the denominator), multiplied 
by 100. The frequency of overlapping reads was calculated in the same way, except 
that the numerator and denominator values were sequencing reads instead of TCR 
clonotypes. To summarise, the first approach ignores TCR clonotype abundance 
whereas the second approach takes TCR clonotype abundance into account. 
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Figure 5.14. Visualisation of overlapping wave 1 TCRs between MHC 
genotypes. Each pair of virtual W1 samples described in Table 5.1 was compared 
using the VDJtools OverlapPair routine. Scatterplots show the abundance (log10 
clonotype frequencies) of the overlapping clonotypes between one MHC genotype on 
x-axis and another MHC genotype on y-axis. Each circle represents an overlapping 
TCR clonotype. The size of the circle is scaled to the geometric mean of clonotype 
frequency in the pair of samples. Horizontal red histogram represents the frequency 
distribution of the overlapping TCR clonotypes in the virtual sample represented on the 
x-axis, whereas the horizontal grey histogram shows the frequency distribution of all 
TCRs (both non-overlapping and overlapping) in the virtual sample represented on the 
x-axis. The vertical histograms show corresponding distributions for the virtual sample 
on the y-axis. Red arrows indicate a single TCR clonotype that contributed to ~18% of 
the reads in the B2m–/–H2-Aa–/– dataset. 
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5.2.8 TRAV and TRAJ usage bias associated with MHC genotypes and cell 
types 
 
5.2.8.1 TRAV usage biases are related to MHC genotype and cell type  
 
A recent study revealed associations between MHC alleles and TRAV segment usage 
in humans (Sharon et al., 2016). This suggests that regions encoded by the TRAV 
segment, likely the CDR1 and CDR2 loops that primarily interact with MHC molecules 
themselves (Rudolph et al., 2006), impose a bias on MHC recognition and T cell 
development. Both TRAV (to a lesser extent) and TRAJ genes encode parts of the 
CDR3a region, which commonly interacts with the peptide within the antigen-binding 
cleft of MHC molecules (Rossjohn et al., 2015). To examine whether the clustering of 
the samples in Fig. 5.8 was mainly based on TRAV or TRAJ segment usage, the TRAV 
and TRAJ segment usage profiles of all samples were analysed using the VDJtools 
CalcSegmentUsage routine. 
 
Most TCRa sequences mapped to five TRAV segments (in order from top to bottom on 
the heatmap in Fig. 5.15): TRAV16D/DV11, TRAV8D-1, TRAV12-3, TRAV21/DV12 
and TRAV12-2. Summaries show the percentage of reads per sample that mapped to 
each of these five TRAV segments (Fig. 5.16). 
 
In the wild-type dataset, TRAV12-3 was detected more frequently in W1 samples than 
in CD4SP samples (Fig. 5.16A). In B2m–/– mice the frequency of TRAV12-3 usage was 
similar in W1 and CD4SP samples, and was lower compared to W1 samples in wild-
type mice (Fig. 5.16A). TRAV12-3 usage in W1 samples from H2-Aa–/– mice exceeded 
its usage in W1 samples from wild-type mice (Fig. 5.16A). These data show that the 
relative enrichment of TCRs using TRAV12-3 in W1 samples requires B2m.  
 
TRAV16D/DV11 had a similar pattern of B2m-dependent enrichment in W1 samples. 
TRAV16D/DV11 was used more commonly in W1 samples than in CD4SP samples in 
wild-type mice, but not in B2m–/– mice (Fig. 5.16B). TRAV16D/DV11 was also highly 
expressed in CD8SP samples in wild-type mice (Fig. 5.16B). These findings suggest 
that, at least when paired with the YAe62.8 TCRb chain, the products of the TRAV12-3 
and TRAV16D/DV11 gene segments favour TCR interactions with B2m-dependent 
ligand(s).  
 
TRAV21/DV12 was commonly detected in W1 and CD4SP samples from wild-type and 
B2m–/– mice; however, it was detected less commonly in W1 samples from H2-Aa–/– 
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mice (Fig. 5.16C). These data suggest that TRAV21/DV12 expression favours TCR 
interactions with MHCII.  
 
TRAV8D-1 was used ~3.5 times more commonly in W1 samples from B2m–/– mice 
(mean = 20.2% of reads) compared to wild-type (5.4%) and H2-Aa–/– mice (5.9%) (Fig. 
5.16D). It is conceivable that TRAV8D-1 favours interaction with MHCII (present in 
MHCI-deficient mice), with this effect most obvious in the absence of B2m expression.  
 
TRAV12-2 usage was relatively homogenous in samples from MHC-expressing mice, 
with group means ranging from 18 to 38% (Fig. 5.16E). At least considering the usage 
of the five TRAV gene segments shown in the summaries, the MHC double-deficient 
W1, CD4SP and CD8SP samples were not obviously different from the samples from 
MHC single deficient- and MHC wild-type mice (Fig. 5.16).  
 
Using the wild-type W1 dataset as a reference point, TRAV12-3 and TRAV16D/DV11 
segments were depleted in W1 from B2m–/– mice (Figs. 5.16A, B), while TRAV21/DV12 
was depleted in W1 from H2-Aa–/– mice (Fig. 5.16C). The depletion of these TRAV 
segments in a single MHC-deficient W1 dataset suggests that these TRAV segments 
facilitate strong TCR-MHC interactions with the "absent" MHC class. 
 
In summary, the TRAV usage bias associated with particular MHC genotypes and cell 
types supports the role of CDR1 and CDR2 loops in MHC recognition and in thymocyte 
fate. 
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Figure 5.15. TRAV segment usage varies with MHC genotypes and cell types. The 
45 TCR sequencing datasets described in Figs. 5.1-5.3 were clustered based on the 
Euclidean distance between the TRAV segment usage (or frequency) vectors (ie. the 
frequency of associated reads in each V segment present in samples). Data were 
analysed using VDJtools CalcSegmentUsage routine. Weighted V profile was used. Z-
score on heatmap:  0, the score is identical to the mean score (green); positive value, 
the score is above the mean, ie., highly expressed (orange); and negative value, the 
score is below the mean (blue).  
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Figure 5.16. Enrichment of TRAV segments supporting interclonal competition 
hypothesis. Summaries show the frequency for each of the five highly used TRAV 
segments in Fig. 5.15, namely (A) TRAV12-3, (B) TRAV16D/DV11, (C) TRAV21/DV12, 
(D) TRAV8D-1 and (E) TRAV12-2 in the 45 TCR sequencing datasets described in 
Figs. 5.1-5.3. 
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5.2.8.2 Enrichment of TRAV usage in MHC single-deficiency provides 
evidence supporting the interclonal competition hypothesis  
 
A ~4-fold enrichment of TRAV8D-1 usage was observed in the B2m–/– W1 dataset 
compared to the wild-type W1 dataset (Fig. 5.16D). This type of enrichment may arise 
from 2 non-mutually exclusive effects. First, enrichment may arise due to the depletion 
of TRAV segments that facilitate TCR-MHC interactions with the "absent" MHC class. 
Removal of these TCRs “non-specifically” increases the frequency of those TCRs 
capable of interacting with the “present” MHC class. Second, in theory, enrichment 
may arise due to the relaxation of interclonal competition as postulated above. 
Because thymocytes bearing TCRs that can only interact with the absent MHC class 
are rendered uncompetitive, competition between remaining thymocytes may be 
altered. This could increase the probability of productive interactions by TCRs using 
certain TRAV segments; in other words, the absence of one MHC class may cause a 
“specific” enrichment of certain TRAV segments over others. TRAV21/DV12 and 
TRAV12-2 segments were used similarly in wild-type and B2m–/– W1 datasets (Fig. 
5.16C, E). Therefore, the ~4-fold TRAV8D-1 enrichment in the B2m–/– W1 dataset 
seems consistent with a “specific” rather than a “non-specific” enrichment.  
 
It is notable that TRAV8D-1 also showed a ~4-fold enrichment in CD8SP samples from 
H2-Aa–/– mice (mean = 10.1%) compared to wild-type mice (mean = 2.6%) (Fig. 
5.16D). TRAV12-3 and TRAV12-2 were found at similar and substantial frequencies in 
CD8SP samples from H2-Aa–/– mice and wild-type mice (Fig. 5.16A, E). This finding 
suggests that TCRs that use TRAV8D-1 have an above-average capacity to interact 
with MHCI. In summary, the disproportionate enrichment of certain TRAV segments in 
mice lacking one MHC class provides preliminary evidence consistent with the 
interclonal competition hypothesis. 
 
5.2.8.3 No evidence of decrease in W1 cells in the absence of one or both 
MHC classes  
 
In mice with normal apoptosis, CD4loCD8lo PD-1+ thymocytes, i.e. W1-phenotype cells, 
are equally abundant in the presence or absence of MHC expression (Fig. 4.22). To 
test whether this is also the case when the mice express the Yae62b transgene, the 
frequency of sorted W1 cells among all thymocytes across MHC genotypes was 
determined (Fig. 5.17). Among all thymocytes, the frequency of W1 cells in B2m–/– mice 
and H2-Aa–/– mice (mean = 0.29% and 0.34%, respectively) was not statistically 
different to the wild-type mice (mean = 0.27%). W1 cells were also detected at a similar 
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frequency in the three B2m–/–H2-Aa–/– mice examined (Fig. 5.17). This suggests that 
thymocytes with the potential to enter Wave 1, but fail to do so because their TCRs 
bind to the “absent” MHC class, are replaced by other thymocytes that “fill the niche”.  
 
 
 
 
 
Figure 5.17: Frequency of wave 1 cells in single MHC-deficient mice is similar to 
MHC wild-type mice.  Graphs show the frequency of sorted wave 1 cells with CCR7– 
CD4loCD8lo PD-1hi phenotype (Fig. 5.2) among all thymocytes across wild-type (n=5), 
H2-Aa–/– (n=5), B2m–/– (n=5) and H2-Aa–/–B2m–/– (n=3) mice. Non-significant P values 
were obtained between all comparison groups using 1-way ANOVA with Tukey’s post-
tests. 
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5.2.8.4  TRAJ usage biases related to the presence or absence of 
any MHC molecules 
 
Analysis of TRAJ segments revealed a very different pattern. There were two clusters 
(Fig. 5.18). The first cluster (in red box) contained all samples from H2-Aa–/–B2m–/– 
mice, plus two W1 H2-Aa–/– samples, which had low numbers of nucleotypes (Fig. 
5.6B). The second cluster (in blue box) contained samples from mice with one or both 
MHC classes (i.e. wild-type, B2m–/– and H2-Aa–/– mice).  
 
Cluster 1 samples commonly used TRAJ18, 21, 24, 15, 5, 12, 23, 9, 7, 4, 2, 30 and 26, 
as highlighted in pink on the right of the heatmap (Fig. 5.18). These TRAJ segments 
were expressed at the highest levels (45.8 to 51.6% cumulative percentage of reads) in 
all cell subsets of H2-Aa–/–B2m–/– mice (Fig. 19A). These segments were used much 
less frequently (~3% to 15.6%) in samples from mice expressing at least one MHC 
class (Fig. 5.19A) as indicated by the decreased density of orange boxes in Cluster 2 
samples on the heatmap (Fig. 5.18). 
 
Cluster 2 samples commonly used TRAJ43, 32, 44, 39, 31, 53, 57, 34, 37, 45, 42, 50, 
52, 58 and 56 highlighted in blue on the right of the heatmap (Fig. 5.18). These 
segments were commonly used in samples from mice expressing one or both MHC 
classes, ranging from 42.75% to 82.6% cumulative percentage of reads (Fig. 5.19B). 
These segments were used less frequently (19.1% to 28.8%) in samples from mice 
lacking both MHC classes (Figs. 5.18, 5.19B). As TRAJ segments encode part of the 
CDR3a loop, this suggests that the CDR3a loops of MHC-independent TCRs have 
different features from the TCRs that engage MHC ligands. 
 
The remaining TRAJ segments (TRAJ11, 6, 13, 28, 16, 35, 38, 27, 22, 17, 33, 40, 49 
and 48) highlighted in white on the right of the heatmap (Fig. 5.18) were expressed 
relatively homogenously across MHC genotypes (14.5% to 28.7%), except for W1 H2-
Aa–/– samples (41.8%) (Fig. 5.19C).   
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Figure 5.18. TRAJ segment usage varies with the presence or absence of any 
MHC molecules. The 45 TCR sequencing datasets described in Figs. 5.1-5.3 were 
clustered based on the Euclidean distance between the TRAJ segment usage (or 
frequency) vectors (ie. the frequency of associated reads in each J segment present in 
samples). Two clusters were formed based on TRAV usage. Cluster 1, indicated by 
dotted red box, comprising the H2-Aa–/–B2m–/– samples that commonly use TRAJ 
segments highlighted in pink. Cluster 2 (blue dotted box) consists of the MHC-
dependent TCRs from samples expressing one or both classes of MHC, with 
commonly used TRAJ segments highlighted in blue. Data were analysed using 
VDJtools CalcSegmentUsage routine. Weighted J profile was used. Z-score on 
heatmap:  0, the score is identical to the mean score (green); positive value, the score 
is above the mean (orange); and negative value, the score is below the mean (blue).  
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Figure 5.19. Commonly used TRAJ segments in presence or absence of any MHC 
molecules. Graphs show the cumulative percentage of reads per sample of TRAJ 
cluster commonly used (analysed in Fig. 5.18) (A) in the absence of MHC molecules 
(TRAJ18, 21, 24, 15, 5, 12, 23, 9, 7, 4, 2, 30 and 26), (B) in the presence of one or 
both classes of MHC (TRAJ43, 32, 44, 39, 31, 53, 57, 34, 37, 45, 42, 50, 52, 58 and 
56), and (C) regardless of the presence or absence of MHC molecules (TRAJ11, 6, 13, 
28, 16, 35, 38, 27, 22, 17, 33, 40, 49 and 48) across TCR sequencing datasets derived 
from the 45 samples described in Figs. 5.1-5.3.   
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5.2.9 CDR3a amino acids profile analysis 
 
TRAV usage thus appears to vary in a manner modulated by both cell type and MHC 
genotype. In addition, the so-called MHC-independent TCRs, which stimulate T cell 
development in Yae62b transgenic mice lacking B2m and MHCII expression, were 
enriched in CDR3a loops encoded by a distinct set of TRAJ genes. This section aims 
to identify factor(s) that distinguish the TRAJ genes that were highly used in H2-Aa–/–
B2m–/– samples from the TRAJ genes used in the other T cell samples. Analysis was 
performed using the VDJtools CalcCdrAAProfile routine, which measures the chemical 
and physical properties of amino acids (Table 5.2) in CDR3a loops detected in each of 
the 45 samples.  
Table 5.2. Chemical and physical properties of amino acids in CDR3a 
analysis. Modified from Shugay et al. (2015). 
Physical 
properties 
Description Reference 
Count 
 
Total number amino acids 
 
- 
Volume 
 
Sum of each amino acid volume 
Number of polar amino acids  
(Pommié et al., 2004; 
Zamyatnin, 1972) 
 
Polarity Total number of polar amino acids (Pommié et al., 2004) 
 
 
Hydropathy Sum of each amino acid 
hydrophobic index according to 
Kyte-Doolittle scale 
 
(Kyte and Doolittle, 
1982; Pommié et al., 
2004) 
 
 
Disorder  
 
 
 
 
 
 
 
Strength 
Intrinsic structural disorder is 
defined as proteins that lack a well-
defined conformation under native 
conditions. A disorder- producing 
amino acid has a positive value 
weighted by the SVM 
 
Number of amino acids that most 
inter-residue contacts (i.e.  
capacity of amino acid to interact 
with other amino acid measured 
using the Miyazawa-Jernigan (M-J) 
matrix 
(Dunker et al., 2008; 
Hansen et al., 2006; 
Weathers et al., 2004) 
 
 
 
 
(Miyazawa and 
Jernigan, 1996) 
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Each CDR3a amino acid sequence is divided into 2 or 3 subregions based on whether 
the residues are encoded by V, VJ or J segments of the Tcra locus. The reason that 
some CDR3 amino acids sequences have only 2 subregions is because the V and J 
gene segments are sometimes joined at the break between codons so that no amino 
acid is encoded by nucleotides at the VJ junction. VJ amino acids are amino acids that 
are partly encoded by a nucleotide derived from a V and/or J gene segment, or are 
completely encoded by non-templated nucleotides. Conserved residues in the CDR3 
amino acid sequence (cysteine (C) at the N-terminus and F (phenylalanine) or W 
(tryptophan) at the C-terminus) are excluded from this analysis. To avoid skewing of 
the results by highly abundant TCRs, as observed in Fig. 5.14 above, the following 
analyses used the "unweighted" option, in which the VDJtools CalcCdrAAProfile 
routine ignores read count for each nucleotype.  
 
5.2.9.1 Relatively homogenous CDR3a amino acid count, volume and 
polarity across the dataset 
The average number of amino acids (“count” or length) per CDR3a subregion of each 
nucleotype shows that the J subregion is the longest, contributing a mean of 7.7 - 8.5 
amino acids, whereas the V and VJ subregions together contribute 3 - 4 amino acids 
(Fig. 5.20). The average lengths of CD4SP and CD8SP CDR3a loops were slightly 
longer than W1 CDR3a loops (8.5 versus 8 in the J subregion), except for the H2-Aa–/– 
group, in which CD8SP and W1 CDR3a loops were similar in length (~8 amino acids in 
the J subregion) (Fig. 5.20). Regardless of cell type, CDR3a loops in H2-Aa–/–B2m–/– 
samples were at the short end of the range observed in MHC-expressing mice (e.g. ~8 
amino acids in the J subregion).  
There are common 20 amino acids used for amino acid physical or chemical property 
analyses: A (alanine), C (cysteine), D (aspartate), E (glutamate), F (phenylalanine), G 
(glycine), H (histidine), I (isoleucine), K (lysine), L (leucine), M (methionine), N 
(asparagine), P (proline), Q (glutamine), R (arginine), S (serine), T (threonine), V 
(valine), W (tryptophan) and Y (tyrosine). Five classes of amino acid volume were 
defined based on the amino acid volumes in angstrom3 (Å3) (Zamyatnin, 1972): very 
small (60 - 90Å3; G, A, S); small (108 - 117Å3; C, D, P, N, T); medium (138 - 154Å3; E, 
V, Q, H); large (162 - 174Å3; M, I, L, K, R); and very large (189 - 228Å3; F, Y, W). The 
average sum of amino acid volumes per nucleotype in all three CDR3a subregions 
(Fig. 5.21) followed a pattern similar to that observed for “count” Fig. 5.20), as 
expected, because the main determinant of “volume” is likely to be the number of 
amino acids present.   
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Figure 5.20. Count (or number) of amino acids in each subregion of CDR3a 
loops. Graphs show the average number of amino acids in the V, VJ and J subregions 
of the CDR3a loops (top to bottom) per nucleotype for each sample. Each circle 
represents a TCR sequencing dataset derived from 1 of the 45 samples described in 
Figs. 5.1-5.3. Lines represent group means. Data were analysed using VDJtools 
CalcCdrAAProfile routine set to “unweighted”, i.e. ignoring TCR nucleotype frequency.   
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Figure 5.21. Volume of amino acids in the subregions of CDR3a loops is similar 
to the profile of “count”. Graphs show the average sum of volume of amino acids, 
measured in units of Å3, in the V, VJ and J subregions of the CDR3a loops per 
nucleotype for each sample. Each circle represents a TCR sequencing dataset derived 
from 1 of the 45 samples described in Figs. 5.1-5.3. Lines represent group means. 
Data were analysed using VDJtools CalcCdrAAProfile routine, unweighted by TCR 
nucleotype frequency.  
  
	 206 
Polar amino acids include all the five charged (H, K, R, D, E) and five uncharged amino 
acids (T, S, Q, N and Y), whereas the remaining 10 amino acids are non-polar amino 
acids with aliphatic side chains (A, V, I, L); sulfur-containing side chains (C, M); or F, 
W, P and G (Pommié et al., 2004). In the V region of CDR3a loops, the average 
number of polar amino acids per nucleotype was higher in all cells subsets in wild-type 
mice and W1 samples in H2-Aa–/– mice compared to the rest of the mouse genotypes 
(Fig. 2.22). The polarity measurements for VJ and J subregions of CDR3a loops were 
relatively homogenous across the dataset (Fig. 2.22). 
 
5.2.9.2 Distinctive “hydropathy”, “strength” and “disorder” CDR3a 
measurements in H2-Aa–/–B2m–/– samples 
Hydropathy measurements are based on the average sum of hydropathy index of each 
amino acid per nucleotype. Hydropathy index for 20 amino acids are designated by 
Kyte and Doolittle (Kyte and Doolittle, 1982). Amino acids I, V, L, F, C, M, A, W are 
classified into hydrophobic (synonymous with hydropathic) as they have hydrophathy 
index of ≥ 1.8, except for W with -0.9. Hydrophilic amino acids include N, D, Q, E, K, R, 
are defined as amino acids with < -3.3 hydropathy index, whereas neutral amino acids 
G, T, S, Y, P, H have hydropathy index < 1.8 but > -3.3 (Pommié et al., 2004) (Table 
5.3). H2-Aa–/–B2m–/– samples had highest hydropathy measurements compared to the 
rest of the MHC mouse genotypes, particularly in the CDR3a J subregion and to a 
lesser extent in the V subregion (Fig. 5.23).  
 
Intrinsic disorder refers to amino acid sequences that lack a well-defined conformation 
and are thus thought to be more flexible or mobile under native conditions (Hansen et 
al., 2006). Disorder of the amino acids are determined by support vector machine 
(SVM) vector weights for 20 amino acids (Weathers et al., 2004). SVM was first trained 
to recognise disordered protein based on amino acid sequences by feeding the 
machine with ordered and disordered proteins (training dataset) and each amino acid 
in the protein was translated into the vector. After training the SVM, the machine’s 
accuracy was calculated based on the ability of SVM to accurately recognise 
disordered protein in a testing dataset. Disorder-producing amino acids include K, P, 
G, N, Q, S, E, D, M and R (yellow), all associated with a positive value and are bias 
towards hydrophilic amino acids (Fig. 5.24) (Hansen et al., 2006; Weathers et al., 
2004). Order-producing amino acids include V, H, F, I, L, C, W and Y (blue), all 
associated with a negative value and are bias towards hydrophobic amino acids (Fig. 
5.24). Neutral amino acids include A and T (red), associated with values close to zero. 
In each TCR nucleotype, VDJtools CalcCdrAAProfile routine annotates   
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Figure 5.22. Polarity of amino acids in the subregions of CDR3a loops. Graphs 
show the average number of polar amino acids (D, E, H, K, R, N, Q, S, T, Y) in the V, 
VJ and J subregions of the CDR3a loops for each sample. Each circle represents a 
TCR sequencing dataset derived from 1 of the 45 samples described in Figs. 5.1-5.3. 
Lines represent group means. Data were analysed using VDJtools CalcCdrAAProfile 
routine, unweighted by TCR nucleotype frequency. 
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Table 5.3. Three hydropathy classes of amino acids. Table shows the most 
hydrophobic amino acid (left) to most hydrophilic amino acid (right). Hydropathy 
(hydrophobicity) index of each amino acid is designated according to the Kyte-Doolittle 
scale. Hydrophobic amino acids (blue) include A (alanine), C (cysteine), I (isoleucine), 
L (leucine), M (methionine), F (phenylalanine), W (tryptophan) and V (valine), with ≥ 1.8 
hydropathy index, except for W with -0.9 as it involves in the hydrophobic core of the 
structural domains. Neutral amino acids (red) include G (glycine), H (histidine), P 
(proline), S (serine), T (threonine) and Y (tyrosine) with hydropathy index < 1.8 but > -
3.3. Hydropholic amino acids (yellow) include R (arginine), N (asparagine), D 
(aspartate), Q (glutamine), E (glutamate) and K (lysine) with hydropathy index < 3.3. 
Diagram is modified from Pommié, et al. (2004). 
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Figure 5.23. H2-Aa–/–B2m–/– samples exhibit high amino acid “hydropathy” in the 
J subregion of CDR3a loops. Graphs show the average sum of hydropathy index of 
amino acids (Table 5.3) per nucleotype for each sample in V, VJ and J subregions of 
CDR3a (top to bottom). Each circle represents a TCR sequencing dataset derived from 
1 of the 45 samples described in Figs. 5.1-5.3. Lines represent group means. Data 
were analysed using VDJtools CalcCdrAAProfile routine set to “unweighted”, i.e. 
ignoring TCR nucleotype frequency.    
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Figure 5.24. Disorder-producing, neutral and order-producing amino acids. 
Disorder of amino acids is based on vector weights for the 20 amino acids by support 
vector machine (SVM) (Weathers et al., 2004). In the VDJtools CalcCdrAAProfile 
routine, each of the disorder-producing amino acids (mostly hydrophilic) including K, P, 
G, N, Q, S, E, D, M and R (yellow), is assigned a value of +1 (positive 1). Each of the 
order-producing amino acids (mostly hydrophobic) including V, H, F, I, L, C, W and Y 
(blue), is assigned a value of –1 (negative 1). Each of the neutral amino acids including 
A and T (red), is assigned a value of 0. Modified from Weathers et al. (2004). 
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each disorder-producing amino acid as “+1”, each neutral amino acid as “0” and each 
order-producing amino acid as “-1”, and sum up these values as the “disorder” 
measurements. The more positive the value is, the higher the intrinsic structural 
disorder of the TCR is. The average sum of amino acid “disorder” per nucleotype for 
each sample in H2-Aa–/–B2m–/– samples in the J subregion and to a lesser extent in the 
V subregion of CDR3a loops was lowest compared to the rest of the MHC-expressing 
samples (Fig. 5.25). “Disorder” measurements were generally lower in W1 samples 
than in CD4SP and/or CD8SP samples in the J subregion across all MHC genotypes 
(Fig. 5.25).  
 
“Strength” refers to the capacity of amino acids to interact with other amino acids and is 
measured using the M-J matrix, conceived by Miyazawa and Jernigan (Miyazawa and 
Jernigan, 1996). VDJtools counts the occurrences of the 8 amino acids found to have 
the most inter-residue attraction, which are L, F, I, M, V, W, C and Y, in each 
nucleotype (Miyazawa and Jernigan, 1996). Almost all of these amino acid residues 
are hydrophobic. “Strength” measurements tended to be higher in H2-Aa–/–B2m–/– 
samples in the CDR3a J subregion, but not in the V or VJ subregions (Fig. 5.26). This 
trend is consistent with the hydropathy mesurements above (Fig. 5.25). 
 
In short, these findings indicate that samples that lack both classes of MHC exhibit high 
hydropathy and strength but low disorder in the J subregion of CDR3a in comparison 
to samples from mice expressing one or both classes of MHC.  
 
5.2.9.3 Hydropathy analysis of J subregion of CDR3a loops 
i) Hydrophobic amino acids are enriched in wave 1 cells of MHC-
dependent and MHC-independent TCRs 
Stadinski et al. (2016) recently reported that self-reactive TCRs may be characterised 
by hydrophobic (which is synonymous with hydropathic) residues in the CDR3 of the 
TCRβ chain. This section examined whether the strongly TCR-signalled W1 TCRs also 
exhibit high hydropathy in the CDR3a J subregion. The hydropathy at individual amino 
acid level was determined by dividing the average hydropathy value in each sample 
with the average number (or count) of amino acids in each sample, all within the J 
subregion, analysed by VDJtools CalcCdrAAProfile routine. 
Wild-type samples were directly compared to H2-Aa–/–B2m–/– samples as these two 
genotypes had all three W1, CD4SP and CD8SP cell subsets. When the data were 
stratified by cell type, W1 samples had significantly higher hydropathy measurements   
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Figure 5.25. H2-Aa–/–B2m–/– samples exhibit low amino acid “disorder” profile in 
the J subregion of CDR3a loops. Graphs show the average sum of disorder values 
of amino acids per nucleotype for each sample in V, VJ and J subregions of CDR3a, 
according to the VDJtools annotation for disorder-producing, neutral and order-
producing amino acids described in Fig. 5.24. Each circle represents a TCR 
sequencing dataset derived from 1 of the 45 samples described in Figs. 5.1-5.3. Lines 
represent group means. Data were analysed using VDJtools CalcCdrAAProfile routine 
set to “unweighted”, i.e. ignoring TCR nucleotype frequency.   
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Figure 5.26. H2-Aa–/–B2m–/– samples demonstrate high amino acid “strength” 
measurements in the J subregion of CDR3a loops. “Strength” measurement is the 
average number of occurrences of the amino acids L, F, I, M, V, W, C and Y per 
nucleotype. Graphs show the average “strength” measurements for each sample in V, 
VJ and J subregions of CDR3a. Each circle represents a TCR sequencing dataset 
derived from 1 of the 45 samples described in Figs. 5.1-5.3. Lines represent group 
means. Data were analysed using VDJtools CalcCdrAAProfile routine set to 
“unweighted”, i.e. ignoring TCR nucleotype frequency.   
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at the individual amino acid level than the positively selected CD8SP (Fig. 5.27). This 
result suggests that both MHC-dependent and MHC-independent strongly signalled 
W1 TCRs, may be characterised by the increased presence of hydrophobic residues in 
the CDR3 of TCRα chain. 
Notably, CD8SP samples in H2-Aa–/– mice had significantly greater hydropathy 
measurements than CD8SP samples from wild-type mice (Fig. 5.28). This finding 
suggests that MHCII expression impinges on, and possibly decreases the self-
reactivity of, the CD8+ T cell TCR repertoire. A caveat of this finding, however, is that 
the Yae62 TCRβ chain may be unusual because it is capable of binding to both the 
MHCII molecule, H2-Ab, and the MHCI molecule, H2-Kb (Huseby et al., 2005; Yin et al., 
2011). This cross-reactivity may increase the impact of MHCII expression in Yae62 
TCRβ transgenic mice compared to mice with a fully diverse CD8+ T cell repertoire. 
ii) MHC-independent TCRs have increased usage of hydrophobic residues in 
the J subregion of CDR3a  
When the data were stratified by MHC genotype, ignoring cell type information, H2-Aa–
/–B2m–/– samples exhibit significantly higher hydropathy per amino acid in the J 
subregion of the CDR3a compared to wild-type mice (Fig. 5.29). This indicates that 
MHC-independent TCRs are characterised by increased usage of hydrophobic 
residues in the J subregion of CDR3 TCRa chain, which is also consistent with the 
finding above (Fig. 5.23).   
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Figure 5.27. Wave 1 TCRs have increased hydropathy per amino acid in the 
CDR3a J subregion. Graphs show the average hydropathy per amino acid in the J 
subregion of CDR3 TCRa chain determined by dividing the average hydropathy value 
in each sample with the average number (or count) of amino acids in each sample. 
Each circle represents a sample from wave 1, CD4SP and CD8SP thymocytes subsets 
of wild-type mice (n=5) and H2-Aa–/–B2m–/– wild-type mice (n=3). Lines represent group 
means. Data were analysed using VDJtools CalcCdrAAProfile routine, unweighted by 
TCR nucleotype frequency. 2-way ANOVA and Tukey’s post-tests; P values are shown 
with symbols: ns, non-significant; ** <0.01; **** <0.0001 (between MHC genotype). 
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Figure 5.28. MHCII-deficient CD8SP TCRs have higher hydropathy per amino acid 
in the CDR3a J subregion than wild-type CD8SP TCRs. Graphs show the average 
hydropathy per amino acid in the J subregion of CDR3 TCRa chain for individual 
samples. Each circle represents a sample from wave 1, CD4SP and CD8SP 
thymocytes subsets and/or TCRβ+ B220– splenocyte subset across four MHC 
genotypes described in Fig. 5.23. Lines represent group means. Data were analysed 
using VDJtools CalcCdrAAProfile routine, unweighted by TCR nucleotype frequency. 
Statistical analysis used unpaired Student’s t-tests. P value symbols: ns, non-
significant; ** <0.01.  
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Figure 5.29. MHC-independent TCRs have increased hydropathy per amino acid 
in the CDR3a J subregion. Graphs show the average hydropathy per amino acid in 
the J subregion of CDR3 TCRa chain for each sample. Each symbol represents a 
sample from one of the four MHC genotypes described in Fig. 5.28, ignoring T cell 
subsets (i.e. wave 1, CD4SP and CD8SP thymocytes subsets and/or TCRβ+ B220– 
splenocyte subset). Lines represent group means. Data were analysed using VDJtools 
CalcCdrAAProfile routine, unweighted by TCR nucleotype frequency. Statistical 
analysis used unpaired Student’s t-tests. P value symbols: ns, non-significant; ** <0.01. 
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5.2.10  Visualisation of CDR3 amino acid sequences for MHC-independent 
and MHC-dependent TCRs by IceLogo 
 
To investigate which amino acids are enriched within the CDR3a of MHC-independent 
TCRs, and their positioning within the CDR3a, IceLogo software was used. IceLogo 
provides a visual and intuitive comparison of two datasets containing peptide 
sequences of a defined length. Icelogo first calculates from a reference dataset the 
occurrences (mean and standard deviation) of each amino acid at each position in the 
sequence by repetitive random sub-sampling of the data. Icelogo repeats this 
procedure in the experimental dataset and displays any amino acid with significantly 
different frequencies in the reference and experimental datasets (p-value <0.05 as 
determined by a t-test). The height of an individual amino acid symbol reflects the 
difference in frequencies in the 2 datasets at that position in the sequence; symbols 
above the x-axis indicate enrichment in the experimental dataset; symbols below 
indicate enrichment in the reference dataset (Colaert et al., 2009; Maddelein et al., 
2015).  
 
Datasets were compiled containing CDR3a sequences of 12, 13, 14, 15 or 16 amino 
acids, inclusive of the conserved residues in the CDR3 amino acid sequence (C at the 
N-terminus and F or W at the C-terminus). These numbers cover the CDR3a lengths 
most commonly observed in the datasets (Fig. 5.30). All TCR samples (i.e., W1, CD4 
and CD8SP thymocyte samples and TCRβ+ B220– splenocyte samples) of H2-Aa–/–
B2m–/– mice were pooled using VDJtools PoolSamples routine to form the MHC-
independent TCR dataset. W1, CD4 and CD8SP TCRs from wild-type mice were 
pooled to form the MHC-dependent TCR dataset.  
 
Unlike “disorder” and “strength”, the “hydropathy” of amino acids can be estimated in 
an objective manner (Pommie et al., 2004) as 20 amino acids are classified into 
hydrophobic (synonymous with hydropathic), neutral and hydrophilic categories 
(Pommié et al., 2004) (Table 5.3). At position 3, hydrophobic amino acids L (leucine) 
and V (valine) were enriched in the MHC-independent dataset (Fig. 5.31). As TRAV12-
1, TRAV12-2 and TRAV12-3 encode an “L” at position 3, this is probably due to these 
TRAV segments being commonly used in H2-Aa–/–B2m–/– samples. Enrichment of “V” 
at position 3 may be due to the “V” at position 3 encoded by TRAV2, which was 
detected only in H2-Aa–/–B2m–/– samples.  On the other hand, hydrophobic A (alanine) 
was enriched in the reference dataset at position 3 (Fig. 5.31). This is probably due to 
TRAV14, TRAV19 and TRAV5D encoding “A” at position 3 of CDR3a sequences in 
wild-type samples.   
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Figure 30. MHC-dependent and MHC-independent TCRs peaked at 12 to 16 
amino acid residues in CDR3a length. TCRs from W1, CD4 and CD8SP thymocyte 
subsets and TCRβ+ B220– splenocyte subset of H2-Aa–/–B2m–/– mice were pooled 
using VDJtools PoolSamples routine, forming the MHC-independent TCRs. W1, CD4 
and CD8SP TCRs from wild-type mice were pooled to form MHC-dependent TCRs. 
Graphs show the number of clonotypes found in every CDR3a length detected in (A) 
wild-type TCRs and (B) B2m–/–H2-Aa–/– TCRs.   
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Figure 31. Hydrophobic amino acid residues (L, W, V) are enriched at 
positions 3, and 6, 7, 9, 10 (J subregion) of the CDR3a in MHC-independent 
TCRs. IceLogos generated from the B2m–/–H2-Aa–/– MHC-independent TCRs 
(experimental set, above x-axis) and the wild-type MHC-dependent TCRs (reference 
set, below x-axis), both with CDR3a length of 12, 13, 14, 15 and 16 amino acid 
residues. IceLogo showed only the significant difference in frequency of each amino 
acid at every position (P < 0.05) in the experimental set (denoted as positive 
frequency) and the reference set (denoted as positive frequency). Positive frequency 
represents the high abundance amino acids in the experimental set over reference set, 
whereas negative frequency shows the low abundance amino acids in the 
experimental set over reference set. The size of an amino acid reflects the difference in 
the frequency of an amino acid in the experimental and its percentage in the reference 
set.  
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All enrichments observed at positions >3 are attributable to the tendency for MHC-
dependent and MHC-independent TCRs to use different TRAJ genes. In the MHC-
independent TCRs, hydrophobic residues W (tryptophan) and/or L were consistently 
enriched at position 6 and/or 7 in all CDR3 lengths analysed (Fig. 5.31). Hydrophobic 
residues L, V and/or W were consistently enriched in MHC-independent TCRs at 
positions 9 and/or 10 (Fig. 5.31). These findings suggest that hydrophobic residues are 
enriched in the J subregion of CDR3a in MHC-independent TCRs. However, 
hydrophilic residues Q (glutamine), R (arginine), D (aspartate) or N (asparagine) were 
commonly enriched at positions 9 and 10 in the MHC-independent TCRs. By contrast, 
in the MHC-dependent TCR reference dataset, the neutral amino acids (G (glycine) or 
T) and hydrophilic amino acids (N, D, E (glutamate) or Q) were enriched at positions 6 
to 10 (Fig. 5.31).  
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5.3 Discussion 
 
To investigate why the individual frequency of TCR-signalled cells in MHCI-deficient 
mice and MHCII-deficient mice sum to 35% greater than the frequency of TCR-
signalled cells in mice bearing both MHCI and MHCII, TCR repertoire sequencing was 
performed. The overlap in TCR usage between MHCI-deficient and MHCII-deficient 
mice did not exceed the overlap between either of these datasets and the dataset from 
mice lacking both classes of MHC. Thus, the data provide no support for the MHC 
class cross-reactivity hypothesis. Differences in TRAV usage associated with particular 
MHC genotypes and/or cell types suggest that the TRAV-encoded portions of the TCR 
bias MHC recognition and thymocyte fate. Increased usage of certain TRAV segments 
in mice lacking one MHC class is consistent with the interclonal competition hypothesis 
to explain the “35% difference”. Interestingly, mice lacking both MHC classes exhibit 
“fusion” of CD4SP and CD8SP TCR repertoires, a distinctive TRAJ segment usage 
profile and enrichment of hydrophobic amino acids in the J subregion of CDR3a loops. 
 
TCRα chain sequencing was performed on sorted T cells from mice with a fixed 
Yae62β (TCRβ) chain. The negatively selected wave 1 TCR repertoire was distinct 
from the positively selected CD4SP and CD8SP TCRs in the presence of one or both 
MHC classes, based on the following evidence. First, wave 1 TCR repertoire formed a 
distinct cluster from CD4SP and CD8SP TCR repertoires using unsupervised clustering 
(Fig. 5.8). Second, certain TRAV segments were detected more frequently in wave 1 
samples than in positively selected CD4SP or CD8SP samples (Fig. 5.16). Third, there 
was little overlap in TCR clonotypes between W1 samples and either CD4SP or 
CD8SP samples (Figs. 5.10, 5.11). Fourth, the strongly TCR-signalled wave 1 TCRs in 
wild-type and MHC-double deficient mice are enriched for hydrophobic amino acids in 
the J subregion of CDR3a loops as compared to positively selected CD8SP (Fig. 5.27, 
Table 6.1). Wave 1 TCRs were also somewhat distinct from CD4SP/CD8SP TCRs in 
mice lacking both classes of MHC (Fig. 5.10B). It is concluded that MHC expression is 
not necessary for a difference to be observed in the TCR repertoires that provoke 
positive versus negative selection.  
 
The TRAV segment encodes the CDR1α and CDR2α loops, which commonly interact 
with the MHC portion of peptide/MHC complexes (Rossjohn et al., 2015; Rudolph et 
al., 2006). When paired with the YAe62β chain, TRAV21/DV12 appears to favour TCR 
interactions with MHCII as it is enriched in CD4SP TCRs of wild-type and B2m–/– mice 
(Fig. 5.16). TRAV16/DV11 and TRAV8D-1 appear to favour TCR interactions with 
MHCI as these TRAV segments are highly expressed in CD8SP cells (Fig. 5.16). A 
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recent study showed that expression of TRAV and TRBV gene segments is 
significantly associated with polymorphisms in MHC genes whereas expression of 
TRDV and TRGV genes is not (Sharon et al., 2016). The effect of TRAV segment on 
CD4 versus CD8 lineage choice is consistent with CD4+ and CD8+ T cells having 
different TRBV segment usage (Klarenbeek et al., 2015). Similarly, the two closely 
related germline-derived Vα3.1 (encoded by TRAV9-2) and Vα3.2 (encoded by 
TRAV9D-2) (Bosc and Lefranc, 2003) segments bias selection into CD4 and CD8 
subsets, respectively (Sim et al., 1996). Three mutations created in Vα3.1 gene were 
sufficient to bias selection from CD4 towards the CD8 subset (Sim et al., 1996). In 
addition, TRAV12-2 gene encoding CDR1a was found to be highly expressed in 
human CD8+ T cell TCRs that bind to ELA:HLA-A*0201 (peptide:MHCI). This is due to 
the TRAV12-2 germline-encoded of CDR1a loop of TCR dominating the recognition of 
residues on MHC surface and bound peptide (Cole et al., 2009). The observed 
associations between TRAV usage, MHC genotype and cell type indicate that TRAV 
usage influences MHC recognition. 
 
Germline-encoded amino acids in the CDR2b play a role in controlling positive 
selection. Substitution of alanine into the CDR2 region of a transgenic TCRβ chain was 
sufficient to reduce the frequency and number of mature CD4SP and CD8SP 
thymocytes and peripheral T cells (Scott-Browne et al., 2009). The present findings 
suggest that CDR1 and CDR2 loops could also have a role in negative selection as 
evident by the enrichment of TRAV usage in wave 1 cells. TRAV12-3 usage was 
enriched in wave 1 samples in a B2m-dependent manner (Fig. 5.16). The enrichment 
of certain TRAV segments in negatively selected wave 1 cells may be due to the role of 
CDR1 and CDR2 loops in self-antigen-binding. Amino acids in the CDR1 can alter 
antigen-binding even when they do not interact at the TCR-pMHC interface. For 
example, the affinity of the J809.B5 TCR for 3K-IAb is reduced by 260-fold by an 
alanine substitution at the CDR1 αY31 residue (aY31A) (Stadinski et al., 2014). 
Another study revealed that two TCRs with identical TCRb chains and an identical 
CDR3 amino acid sequence in the TCRa chain, but a different TRAV segment, had 
different antigen-binding properties (Lee et al., 2012). The findings of TRAV usage 
enrichment associated with particular MHC genotypes and/or cell types suggest that 
portions of the TCR encoded by TRAV segments can bias thymocyte fate.  
 
Compared to wild-type wave 1 samples, TRAV8D-1 usage was increased by 3.5-fold in 
B2m–/– wave 1 samples, versus 1.1-fold for TRAV12-2 and 1.28-fold for TRAV21/DV12 
(Fig. 5.16). This “preferential” increase suggests that thymocytes bearing TCRs using 
TRAV8D-1 compete more effectively for APCs when the APCs cannot express B2m 
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compared to when the APCs can express B2m. This provides preliminary evidence 
supporting the interclonal competition hypothesis as an explanation for the “35% 
difference” described above.  
 
No evidence was found to support the MHC class cross-reactivity hypothesis. The 
percentage of negatively selected wave 1 TCRs shared between MHCI-deficient mice 
and MHCII-deficient mice was not greater than the percentage shared between either 
of these groups and the group lacking MHC expression (Table 5.1). This result was 
surprising because it was recently shown that TCRs that induce clonal deletion are 
often MHC class cross-reactive (McDonald et al., 2015). The Yae62β transgenic mice 
used in this thesis would be expected to provide an ideal setting to detect MHC class 
cross-reactive TCRs. This is because the Yae62 TCRβ chain is known to be capable of 
binding to the α1 chain of H2-Kb (MHCI) and the α chain of H2-Ab (MHCII) (Yin et al., 
2011). To explain the apparent discrepancy, it is possible that the wave 1 cells sorted 
here may represent only a small portion of the true wave 1 TCR repertoire. The sorting 
strategy may only capture a subset of thymocytes that have survived deletion at wave 
1 and progressed to the next stage of IEL differentiation. It is possible that MHC class 
cross-reactive TCRs are deleted at the DP stage, explaining the failure to detect MHC 
class cross-reactive TCRs in this thesis. MHC class cross-reactive TCRs may be 
detected if the apoptosis-defective Bcl-2 Tg mice are used. This is because the 
apoptosis defect might enable cells bearing MHC class cross-reactive TCRs to survive 
long enough to attain the CD4loCD8lo PD-1hi phenotype used for wave 1 cell sorting.  
 
Unlike samples from mice expressing at least one MHC class, the CD4SP and CD8SP 
TCR repertoires of B2m–/–H2Aa–/– mice were clustered together (Fig. 5.8). CD4SP TCR 
clonotypes commonly overlapped with CD8SP TCR clonotypes in B2m–/–H2Aa–/– mice 
(Fig. 5.13). These findings indicate that MHC expression is required for the CD4SP and 
CD8SP TCR repertoires to be distinct from each other. TCRs in B2m–/–H2Aa–/– mice 
and wild-type mice are referred to as MHC-independent and MHC-dependent TCRs, 
respectively, hereon. The “fusion” of CD4SP and CD8SP TCR repertoires in mice 
lacking both MHC classes suggests that MHC expression is required for coreceptors to 
affect T cell selection. Although the αβT cells that develop in mice lacking both CD4 
and CD8 coreceptors and both MHC molecules (referred to as Quad-deficient mice) 
have been described, there was no report of “fusion” of CD4SP and CD8SP TCR 
repertoires in Quad-deficient mice (Van Laethem et al., 2007; Van Laethem et al., 
2013). It was concluded that coreceptor-free Lck (Lck that is not bound to a coreceptor) 
promotes thymic selection of MHC-independent TCRs, as opposed to the coreceptor-
associated Lck that promotes thymic selection of MHC-restricted TCRs (Van Laethem 
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et al., 2013). The observed CD4SP and CD8SP TCR repertoire “fusion” is consistent 
with the hypothesis that coreceptors have a key role in the CD4/CD8 lineage decision. 
 
The MHC-independent TCR repertoire has a distinctive TRAJ segment usage profile 
compared to TCR repertoires in mice expressing one or both MHC classes (Figs. 5.18, 
5.19). CDR3 loops are predominantly encoded by the TRAJ segment and form the 
region that commonly binds to the peptide portion of peptide-MHC complexes. MHC-
independent αβTCRs are thought to interact with ligands in a manner resembling 
antibody-antigen interactions (Tikhonova et al., 2012). CDR3α sequences are required 
for the interaction of one MHC-independent TCR with glycosylation-dependent 
conformational epitopes on the self-protein, CD155 (Tikhonova et al., 2012). This 
recognition is in contrast to the MHC-dependent TCRs recognising peptide-MHC 
complexes, potentially explaining why MHC-independent TCRs have a unique TRAJ 
segment usage. 
 
The MHC-independent TCR repertoire is enriched in hydrophobic amino acids in the J 
subregion of CDR3α loops (Figs. 5.23, 5.28, 5.29). In particular, the enrichment of 
hydrophobic amino acid residues (tryptophan (W), leucine (L) and valine (V)) was 
commonly found at positions 6, 7 and 9, 10 of CDR3α regardless of the CDR3α length 
analysed (Fig. 5.31). The presence of hydrophobic amino acid residues at position 6 
and 7 in CDR3b was found to increase the self-reactivity of T cells (Stadinski et al., 
2016). This is also consistent with enrichment of hydrophobic amino acids in negatively 
selected wave 1 TCRs in MHC-dependent and MHC-independent TCRs (Fig. 5.27). 
Structural analyses indicate that the CDR3 loops of both a and b chains fold into the 
interior of the TCR heterodimer (Rossjohn et al., 2015). It is conceivable that 
hydrophobic amino acids in the CDR3 loops help to stabilise the TCR heterodimer itself 
as well as stabilise the interaction between the TCR and its ligand in the negatively 
selected wave 1 TCRs and MHC-independent TCRs. In folded proteins, hydrophobic 
residues tend to occupy the interior of the molecule, away from the surrounding water. 
Although the MHC-independent or -dependent TCR-ligand interface is composed of 
multiple proteins, the entire assembly might be considered as a unit that is stabilised by 
a hydrophobic interior consisting of the CDR3a and CDR3b loops. The potential role of 
high amino acid hydrophobicity in the CDR3α J subregion of MHC-independent TCRs 
in stabilising the TCR-ligand interaction is supported by the low intrinsic structural 
disorder (stable protein under native condition) within the same region (Fig. 5.26). This 
is consistent with previous literature reporting that hydrophobic amino acids promote 
structure order (Hansen et al., 2006; Uversky et al., 2000). 
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Based on surface plasmon resonance measurements,  the MHC-independent αβTCR 
(B12A) and its ligand CD155 have a Kd of 230 nM (=0.23μM) (Tikhonova et al., 2012), 
as opposed to the 6-60μM reported for αβTCRs and peptide-MHC complexes in mice 
(Margulies, 1997; Matsui et al., 1991; Naeher et al., 2007). The smaller the Kd value 
(i.e. nM versus μM), the greater the binding affinity. So, the MHC-independent 
interaction is 26- to 260-fold higher in affinity than typical MHC-dependent interactions 
in mice. In humans however, it has been reported that MHC-dependent TCRs could 
have a wide range of binding affinities between TCR peptide-MHC (Kd of 1μM-500μM) 
(Bridgeman et al., 2012; Cole et al., 2007). The affinity threshold that discriminates 
positive versus negative selecting ligands in MHCI-restricted TCRs (T1, S14, and OT-1 
TCR) is ~6 μM Kd (Naeher et al., 2007). The high “strength” (i.e. high capacity of amino 
acid-amino acid interaction) (Fig. 5.26) that is closely associated with hydrophobic 
amino acids (Miyazawa and Jernigan, 1996), and the high hydrophobicity in CDR3α J 
subregion of MHC-independent TCRs, may contribute to the high binding affinity of 
MHC-independent TCR with its ligand. Why might a high affinity MHC-independent 
interaction (~230 nM) not result in strong TCR signalling and clonal deletion? A simple 
explanation is that coreceptors contribute less, or not at all, to MHC-independent TCR-
ligand interactions compared to MHC-dependent TCR-pMHC interactions. Without 
coreceptors, a greater intrinsic affinity between TCR and ligand may be required to 
induce equivalent TCR clustering at the cell surface and signalling inside the T cell 
(Taylor et al., 2017). Assuming that high affinity MHC-independent interaction (~230 
nM) induces positive selection, an even higher affinity may be required for negative 
selection in MHC-independent TCRs.  
 
One potential weakness of this experimental system is that each TCRb transgenic cell 
that was TCR-sequenced could potentially express two TCRa chains. As dual-TCRa 
expressing cells can be found in the thymus and in the periphery (Hale and Fink, 2010; 
Simmons et al., 2012), some of the TCRa sequences detected were very likely to be 
from dual-TCR expressing T cells. However, the fact that TCR sharing was more 
common within than across cell-type boundaries indicates a clear association between 
TCR sequence and cell fate. Since sequences from dual-TCR expressing T cells would 
be expected to decrease the strength of this association, the actual association is 
probably stronger than what is reflected in the data.   
 
In summary, this study did not find evidence of MHC class cross-reactive TCRs within 
the wave 1 repertoire, but did provide evidence supporting the interclonal competition 
hypothesis. The MHC class cross-reactive TCR hypothesis cannot be excluded, 
however, because it is possible that the sorting strategy used here captured only a 
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portion of the true wave 1 TCR repertoire.  
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CHAPTER 6  
 
General discussion 
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6.1 The partition of two waves of thymic negative selection 
 
Thymocytes that receive strong TCR signalling undergo negative selection (which 
encompasses clonal deletion or agonist selection) at either the immature CCR7– or DP 
stage (wave 1), or the mature CCR7+ or SP stage (wave 2). The thymic negative 
selection mechanisms examined in this thesis and previous studies, focusing on the 
roles of thymic APC types (MHCII+ BM-APCs and Aire+ mTECs) and MHC molecules 
are depicted in Fig. 6.1. The characteristics of MHC-dependent and MHC-independent 
TCR selection investigated in this study are discussed below (Table 6.1).  
 
In wave 1 CCR7– (or DP) negative selection, presumably in the thymic cortex (Kurd 
and Robey, 2016; McCaughtry et al., 2008), wave 1 cells are characterised by the 
dulling of CD4 and CD8 coreceptors (CD4loCD8lo) and PD-1 upregulation (Daley et al., 
2013; McCaughtry et al., 2008). The strongly TCR-signalled thymocytes undergo one 
of two processes.  Firstly, they may undergo wave 1 clonal deletion, which accounts for 
more than half of all negative selection (Daley et al., 2013; Sinclair et al., 2013; 
Stritesky et al., 2013). This occurs at 1-2 days after proliferation during the DN-DP 
transition (Hu et al., 2016). Alternatively, wave 1 thymocytes that do not undergo clonal 
deletion at the CCR7– stage become CD4loCD8lo PD-1hi iIEL thymic precursors and 
may eventually differentiate into TCRαβ+ CD8αα+ iIEL in the periphery (McDonald et 
al., 2014; Pobezinsky et al., 2012) (Fig. 6.1). This is based on the evidence that 
thymocytes that survived superantigen-mediated clonal deletion (Pobezinsky et al., 
2012) or survived negative selection by thymic self-ligands (e.g., Bcl-xL Tg 
thymocytes), exhibiting CD4loCD8lo PD-1hi phenotype, differentiate into CD8αα+ iIELs in 
the gut (Gangadharan et al., 2006; Leishman et al., 2002; McDonald et al., 2014). 
Direct evidence that Helios+ CCR7– thymocytes give rise to iIELs in the periphery 
remains lacking. This could be tested by generating HeliosGFP mice, sorting GFP+ 
CCR7– thymocytes, injecting them into recipient mice and detecting the presence or 
absence of GFP+ cells in the small intestine of the recipient mice.  
 
Some wave 1 negatively selected thymocytes have been reported to be MHC class 
cross-reactive (McDonald et al., 2015), although this study fails to provide evidence of 
MHC class cross-reactive TCRs within the wave 1 cells as discussed in Chapter 5. This 
study demonstrates a requirement for MHCII+ BM-APCs in mediating stringent wave 1 
negative selection (clonal deletion and iIEL thymic precursors) to establish central 
tolerance. Wave 1 negative selection was found to be more dependent on MHCII than 
MHCI, although this effect was evident only in apoptosis-defective mice (Fig. 6.1).  
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Figure 6.1. Thymic negative selection mechanisms. Pre-selection thymocytes have 
a Helios– CCR7– phenotype. Thymocytes that receive a strong TCR signal upregulate 
Helios. Helios+ thymocytes at CCR7– (similar to DP) or CCR7+ (similar to SP) stages of 
development are characterised as undergoing "wave 1" and "wave 2" negative 
selection, respectively. Timecourse experiments revealed that, on average, thymocytes 
enter wave 1 approximately 2 days after they proliferate during beta selection. Wave 1 
is presumed to occur in the thymic cortex. Wave 1 thymocytes exhibit a phenotype of 
coreceptor dulling and PD-1 upregulation. The present study demonstrates that MHCII+ 
BM-APCs are required for wave 1 negative selection (mechanism 1). Within 
mechanism 1 in wave 1, it is possible that some self-antigens are handed over from 
cTECs to MHCII+ BM-APCs (mechanism 3?), or self-antigens are derived from the 
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bloodstream. Other antigen-presenting mechanisms that may contribute to wave 1 
include direct presentation by cTECs (mechanism 4) and B2m-dependent presentation 
by thymocytes or other BM-APCs (mechanism 5). A substantial proportion of wave 1 
thymocytes are thought to be MHC class cross-reactive. Most of the wave 1 
thymocytes undergo clonal deletion (apoptosis), in which MHCII-responsive 
thymocytes may die quicker than MHCI-responsive thymocytes, but some wave 1 cells 
that survived a strong TCR signal in the thymic cortex differentiate into CD4–CD8β– 
iIEL thymic precursors, which predominantly recognise B2m-dependent ligands. Wave 
2 negative selection occurs 4-8 days after thymocyte proliferation, and presumably 
occurs in the thymic medulla. This study shows that tissue-specific antigens can either 
require handover from TECs to MHCII+ BM-APCs to induce negative selection 
(mechanism 2). Although speculative, if migratory DCs that acquire self-antigens 
derived from mTECs (Koble and Kyewski, 2009) transport them into the cortex, this 
may provide an explanation for how Aire, which is expressed within mTECs (Heino et 
al., 1999), contributes to wave 1 in the cortex (mechanism 2?). Tissue-specific antigens 
expressed within mTECs may also be directly presented to thymocytes by mTECs 
(mechanism 6). Strong TCR signalling drives concurrent pro-apoptotic and pro-survival 
signals in wave 2 thymocytes, resulting in medullary clonal deletion and FoxP3+ T-reg 
cell differentiation, respectively. Pre-selection thymocytes that receive a weak TCR 
signal in the cortex and in the medulla are allowed to mature into Helios– CCR7+ naïve 
T cells that emigrate to the periphery, a process termed "positive selection" in this 
thesis. H, Helios; C, CCR7; Tn, naïve T cells; W1, wave 1 negatively selected 
thymocytes; W2, wave 2 negatively selected thymocytes; iIEL, intestine intraepithelial 
lymphocyte; FoxP3+, T-regulatory cells. 
  
	 234 
However, the CD4loCD8lo PD-1hi iIEL thymic precursors in apoptosis-intact mice appear 
to commonly express TCRs that bind to B2m-dependent ligands (Fig. 6.1). Since TCR 
cross-reactivity could contribute to autoimmunity, in part due to the structural similarity 
between foreign and self-peptides (Li et al., 2005), wave 1 may be important in 
eliminating the cross-reactive TCRs via clonal deletion (McDonald et al., 2015). Wave 
1 negative selection takes place before the distinct process of T-reg selection occurs in 
wave 2 (Fig. 6.1). If these cross-reactive cells are allowed to mature into T-reg cells 
that recognise multiple pMHC complexes, it may result in excessive immune 
suppression in the periphery. 
 
Wave 2 negative selection at the CCR7+ (or SP) stage presumably occurs in the thymic 
medulla (Kurd and Robey, 2016). The strongly TCR-signalled thymocytes either 
undergo wave 2 clonal deletion, accounting for a minority of negative selection (Daley 
et al., 2013; McDonald et al., 2015) or differentiate into thymic FoxP3+ T-reg cells 
(Cowan et al., 2013; Hu et al., 2016) (Fig. 6.1). Our group recently delineated two 
bottlenecks at which wave 2 cells either undergo deletion or progress to the next stage 
of T-reg differentiation: Card11 signalling regulates the first bottleneck and IL-2 
signalling regulates the second (Hu et al., 2017). Wave 2 cells are phenotypically 
distinct from wave 1 cells. Wave 2 cells induce Card11/NF-κβ gene activation that 
opposes Bim-mediated apoptosis (Daley et al., 2013). Wave 2 cells form 4-8 days after 
DN-DP proliferation versus 0-2 days for wave 1 cells (Hu et al., 2016). The thymus may 
have evolved to make T-reg selecting self-antigens accessible only to wave 2 
thymocytes, in part due the supportive medullary environment facilitating T-reg 
selection (discussed in section 6.3). This is consistent with recent evidence of the 
requirement for Aire in shaping the T-reg TCR repertoire (Malchow et al., 2016; Perry 
et al., 2014; Yang et al., 2015). This study provided preliminary evidence that Aire is 
required for normal induction of negative selection at wave 2, although confirmation of 
this point awaits analysis at 5 days after EdU injection instead of 3 days. 
 
Several groups have detected a clear overlap in the TCR repertoires of naïve CD4+ T 
cells and T-reg cells (Hsieh et al., 2004; Pacholczyk et al., 2006; Wong et al., 2007). 
How can this observation be reconciled with the hypothesis that strongly TCR-signalled 
wave 2 cells either undergo deletion or differentiate into T-reg cells? It is hypothesised 
that not all medullary self-antigens are scanned by each medullary thymocyte. 
Consequently, a self-reactive thymocyte can emerge from the thymus “ignorant” of the 
self-antigen to which it binds. It was recently shown that the probability of a self-
reactive T cell becoming an “ignorant” naïve T cell increases as the number of thymic 
APCs that express the self-antigen decreases (Malhotra et al., 2016). Thus, the 
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observation that overlap exists between naïve CD4 and T-reg TCR repertoires can be 
explained by the concept of “ignorance”.  
 
It is also important to consider the TCR repertoire of thymocytes that are deleted at 
wave 2. The TCR repertoire of thymocytes that are deleted at wave 2 has yet to be 
examined directly. However, preliminary evidence that Aire-deficiency diminishes wave 
2 (this thesis) suggests that TCRs that are normally deleted at wave 2 may enter the 
naïve CD4+ repertoire in Aire–/– mice. The TCR repertoire of CD4+ Foxp3– T cells in the 
prostate of Aire–/– mice overlapped substantially with the T-reg TCR repertoire in Aire+/+ 
mice (Malchow et al., 2016). A smaller number of TCRs expressed by CD4+ Foxp3– T 
cells in the prostate of Aire–/– mice were never found in Aire+/+ mice. These latter TCRs 
may correspond to TCRs that are deleted at wave 2 in wild-type mice (Malchow et al., 
2016). Taken together, the available data suggest that a defect in wave 2 caused by 
Aire-deficiency alters the peripheral TCR repertoire mainly by allowing T-reg TCRs, 
and not “deletable” TCRs, into the CD4+ Foxp3– pool. To explain this, we hypothesise 
that wave 2 deletes TCRs with an affinity for self-antigen that is too low for T-reg 
selection (Daley et al., 2017; Hu et al., 2017). TCRs that are normally deleted at wave 
2 may have an affinity for self-antigen that is too weak for the T cell to be activated in 
the periphery, explaining why they are uncompetitive at infiltrating the prostate. On the 
other hand, TCRs that normally drive T-reg selection have very high affinity for self-
antigen and are highly competitive at infiltrating the prostate.  
 
This study applied two analytical approaches to quantify wave 1 negative selection at 
the immature CCR7– stage: (1) The Helios+ CCR7– approach devised by our group and 
(2) the CD4loCD8lo PD-1hi iIEL thymic precursor approach (Mayans et al., 2014; 
McDonald et al., 2015; McDonald et al., 2014; Pobezinsky et al., 2012). Second 
approach was applied to check whether the conclusions based on analysis of 
Helios/CCR7 were supported. 
 
In addition, this study used the TCRβ+ CD5+ approach to quantify all TCR-signalled 
thymocytes, EdU to label the newly proliferating thymocytes, and TCR/antigen 
transgenic model systems, all dependent on flow cytometry and/or TCR sequencing 
methods, to investigate the contributions of thymic APCs and MHC molecules to thymic 
negative selection, particularly at the immature stage. 
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6.2 Comparisons of two approaches to analyse wave 1 negative selection  
 
The Helios+ CCR7– wave 1 approach characterises thymocytes that have received 
strong TCR signalling at an early CCR7– maturation stage (Daley et al., 2013; Hu et al., 
2016). Unlike the of the TCRb/CD5 gating approach which was straightforward 
because B2m–/– and Tcra–/– mice were available as gating controls, the cutoff for Helios 
staining in the Helios+ CCR7– gate was more subjective, but was always placed above 
the outer edge of the main CCR7– population detected in apoptosis-sufficient mice. 
Similarly, the cutoff for Helios staining in the Helios+ CCR7+ gate was placed just above 
the outer edge of the main CCR7– population from apoptosis-sufficient mice. Helios+ 
CCR7– thymocytes exhibit the phenotype of coreceptor dulling (CD4loCD8lo) and PD-1 
upregulation in superantigen reactive thymocytes and in apoptosis-defective mice 
(Daley et al., 2013; Hu et al., 2016), similar to the phenotype of TCRβhi CD4loCD8lo PD-
1hi iIEL thymic precursors in the second approach to analyse wave 1 negative 
selection. This phenotype of coreceptor-dulling is similar that of DP thymocytes 
undergoing negative selection in vitro (Page et al., 1993; Swat et al., 1991; Vasquez et 
al., 1992) or in vivo (McCaughtry et al., 2008; Pobezinsky et al., 2012).  
The CD4loCD8lo PD-1hi iIEL thymic precursors have also received strong TCR signalling 
as evident by the upregulation of Nur77, Bim, Helios and increased active caspase 3 
(McDonald et al., 2015; McDonald et al., 2014; Pobezinsky et al., 2012). TCRs that 
induce CD4loCD8lo PD-1hi thymocytes also commonly facilitate clonal deletion at the 
CCR7– stage (McDonald et al., 2015).  
 
In this study, the Helios+ CCR7– approach analyses nascent thymocyte cohorts, 
whereas the CD4loCD8lo PD-1hi approach analyses thymocytes in steady state. This 
present study reveals that the formation of both the TCRβ+ CD5+ Helios+ CCR7– 
thymocytes (in normal and apoptosis-defective mice), and the CD4loCD8lo PD-1hi iIEL 
thymic precursors (in apoptosis-defective mice) requires MHC molecules. This is 
consistent with the drastic impairment of Helios+ CCR7– and CD4loCD8lo PD-1hi CD69+ 
thymocyte populations in the absence of both MHC classes (Hu et al., 2016; McDonald 
et al., 2015).  
 
The potential differences between the two wave 1 approaches is that the Helios+ 
CCR7– approach contains strongly TCR-signalled DP cells that are deleted quickly 
before acquiring the CD4loCD8lo phenotype and thus encompassing DP and 
CD4loCD8lo thymocytes undergoing negative selection. In the CD4loCD8lo PD-1hi iIEL 
thymic precursor approach, only CD4loCD8lo thymocytes, constituting a portion of true 
Helios+ CCR7– wave 1 cells, that survived longer are captured, but not the DP cells that 
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undergo apoptosis quickly. In short, the CD4loCD8lo PD-1hi iIEL thymic precursors 
probably represent a more mature subset of wave 1 cells that survived the initial period 
of strong TCR signalling. This difference could provide an explanation as to why 
CD4loCD8lo PD-1hi thymic iIEL precursors are not decreased in the absence of MHCI, 
but Helios+ CCR7– cells are decreased. This difference could also explain why TCRα 
chain sequencing results fail to provide evidence of MHC class cross-reactive TCRs 
within wave 1 cells (CD4loCD8lo PD-1hi CCR7–) sorted in apoptosis-intact mice with a 
fixed TCRβ chain (Chapter 5). Future TCRα sequencing experiments in apoptosis-
defective mice with a fixed TCRβ chains across all four MHC genotypes (i.e. MHC 
single- or double-deficient mice and wild-type mice) could be performed to re-examine 
whether MHC class cross-reactive TCRs are enriched within wave 1 cells. The use of 
apoptosis-defective mice will also allow parallel comparisons of data between the 
quantitative and sequencing approaches in examining the contributions of MHC 
molecules to thymic selection.  
 
 
6.3 Requirement for MHCII+ BM-APCs in inducing wave 1 negative selection  
 
The role of thymic APCs (i.e. DCs, MHCII+ BM-APCs, Aire, mTECs) in clonal deletion 
has been inferred by an increase of CD4SP frequency, or number, in mice with 
defective APCs (Hinterberger et al., 2010; Liston et al., 2004a; Liston et al., 2008; 
Malhotra et al., 2016; Ohnmacht et al., 2009; van Meerwijk et al., 1997). The limitations 
of this approach are the inability to provide direct estimation of strongly TCR-signalled 
thymocytes undergoing negative selection, and the lack of information about the stage 
at which clonal deletion occurs. By contrast, the Helios/CCR7 approach provides not 
only direct quantification of strongly and weakly TCR-signalled thymocytes, but also 
quantifies negative selection at immature CCR7– and mature CCR7+ developmental 
stages. 
 
Studies in a monoclonal thymocyte repertoire 
 
This study provides evidence that MHCII+ BM-APCs are required to mediate strongly 
TCR-signalled Helios+ CCR7– wave 1 negative selection in monoclonal and polyclonal 
thymocyte repertoires. In the insHEL x 3A9 and thyroHEL x 3A9 transgenic models, the 
HEL self-antigens are not derived from the BM-APCs, but rely on an antigen handover 
mechanism to induce negative selection (Fig. 6.1). Introducing a defect in BM-APCs 
changes thymocyte fate, by abolishing clonal deletion altogether in insHEL, or by 
shifting clonal deletion from the CCR7– to the CCR7+ stage in thyroHEL. These findings 
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highlight the crucial role of MHCII+ BM-APCs in mediating stringent wave 1 negative 
selection. 
 
The role of an antigen handover mechanism in mediating negative selection has 
recently been appreciated, although this study did not define the stage at which antigen 
handover leads to clonal deletion (Perry et al., 2014). It remains unclear why self-
antigens that are expressed by mTECs are required to be presented by BM-APCs, but 
Klein et al. (2014) proposed that antigen handover mechanisms to adjacent BM-APCs 
may increase the antigen presentation area in a mosaic fashion, in which antigen 
presentation by mTECs alone could not perform. Alternatively, this present study 
hypotheses that antigen handover mechanism may serve as a back-up mechanism to 
induce central tolerance if antigen expressing-mTECs are defective in antigen 
presentation. This speculation is based on the case of thyroHEL in which central 
tolerance can be established by the antigen expressing-mTECs, although tolerance 
appears more robust when the antigen handover mechanism is functional. 
 
Defective antigen handover can change the strength of TCR signalling, the maturation 
stage at which thymocytes encounter self-antigens and the fate of thymocytes. 
Defective antigen handover abrogates negative selection altogether in insHEL, causing 
the strongly TCR-signalled thymocytes to be weakly TCR-signalled and positively 
selected into Helios– CCR7+ or CD4SP naïve T cells. Defective antigen handover shifts 
negative selection from wave 1 CCR7– stage towards wave 2 CCR7+ stage in 
thyroHEL, whereby thymocytes are able to mature into CCR7+ thymocytes and 
upregulate OX40, a hallmark of wave 2 negative selection (Daley et al., 2013). This is 
accompanied by an increase in FoxP3+ T-reg differentiation in the thyroHEL, instead of 
being deleted at wave 1. 
 
The change of thymocyte fate from wave 1 negative selection to wave 2 FoxP3+ T-reg 
differentiation in thyroHEL when antigen handover mechanism is defective is 
consistent with evidence that T-reg selection occurs at wave 2 (Hu et al., 2016). 
FoxP3+ T-regs were known to express high levels of Helios (Thornton et al., 2010). The 
thymic medulla is necessary to support FoxP3+ CD25+ CCR7+ T-reg differentiation 
(Cowan et al., 2015; Hsieh et al., 2012). The facilitation of T-reg selection in medullary 
wave 2 negative selection may be due to the importance of NF-κB transcription factor 
(RELB) in supporting mTEC differentiation as the absence of RELB impairs thymic T-
reg selection (Cowan et al., 2013). The RELB-mediating mTEC differentiation allows 
the mTECs to express and present diverse TSAs that are dependent on Aire or Fezf2 
(Takaba et al., 2015), providing a diverse array of self-antigens to induce T-reg 
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differentiation at the CCR7+ stage.  
 
The partial impairment of clonal deletion accompanied by an increase in T-reg 
differentiation in thyroHEL has been observed in an Ins2eGFP model (Malhotra et al., 
2016). The authors associate low thymic expression of self-antigens with partial clonal 
deletion and enhanced T-reg differentiation as a mechanism to establish polyclonal 
CD4+ T central tolerance (Malhotra et al., 2016). This study provides the new insight 
that partial impairment of clonal deletion accompanied by enhancement of T-reg 
differentiation could also be attributed to the maturation stages in which thymocytes 
encounter self-antigens. These observations also highlight how the immune system 
evolved to maintain central tolerance by enhancing the T-reg selection when clonal 
deletion is incomplete. 
 
The 3A9 transgenic/HEL system shows that the antigen handover mechanism for 
antigen presentation is effective at inducing central tolerance in a large number of 
thymocytes. The mechanism may be even more efficient in a physiological setting with 
natural thymocyte and self-antigen repertoires. In the thymus, lowering the number of 
TCR3A9 thymocytes increases Helios induction in the remaining TCR3A9 thymocytes by 
the insHEL antigen (Daley et al., 2013). This suggests that the antigen handover 
mechanism is partially overwhelmed by the high number of self-reactive thymocytes in 
the 3A9 transgenic/HEL system. Thus, the antigen handover mechanism could be 
even more effective at inducing central tolerance in physiological settings. 
 
Studies in the polyclonal thymocyte repertoire 
 
MHCII-deficiency within BM-APCs leads to ~42% reduction in negative selection at 
wave 1, based on Helios+ CCR7– approach, analysed on a synchronised cohort of 
nascent thymocytes. DCs play a role in cortical clonal deletion as thymocytes are 
arrested and signalled adjacent to DCs in situ even when the antigen is also available 
to cTECs (Melichar et al., 2013). A more efficient endocytic pathway in DCs compared 
to cTECs might explain this difference. cTECs are five times less efficient than DCs at 
presenting peptide to T hybridoma cells, and are >100 times less efficient than DCs at 
processing a protein into peptide and presenting it to T hybridomas (Klein et al., 2001). 
Immunofluoresent microscopy observations show that apoptotic HYcd4 DP thymocytes 
tend to be associated with DCs in the thymic cortex despite the cTECs also expressing 
the relevant self-antigen (McCaughtry et al., 2008). The frequency of apoptotic DP 
thymocytes was reduced when CD11c+ DCs were absent (McCaughtry et al., 2008). It 
is interesting that DCs play an essential role in wave 1 negative selection, considering 
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the low abundance DCs (or BM-derived cells) within the thymic cortex (Barclay and 
Mayrhofer, 1981; Le Borgne et al., 2009; McCaughtry et al., 2008) compared to the 
thymic medulla. It is noteworthy that ~50% of wave 1 cells does not require the well-
described negative selecting APC types, MHCII+ BM-APCs or Aire. cTECs may directly 
present self-antigen to mediate wave 1 deletion (Fig. 6.1) as K14-driven HYp 
expression (only expressed in cTECs) was sufficient to induce coreceptor dulling and 
PD-1 expression, hallmarks of wave 1 negative selection, in HYcd4 thymocytes 
(McCaughtry et al., 2008). Therefore, the data suggest that the traditional view that 
cTECs are ineffective at inducing negative selection should perhaps be revisited. 
Furthermore, two photon imaging on thymic slice revealed that direct presentation of 
self-antigen OVA by OT-I Tg thymocytes to OT-I Tg DP thymocytes in the thymc cortex 
resulted in strong TCR signaling (increased and persistant Ca2+ signaling) (Melichar et 
al., 2015). This indicates that B2m-dependent direct presentation by thymocytes 
themselves to other thymocytes could induce negative selection at DP stage (Fig. 6.1) 
(Melichar et al., 2015).  
 
Apoptosis-defective mice (i.e. Bcl-2 Tg or Bim–/–) are useful in enumerating the strongly 
TCR-signalled negatively selected thymocytes. Defective apoptosis prolongs the 
survival of strongly TCR-signalled cells that would otherwise have been phagocytosed 
rapidly by macrophages (Dzhagalov et al., 2013) or died. Nevertheless, one potential 
limitation of using apoptosis defective mice is that the presence of undeleted 
thymocytes could interfere with the access of newly formed thymocytes to the APC 
network. Due to increased competition from “undeleted” thymocytes, assays that use 
apoptosis-defective mice might underestimate the true scale of negative selection (and 
positive selection). 
 
 
6.4 Preliminary evidence: Requirement for Aire in wave 2 negative selection  
 
This present study reveals that Aire plays a role in wave 2 (Helios+ CCR7+) negative 
selection as evident by the ~50% reduction in wave 2 polyclonal thymocytes in the 
absence of Aire. This is consistent with the requirement for Aire in mediating the 
negative selection (clonal deletion) of self-reactive CD4SP monoclonal thymocytes in 
RIP-mOVA and insHEL models (Anderson et al., 2005; Liston et al., 2003). Aire is 
important in ectopic expression of TSAs in mTECs (Anderson et al., 2002), which 
suggests that the Aire+ mTECs, serving as a thymic APC, have a role in mediating 
wave 2 negative selection. However, a previous study based on the deletion of Aire-
dependent IRBP-specific CD4SP polyclonal thymocytes suggests that Aire-dependent 
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deletion not only relies on the role of Aire in TSA expression in the mTECs, but also 
requires antigen handover to BM-APCs to induce negative selection (Taniguchi et al., 
2012). Similarly, another study shows that although that Aire is not required for 
transcription of RIP-OVAhi in mTECs, Aire is required for RIP-OVAhi-dependent deletion 
of OT-II CD4SP thymocytes (Hubert et al., 2011). The authors concluded that Aire is 
required to regulate the transfer of self-antigen from mTECs to DCs to induce central 
tolerance. 
 
Several other functions of Aire in the thymic medulla, in addition to its promotion of 
TSA expression in mTECs, are reviewed (Anderson and Su, 2016). For instance, Aire 
may regulate T cell negative selection by a TSA-independent mechanism since the 
transcript levels of membrane-bound OVA neo-self-antigen are barely affected in the 
absence of Aire, although deletion of OT-II thymocytes is Aire-dependent (Anderson et 
al., 2005). Aire may also enhance self-tolerance by promoting apoptosis of mTECs as 
Aire-deficiency results in an increase in MHCIIhi mTEC number, potentially promoting 
cross presentation and phagocytosis of the TSAs by thymic APCs (Gray et al., 2007). 
Aire has a role in proper localisation or migration of BM-APCs in the thymic medulla 
(Lei et al., 2011). Aire has been reported to maintain thymic organisation and mTEC 
morphology as Aire-deficiency alters the complexity of cell shape in mTECs and their 
distribution (Yano et al., 2008), and has role in late-stage of mTEC differentiation 
(Wang et al., 2012).  
 
Aire also has a role in regulating non-mTECs. Aire-expressing thymic B cells are 
reported to have an immunoregulatory function in promoting central tolerance (Yamano 
et al., 2015). This present study did not measure FoxP3+ Helios+ CCR7+ thymic T-regs 
in the absence of Aire, as the day 3 post-EdU time point may have been early to detect 
wave 2 T-reg thymocytes. But, it is possible that Aire plays a role in promoting thymic 
T-reg differentiation. This is because Aire-deficiency decreases the number of CD4+ T-
reg cells in neonatal mice (Yang et al., 2015) and decreases the Aire-dependent 
prostate-antigen specific thymic T-regs in adult mice (Malchow et al., 2013). Also, low 
abundance T-reg clones are reported to be more Aire-dependent than the high 
abundance T-reg clones (Perry et al., 2014). Recently, Aire has been suggested to 
prevent autoimmunity by directing self-reactive cells into the T-reg cell lineage, as the 
conventional T cell TCR clonotypes infiltrating target lesions in the periphery of Aire–/– 
mice are found to be the same TCR clonotypes expressed in FoxP3+ T-reg cells in 
Aire+/+ mice (Malchow et al., 2016). All these functions of Aire may explain its role in 
wave 2 negative selection.  
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6.5 Contributions of MHC molecules to T cell signalling provide preliminary 
support for the interclonal competition hypothesis 
 
After discussing the cellular interaction between thymic APCs and thymocytes, this 
section emphasises the contribution of MHC molecules to thymic selection. The EdU+ 
TCRβ+CD5+ analytical approach was used to quantify all TCR-signalled cells (strong or 
weak) in nascent thymocyte cohorts. TCRβ+CD5+ thymocyte formation relies on MHC-
dependent mechanisms. In apoptosis-defective mice, MHCI induces TCR signalling in 
a similar fraction of thymocytes as MHCII. However, both wave 1 analytical 
approaches: (1) Helios+ CCR7– and (2) CD4loCD8lo PD-1hi iIEL thymic precursors, find 
that induction of strongly TCR-signalled thymocytes at the CCR7– stage is more 
dependent on MHCII than MHCI, in apoptosis-defective mice.  
 
A previous study proposed the existence of intraclonal competition for peptide-MHC 
complexes to explain the correlation between the low clonal frequency and high 
efficiency of thymic T-reg selection in mice (Bautista et al., 2009). This present study 
provides a new but preliminary concept regarding interclonal competition between 
MHCI-responsive and MHCII-responsive thymocytes, to explain why the combined 
fractions of TCR-signalled cells induced by MHCI (in MHCII-deficient mice) and by 
MHCII (in MHCI-deficient mice) are not equal to, but 35% greater than the fraction of 
TCR-signalled cells induced in wild-type mice. This unequal sum of TCR-signalled 
thymocytes induced by MHCI and by MHCII is similar to Sinclair et al.’s (2013) 
observation in TetZap70 mice. The evidence for interclonal competition stems from the 
enrichment of certain TRAV segments in single MHC-deficient mice in comparison to 
wild-type mice. For instance, MHCI-responsive thymocytes may have less competition 
for MHCI molecules on APCs in MHCII-deficient mice, compared to the higher 
competition between MHCI-responsive and MHCII-responsive thymocytes for MHCI 
molecules on APCs in wild-type mice. Future experiment could be performed to verify 
this finding by transferring carboxyfluorescein succinimidyl ester (CFSE)-labelled 
MHCI-restricted OT-I Tg (CD45.1) and cell trace violet (CTV)-labelled MHCII-restricted 
OT-II Tg thymocytes (CD45.1), via intrathymic injection, into mice (CD45.2) with either 
both MHC classes or with a single MHC class. Positive selection of CFSE+ OT-I Tg T 
cells in the presence of both MHC classes could be compared to positive selection of 
CFSE+ OT-I Tg T cells in the absence of a single MHC class (MHCII-deficient mice). 
Similarly, positive selection of CTV+ OT-II Tg T cells in the presence of both MHC 
classes could be compared to positive selection of CTV+ OT-II Tg T cells in the 
absence of a single MHC class (MHCI-deficient). If the hypothesis is correct, more 
CFSE+ OT-I or CTV+ OT-II Tg thymocytes will be found to undergo positive selection in 
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MHCII-deficient mice and MHCI-deficient mice, respectively, compared to wild-type 
mice. 
 
 
6.6 The CD4loCD8lo PD-1hi CCR7– TCR repertoire appears to be enriched in 
TCRs that recognise B2m-dependent ligands  
 
In the periphery, there is a requirement for B2m-dependent classical Kb or Db 
(polymorphic) and/or non-classical (non-polymorphic) MHCI molecules in iIEL 
development (Das et al., 2000; Fujiura et al., 1996; Gapin et al., 1999; Leishman et al., 
2002; Mayans et al., 2014; Park et al., 1999; Pobezinsky et al., 2012). A recent study 
revealed IEL TCRs can recognise classical MHCI or as yet uncharacterised B2m-
dependent ligand(s) (Mayans et al., 2014). Some iIEL-inducing ligands are TAP-
independent, indicating that iIELs recognise antigens that are distinct from the MHCI-
restricted conventional CD8+ T cells (Fujiura et al., 1996; Mayans et al., 2014; Park et 
al., 1999). 
 
In the thymus, this present study demonstrates that the development of CD4loCD8lo 
PD-1hi iIEL thymic precursors in apoptosis-defective mice is MHC-dependent. 
Substantial CD4loCD8lo PD-1hi iIEL populations were detectable in apoptosis-defective 
mice lacking one MHC class, indicating that either MHCI or MHCII is sufficient for the 
induction of these cells. The BM chimera experiments reported above demonstrate a 
role for MHCII+ BM-APCs in inducing CD4loCD8lo PD-1hi iiEL thymic precursors in 
apoptosis-defective mice with or without B2m expression in the thymic epithelium. 
Although apoptosis defects “artificially” expand the CD4loCD8lo PD-1hi population, this 
enables the capacity of the APC network to induce these cells to be measured. The 
data show that MHCII expression on BM-APCs is required for the normal induction of 
CD4loCD8lo PD-1hi iIEL thymic precursors. 
 
Despite the ability of CD4loCD8lo PD-1hi iIEL thymic precursors to recognise B2m- 
and/or MHCII-dependent ligands, this present study provides new insight that 
CD4loCD8lo PD-1hi CCR7– iIEL thymic precursors are enriched for B2m-dependent 
ligands in apoptosis-intact mice (Fig. 6.1). This is evident by the higher TCR 
overlapping between wild-type mice and H2-Aa–/– (TCR signalling induced by MHCI) 
than the TCR overlapping between the wild-type and B2m–/– (TCR signalling induced 
by MHCII) in the CD4loCD8lo PD-1hi CCR7– wave 1 subset. It is hypothesised that, 
within wave 1, MHCII-responsive thymocytes die faster than MHCI-responsive 
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thymocytes. This can explain why the wave 1 cells that were sorted and sequenced 
more commonly expressed MHCI-responsive TCRs. 
 
Since Bcl-2 Tg expression enables more MHCII-responsive CD4loCD8lo PD-1hi CCR7– 
thymocytes to survive long enough to downregulate both coreceptors, the hypothesis 
that MHCII-responsive iIEL thymic precursors are short-lived could be tested by 
comparing the sorted CD4loCD8lo PD-1hi CCR7– thymocytes in Bcl-2 Tg B2m–/– mice 
and Bcl-2 Tg wild-type mice. If this hypothesis is correct, a higher TCR overlapping 
between these two groups of mice within CD4loCD8lo PD-1hi CCR7– thymocytes would 
be expected in comparison to non-Tg B2m–/– mice and non-Tg wild-type mice. 
 
 
6.7 The distinctions between MHC-independent and MHC-dependent αβTCR 
repertoires 
 
At the TCR clonal level in Yae62β transgenic mice, this present study has shed light on 
the distinctive characteristics of MHC-independent αβTCRs (derived from mice 
deficient in both MHC classes) versus MHC-dependent αβTCRs (derived from mice 
with single or both MHC classes) (Table 6.1). First, the thymic MHC-independent 
CD4SP and CD8SP TCR repertoires are indistinguishable from each other, as 
opposed to the highly distinguishable thymic MHC-dependent CD4SP and CD8SP 
TCR repertoires. This finding supports the theory that coreceptor-independent 
signalling promotes MHC-independent TCRs, whereas coreceptor-dependent 
signalling promotes MHC-dependent TCRs (Tikhonova et al., 2012; Van Laethem et 
al., 2007; Van Laethem et al., 2013). Second, MHC-independent TCRs have a 
distinctive TRAJ segment usage profile. Third, MHC-independent TCRs are enriched 
with high hydrophobic amino acids in the CDR3α J subregion, revealing the role of 
CDR3α, mainly encoded by the J segment, in the development of MHC-independent 
TCRs.  
 
Among MHC-dependent TCRs, this study shows that the usage of TRAV segments, 
encoding the CDR1 and CDR2 of TCRα chains, is biased according to the MHC 
genotypes and cell types (Table 6.1). This suggests that CDR1α and CDR2α impose 
biases in MHC restriction (MHCI- or MHCII-restriction) and the selection fate of 
thymocytes (positive or negative selection). These findings support the theory that 
MHC restriction is imposed by the conserved interaction between the germline-
encoded TCR sequences (CDR1 and CDR2 loops) and MHC, thereby eliminating 
TCRs that are unable to recognise MHC (Feng et al., 2007; Garcia, 2012; Garcia et al., 
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2009; Marrack et al., 2008; Scott-Browne et al., 2009). In short, this study supports 
both MHC restriction theories: (1) the coreceptor-dependent signalling theory and (2) 
the germline-encoded TCR sequences theory. 
 
 
 
Table 6.1 Characteristics of MHC-independent TCR repertoire versus MHC-
dependent TCR repertoire 
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6.8 Remarks on EdU+ Helios/CCR7 approach  
 
This study shows that the EdU+ Helios/CCR7 approach appears to be a more sensitive 
approach in detecting thymocytes undergoing wave 1 CCR7– negative selection than 
the CD4loCD8lo PD-1hi approach. This is evident by a slight defect (~20%) in wave 1 
Helios+ CCR7– cells could be detected in Aire-deficiency but no impairment is observed 
by using a CD4loCD8lo PD-1hi approach. Similarly, MHCI-deficiency significantly 
reduces wave 1 Helios+ CCR7– thymocytes but it does not reduce CD4loCD8lo PD-1hi 
thymocytes. However, this discrepancy could also be due to the fact that the former 
approach analyses nascent thymocyte cohorts, whereas the latter approach analyses 
thymocytes in steady state. Ideally, nascent thymocyte cohorts should be analysed 
with both approaches for an objective comparison of sensitivity in detecting negatively 
selected thymocytes at the CCR7– stage. Importantly, the two approaches generally 
produce consistent conclusions. For instance, both clearly demonstrate that MHCII+ 
BM-APCs are required to induce CCR7– wave 1 negative selection. 
 
The potential caveat of analysing EdU+ Helios/CCR7 thymocytes on day 3 post-EdU 
injection is that this time point may not be optimal in detecting wave 2 Helios+ CCR7+ 
thymocytes, which peak at day 5, but are detectable between day 4 and day 8 (Hu et 
al., 2016). However, wave 2 cells could be detected as early as day 3, and a few BrdU+ 
thymocytes were found in the thymic medulla 3 days post injection (Penit, 1986). The 
fact that Aire deficiency significantly impaired wave 2 thymocytes strongly suggests 
that wave 2 cells are detectable 3 days post-EdU injection, although it may not be 
sensitive enough to detect wave 2 cells that are subtly affected due to defective thymic 
APCs or deficiencies in single MHC class in mice. On the other hand, the inability to 
detect the impairment of wave 2 cells either by depriving MHCII+ BM-APCs or single 
MHC class, may not exclude the qualitative thymocyte repertoire changes in wave 2 
thymocytes. This is because wave 2 thymocytes might be confounded by wave 1 
escapees that fail to undergo wave 1 negative selection, upregulate CCR7, and enter 
wave 2 negative selection. This explanation is evident by the finding in thyroHEL in 
which MHCII-deficiency within BM-APCs could delay negative selection from wave 1 to 
wave 2. To overcome this potential caveat, mice could be analysed at day 5 post-EdU 
injection to confirm the role of MHCII+ BM-APCs, MHCI or MHCII in inducing wave 2 
negative selection.  
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6.9 Concluding remarks 
 
This study provides new insights into thymic negative selection mechanisms, especially 
on the roles of thymic APCs and MHC molecules in mediating thymic negative 
selection. MHCII+ BM-APCs are required to induce ~42% wave 1 CCR7– negative 
selection. Ablation of MHCII+ BM-APCs either abrogated negative selection completely 
or delayed negative selection from wave 1 to wave 2. Preliminary evidence suggests 
that Aire induces wave 2 CCR7+ negative selection, suggesting that different APC 
types are required for thymic negative selection at distinct developmental stages. MHCI 
induces a similar fraction of TCR-signalled thymocytes as MHCII, but MHCII induces 
more negative selection, at least as measured by Helios expression. The enrichment of 
TRAV usage associated with MHC genotypes and cell types provides evidence 
supporting the interclonal competition hypothesis between MHCI-responsive and 
MHCII-responsive thymocytes to access limited APCs. TRAV segment usage, 
encoding CDR1 and CDR2, is sufficient to impose bias in CD4/CD8 lineage 
commitment and in thymic (positive or negative) selection fate. The CD4loCD8lo PD-1hi 
CCR7– wave 1 cells, constituting the iIEL thymic precursors, are enriched for B2m-
dependent ligands in apoptosis-intact mice. The negatively selected CD4loCD8lo PD-1hi 
CCR7– wave 1 cells are enriched with hydrophobic amino acids in the CDR3α J 
subregion. Finally, MHC-independent TCRs are distinct from the MHC-dependent 
TCRs, in that the former have indistinguishable CD4SP and CD8SP TCR repertoires, 
use a distinct set of TRAJ segments and are enriched with hydrophobic amino acid 
residues in the CDR3α J subregion.  
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